<SEC-DOCUMENT>0001213900-25-052677.txt : 20250609
<SEC-HEADER>0001213900-25-052677.hdr.sgml : 20250609
<ACCEPTANCE-DATETIME>20250609170047
ACCESSION NUMBER:		0001213900-25-052677
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20250609
DATE AS OF CHANGE:		20250609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Capstone Holding Corp.
		CENTRAL INDEX KEY:			0000887151
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-LUMBER & OTHER CONSTRUCTION MATERIALS [5030]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				860585310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287745
		FILM NUMBER:		251034896

	BUSINESS ADDRESS:	
		STREET 1:		5141 W. 122ND STREET
		CITY:			ALSIP
		STATE:			IL
		ZIP:			60803
		BUSINESS PHONE:		7083710660

	MAIL ADDRESS:	
		STREET 1:		5141 W. 122ND STREET
		CITY:			ALSIP
		STATE:			IL
		ZIP:			60803

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Capstone Therapeutics Corp.
		DATE OF NAME CHANGE:	20100521

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHOLOGIC CORP
		DATE OF NAME CHANGE:	19940211
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>ea0245084-s1a1_capstone.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM S-1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>As&nbsp;filed&nbsp;with&nbsp;the&nbsp;Securities&nbsp;and&nbsp;Exchange&nbsp;Commission&nbsp;on&nbsp;June
9, 2025.</B> </P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"> <B>Registration No. 333-287745</B> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>AMENDMENT NO.1 TO</B> <B><BR>
FORM S-1<BR>
REGISTRATION STATEMENT<BR>
Under The Securities Act&nbsp;of&nbsp;1933</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>CAPSTONE HOLDING CORP.</U><BR>
<FONT STYLE="font-size: 10pt">(Exact name of Registrant as specified in its charter)</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-size: 10pt"><B>5090</B></FONT></TD>
    <TD STYLE="white-space: nowrap; width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><FONT STYLE="font-size: 10pt"><B>86-0585310</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(State or Other Jurisdiction of <BR>
Incorporation or Organization)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(Primary Standard Industrial <BR>
Classification Code Number)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>(I.R.S.&nbsp;Employer <BR>
Identification Number)</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5141 W. 122<SUP>nd</SUP> Street<BR>
Alsip, IL&nbsp;60803<BR>
<U>(708)&nbsp;371-0660<BR>
</U>(Address,&nbsp;including&nbsp;zip&nbsp;code,&nbsp;and&nbsp;telephone&nbsp;number,&nbsp;including&nbsp;area&nbsp;code,&nbsp;of&nbsp;Registrant&rsquo;s&nbsp;principal&nbsp;executive&nbsp;offices)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Matthew Lipman, Chief Executive Officer<BR>
Edward Schultz, Chief Financial Officer<BR>
Capstone Holding Corp.<BR>
5141 W. 122<SUP>nd</SUP> Street<BR>
Alsip, IL&nbsp;60803<BR>
<U>(708)&nbsp;371-0660<BR>
</U>(Name, address, including zip code, and telephone number&nbsp;including area code, of agent for service)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">With Copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Joseph M.&nbsp;Lucosky, Esq.<BR>
Lawrence Metelitsa, Esq.<BR>
Steven A. Lipstein, Esq.<BR>
Lucosky Brookman LLP<BR>
101 Wood Avenue South, 5</B><SUP>th</SUP> <B>Floor<BR>
Woodbridge, New Jersey 08830<BR>
Phone: (732)&nbsp;395-4400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Fax: (732) 395-4401</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approximate date of commencement of proposed
sale to the public:</B> As soon as practicable after the effective date of this Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act&nbsp;of&nbsp;1933, check the
following box.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register <B>additional</B>
securities for an offering pursuant to Rule&nbsp;462(b)&nbsp;under the Securities Act, please check the following box and list the Securities
Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule&nbsp;462(c)&nbsp;under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment filed
pursuant to Rule&nbsp;462(d)&nbsp;under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.
See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company,&rdquo;
and &ldquo;emerging growth company&rdquo; in Rule&nbsp;12b-2 of the Exchange&nbsp;Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-indent: 0pt; width: 25%"><FONT STYLE="font-size: 10pt">Large-Accelerated Filer</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt; width: 25%"><FONT STYLE="font-size: 10pt">Accelerated Filer</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt">Non-Accelerated Filer</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-size: 10pt">Smaller Reporting Company</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-size: 10pt">Emerging Growth Company</FONT></TD>
    <TD STYLE="padding: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section&nbsp;7(a)(2)(B)&nbsp;of the Securities Act.&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The registrant hereby amends this Registration
Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which
specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a)&nbsp;of the
Securities Act&nbsp;of&nbsp;1933, or until this Registration Statement shall become effective on such date as the Securities and Exchange
Commission, acting pursuant to Section&nbsp;8(a), may determine.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>The
information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement
filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting
an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="color: Red; vertical-align: top; font: bold 10pt Times New Roman, Times, Serif">
    <TD STYLE="color: Red; padding: 0pt; width: 32%; text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt"><B>PRELIMINARY
    PROSPECTUS</B></FONT> </TD>
    <TD STYLE="color: Red; padding: 0pt; white-space: nowrap; width: 2%; text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="color: Red; padding: 0pt; width: 32%; text-align: center; text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt"><B>SUBJECT
    TO COMPLETION</B></FONT> </TD>
    <TD STYLE="color: Red; padding: 0pt; white-space: nowrap; width: 2%; text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif"> &nbsp; </TD>
    <TD STYLE="color: Red; padding: 0pt; width: 32%; text-align: right; text-indent: 0pt; font: bold 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-size: 10pt"><B>DATED:
    JUNE 9, 2025</B></FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CAPSTONE HOLDING CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5,190,251 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus relates to the offer and resale from time to time by
the selling stockholder identified in this prospectus of up to an aggregate of 5,190,251 shares of common stock, par value $0.0005 per
share (the &ldquo;Common Stock&rdquo;), of Capstone Holding Corp., a Delaware corporation (the &ldquo;Company,&rdquo; &ldquo;we,&rdquo;
&ldquo;us,&rdquo; &ldquo;our&rdquo;), consisting of (i) 215,054 shares to be issued as Commitment Shares (as defined herein) and (ii)
4,975,197 to be issued as Equity Line Securities (as defined herein), issuable pursuant to the common stock purchase agreement, dated
May 14, 2025 (the &ldquo;Purchase Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our registration of the shares of Common Stock
covered by this prospectus does not mean that the selling stockholder will offer or sell any of the shares. The selling stockholder may
offer and sell or otherwise dispose of the shares of Common Stock described in this prospectus from time to time through public or private
transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. See &ldquo;Plan
of Distribution&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not selling any shares of Common Stock
offered by this prospectus and will not receive any of the proceeds from the sale by the selling stockholder of the shares of Common Stock
offered hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The selling stockholder will pay all underwriting
discounts and selling commissions, if any, in connection with the sale of the shares of Common Stock. We have agreed to pay certain expenses
in connection with this registration statement and to indemnify the selling stockholder and certain related persons against certain liabilities.
No underwriter or other person has been engaged to facilitate the sale of shares of Common Stock in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> The selling stockholder is an &ldquo;underwriter&rdquo;
within the meaning of Section 2(a)(11) of the Securities Act and any profits on the sales of shares of our Common Stock by the selling
stockholder and any discounts, commissions, or concessions received by the selling stockholder are deemed to be underwriting discounts
and commissions under the Securities Act. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares of our Common Stock are listed on the Nasdaq Capital Market
(&ldquo;Nasdaq&rdquo;) under the symbol &ldquo;CAPS&rdquo;. On May 30, 2025, the closing sale price of our Common Stock was $1.82 per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are a &ldquo;controlled company&rdquo; following
this offering as defined under the Nasdaq Stock Market Rules. We are a &ldquo;controlled company&rdquo; because entities individually
or jointly controlled by Matthew Lipman, our chief executive officer and a member of our board of directors, and Michael Toporek, the
chairman of our board of directors (Brookstone Partners Acquisition XIV, LLC (&ldquo;BPA XIV, LLC&rdquo;), BP Peptides LLC, and Nectarine
Management LLC) have the ability to control all matters requiring shareholder approval because these entities own over 50% of our Common
Stock and control over 50% of our voting stock (inclusive of the votes of the over 50% of the Series B Preferred Stock shares outstanding).
Although we are considered a &ldquo;controlled company&rdquo;, we do not intend to rely on the exemptions to corporate governance requirements
as a &ldquo;controlled company.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &ldquo;emerging growth company&rdquo;
and a &ldquo;smaller reporting company,&rdquo; as defined in Rule&nbsp;12b-2 of the Securities Exchange&nbsp;Act&nbsp;of&nbsp;1934, as
amended, and have elected to take advantage of certain scaled disclosure available to smaller reporting companies. This prospectus is
intended to comply with the requirements that apply to an issuer that is a smaller reporting company. See &ldquo;<I>Prospectus Summary</I>&nbsp;<I>&mdash;&nbsp;Implications
of Being an Emerging Growth Company and a Smaller Reporting Company</I>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our securities involves a
high degree of risk. See &ldquo;Risk Factors&rdquo; beginning on page 8 of this prospectus and under similar headings in the other
documents that are incorporated by reference into this prospectus for a discussion of information that should be considered in
connection with an investment in our securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should rely only on the information contained
in this prospectus, contained in the other documents that are incorporated by reference into this prospectus, or contained any prospectus
supplement or amendment hereto. We have not authorized anyone to provide you with different information.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of the securities offered hereby, or determined if this prospectus is
truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The date of this prospectus is __, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0pt; width: 90%; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; width: 1%; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; border-bottom: Black 1.5pt solid; width: 9%; text-align: center; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_001">Prospectus Summary</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_002">Risk Factors</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">8</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_003">Use of Proceeds</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">11</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_004">Cautionary Note Regarding Forward-Looking Statements</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">11</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_005">Determination of Offering Price</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">12</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><A HREF="#a_013">Dilution</A></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">13</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_006">The Tumim Stone Capital Equity Financing</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">14</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_007">Selling Stockholders</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">15</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_008">Plan of Distribution</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">16</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_009">Legal Matters</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">18</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_010">Experts</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">18</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_011">Incorporation of Certain Information by Reference</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">18</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding: 0pt; text-indent: 0pt"><FONT STYLE="font-size: 10pt"><A HREF="#a_012">Where You Can Find More Information</A></FONT></TD>
    <TD STYLE="padding: 0pt; white-space: nowrap; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; text-align: center; text-indent: 0pt">19</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You should rely only on information contained
in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. We have not, and the selling
stockholder has not, authorized anyone to provide you with additional information or information different from that contained in this
prospectus or in any free writing prospectus. Neither the delivery of this prospectus nor the sale of our securities means that the information
contained in this prospectus or any free writing prospectus is correct after the date of this prospectus or such free writing prospectus.
This prospectus is not an offer to sell or the solicitation of an offer to buy our securities under any circumstances in which the offer
or solicitation is unlawful or in any state or other jurisdiction where the offer is not permitted.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The information in this prospectus is accurate
only as of the date on the front cover of this prospectus and the information in any free writing prospectus that we may provide you in
connection with this offering is accurate only as of the date of that free writing prospectus. Our business, financial condition, results
of operations and prospects may have changed since those dates.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>No person is authorized in connection with
this prospectus to give any information or to make any representations about us, the securities offered hereby or any matter discussed
in this prospectus, other than the information and representations contained in this prospectus. If any other information or representation
is given or made, such information or representation may not be relied upon as having been authorized by us.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither we nor the selling stockholder have
done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that
purpose is required, other than the United&nbsp;States. You are required to inform yourself about, and to observe any restrictions relating
to, this offering and the distribution of this prospectus.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>PROSPECTUS SUMMARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This summary highlights selected information
appearing elsewhere in this prospectus. While this summary highlights what we consider to be important information about us, you should
carefully read this entire prospectus and the documents incorporated by reference in this prospectus before investing in our Common Stock,
especially the risks and other information we discuss under the heading &ldquo;Risk Factors&rdquo; and our consolidated financial statements
and related notes incorporated by reference herein. Our fiscal year end is December&nbsp;31, and our fiscal&nbsp;years ended December&nbsp;31,
2024 and 2023 are sometimes referred to herein as fiscal&nbsp;years 2024 and 2023, respectively. Some of the statements made in this
prospectus discuss future events and developments, including our future strategy and our ability to generate revenue, income and cash
flow. These forward-looking statements involve risks and uncertainties which could cause actual results to differ materially from those
contemplated in these forward-looking statements. See &ldquo;Cautionary Note&nbsp;Regarding Forward-Looking Statements&rdquo;. Unless
otherwise indicated or the context requires otherwise, the words &ldquo;Capstone,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo;,
the &ldquo;Company&rdquo; or &ldquo;our Company&rdquo; refer to Capstone Holding Corp., a Delaware corporation, and its subsidiaries.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capstone Holding Corp. is a building products
distribution network. The existing company is comprised of Instone, a leading distributor of thin veneer stone and related masonry products
in the United States, serving both residential and commercial construction markets. Founded over 30 years ago, we have grown to become
the largest wholesale distributor in the thin veneer masonry products industry. Our comprehensive product offering includes a wide range
of manufactured and natural stone products, supported by a strategically located distribution network designed to provide reliable and
efficient service to our diverse customer base.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are committed to being the preferred partner
for our customers by providing high-quality products, expert support, and exceptional service. Our success is driven by our deep industry
expertise, long-standing customer relationships, and a relentless focus on operational excellence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate History</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company was formed in 1987 as OrthoLogic Corp.
In 2005, the Company filed its restated certificate of incorporation (the &ldquo;Restated Certificate of Incorporation&rdquo;). In 2010,
the Company changed its name to Capstone Therapeutics Corp. On August 22, 2019, the Company filed a certificate of amendment to its Restated
Certificate of Incorporation effecting a 1 for 1,000 reverse stock split of the Common Stock of the Company, whereby each 1,000 shares
of Common Stock of the Company became 1 share of Common Stock. In 2021, the Company filed a certificate of amendment to its Restated Certificate
of Incorporation decreasing the total number of shares of Common Stock authorized to be issued by the Company from 150,000,000 shares
to 205,000 shares, consisting of 200,000 shares of Common Stock, par value $0.0005 per share and 5,000 shares of preferred stock, par
value $0.0005 per share. On February 18, 2022, the Company filed a certificate of amendment to its Restated Certificate of Incorporation,
changing the Company&rsquo;s name from Capstone Therapeutics Corp. to Capstone Holding Corp. On February 20, 2025, following the Company&rsquo;s
controlling shareholder&rsquo;s approval, the Company filed an amendment to its Restated Certificate of Incorporation with the Secretary
of State of the State of Delaware to increase the authorized shares of Common Stock to 50,000,000 shares and increase the authorized shares
of preferred stock to 25,000,000 shares. On February 20, 2025, the Company filed a Certificate of Designation (the &ldquo;Series B Certificate
of Designation&rdquo;) with the Delaware Secretary of State which designated 2 million shares of the Company&rsquo;s authorized preferred
stock as Series B Preferred Stock (&ldquo;Series B Preferred Stock&rdquo;), no par value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>
</DIV>
<!-- Field: Page; Sequence: 4; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Business Strategy and Operating Model</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Capstone</B>&nbsp;<B>Long-Term</B>&nbsp;<B>Growth
Strategy.&nbsp;</B>Our long-term growth strategy is built on the foundational strengths of our current operating subsidiary and the strategic
opportunities available in the building products distribution and manufacturing industry. Our strategy has the following characteristics:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Deep Team</B>.&nbsp;Capstone is controlled
by Brookstone Partners, a private equity group with 25 years of deep expertise in building products investment. Brookstone Partners is
controlled by Matthew Lipman, our chief executive officer and a member of our board of directors, and Michael Toporek, the chairman of
our board. The Capstone leadership team includes seasoned operating executives and building products acquisition and investment professionals.
Capstone&rsquo;s leadership team includes its Lead Independent Director, Charles &ldquo;Chuck&rdquo; Dana. Mr. Dana spent 19 years at
Owens Corning, a leading building materials company. At Owens Corning, Mr. Dana held various positions including Controller, President
Global Composites and then Group President Building Materials. In addition, from the Company&rsquo;s acquisition of Instone in April
2020 through December 31, 2024, Instone&rsquo;s revenues have increased from approximately $32.2 million to approximately $44.9 million.
In February 2008, a Brookstone Partners affiliate invested $8.8 million in Woodcrafter&rsquo;s Home Products Holdings LLC. Brookstone&rsquo;s
team worked with Woodcrafter&rsquo;s management to grow earnings and Brookstone completed the sale of all of its interests in Woodcrafter&rsquo;s
for $32 million in December 2013. The ability to identify, acquire and integrate acquisition candidates is a critical skill set to augment
the operating expertise that drives organic growth. The current operating company has successfully executed multiple acquisitions and
integrations, laying a solid foundation for continued expansion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Strategic Timing.&nbsp;</B>We believe
we are strategically positioned to capitalize on market conditions within the building products sector. Historically, acquiring companies
at interest rate peaks has yielded strong returns, and we are poised to leverage these strategic investment opportunities as the market
evolves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Industry Dynamics.</B>&nbsp;According
to the Bain &amp; Company Global M&amp;A Report published in 2024 (the &ldquo;Bain Report&rdquo;), this is &ldquo;just the type of environment
that has proved to offer opportunities to companies that are willing to make bold moves.&rdquo; The Bain Report goes on to say, &ldquo;building
products companies that make frequent and material acquisitions substantially outpace inactive companies in total shareholder returns,
9.6% vs 2.7%&rdquo; and &ldquo;the most successful companies will pursue scope M&amp;A to build product, geography, and capability adjacencies.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">The M&amp;A environment for the building
products sector is expected to improve because, according to the Bain Report, &ldquo;there are ample one-off opportunities to acquire
struggling assets&rdquo;, and &ldquo;financial investors have taken a step back, especially in North America, removing a potentially formidable
layer of competition.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><U>Scale.</U>&nbsp;For scale M&amp;A,
opportunities in core businesses allow for more operational synergies. The Bain Report states that &ldquo;allowing management to focus
on a more related group of products with some level of shared channels, end markets, or manufacturing processes helps focus efforts and
tells a clearer equity story.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><U>Scope.</U>&nbsp;Given macroeconomic
uncertainty, companies who leverage their parenting advantage, the ability to effectively manage and integrate acquisitions, will be the
most successful with regards to scope M&amp;A. The Bain Report states that &ldquo;the path to leadership generally means overlooking smaller
assets in favor of bigger players for a first move in a new space.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"></P>
</DIV>
<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">The &ldquo;Annual total shareholder returns
for building products companies&rdquo; chart and quotes from the Bain Report are used with permission from Bain &amp; Company. The Bain
Report was not commissioned by the Company. The Company does not currently and has not in the past had a direct or indirect business relationship
with Bain &amp; Company. The Bain Report is publicly available via the Insight - Featured Topics portion of Bain &amp; Company&rsquo;s
website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Strategic Positioning.</B>&nbsp;We
believe we are strategically well-positioned to take advantage of the current market opportunities because of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><U>Team strength.</U>&nbsp;The industry
experience of the Board and Instone management provides the Company with the expertise to evaluate, acquire, and integrate acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><U>Experience integrating acquisitions.</U>&nbsp;Since
2006, the Company has successfully integrated four acquisitions. The team believes the Company has the resources and expertise to continue
to integrate acquisitions successfully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><U>Geographic distribution footprint
of Instone.</U>&nbsp;The current service area of the Company, which includes 31 states (with such states having over 60% of American households),
provides a good basis on which to make both &ldquo;scale&rdquo; and &ldquo;scope&rdquo; acquisitions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Growth Premium.&nbsp;</B>As Capstone
continues to scale, growing its EBITDA, we anticipate benefiting from valuation premiums associated with increased size. This growth,
coupled with consistent earnings performance, is expected to drive substantial shareholder value and enhance our market positioning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Our current operating company, Instone,
intends to drive sustainable growth, expands its geographic presence in the building products industry, and delivers superior value to
its customers, shareholders, and other stakeholders.</I></B>&nbsp;We expect to work with Instone to achieve this through the following
strategic pillars:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Expand Market Presence.&nbsp;</B>We
are committed to expanding our geographic footprint, increasing penetration in existing markets, and entering new, underserved regions.
Our sales and marketing team continues to seek new opportunities to onboard customers in markets we are not currently servicing. In 2024,
we onboarded customers in 6 new states, which are included in our distribution network of 31 states. We will achieve this through both
organic growth and strategic acquisitions that complement our existing business and provide opportunities to broaden our product offerings
and customer base.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Enhance Product Portfolio.&nbsp;</B>We
continuously strive to expand and diversify our product offerings to meet the evolving needs of our customers. This includes introducing
new textures, colors, and materials within our stone product lines, as well as expanding into adjacent building products and stone substitutes.
By broadening our portfolio, we aim to increase our share of wallet with existing customers and attract new customers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Operational Excellence.&nbsp;</B>We
are focused on optimizing our operations to improve efficiency, reduce costs, and enhance customer satisfaction. This involves investing
in advanced technologies, streamlining our supply chain, and implementing best practices across all aspects of our business. Operational
excellence is key to maintaining our competitive edge and ensuring long-term profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Customer-Centric</B>&nbsp;<B>Approach.&nbsp;</B>Our
customers are at the heart of everything we do. We are committed to building strong, long-lasting relationships by providing high-quality
products, exceptional service, and expert support. Our goal is to be the preferred partner for our customers, helping them succeed in
their projects and achieve their business objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><B>Innovation.&nbsp;</B>We recognize
the importance of innovation in the building products sector and prioritize it, continually seeking new ways to improve our products,
processes, and services to stay ahead of industry trends and meet the demands of a changing market. The most recent example is our introduction
of the Toro<SUP>&reg;</SUP>&nbsp;family of manufactured stone products. We used our 30 years of market knowledge to formulate a product
offering that is well thought out to meet the needs of end use customers and distributors. We painstakingly designed each color family.
We honed in on key manufacturing steps to drive quality and consistency then thoughtfully designed packaging to meet the needs of distributors.
The end result was a set of products that competes with high-end alternatives in the sector on aesthetics, but for a better value. We
expect Toro<SUP>&reg;</SUP>&nbsp;to help drive significant organic revenue growth in the next three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
</DIV>
<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>TotalStone, LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TotalStone, LLC is the Company&rsquo;s primary
operating subsidiary, engaged in distributing masonry stone products for residential and commercial construction across the Midwest and
Northeast U.S. The Company acquired a controlling interest in TotalStone on April 1, 2020, and, upon completion of the public offering
on March 7, 2025, now owns 100% of its equity interests.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TotalStone operated under a management agreement
with the Company for strategic and financial advisory services. On March 7, 2025, a restructuring was completed, under which all of TotalStone&rsquo;s
outstanding Class B and Class C membership interests were exchanged for 3,782,641 shares of the Company&rsquo;s Common Stock. Following
this exchange, the Company became the sole member of TotalStone. Effective April 1, 2025, the management agreement between TotalStone
and the Company was terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the restructuring, certain
TotalStone management warrants were cancelled, and TotalStone&rsquo;s special preferred interests were exchanged for debt obligations
under the Company&rsquo;s credit agreement with Stream Finance, LLC. TotalStone continues to maintain a revolving credit facility with
Berkshire Bank, which provides for up to $14 million in working capital financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Public Offering and Uplisting on Nasdaq
Capital Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 7, 2025, the Company closed its follow-on
public offering (the &ldquo;Public Offering&rdquo;) of 1,250,000 shares of Common Stock. On March 6, 2025, the Company&rsquo;s Common
Stock began trading on the Nasdaq Capital Market under the symbol &ldquo;CAPS&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brookstone Investment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As described in an 8-K filing with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) on July&nbsp;17, 2017 (filed under the issuer name of Capstone Therapeutics Corp.), on
July&nbsp;14, 2017, the Company entered into a Securities Purchase, Loan and Security Agreement (the &ldquo;Brookstone Agreement&rdquo;)
with BP Peptides, LLC (&ldquo;Brookstone&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Brookstone Agreement, Brookstone
funded an aggregate of $3,440,000, with net proceeds of approximately $2,074,000, after paying off (a)&nbsp;certain convertible promissory
notes dated December&nbsp;11, 2015 and due July&nbsp;14, 2017, payable to Biotechnology Value Fund, L.P. and affiliated entities and (b)&nbsp;transaction
costs. Of this amount, $1,012,500 went towards the purchase of 18,000 (following a 1 for 750 reduction in the authorized Common Stock
in February&nbsp;2021) newly issued shares of our Common Stock, and $2,427,500 was in the form of a secured loan, due October&nbsp;15,
2020. On July&nbsp;14, 2017 Brookstone also purchased 6,722 (following a 1 for 750 reduction in the authorized Common Stock in February&nbsp;2021)
shares of the Company&rsquo;s Common Stock directly from Biotechnology Value Fund affiliated entities, resulting in ownership of 24,722&nbsp;shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August&nbsp;2019 the Company filed a Form&nbsp;15
and received approval from its shareholders for a 1-for-750 reverse stock split of common shares to reduce the number of authorized common
shares to 200,000 and a 1 for 400 reverse stock split of the preferred shares to reduce the number of preferred shares to 2,500. This
split brought shareholders of record to below 300 and allowed Capstone to become exempt from standard reporting requirements of the SEC.&nbsp;The
Company continues to fully comply with the Alternate Reporting Format guidelines of the OTCQB, which, in part, requires filing of quarterly
financial statements and audited annual financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
</DIV>
<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Building Materials Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March&nbsp;2020, the Company entered into a
transaction, which was effective April&nbsp;1, 2020, whereby it obtained a 100% interest in TotalStone, a materials distribution company
that distributes masonry stone products for residential and commercial construction in the Midwest and Northeast United&nbsp;States, under
the trade names Instone and Northeast Masonry Distributors (NMD), which has been the Company&rsquo;s primary business activity since 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TotalStone, LLC (<I>dba</I> &ldquo;Instone&rdquo;),
a Delaware limited liability company, was formed on October&nbsp;4, 2006. The Company is engaged in the distribution of pre-cast specialty
items and thin stone products and related accessories. All of its operations are performed in Illinois, Ohio and New Jersey. Its administrative
functions are performed in Massachusetts and Illinois, with its corporate headquarters located in New Jersey. Instone services the Northeast
and Midwest regions, which comprise 31 states.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TotalStone, LLC has a wholly owned subsidiary
that is a single member Delaware limited liability company, Northeast Masonry Distributors, LLC (&ldquo;NMD&rdquo;, f/k/a NEM Purchaser,
LLC), that was formed on September&nbsp;23, 2019. On November&nbsp;14, 2019, NEM Purchaser, LLC completed the purchase of Northeast Masonry
Distributors, LLC including all of the assets and assumed liabilities, receivables, fixed assets, and other assets. The aggregate purchase
price was $6,029,342. Post acquisition, NEM Purchaser LLC changed its name to Northeast Masonry Distributors, LLC. Prior to the acquisition,
NMD was engaged in light fabrication and distribution of natural stone products with operations in Plainville, Massachusetts. All of its
manufacturing and distribution operations are performed in Massachusetts. Administrative functions are performed in Massachusetts and
New Jersey. NMD services the Northeast and Midwest regions, which comprise 31 states.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Other Corporate Actions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March&nbsp;2020, the Company and Brookstone
amended the Brookstone Agreement to extend the Secured Debt&rsquo;s maturity to March&nbsp;31, 2022 and continued deferral of interest
payable. As consideration, the Company has provided an option, for a period ending December&nbsp;31, 2021, to convert all or part of the
aggregate outstanding principal amount and any accrued interest of the Secured Debt or exercise of any warrant into Capstone Common Stock
at a conversion price range of between $10.00 and $30.00 per share, as determined by an independent valuation at the time of conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December&nbsp;2020, Brookstone exercised its
option to convert $572,700 of accrued interest and secured debt into 24,900&nbsp;shares of Capstone Common Stock at an exercise price
of $23 per share as supported by independent valuation. With this acquisition, Brookstone owned 54.8% of the Company&rsquo;s outstanding
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March&nbsp;2021, the Company and Brookstone
amended the Brookstone Agreement to extend the Secured Debt&rsquo;s maturity to April&nbsp;1, 2024 (subsequently extended to December&nbsp;31,
2024) with continued interest deferral on the loan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February&nbsp;2022, the Company legally changed
its name from Capstone Therapeutics Corp. to Capstone Holding Corp. reflecting its primary line of business in building products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In March&nbsp;2022, Brookstone exercised its option
to convert $688,104 of accrued interest and $1,951,260 of secured debt into 78,153&nbsp;shares of Capstone Common Stock at an exercise
price of $24.75 per share as supported by independent valuation. With this acquisition, Brookstone currently owns 77.3% of the Company&rsquo;s
outstanding Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In November 2023, Capstone and Brookstone Acquisition
Partners XXI, LLC (&ldquo;Brookstone XXI&rdquo;), a related entity to the Company&rsquo;s majority shareholder, agreed to terms of an
unsecured promissory note in the amount of $800,000 as part of a 2021 transaction through its Capstone Beta, LLC (&ldquo;Beta&rdquo;)
subsidiary to own a minority membership interest in Diamond Products Holdings, LLC (&ldquo;DPH&rdquo;) valued at $8&nbsp;million for a
$8&nbsp;million secured note payable to Brookstone Acquisition Partners XXI. The agreed to terms of the $800,000 note were formalized
in a note agreement executed on March&nbsp;31, 2024. The sole assets of DPH consisted of a 95% membership interest in Diamond Products
LLC (&ldquo;Diamond&rdquo;), a consumer products holding company. The majority membership interests in DPH and Diamond were controlled
by Brookstone XXI. The $800,000 unsecured promissory note was triggered when the members of Diamond sold their membership interests to
a third party as part of a restructuring and recapitalization transaction of the Diamond operating entities. This $800,000 unsecured promissory
note was issued on March&nbsp;31, 2024. The primary consideration received in the transaction was the release of guarantees of the senior
debt of Diamond operating entities. No cash proceeds were received in the transaction. Pursuant to the terms of the Beta and Brookstone
XXI $8&nbsp;million secured note, upon sale or disposition of the membership interests in Diamond, Brookstone XXI&rsquo;s remaining payments
due under the note are limited to cash proceeds received by DPH from the sale, accrued interest and a limited payment guaranty of $800,000
provided by Capstone. Since no cash proceeds were received upon the sale of the Diamond membership interests, the $8&nbsp;million note
payable to Brookstone XXI was forgiven and replaced by the new $800,000 note issued by Capstone resulting in a net $7.2&nbsp;million gain
on extinguishment of debt which offset the $8&nbsp;million write-off of the investment in DPH. This promissory note of $800,000 plus accrued
interest of $240,555 (as of September&nbsp;30, 2024) has been amended and extended for maturity through June&nbsp;30, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
</DIV>
<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In May&nbsp;2024, the Board authorized and declared
a dividend distribution of one right (a &ldquo;Right&rdquo;) for each outstanding share of Common Stock, par value $0.0005 per share,
of the Company to shareholders of record as of the close of business on May&nbsp;1, 2024. Each Right entitles the registered holder to
purchase from the Company one one-hundredth of a share of Series&nbsp;A Preferred Stock, par value $0.0005 per share, of the Company at
an exercise price of $5.00 per one one-hundredth of a Preferred Share, subject to adjustment. The terms of the Rights are set forth in
a Tax Benefit Preservation Plan (the &ldquo;Benefit Plan&rdquo;), dated as of May&nbsp;1, 2024, between the Company and Computershare
Inc., as rights agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By adopting the Benefit Plan, the Board is seeking to protect the Company&rsquo;s
ability to use its net operating losses and other tax attributes (collectively, &ldquo;Tax Benefits&rdquo;). The Company views its Tax
Benefits as highly valuable assets that are likely to inure to the benefit of the Company and its shareholders. The Board believes that
it is in the best interests of the Company and its shareholders that the Company provide for the protection of these assets. The final
expiration date of the Benefit Plan is April&nbsp;1, 2027. The Benefit Plan was cancelled per the Master Exchange and Other Transaction
Agreement executed on March 3, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November&nbsp;11, 2024, BP Peptides, LLC (a
Brookstone entity) and the Company agreed to the terms of the Second Amended and Restated Note, with a principal amount of $700,617.52
and an accrued interest of $101.810.28, at an initial interest rate of 6.0% per annum, to extend the maturity date through June&nbsp;30,
2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Implications of Being an Emerging Growth and
Smaller Reporting Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an &ldquo;emerging growth company&rdquo;
as defined in Section 2(a)(19) of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), as modified by the Jumpstart
Our Business Startups Act of 2012 (the &ldquo;JOBS Act&rdquo;). As an emerging growth company, we are eligible to take advantage of certain
exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including,
but not limited to: (1) presenting only two years of audited financial statements in addition to any required unaudited interim financial
statements with correspondingly reduced &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo;
disclosure in this prospectus; (2) not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley
Act of 2002 (the &ldquo;Sarbanes-Oxley Act&rdquo;); (3) having reduced disclosure obligations regarding executive compensation; (4) being
exempt from the requirements to hold a non-binding advisory vote on executive compensation or to seek stockholder approval of any golden
parachute payments not previously approved; and (5) not being required to adopt certain accounting standards applicable to public companies
until those standards would otherwise apply to private companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we are still evaluating our options under
the JOBS Act, we may take advantage of some or all of the reduced regulatory and reporting obligations that will be available to us so
long as we qualify as an &ldquo;emerging growth company,&rdquo; and thus the level of information we provide may be different than that
of other public companies. If we do take advantage of any of these exemptions, some investors may find our securities less attractive,
which could result in a less active trading market for our Common Stock, and the price of our Common Stock may be more volatile. As an
&ldquo;emerging growth company&rdquo; under the JOBS Act, we are permitted to delay the adoption of new or revised accounting pronouncements
applicable to public companies until such pronouncements are made applicable to private companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not intend to take advantage of this extended
transition period, which means that the financial statements included in this prospectus, as well as any financial statements that we
file in the future, will be subject to all new or revised accounting standards generally applicable to public companies. The decision
not to take advantage of the extended transition period is irrevocable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We could remain an &ldquo;emerging growth company&rdquo;
until the earliest to occur of: (1) the end of the fiscal year following the fifth anniversary of this offering; (2) the first fiscal
year after our annual gross revenues are $1.235&nbsp;billion or more; (3) the date on which we have, during the previous three-year period,
issued more than $1.0&nbsp;billion in non-convertible debt securities; or (4) the date on which we are deemed to be a &ldquo;large accelerated
filer&rdquo; under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). We have taken advantage of reduced
disclosure regarding executive compensation arrangements and the presentation of certain historical financial information in this prospectus,
and we may choose to take advantage of some but not all of these reduced disclosure obligations in future filings. If we do, the information
that we provide to our stockholders may be different from what you might get from other public companies in which you hold stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are also a smaller reporting company, as defined
in the Exchange Act. Even after we no longer qualify as an emerging growth company, we may still qualify as a smaller reporting company,
which would allow us to continue taking advantage of many of the same exemptions from disclosure requirements, including reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements. In addition, for so long as we continue to
qualify as a non-accelerated filer, we will not be required to comply with the auditor attestation requirements of Section 404(b) of the
Sarbanes-Oxley Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Corporate Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Capstone Holding Corp., formerly known as Capstone
Therapeutics Corp. and OrthoLogic Corp., was incorporated in Delaware in 1987 as a domestic corporation, with formal name changes in February&nbsp;2022
and May&nbsp;2010, respectively. The Company&rsquo;s principal executive offices are located at 5141 W. 122<SUP>nd</SUP> St. Alsip, IL&nbsp;60803
and the telephone number is (708)&nbsp;371-0660.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>
</DIV>
<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<DIV STYLE="padding: 5; border: Black 1.5pt solid; width: 98%">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE OFFERING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; width: 30%"><B>Securities offered by the selling stockholder</B></TD>
    <TD STYLE="white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 69%"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Up to 5,190,251 shares of our Common Stock, consisting of (i) 215,054
shares to be issued as Commitment Shares and (ii) 4,975,197 shares to be issued as Equity Line Securities, issuable pursuant to the Purchase
Agreement.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in"><B>Common Stock outstanding before the offering</B></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">5,190,251 shares of Common Stock.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in"><B>Common Stock to be outstanding after this offering</B><SUP></SUP></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">10,380,502 shares of Common Stock.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in"><B>Use of proceeds</B></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">We will not receive any of the proceeds from the resale by the selling
stockholder of the securities. We may receive up to $20.0 million in aggregate gross proceeds from sales of our Common Stock that we may
elect to make to the selling stockholder pursuant to the Purchase Agreement from time to time in our sole discretion, from and after the
initial satisfaction of all of the conditions set forth in the Purchase Agreement. We may use the proceeds from sales of our Common Stock
to the selling stockholder for working capital and general corporate purposes. See section entitled &ldquo;<I>Use of Proceeds</I>&rdquo;.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in"><B>Nasdaq Capital Market Trading Symbol </B></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">Our Common Stock is listed on the Nasdaq Capital Market under the symbol &ldquo;CAPS&rdquo;.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in"><B>Dividends</B></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">We do not anticipate paying dividends on our Common Stock for the foreseeable future.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in"><B>Risk factors</B></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: justify">Investing in our securities is highly speculative and involves a high degree of risk. You should
    carefully consider the information set forth in the &ldquo;Risk Factors&rdquo; section beginning on page 8 before deciding to invest
    in our securities.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
</DIV>
<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>RISK FACTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Investing in our securities involves a great
deal of risk. Careful consideration should be made of the following factors as well as other information included in this prospectus before
deciding to purchase our securities. We have also identified a number of these factors under the heading &ldquo;Risk Factors&rdquo; in
our periodic reports we file with the SEC, including our annual report on Form 10-K for the year ended December 31, 2024 (the &ldquo;Annual
Report&rdquo;), which section is incorporated by reference herein. There are many risks that affect our business and results of operations,
some of which are beyond our control. Our business, financial condition or operating results could be materially harmed by any of these
risks. This could cause the trading price of our securities to decline, and you may lose all or part of your investment. Additional risks
that we do not yet know of or that we currently think are immaterial may also affect our business and results of operations.</I></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Risks related to this offering</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>It is not possible to predict the actual
number of shares we will sell under the&nbsp;Purchase Agreement, or the actual gross proceeds resulting from those sales. We may not have
access to the full amount available under the&nbsp;Purchase Agreement with the selling stockholder.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2025, we entered into the&nbsp;Purchase
Agreement with the selling stockholder, pursuant to which the selling stockholder committed to purchase up to $20.0 million in shares
of our Common Stock, subject to certain limitations and conditions set forth in the&nbsp;Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares of our Common Stock that may be issued
under the Purchase Agreement may be sold by us to the selling stockholder at our discretion from time to time over an&nbsp;approximately
24-month period&nbsp;commencing on the effective date of the registration statement of which this prospectus forms a part, provided that
one or more registration statements covering the resale of shares of Common Stock that have been and may be issued under the Purchase
Agreement is declared effective by the SEC, a final prospectus in connection therewith is filed, and the other conditions set forth in
the&nbsp; Purchase Agreement are satisfied. We generally have the right to control the timing and amount of any sales of our shares of
our Common Stock to the selling stockholder under the Purchase Agreement. Sales of our Common Stock to the selling stockholder under the
Purchase Agreement will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to the
selling stockholder all or a portion of the shares of our Common Stock that may be available pursuant to the&nbsp;Purchase Agreement,
or decide to terminate the&nbsp;Purchase Agreement and not sell to the selling stockholder any shares of our Common Stock that may be
available for us to sell to the selling stockholder thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the purchase price per share to be paid
by the selling stockholder for the shares of our Common Stock that we may elect to sell to the selling stockholder under the Purchase
Agreement will fluctuate based on the market prices of our Common Stock during the applicable Purchase Valuation Period for each purchase,
it is not possible for us to predict, as of the date of this prospectus, the number of shares of our Common Stock that we will sell to
the selling stockholder under the Purchase Agreement, the purchase price per share that the selling stockholder will pay for shares purchased
from us under the Purchase Agreement, or the aggregate gross proceeds that we will receive from those purchases by the selling stockholder
under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although the Purchase Agreement provide that we may sell up to an aggregate
of $20.0 million of our Common Stock to the selling stockholder, only 5,190,251 shares of our Common Stock are being registered for resale
by the selling stockholder under the registration statement of which this prospectus forms a part, which represents the Commitment Shares
and 4,975,197 shares of our Common Stock that may be issued to the selling stockholder under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we elect to sell to the selling stockholder all of the 4,975,197
shares, which reflects the number of shares registered hereunder excluding the Commitment Shares, in the registration statement of which
this prospectus forms a part, the actual gross proceeds from the sale of all such shares may be substantially less than the $20.0 million
total commitment originally available to us under the Purchase Agreement, which could materially adversely affect our liquidity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If it becomes necessary for us to issue and sell to the selling stockholder
under the&nbsp;Purchase Agreement more than the 4,975,197 shares, which reflects the number of shares registered hereunder excluding the
Commitment Shares, being registered for resale under the registration statement of which this prospectus forms a part in order to receive
aggregate gross proceeds equal to the total commitment of an aggregate of $20.0 million under the Purchase Agreement, we must file with
the SEC one or more additional registration statements to register under the&nbsp;Securities Act&nbsp;the resale by the selling stockholder
of any such additional shares of our Common Stock we wish to sell from time to time under the Purchase Agreement, which the SEC must declare
effective. We will need to obtain stockholder approval to issue shares of our Common Stock in excess of the Exchange Cap under the&nbsp;
Purchase Agreement in accordance with the Nasdaq listing rules, unless the average per share purchase price paid by the selling stockholder
for all shares of our Common Stock sold under the Purchase Agreement equals or exceeds $1.77, in which case, under the Nasdaq listing
rules, the Exchange Cap limitation will not apply to issuances and sales of our Common Stock under the Purchase Agreement. In addition,
the selling stockholder will not be required to purchase any shares of our Common Stock if such sale would result in the selling stockholder&rsquo;s
beneficial ownership exceeding 4.99% of the then outstanding shares of our Common Stock, subject to adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any issuance and sale by us under the Purchase
Agreement of a substantial amount of shares of our Common Stock in addition to the 5,190,251 shares being registered for resale by the
selling stockholder under the registration statement of which this prospectus forms a part could cause additional substantial dilution
to our stockholders. The number of shares of our Common Stock ultimately offered for resale by the selling stockholder is dependent upon
the number of shares of our Common Stock we ultimately sell to the selling stockholder under the&nbsp;Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our inability to access a portion or the full
amount available under the Purchase Agreement, in the absence of any other financing sources, could have a material adverse effect on
our business. The extent to which we rely on the selling stockholder as a source of funding will depend on a number of factors including
the prevailing market price of our Common Stock and the extent to which we are able to secure working capital from other sources. If obtaining
sufficient funding from the selling stockholder were to prove unavailable or prohibitively dilutive, we will need to secure another source
of funding in order to satisfy our working capital needs. Even if we were to receive all $20.0 million in gross proceeds under the&nbsp;Purchase
Agreement, we may still need additional capital to fully implement our business, operating and development plans. Should the financing
we require to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the consequences could have
a material adverse effect on our business, operating results, financial condition and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Investors who buy shares at different times
will likely pay different prices.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the&nbsp;Purchase Agreement, we will
have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold to the selling stockholder. If and when
we do elect to sell shares of our Common Stock to the selling stockholder under the Purchase Agreement, after the selling stockholder
has acquired such shares, the selling stockholder may resell all or a portion of such shares at any time or from time to time in its discretion
and at different prices. As a result, investors who purchase shares from the selling stockholder at different times will likely pay different
prices for those shares, and so may experience different levels of dilution and in some cases substantial dilution and different outcomes
in their investment results. Investors may experience a decline in the value of the shares they purchase from the selling stockholder
as a result of future sales made by us to the selling stockholder at prices lower than the prices such investors paid for their shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>We may require additional financing to sustain
our operations and without it we will not be able to continue operations.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the terms and conditions of the&nbsp; Purchase Agreement,
as applicable, we may, at our discretion, direct the selling stockholder to purchase up to an aggregate of up to $20.0 million of our
Common Stock under the&nbsp;Purchase Agreement from time to time over an approximately&nbsp;24-month period&nbsp;beginning on the effective
date of the registration statement of which this prospectus forms a part, provided that one or more registration statements covering the
resale of shares of common stock that have been and may be issued under the&nbsp; Purchase Agreement are declared effective by the SEC,
a final prospectus in connection therewith is filed, and the other conditions set forth in the&nbsp; Purchase Agreement are satisfied.
Although the Purchase Agreement provides that we may sell up to an aggregate of $20.0 million of our Common Stock to the selling stockholder,
only 4,975,197 shares of our Common Stock that we may elect to sell to the selling stockholder m are being registered on the registration
statement of which this prospectus forms a part. The purchase price per share for the shares of our Common Stock that we may elect to
sell to the selling stockholder under the&nbsp;Purchase Agreement will fluctuate based on the market prices of our Common Stock during
the applicable Purchase Valuation Period for each purchase made pursuant to the&nbsp;Purchase Agreement. Accordingly, it is not currently
possible to predict the number of shares that will be sold to the selling stockholder, the actual purchase price per share to be paid
by the selling stockholder for those shares, the actual gross proceeds to be raised in connection with those sales, and whether or not
we will need to register additional shares for resale by the selling stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The extent to which we rely on the selling stockholder
as a source of funding will depend on a number of factors, including the prevailing market price of our Common Stock and the extent to
which we are able to secure working capital from other sources. If obtaining sufficient funding from the selling stockholder were to prove
unavailable or prohibitively dilutive, we may need to secure another source of funding in order to satisfy our working capital needs.
Even if we were to sell to the selling stockholder all of the shares of our Common Stock available for sale to the selling stockholder
under the Purchase Agreement, we will still need additional capital to fully implement our business plan. Should the financing we require
to sustain our working capital needs be unavailable or prohibitively expensive when we require it, the consequences would have a material
adverse effect on our business, operating results, financial condition and prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Management will have broad discretion as
to the use of the proceeds from our sale of Common Stock to the selling stockholder under the&nbsp;Purchase Agreement, and such uses may
not improve our financial condition or market value.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently intend to use the proceeds from any
sales of shares of Common Stock under the&nbsp;Purchase Agreement for the repayment of outstanding indebtedness and for general corporate
purposes, including working capital. Our management will have broad discretion in the application of such proceeds, including for any
of the purposes described in&nbsp;<I>&ldquo;Use of Proceeds,&rdquo;</I>&nbsp;and we could spend the proceeds from the sale of shares of
Common Stock under the&nbsp; Purchase Agreement, if any, in ways our stockholders may not agree with or that do not yield a favorable
return, or for corporate purposes that may not improve our financial condition or advance our business objectives. You will not have the
opportunity, as part of your investment decision, to assess whether such proceeds are being used in a manner agreeable to you. You will
be relying on the judgment of our management concerning these uses and you will not have the opportunity, as part of your investment decision,
to assess whether the proceeds are being used appropriately. The failure of our management to apply these funds effectively could result
in unfavorable returns and uncertainty about our prospects, each of which could cause the price of our Common Stock to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>The selling stockholder may choose to sell
the shares at prices below the current market price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The selling stockholder is not restricted as to the prices at which
it may sell or otherwise dispose of the shares covered by this prospectus. Sales or other dispositions of the shares below the then-current
market prices could adversely affect the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>You may experience future dilution as a
result of issuance of the shares, future equity offerings by us and other issuances of our Common Stock or other securities. In addition,
the issuance of the shares and future equity offerings and other issuances of our Common Stock or other securities may adversely affect
our Common Stock price.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares sold by the selling stockholder will
be freely tradable without restriction or further registration under the&nbsp;Securities Act. As a result, a substantial number of shares
of our Common Stock may be sold in the public market following this offering. If there are significantly more shares of our Common Stock
offered for sale than buyers are willing to purchase, then the market price of our Common Stock may decline to a market price at which
buyers are willing to purchase the offered Common Stock and sellers remain willing to sell our Common Stock. The issuance of the shares
or any future sales of a substantial number of shares of our Common Stock in the public market, or the perception that such sales may
occur, could also adversely affect the price of our Common Stock. We cannot predict the effect, if any, that market sales of those shares
of Common Stock or the availability of those shares for sale will have on the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in order to raise additional capital,
we may in the future offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock
at prices that may not be the same as the price per share as prior issuances of Common Stock. We may not be able to sell shares or other
securities in any other offering at a price per share that is equal to or greater than the price per share previously paid by investors,
and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share
at which we sell additional shares of our common stock or securities convertible into Common Stock in future transactions may be higher
or lower than the prices per share previously paid. In addition, the exercise price of the Warrant may be greater than the price per share
previously paid by certain investors. You will incur dilution upon exercise of any outstanding stock options, warrants or upon the issuance
of shares of Common Stock under our stock incentive programs. In addition, the issuance of the shares and any future sales of a substantial
number of shares of our Common Stock in the public market, or the perception that such sales may occur, could adversely affect the price
of our Common Stock. We cannot predict the effect, if any, that market sales of those shares of Common Stock or the availability of those
shares for sale will have on the market price of our Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Future sales and issuances of our common
stock under the&nbsp;Purchase Agreement or otherwise, or future sales of other securities, might result in significant dilution and could
cause the price of our common stock to decline.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To raise capital, we may sell our Common Stock,
convertible securities or other equity securities in one or more transactions other than those contemplated by the&nbsp;Purchase Agreement,
at prices and in a manner we determine from time to time. We may sell shares or other securities in any other offering at a price per
share that is less than the price per share paid by the selling stockholder, and investors purchasing shares or other securities in the
future could have rights superior to existing stockholders. The price per share at which we sell additional shares of our Common Stock,
or securities convertible or exchangeable into our Common Stock, in future transactions may be higher or lower than the price per share
paid by the selling stockholder. Any sales of additional shares will dilute our stockholders. Sales of a substantial number of shares
of our Common Stock in the public market or the perception that these sales might occur could depress the market price of our Common Stock
and could impair our ability to raise capital through the sale of additional equity securities. We are unable to predict the effect that
sales may have on the prevailing market price of our Common Stock. In addition, the sale of substantial amounts of our Common Stock could
adversely impact its price.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>USE OF PROCEEDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All securities sold pursuant to this prospectus
will be offered and sold by the selling stockholder. We will not receive any proceeds from the resale of Common Stock offered by the selling
stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We may receive up to $20.0 million in aggregate
gross proceeds from sales of our Common Stock that we may elect to make to the selling stockholder pursuant to the Purchase Agreement
from time to time in our sole discretion, from and after the initial satisfaction of all of the conditions set forth in the Purchase Agreement.
We may use the proceeds from sales of our Common Stock to the selling stockholder for working capital and general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our expected use of proceeds from sales of our
Common Stock that we may elect to make to the selling stockholder pursuant to the Equity Line Purchase Agreement, if any, represents our
intentions based on our present plans and business conditions, which could change as our plans and business conditions evolve. The amounts
and timing of our actual expenditures will depend on numerous factors, including cash flows from operations, the extent and results of
our research and development efforts, the anticipated growth of our business, and other factors. We may find it necessary or advisable
to use such proceeds for other purposes, and, except as set forth above, we will have broad discretion in the application of such proceeds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This prospectus, including the information incorporated
by reference into this prospectus, contains forward-looking statements. Forward-looking statements give our current expectations or forecasts
of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward-looking
statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability,
our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. They are generally
identifiable by use of the words &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;plans,&rdquo; &ldquo;potential,&rdquo; &ldquo;projects,&rdquo; &ldquo;continuing,&rdquo; &ldquo;ongoing,&rdquo; &ldquo;expects,&rdquo;
&ldquo;management believes,&rdquo; &ldquo;we believe,&rdquo; &ldquo;we intend&rdquo; or the negative of these words or other variations
on these words or comparable terminology. These statements may be found under the sections entitled &ldquo;Management&rsquo;s Discussion
and Analysis of Financial Condition and Results of Operations&rdquo; and &ldquo;Business,&rdquo; in our Annual Report, as well as in this
prospectus generally. In particular, these include statements relating to future actions, prospective products, market acceptance, future
performance or results of current and anticipated products, sales efforts, expenses, and the outcome of contingencies such as legal proceedings
and financial results. Such forward-looking statements include, without limitation, statements regarding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our need for, and our ability to raise, additional equity or
debt financing on acceptable terms, if at all;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our need to take additional cost reduction measures, cease operations
or sell our operating assets, if we are unable to obtain sufficient additional financing;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our belief that we have sufficient liquidity to finance normal
operations;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the options we may pursue in light of our financial condition;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the amount of cash necessary to operate our business;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">general economic conditions;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">the anticipated future financial performance and business operations
of our company; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify">our ability to retain our core group of personnel.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We operate in a very competitive and rapidly changing
environment. New risks emerge from time to time. It is not possible for us to predict all of those risks, nor can we assess the impact
of all of those risks on our business or the extent to which any factor may cause actual results to differ materially from those contained
in any forward-looking statement. The forward-looking statements in this prospectus are based on assumptions management believes are reasonable.
However, due to the uncertainties associated with forward-looking statements, you should not place undue reliance on any forward-looking
statements. Further, forward-looking statements speak only as of the date they are made, and unless required by law, we expressly disclaim
any obligation or undertaking to publicly update any of them in light of new information, future events, or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>DETERMINATION OF OFFERING PRICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The selling stockholder will offer shares of our
Common Stock for sale under this prospectus at prevailing market prices or privately negotiated prices. We cannot currently determine
the price or prices at which the shares of Common Stock may be sold by the selling stockholder under this prospectus. The offering price
of our Common Stock does not necessarily bear any relationship to our book value, assets, past operating results, financial condition
or any other established criteria of value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_013"></A>DILUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The sale of our Common Stock to the selling stockholder
pursuant to the Purchase Agreement will have a dilutive impact on our stockholders. In addition, the lower our stock price is at the time
we exercise our right to sell shares to the selling stockholder, the more shares of our Common Stock we will have to issue to the selling
stockholder pursuant to the Purchase Agreement, as a result of which our existing stockholders would experience greater dilution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our net tangible book value represents total tangible
assets less total liabilities divided by the number of shares of Common Stock outstanding on March 31, 2025. As of March 31, 2025, we
had a historical net tangible book value (deficit) of $(6,952,292), or $(1.34) per share of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">After giving effect to the issuance of 5,190,251 shares
of our Common Stock to the selling stockholder pursuant to the Purchase Agreement at an assumed sale price of $1.82 per share of our Common
Stock, which is the closing price of our Common Stock on Nasdaq on May 30, 2025, and after deducting estimated offering expenses payable
by us, our as-adjusted net tangible book value (deficit) as of March 31, 2025 would have been approximately $(7,083,792), or $(0.68) per
share. This represents an immediate increase in net tangible book value of $0.66 per share to existing stockholders and an immediate dilution
of $(2.50) per share to new investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table illustrates this per share
dilution:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-indent: -10pt; padding-left: 10pt">Assumed offering price per share of Common Stock</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1.82</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">Net tangible book deficit value per share as of March 31, 2025</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1.34</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Increase/Decrease in net tangible book deficit value per share attributable to the effects to this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.66</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">As adjusted net tangible book deficit value per share after giving effect to this offering</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.68</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Dilution in net tangible book deficit value per share to new investors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(2.50</TD><TD STYLE="text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The calculations above are based on 5,190,251
shares of our Common Stock outstanding as of March 31, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_006"></A>The
Tumim Stone Capital Equity Financing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 14, 2025, the Company entered into the
Purchase Agreement and a registration rights agreement (the &ldquo;Registration Rights Agreement&rdquo;) with the selling stockholder,
Tumim Stone Capital, LLC (&ldquo;Tumim Stone Capital&rdquo;). Under the terms and subject to the conditions set forth in the Purchase
Agreement, the Company has the right, but not the obligation, to sell to Tumim Stone Capital, and Tumim Stone Capital is obligated to
purchase, up to the lesser of (a) $20,000,000 in aggregate gross purchase price of the Company&rsquo;s Common Stock (the &ldquo;Equity
Line Securities&rdquo;) and (b) the Exchange Cap (as defined below) (the &ldquo;Tumim Stone Capital Equity Financing&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares of Common Stock to be issued by the
Company and purchased by the Tumim Stone Capital will be sold at a purchase price equal to 97% of the lowest daily volume-weighted average
price of the Common Stock on the Nasdaq Capital Market during the three consecutive trading days immediately following the trading date
on which a valid purchase notice is delivered to Tumim Stone Capital by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with certain applicable Nasdaq rules,
the Company may not issue to Tumim Stone Capital more than 1,038,050 shares of its Common Stock (the &ldquo;Exchange Cap&rdquo;) under
the Purchase Agreement, which number of shares is equal to 19.99% of the shares of the Company&rsquo;s Common Stock issued and outstanding
immediately prior to the execution of the Purchase Agreement, unless the Company obtains stockholder approval to issue shares of its Common
Stock in excess of such limit in accordance with applicable rules of Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moreover, the Company may not issue or sell any
shares of Common Stock to Tumim Stone Capital which, when aggregated with all other shares of common stock then beneficially owned by
Tumim Stone Capital and its affiliates (as calculated pursuant to Section 13(d) of the&nbsp; Exchange Act and Rule 13d-3 promulgated thereunder),
would result in Tumim Stone Capital beneficially owning more than 4.99% of the issued and outstanding shares of Common Stock, unless such
limit is increased by Tumim Stone Capital up to a maximum of 9.99%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As consideration for Tumim Stone Capital&rsquo;s
irrevocable commitment to purchase shares of Common Stock, upon execution of the Purchase Agreement, the Company became obligated to issue
to Tumim Stone Capital a number of shares of Common Stock equal to $400,000 divided by the lower of (i) the Nasdaq official closing price
of its Common Stock on the trading day immediately prior to the Company&rsquo;s initial filing of the registration statement covering
the resale of the shares under this prospectus, or (ii) the average Nasdaq official closing price over the five consecutive trading days
ending on the trading day immediately prior to such filing (the &ldquo;Commitment Shares&rdquo;). The Commitment Shares are to be issued
following the effective date of the registration statement. In certain circumstances, the Company may become obligated to pay to Tumim
Stone Capital a cash fee equal to $400,000 in lieu of issuing such shares of Common Stock, under the terms and subject to the conditions
described in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Purchase Agreement provides customary representations,
warranties, and covenants of the Company and Tumim Stone Capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Registration Rights Agreement,
the Company agreed to file a resale registration statement covering the resale of the Registrable Securities (as defined in the Registration
Rights Agreement) with the SEC within 30 calendar days after the date of the Registration Rights Agreement (the &ldquo;Filing Deadline&rdquo;),
and to use commercially reasonable efforts to cause such resale registration statement to be declared effective by the SEC as soon as
reasonably practicable following the filing thereof, no later than (i) with respect to the initial registration statement, the earlier
of (A) the seventy-fifth (75th) calendar day after the earlier of (1) the date on which the initial registrations statement is filed and
(2) the Filing Deadline, if such registration statement is subject to review by the SEC, and (B) the thirtieth (30th) calendar day after
the earlier of (1) the date on which the initial registration statement is filed and (2) the Filing Deadline, if the Company is notified
by the SEC that such registration statement will not be reviewed; and (ii) with respect to any subsequent registration statements that
may be required to be filed by the Company pursuant to the Purchase Agreement, the earlier of (A) the sixtieth (60th) calendar day following
the date on which the Company was required to file such additional registration statement, if such registration statement is subject to
review by the SEC, and (B) the thirtieth (30th) calendar day following the date on which the Company was required to file such subsequent
registration statement, if the Company is notified by the SEC that such registration statement will not be reviewed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Joseph Gunnar &amp; Co., LLC (the &ldquo;Placement
Agent&rdquo;) acted as the sole sales agent for the Tumim Stone Capital Equity Financing. Pursuant to the placement agency agreement,
dated May 15, 2025, the Company agreed to pay the Placement Agent a cash fee equal to 7.0% of the gross proceeds upon each closing of
a drawdown (each, a &ldquo;Closing&rdquo;) under the Tumim Stone Capital Equity Financing and to reimburse up to $15,000 for expenses
incurred in connection with the Tumim Stone Capital Equity Financing at the initial Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><A NAME="a_007"></A>SELLING
STOCKHOLDER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 7pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This prospectus relates to
the possible resale from time to time by Tumim Stone Capital of any or all of the shares of Common Stock that may be issued by us to Tumim
Stone Capital under the Purchase Agreement. For additional information regarding the issuance of Common Stock covered by this prospectus,
see the section titled &ldquo;<I>The Tumim Stone Capital Equity Financing</I>&rdquo; above. We are registering the shares of Common Stock
pursuant to the provisions of the Registration Rights Agreement we entered into with Tumim Stone Capital on May 14, 2025, in order to
permit the selling stockholder to offer the shares for resale from time to time. Except for the transactions contemplated by the Purchase
Agreement and the Registration Rights Agreement, Tumim Stone Capital has not had any material relationship with us within the past three
years. As used in this prospectus, the term &ldquo;selling stockholder&rdquo; means Tumim Stone Capital, LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The table below presents information regarding the selling stockholder
and the shares of Common Stock that it may offer from time to time under this prospectus. This table is prepared based on information
supplied to us by the selling stockholder, and reflects holdings as of May 30, 2025. The number of shares in the column &ldquo;Maximum
Number of Shares of Common Stock to be Offered Pursuant to this Prospectus&rdquo; represents all of the shares of Common Stock the selling
stockholder may offer under this prospectus. The selling stockholder may sell some, all, or none of its shares in this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We do not know how long the
selling stockholder will hold the shares before selling them, and we are not currently aware of any existing agreements, arrangements
or understandings between the selling stockholder and any other stockholder, broker, dealer, underwriter or agent relating to the sale
or distribution of the shares of our Common Stock offered by this prospectus by the selling stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Beneficial ownership is determined in accordance with Rule 13d-3(d)
promulgated by the SEC under the Exchange Act, and includes shares of Common Stock with respect to which the selling stockholder has voting
and investment power. The percentage of shares of Common Stock beneficially owned by the selling stockholder prior to the offering shown
in the table below is based on an aggregate of 5,190,251 shares of our Common Stock outstanding on May 30, 2025. Because the purchase
price of the shares of Common Stock issuable under the Purchase Agreement is determined on each VWAP Purchase Date, with respect to a
VWAP Purchase, the number of shares that may actually be sold by the Company under the Purchase Agreement may be fewer than the number
of shares being offered by this prospectus. The fourth column assumes the sale of all of the shares offered by the selling stockholder
pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of Shares of<BR>
Common Stock Owned<BR>
Prior to Offering</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum Number of Shares of Common Stock to be Offered Pursuant to this</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum Number of<BR>
Shares of Common Stock<BR>
Owned After Offering</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name of Selling Stockholder</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prospectus<SUP>(3)</SUP>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number<SUP>(4)</SUP>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percent<SUP>(2)</SUP>&nbsp;</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tumim Stone Capital, LLC<SUP>(5)</SUP></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,190,251</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">546,341</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.99</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Represents less than 1.0%.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">In accordance with Rule 13d-3(d) under the Exchange Act, we have excluded
from the number of shares beneficially owned prior to the offering all of the shares that Tumim Stone Capital may be required to purchase
under the Purchase Agreement, because the issuance of such shares is solely at our discretion and is subject to conditions contained in
the Purchase Agreement, the satisfaction of which are entirely outside of Tumim Stone Capital&rsquo;s control, including the registration
statement that includes this prospectus becoming and remaining effective.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Applicable percentage ownership is based on 5,190,251 shares of our
common stock outstanding as of May 30, 2025.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="text-align: justify"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">The 5,190,251 shares of Common Stock consist of (i) 215,054 shares
to be issued as Commitment Shares and (ii) up to 4,975,197 shares to be issued as Equity Line Securities, issuable pursuant to the Purchase
Agreement.</P></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"></FONT>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The VWAP Purchases of Common Stock are
subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement
prohibits us from issuing and selling any shares of our Common Stock to Tumim Stone Capital to the extent such shares, when
aggregated with all other shares of our Common Stock then beneficially owned by Tumim Stone Capital, would cause Tumim Stone
Capital&rsquo;s beneficial ownership of our Common Stock to exceed 4.99%, unless such limit is increased by Tumim Stone Capital up
to a maximum of 9.99%. The amount presented in this table represents such number of shares pursuant to the blocker provision in the
Purchase Agreement that prohibits Tumim Stone Capital&rsquo;s beneficial ownership of our common stock to exceed 4.99%, unless such
limit is increased by Tumim Stone Capital up to a maximum of 9.99%. In the absence of such 4.99% blocker provisions, Tumim Capital
Stone would be deemed to have beneficial ownership of 5,190,251 shares of our Common Stock after the Offering. The Purchase
Agreement also prohibits us from issuing or selling shares of our Common Stock under the Purchase Agreement in excess of the 19.99%
Exchange Cap unless we obtain stockholder approval to do so, or unless sales of Common Stock are made at a price equal to or greater
than $1.77 per share, such that the Exchange Cap limitation would not apply under applicable Nasdaq rules. Neither the beneficial
ownership limitation nor the Exchange Cap (to the extent applicable under Nasdaq rules) may be amended or waived under the Purchase
Agreement.</P>
<FONT STYLE="font-size: 10pt"></FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">The business address of Tumim Stone Capital is 2 Wooster Street,
2nd Floor, New York, New York 10013. Tumim Stone Capital&rsquo;s principal business is that of a private investor. Maier Joshua Tarlow
is the manager of 3i Management, LLC, the general partner of 3i, LP, which is the sole member of Tumim Stone Capital, and has sole voting
control and investment discretion over securities beneficially owned directly by Tumim Stone Capital and indirectly by 3i Management,
LLC and 3i, LP. 3i Management, LLC is also the manager of Tumim Stone Capital. We have been advised that none of Mr. Tarlow, 3i Management,
LLC, 3i, LP, or Tumim Stone Capital is a member of the FINRA or an independent broker-dealer, or an affiliate or associated person of
a FINRA member or independent broker-dealer. The foregoing should not be construed in and of itself as an admission by Mr. Tarlow as
to beneficial ownership of the securities beneficially owned directly by Tumim Stone Capital and indirectly by 3i Management, LLC and
3i, LP.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_008"></A>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The shares of Common Stock
offered by this prospectus are being offered by the selling stockholder, Tumim Stone Capital. The shares may be sold or distributed from
time to time by the selling stockholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely
as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or
at fixed prices, which may be changed. The sale of the ordinary shares offered by this prospectus could be effected in one or more of
the following methods:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;</TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">ordinary brokers&rsquo; transactions;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">transactions involving cross or block trades;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">through brokers, dealers, or underwriters who may act solely as agents;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;at the market&rdquo; into an existing market for the ordinary shares;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in privately negotiated transactions; or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any combination of the foregoing.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In order to comply with the
securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state&rsquo;s registration or qualification requirement is available and complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Tumim Stone Capital has informed
us that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our Common Stock that it has acquired
and may in the future acquire from us pursuant to the Purchase Agreement. Such sales will be made at prices and at terms then prevailing
or at prices related to the then current market price. Each such registered broker-dealer will be an underwriter within the meaning of
Section&nbsp;2(a)(11) of the Securities Act. Tumim Stone Capital has informed us that each such broker-dealer will receive commissions
from Tumim Stone Capital that will not exceed customary brokerage commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> Tumim Stone Capital is an &ldquo;underwriter&rdquo;
within the meaning of Section 2(a)(11) of the Securities Act, and any profits on the sales of shares of our Common Stock by Tumim Stone
Capital and any discounts, commissions, or concessions received by Tumim Stone Capital are deemed to be underwriting discounts and commissions
under the Securities Act. We will file a post-effective amendment to the registration statement of which this prospectus forms a part
to identify the name of any permitted transferee of the Investor and such permitted transferee will be named an underwriter with respect
to the shares offered by this prospectus. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Brokers, dealers, underwriters
or agents participating in the distribution of the shares of our Common Stock offered by this prospectus may receive compensation in the
form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by
the selling stockholder through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of
shares of our Common Stock sold by the selling stockholder may be less than or in excess of customary commissions. Neither we nor the
selling stockholder can presently estimate the amount of compensation that any agent will receive from any purchasers of shares of our
Common Stock sold by the selling stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We know of no existing arrangements
between the selling stockholder or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of
the shares of our Common Stock offered by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We may from time to time file
with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part
to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to
disclose certain information relating to a particular sale of shares offered by this prospectus by the selling stockholder, including
the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by the selling stockholder,
any compensation paid by the selling stockholder to any such brokers, dealers, underwriters or agents, and any other required information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will pay the expenses incident to the registration under the Securities
Act of the offer and sale of the shares of our Common Stock covered by this prospectus by the selling stockholder, and have agreed to
reimburse Tumin Stone Capital for the fees and disbursements of its counsel incurred in connection therewith, in an amount not to exceed
$10,000. As consideration for its irrevocable commitment to purchase our Common Stock under the Purchase Agreement, we are required to
issue to Tumim Stone Capital up to 215,054 shares of our Common Stock as the Commitment Shares, which equals $400,000 divided by $1.86,
the average Nasdaq official closing price over the five consecutive trading days ending on the trading day immediately prior to the Company&rsquo;s
initial filing of the registration statement. We also have agreed to reimburse Tumim Stone Capital for the fees and disbursements of its
counsel, payable upon execution of the Purchase Agreement, in an amount not to exceed $80,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We also have agreed to indemnify
Tumim Stone Capital and certain other persons against certain liabilities in connection with the offering of shares of our Common Stock
offered hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required
to be paid in respect of such liabilities. Tumim Stone Capital has agreed to indemnify us against liabilities under the Securities Act
that may arise from certain written information furnished to us by Tumim Stone Capital specifically for use in this prospectus or, if
such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar as indemnification for
liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised
that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore, unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We estimate that the total expenses for the offering will be approximately
$131,500.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Tumim Stone Capital has represented
to us that at no time prior to the date of the Purchase Agreement has Tumim Stone Capital or its agents, representatives or affiliates
engaged in or effected, in any manner whatsoever, directly or indirectly, any short sale (as such term is defined in Rule 200 of Regulation
SHO of the Exchange Act) of our Common Stock or any hedging transaction, which establishes a net short position with respect to our Common
Stock. Tumim Stone Capital has agreed that during the term of the Purchase Agreement, neither Tumim Stone Capital, nor any of its agents,
representatives or affiliates will enter into or effect, directly or indirectly, any of the foregoing transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We have advised the selling
stockholder that it is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M
precludes the selling stockholder, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution
from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution
until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a
security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered
by this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">This offering will terminate
on the date that all shares of our Common Stock offered by this prospectus have been sold by the selling stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Our Common Stock is currently
listed on The Nasdaq Capital Market under the symbol &ldquo;CAPS.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_009"></A>LEGAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain legal matters with respect to the securities
offered hereby will be passed upon by Lucosky Brookman LLP, Woodbridge, New Jersey.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_010"></A><B>EXPERTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements as of December&nbsp;31,
2024 and 2023, and for each of the&nbsp;years in the two-year period ended December&nbsp;31, 2024, incorporated by reference in this prospectus,
have been audited by GBQ Partners LLC, an independent registered public accounting firm. Such financial statements are incorporated by
reference in reliance upon the report of such firm given their authority as experts in accounting and auditing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_011"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC allows us to &ldquo;incorporate by reference&rdquo;
information from other documents that we file with it, which means that we can disclose important information to you by referring you
to those publicly available documents. The information incorporated by reference is considered to be part of this prospectus. Information
in this prospectus supersedes information incorporated by reference that we filed with the SEC prior to the date of this prospectus. We
incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or documents
listed below &nbsp;that we filed with the SEC:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Our Annual Report on <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025026436/ea0235933-10k_capstone.htm">Form 10-K</A> for the year ended December 31, 2024 filed with the SEC on March 31, 2025;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Our Quarterly Report on <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025044408/ea0242293-10q_capstone.htm">Form 10-Q</A> for the period ended March 31, 2025 filed with the SEC on May 15, 2025;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Our Current Report on <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025022822/ea0233925-8k_capstone.htm">Form 8-K</A> filed with the SEC on March 11, 2025; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">The description of our Common Stock contained in our registration statement on <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025013797/ea023111101-8a12b_capstone.htm">Form 8-A12B</A> filed with the SEC on February 14, 2025.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Notwithstanding the statements in the preceding paragraphs, no document, report or exhibit (or portion of any of the foregoing) or any other information that we have &ldquo;furnished&rdquo; to the SEC pursuant to the Exchange Act shall be incorporated by reference into this prospectus.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also incorporate by reference into this prospectus
all documents (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are
related to such items) that are filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after
the date of the initial filing of the registration statement of which this prospectus forms a part and prior to effectiveness of the registration
statement, or (ii) after the date of this prospectus but prior to the termination of the offering. These documents include periodic reports,
such as Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, as well as proxy statements on Schedule
14A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon request, we will provide, without charge,
to each person, including any beneficial owner, to whom a copy of this prospectus is delivered a copy of the documents incorporated by
reference into this prospectus. You may request a copy of these filings, and any exhibits we have specifically incorporated by reference
as an exhibit in this prospectus, at no cost by writing or telephoning us at the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Capstone Holding Corp.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Attn: Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">5141 W. 122nd Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Alsip, IL 60803</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(708) 371-0660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statement contained in a document incorporated
or deemed to be incorporated by reference in this prospectus will be deemed modified, superseded or replaced for purposes of this prospectus
to the extent that a statement contained in this prospectus modifies, supersedes or replaces such statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_012"></A>WHERE YOU CAN FIND MORE INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For further information with respect to our company
and the securities being offered hereby, reference is hereby made to the registration statement, including the exhibits thereto and the
financial statements, notes, and schedules filed as a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No person is authorized to give you any information
or make any representation other than those contained or incorporated by reference in this prospectus. Any such information or representation
must not be relied upon as having been authorized. Neither the delivery of this prospectus nor any sale made hereunder shall, under any
circumstances, create any implication that there has been no change in our affairs since the date of the prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to the informational requirements
of the Exchange Act, and must file reports, proxy statements and other information with the SEC, such as current, quarterly and annual
reports on Forms 8-K, 10-Q and 10-K, respectively. These filings are available on the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>5,190,251 Shares of Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Capstone Holding Corp.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;13. Other Expenses of Issuance and
Distribution</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the costs and expenses, other than underwriting
discounts and commissions, to be paid by the Registrant in connection with the issuance and distribution of the Common Stock being registered.
All amounts other than the SEC registration fees are estimates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; white-space: nowrap; vertical-align: bottom">&nbsp;</TD><TD STYLE="text-align: center; white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; white-space: nowrap; font-weight: bold; text-align: center">Amount to <BR> be Paid</TD><TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: left; text-indent: -10pt; padding-left: 10pt">SEC Registration Fees</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">1,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Legal Fees and Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Accounting Fees and Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"><P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif">36,500</P></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;14. Indemnification of Directors
and Officers</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The restated certificate of incorporation, as
amended, and the bylaws of the Company provide that the Company shall indemnify its officers, directors and certain others to the fullest
extent permitted by the Delaware General Corporation Law (&ldquo;DGCL&rdquo;). Section&nbsp;145 of the DGCL, provides in pertinent part
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(a)</TD><TD STYLE="text-align: justify">A corporation may indemnify any person who was or is a party
or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative (other than an action by or in the right of the corporation) by reason of the fact that he is or was a director, officer,
employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent
of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&rsquo; fees), judgments,
fines and amounts paid in settlement actually and reasonably incurred by him in connection with such action, suit or proceeding if he
acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, with
respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The termination of any action,
suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself,
create a presumption that the person did not act in good faith and in a manner which he reasonably believed to be in or not opposed to
the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his
conduct was unlawful.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(b)</TD><TD STYLE="text-align: justify">A corporation may indemnify any person who was or is a party
or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure
a judgment in its favor by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was
serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture,
trust or other enterprise against expenses (including attorneys&rsquo; fees) actually and reasonably incurred by him in connection with
the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed
to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as
to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery
or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but
in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the
Court of Chancery or such other court shall deem proper.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(c)</TD><TD STYLE="text-align: justify">To the extent that a present or former director or officer
of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections
(a)&nbsp;and (b)&nbsp;of this Section, or in defense of any claim, issue or matter therein, he shall be indemnified against expenses
(including attorneys&rsquo; fees) actually and reasonably incurred by him in connection therewith.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(d)</TD><TD STYLE="text-align: justify">Any indemnification under subsections (a)&nbsp;and (b)&nbsp;of
this Section (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination
that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because he has met
the applicable standard of conduct set forth in subsections (a)&nbsp;and (b)&nbsp;of this Section. Such determination shall be made with
respect to a person who is a director or officer at the time of such determination (1)&nbsp;by a majority vote of directors who are not
parties to such action, suit or proceeding, even though less than a quorum, (2)&nbsp;by a committee of such directors designated by majority
vote of such directors, even though less than a quorum, (3)&nbsp;if there are no such directors, or if such directors so direct, by independent
legal counsel in a written opinion or (4)&nbsp;by the stockholders.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(e)</TD><TD STYLE="text-align: justify">Expenses (including attorneys&rsquo; fees) incurred by an
officer or director in defending any civil, criminal, administrative or investigative action, suit or proceeding may be paid by the corporation
in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director
or officer to repay such amount if it shall ultimately be determined that he is not entitled to be indemnified by the corporation as
authorized in this section. Such expenses (including attorneys&rsquo; fees) incurred by former directors and officers or other employees
and agents may be so paid upon such terms and conditions, if any, as the corporation deems appropriate.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(f)</TD><TD STYLE="text-align: justify">The indemnification and advancement of expenses provided by,
or granted pursuant to, the other subsections of this Section shall not be deemed exclusive of any other rights to which those seeking
indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors
or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(g)</TD><TD STYLE="text-align: justify">A corporation shall have power to purchase and maintain insurance
on behalf of any person, who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request
of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise
against any liability asserted against him and incurred by him in any such capacity, or arising out of his status as such, whether or
not the corporation would have the power to indemnify him against such liability under this Section.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(h)</TD><TD STYLE="text-align: justify">For purposes of this Section, references to &ldquo;the corporation&rdquo;
shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed
in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors,
officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation,
or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, shall stand in the same position under this Section with respect to the resulting
or surviving corporation as he would have with respect to such constituent corporation if its separate existence had continued.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">For purposes of this Section, references to &ldquo;other enterprises&rdquo;
shall include employee benefit plans; references to &ldquo;fines&rdquo; shall include any excise taxes assessed on a person with respect
to any employee benefit plan; and references to &ldquo;serving at the request of the corporation&rdquo; shall include any service as
a director, officer, employee or agent of the corporation, which imposes duties on, or involves services by, such director, officer,
employee, or agent of the corporation, which imposes duties on, or involves services by, such director, officer, employee, or agent with
respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he reasonably
believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner
&ldquo;not opposed to the best interests of the corporation&rdquo; as referred to in this Section.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(j)</TD><TD STYLE="text-align: justify">The indemnification and advancement of expenses provided by,
or granted pursuant to, this Section shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased
to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As permitted by Section&nbsp;102(b)(7)&nbsp;of
the DGCL, the Company&rsquo;s restated certificate of incorporation, as amended, eliminates the personal liability of each of the Company&rsquo;s
directors to the Company and its stockholders for monetary damages for breaches of his or her fiduciary duties as a director except that
a director shall be liable to the extent provided by applicable law (i) for breach of the director&rsquo;s duty of loyalty to the Company
or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law,
(iii) pursuant to Section 174 of the Delaware General Corporation Law or (iv) for any transaction from which the director derived an improper
personal benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;15. Recent Sales of Unregistered
Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following sets forth information regarding
all unregistered securities sold by us in transactions that were exempt from the requirements of the Securities Act in the last three&nbsp;years.
Except where noted, all of the securities discussed in this Item&nbsp;15 were all issued in reliance on the exemption under Section&nbsp;4(a)(2)&nbsp;of
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June&nbsp;15, 2022, Brookstone converted $1.9&nbsp;million
of accrued interest and secured debt into 78,333&nbsp;shares of the Company&rsquo;s Common Stock ($24.75 per share conversion price).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On February 25, 2025, the Company entered into
a subscription agreement with Nectarine Management LLC, an entity controlled by Michael Toporek, for the sale and issuance of 985,063
shares of Series B Preferred Stock for a total purchase price of $30,000. The shares of Series B Preferred Stock were issued on March
6, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 7, 2025, all of TotalStone&rsquo;s outstanding
Class B and Class C membership interests were exchanged for 3,782,641 shares of the Company&rsquo;s Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;16. Exhibits and Financial Statement
Schedules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><B>(a)
EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have filed the exhibits listed on the accompanying
Exhibit Index of this registration statement and below in this Item&nbsp;16:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; padding-bottom: 0pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="padding-left: 0pt; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporated
    by <BR>
    Reference</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 0pt; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    or</B><BR>
    <B>Furnished</B></FONT></TD></TR>
  <TR STYLE="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-left: 0pt; padding-bottom: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 6%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 1%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 0pt; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 55%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 1%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 0pt; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 6%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 1%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 0pt; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 6%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 1%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 0pt; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
    Date</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center; width: 1%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 0pt; border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 10%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith
    &nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> 1.1 </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025050786/ea024391901ex1-1_capstone.htm">Placement
    Agency Agreement, dated May 15, 2025, by and between Capstone Holding Corp. and Joseph Gunnar &amp; Co., LLC</A> </TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"> S-1 </TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 1.1 </P></TD>
    <TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 6/3/2025 </P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex3-1_capst.htm">Restated
    Certificate of Incorporation, dated April&nbsp;22, 2005, as amended on May&nbsp;21, 2010, June&nbsp;22, 2015, August&nbsp;22, 2019,
    February&nbsp;10, 2021, and February&nbsp;18, 2022</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184315003566/exh_42.htm">Bylaws
    of the Company</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-8</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">06/23/2015</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex3-3_capst.htm">Amended
    and Restated Certificate of Designation of Series&nbsp;A Preferred Stock, dated June&nbsp;22, 2015</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex3-4_capst.htm">Form of Certificate of Amendment to the Restated Certificate of Incorporation</A> </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex3-5_capst.htm">Form of Certificate of Designation of Series B Preferred Stock</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT> </TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex4-1_capst.htm"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Representative&rsquo;s Warrant</FONT> </A></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT> </TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT> </TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT> </TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex4-2_capst.htm">Amended
    and Restated Warrant to Purchase Common Stock, dated March&nbsp;20, 2020, issued to BP Peptides, LLC</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184318000822/exh_102.htm">Warrant
    to Purchase Common Stock, dated January&nbsp;30, 2018, issued to BP Peptides, LLC</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/01/2018</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT> </TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025050786/ea024391901ex5-1_capstone.htm">Opinion
    of Lucosky Brookman LLP</A></FONT> </TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT> </TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"> 5.1 </P><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6/3/2025</FONT> </TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex10-1_capst.htm">Form of Indemnification Agreement</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184316011964/exh_101.htm">Series&nbsp;B Preferred Stock and Warrant Purchase Agreement, dated August&nbsp;25, 2016, by and between LipimetiX Development, Inc. and Capstone Therapeutics Corp.</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/26/2016</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317004105/exh_101.htm">Securities
    Purchase, Loan and Security Agreement dated July&nbsp;14, 2017, by and between Capstone Therapeutics Corp. and BP Peptides, LLC</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/17/2017</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184318000822/exh_101.htm">First
    Amendment to Securities Purchase Loan and Security Agreement dated January&nbsp;30, 2018, by and between Capstone Therapeutics, Corp.
    and BP Peptides, LLC</A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/01/2018</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD ROWSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: left; padding-bottom: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR>
    Number</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 0pt"></TD>
    <TD ROWSPAN="2" STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="padding-bottom: 0pt; border-bottom: black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><BR>
    Incorporated by <BR>
    Reference</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    or </B><BR>
    <B>Furnished</B></FONT></TD></TR>
  <TR STYLE="font: bold 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 0pt; border-bottom: black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    Description</B></FONT></TD>
    <TD STYLE="padding-bottom: 0pt; border-bottom: black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; border-bottom: black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center; white-space: nowrap; vertical-align: bottom; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; border-bottom: black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
    Date</B></FONT></TD>
    <TD STYLE="padding-left: 0pt; font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; border-bottom: black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="width: 6%; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; width: 55%; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184319001827/exh_101.htm">Second
    Amendment to Securities Purchase Loan and Security Agreement dated March&nbsp;15, 2019, by and between Capstone Therapeutics, Corp.
    and BP Peptides, LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; width: 1%; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 6%; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; width: 1%; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 6%; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; width: 1%; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 12%; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">03/19/2019</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 10%; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-6_capst.htm">Third
    Amendment to Securities Purchase Loan and Security Agreement dated March&nbsp;27, 2020, by and between Capstone Therapeutics, Corp.
    and BP Peptides, LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-7_capst.htm">Fourth
    Amendment to Securities Purchase Loan and Security Agreement dated March&nbsp;15, 2021, by and between Capstone Therapeutics, Corp.
    and BP Peptides, LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-8_capst.htm">Termination
    of Securities Purchase, Loan and Security Agreement, dated November&nbsp;13, 2024, by and between Capstone Holding Corp. and BP Peptides,
    LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317004105/exh_102.htm">Promissory
    Note dated July&nbsp;14, 2017, payable to BP Peptide, LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/17/2017</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-10_capst.htm">Fourth
    Amended and Restated Operating Agreement of TotalStone, LLC, dated March&nbsp;27, 2020 and Effective as of November&nbsp;26, 2021</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-11_capst.htm">Consent
    and First Amendment to the Fourth Amended and Restated Operating Agreement of TotalStone, LLC, dated March&nbsp;27, 2020 and Effective
    as of November&nbsp;26, 2021</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-12_capst.htm">Second
    Amended and Restated Credit Agreement, dated March&nbsp;8, 2023, by and between TotalStone, LLC, Northeast Masonry Distributors,
    LLC, TotalStone Properties, LLC, and Stream Finance, LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-13_capst.htm">Consent,
    Waiver and Amendment to Second Amended and Restated Credit Agreement, dated October&nbsp;18, 2024, by and between TotalStone, LLC,
    Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Stream Finance, LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-14_capst.htm">Non-negotiable
    Secured Subordinated Promissory Note by and between TotalStone, LLC and Northeast Masonry Distributors, LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-15_capst.htm">Non-negotiable
    Secured Subordinated Contingent Value Promissory Note by and between NEM Purchaser, LLC and Northeast Masonry Distributors, LLC</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-16_capst.htm">Brookstone
    Partners IAC, Inc. Amended and Restated Management Fee Agreement Dated March&nbsp;1, 2020 by and between TotalStone, LLC and Brookstone
    Partners IAC, Inc.</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-17_capst.htm">Management
    Fee Agreement, dated March&nbsp;27, 2020, by and between TotalStone, LLC and Capstone Holding Corp.</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-18_capst.htm">Amendment
    of Amended and Restated Management Fee and Transaction Fee Agreement, dated November&nbsp;15, 2024, by and between Capstone Holding
    Corp., TotalStone, LLC, and Brookstone Partners IAC, Inc.</A></FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="text-align: center; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt; padding-left: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD ROWSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit<BR> Number</B></FONT></TD>
    <TD ROWSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD ROWSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporated by <BR> Reference</B></FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed or<BR> Furnished</B></FONT></TD></TR>
  <TR STYLE="font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit Description</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing Date</B></FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Herewith</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify; width: 55%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-19_capst.htm">Limited Payment Guarantee dated March&nbsp;31, 2021, between Capstone Therapeutics Corp. and Brookstone Acquisition Partners&nbsp;XXI Corporation</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317005009/exh_101.htm">Series&nbsp;B-2 Preferred Stock Purchase Agreement, dated August&nbsp;11, 2017, by and between Capstone Therapeutics Corp. and LipimetiX Development, Inc.</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/14/2017</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317005009/exh_102.htm">First Amendment to the Amended and Restated Stockholders Agreement of LipimetiX Development, Inc., dated August&nbsp;11, 2017</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/14/2017</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000117184317005009/exh_103.htm">Joinder of August&nbsp;25, 2016 Registration Rights Agreement of LipimetiX Development, Inc., dated August&nbsp;11, 2017</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">08/14/2017</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-23_capst.htm">LipimetiX Development, Inc. Contingent Value Rights Agreement, dated August&nbsp;23, 2019, by and among Capstone Therapeutics Corp., the Shareholder Representative and Computershare Inc., and Computershare Trust Company, N.A., as Rights Agent</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-24_capst.htm">Second Amended and Restated Promissory Note, dated November&nbsp;11, 2024, issued by Capstone Holding Corp. to BP Peptides, LLC</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-25_capst.htm">Revolving Credit, Term Loan and Security Agreement by and among TotalStone, LLC, Northeast Masonry Distributors, LLC, TotalStone Properties, LLC, and Berkshire Bank, dated December 20, 2017</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-26_capst.htm">Amendments to Revolving Credit, Term Loan and Security Agreement Still in Effect As of December 30, 2024</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-27_capst.htm">Second Amended and Restated Revolving Credit Note Issued by TotalStone, LLC and Northeast Masonry Distributors, LLC to Berkshire Bank, dated November 14, 2019</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-28_capst.htm">Term Note Issued by TotalStone, LLC, Northeast Masonry Distributors, LLC, and TotalStone Properties, LLC to Berkshire Bank, dated November 22, 2021</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex10-29_capst.htm">Second Amended and Restated Promissory Note Issued by Capstone Holding Corp. to Brookstone Partners Acquisition XXI Corporation, dated November 11, 2024</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex10-30_capst.htm">Form of Master Exchange Agreement by and among Capstone Holding Corp., TotalStone, LLC, and TotalStone&rsquo;s Class B Member</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0pt; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;2/6/2025</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex10-31_capst.htm">Form of Subscription Agreement for Purchase of Series B Preferred Stock</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0pt; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;2/6/2025</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex10-32_capst.htm">Executive Employment Agreement by and between Capstone Holding Corp. and Matthew Lipman</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0pt; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;2/6/2025</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify">10.33</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025010833/ea021443308ex1-1_capst.htm">Form of Underwriting Agreement</A></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt">S-1</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-left: 0pt; padding-bottom: 0pt">1.1</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt">2/6/2025</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34&dagger;</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"> <A HREF="ea024508401ex10-34_capstone.htm">Common Stock Purchase Agreement,
    dated May 14, 2025, by and between Capstone Holding Corp. and Tumim Stone Capital, LLC</A> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 2.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: center; text-indent: -10pt"> X </TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35&dagger;</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"> <A HREF="ea024508401ex10-35_capstone.htm">Registration Rights Agreement,
    dated May 14, 2025, by and between Capstone Holding Corp. and Tumim Stone Capital, LLC</A> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 2.25pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; padding-bottom: 0pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: center; text-indent: -10pt"> X </TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390024114111/ea021443304ex21-1_capst.htm">List of Subsidiaries</A></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2024</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"><A HREF="ea024508401ex23-1_capstone.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of GBQ Partners LLC</FONT></A></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0pt; padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; padding-left: 10pt; text-align: center; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025050786/ea024391901ex5-1_capstone.htm">Consent
    of Lucosky Brookman LLP (included in Exhibit 5.1)</A></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0pt; padding-bottom: 0pt"> 23.2 </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"> 6/3/2025 </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="http://www.sec.gov/Archives/edgar/data/887151/000121390025050786/ea024391901ex-fee_capstone.htm">Filing
    Fee Table</A></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">S-1</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0pt; padding-bottom: 0pt"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0pt; text-align: center; padding-bottom: 2.25pt"> 6/3/2025 </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">&dagger;</TD><TD STYLE="text-align: justify">Schedules and exhibits to this agreement have been omitted.
A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>(b)&nbsp;Financial statement schedules.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All schedules have been omitted because either
they are not required, are not applicable or the information is otherwise set forth in the financial statements and related notes thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item&nbsp;17. Undertakings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">To file, during any period in which offers, or sales are being
made, a post-effective amendment to this registration statement:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">To include any prospectus required by Section&nbsp;10(a)(3)&nbsp;of
the Securities Act&nbsp;of&nbsp;1933;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">To reflect in the prospectus any facts or events arising after
the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the SEC pursuant to Rule&nbsp;424(b)&nbsp;if, in the aggregate, the changes in volume and price represent no more than a 20
percent change in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective
registration statement;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(iii)</TD><TD STYLE="text-align: justify">To include any material information with respect to the plan
of distribution not previously disclosed in the registration statement or any material change to such information in the registration
statement;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">That for the purpose of determining any liability under the
Securities Act&nbsp;of&nbsp;1933 each such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of the offering.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">That, for the purpose of determining liability under the Securities
Act&nbsp;of&nbsp;1933 to any purchaser, each prospectus filed pursuant to Rule&nbsp;424(b)&nbsp;as part of a registration statement relating
to an offering, other than registration statements relying on Rule&nbsp;430B or other than prospectuses filed in reliance on Rule&nbsp;430A,
shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided,
however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document
incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement
will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the
registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such
date of first use.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">That, for the purpose of determining liability of the registrant
under the Securities Act&nbsp;of&nbsp;1933 to any purchaser in the initial distribution of the securities:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The undersigned registrant undertakes
that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting
method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to
such purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">Any preliminary prospectus or prospectus of the undersigned
registrant relating to the offering required to be filed pursuant to Rule&nbsp;424;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">Any free writing prospectus relating to the offering prepared
by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(iii)</TD><TD STYLE="text-align: justify">The portion of any other free writing prospectus relating
to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned
registrant; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(iv)</TD><TD STYLE="text-align: justify">Any other communication that is an offer in the offering made
by the undersigned registrant to the purchaser.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(6)</TD><TD STYLE="text-align: justify">The undersigned Registrant hereby undertakes to provide to
the underwriter at the closing specified in the underwriting agreement certificates in such denominations and registered in such names
as required by the underwriter to permit prompt delivery to each purchaser.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(7)</TD><TD STYLE="text-align: justify">Insofar as indemnification for liabilities arising under the
Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described
in Item&nbsp;14 above, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the
Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">(8)</TD><TD STYLE="text-align: justify">The undersigned Registrant hereby undertakes:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(i)</TD><TD STYLE="text-align: justify">That for purposes of determining any liability under the Securities
Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule&nbsp;430A
and contained in a form of prospectus filed by the Registrant pursuant to Rule&nbsp;424(b)(1)&nbsp;or (4), or 497(h)&nbsp;under the Securities
Act shall be deemed to be part of this registration statement as of the time it was declared effective.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left">(ii)</TD><TD STYLE="text-align: justify">That for the purpose of determining any liability under the
Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating
to the securities offered therein, and this offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> Pursuant to the requirements of the Securities
Act&nbsp;of&nbsp;1933, the Registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized in the City of Alsip, Illinois, on June 9, 2025. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>Capstone Holding Corp.</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%"><I>/s/ Matthew E. Lipman</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Matthew E. Lipman</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Act&nbsp;of&nbsp;1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; border-bottom: Black 1.5pt solid; width: 33%"> <FONT STYLE="font-size: 10pt"><B>Signature</B></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt; width: 1%"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; border-bottom: Black 1.5pt solid; text-align: center; width: 40%"> <FONT STYLE="font-size: 10pt"><B>Title</B></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt; width: 1%"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; border-bottom: Black 1.5pt solid; text-align: center; width: 25%"> <FONT STYLE="font-size: 10pt"><B>Date</B></FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0pt"> <FONT STYLE="font-size: 10pt"><I>/s/ Matthew E. Lipman</I></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">Chief Executive Officer and Director</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">June 9, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Matthew E. Lipman</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">(Principal Executive Officer)</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0pt"> <FONT STYLE="font-size: 10pt"><I>/s/ Edward C. Schultz</I></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">June 9, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Edward C.&nbsp;Schultz</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">(Principal Financial and Accounting Officer)</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0pt"> <FONT STYLE="font-size: 10pt"><I>/s/ Michael M. Toporek</I></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">Chairman</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">June 9, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Michael M. Toporek, III</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0pt"> <FONT STYLE="font-size: 10pt"><I>/s/ Charles Dana</I></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">June 9, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Charles Dana</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0pt"> <FONT STYLE="font-size: 10pt"><I>/s/ John M. Holliman</I></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">June 9, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; text-align: justify"> <FONT STYLE="font-size: 10pt">John M.&nbsp;Holliman, III</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0pt"> <FONT STYLE="font-size: 10pt"><I>/s/ Gordon Strout</I></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">June 9, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Gordon Strout</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0pt"> <FONT STYLE="font-size: 10pt"><I>/s/ Fredric J. Feldman</I></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">June 9, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Fredric J. Feldman</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> &nbsp; </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0pt"> <FONT STYLE="font-size: 10pt"><I>/s/ Elwood D. Howse</I></FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt; text-align: center"> <FONT STYLE="font-size: 10pt">June 9, 2025</FONT> </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 0pt; text-align: justify"> <FONT STYLE="font-size: 10pt">Elwood D. Howse</FONT> </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 0pt"> &nbsp; </TD>
    <TD STYLE="padding-bottom: 0pt"> &nbsp; </TD></TR>
  </TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">II-9</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 1.5pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.34
<SEQUENCE>2
<FILENAME>ea024508401ex10-34_capstone.htm
<DESCRIPTION>COMMON STOCK PURCHASE AGREEMENT, DATED MAY 14, 2025, BY AND BETWEEN CAPSTONE HOLDING CORP. AND TUMIM STONE CAPITAL, LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><P STYLE="font: normal bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-variant: normal"><B>Exhibit</B></FONT><B>
10.34</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution Version</I></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">COMMON STOCK PURCHASE
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">dated
as of May 14, 2025</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">by
and between</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">CAPSTONE HOLDING
CORP.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">and</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>



<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 9.65pt; text-align: center">TUMIM STONE CAPITAL, LLC</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">table of contents</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article I DEFINITIONS</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="width: 14%; padding-right: 0.25in; text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="width: 78%; padding-right: 0.25in; text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="width: 8%; padding-right: 0.25in; text-align: center; text-transform: uppercase">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article II PURCHASE AND SALE OF COMMON STOCK</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 2.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Purchase and Sale of Stock</FONT></TD>
    <TD STYLE="text-align: center">1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 2.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Closing Date; Settlement Dates</FONT></TD>
    <TD STYLE="text-align: center">2</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 2.3</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Initial Public Announcement and Required Filings</FONT></TD>
    <TD STYLE="text-align: center">2</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 2.4</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Commitment Shares</FONT></TD>
    <TD STYLE="text-align: center">3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: center; text-transform: uppercase">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article III PURCHASE TERMS</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 3.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">VWAP Purchases</FONT></TD>
    <TD STYLE="text-align: center">3</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 3.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Settlement</FONT></TD>
    <TD STYLE="text-align: center">4</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 3.3</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Compliance with Rules of Trading Market</FONT></TD>
    <TD STYLE="text-align: center">5</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 3.4</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Beneficial Ownership Limitation</FONT></TD>
    <TD STYLE="text-align: center">5</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: center; text-transform: uppercase">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article IV REPRESENTATIONS AND WARRANTIES OF THE INVESTOR</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">6</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Organization and Standing of the Investor</FONT></TD>
    <TD STYLE="text-align: center">6</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Authorization and Power</FONT></TD>
    <TD STYLE="text-align: center">6</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.3</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Conflicts</FONT></TD>
    <TD STYLE="text-align: center">6</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.4</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Investment Purpose</FONT></TD>
    <TD STYLE="text-align: center">7</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.5</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Accredited Investor Status</FONT></TD>
    <TD STYLE="text-align: center">7</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.6</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Reliance on Exemptions</FONT></TD>
    <TD STYLE="text-align: center">7</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.7</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Information</FONT></TD>
    <TD STYLE="text-align: center">7</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.8</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Governmental Review</FONT></TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.9</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No General Solicitation</FONT></TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.10</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Not an Affiliate</FONT></TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.11</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Prior Short Sales</FONT></TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.12</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Statutory Underwriter Status</FONT></TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 4.13</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Resales of Securities</FONT></TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: center; text-transform: uppercase">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article V REPRESENTATIONS AND WARRANTIES OF THE COMPANY</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">9</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Organization, Good Standing and Power</FONT></TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Authorization, Enforcement</FONT></TD>
    <TD STYLE="text-align: center">9</TD></TR>

<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.3</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Capitalization</FONT></TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.4</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Issuance of Securities</FONT></TD>
    <TD STYLE="text-align: center">10</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.5</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Conflicts</FONT></TD>
    <TD STYLE="text-align: center">10</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.6</FONT></TD>
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><FONT STYLE="font-size: 10pt">SEC Documents, Financial Statements; Disclosure Controls and Procedures; Internal Controls Over Financial Reporting; Accountants</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">11</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.7</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Subsidiaries</FONT></TD>
    <TD STYLE="text-align: center">13</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.8</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Material Adverse Effect or Material Adverse Change</FONT></TD>
    <TD STYLE="text-align: center">13</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.9</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Undisclosed Liabilities</FONT></TD>
    <TD STYLE="text-align: center">13</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.10</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Undisclosed Events or Circumstances</FONT></TD>
    <TD STYLE="text-align: center">13</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.11</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Indebtedness; Solvency</FONT></TD>
    <TD STYLE="text-align: center">14</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.12</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Title To Assets</FONT></TD>
    <TD STYLE="text-align: center">14</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.13</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Actions Pending</FONT></TD>
    <TD STYLE="text-align: center">14</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.14</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Compliance With Law; Compliance with Continued Listing Standards</FONT></TD>
    <TD STYLE="text-align: center">14</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.15</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Certain Fees</FONT></TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.16</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Disclosure</FONT></TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.17</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Operation of Business</FONT></TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.18</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Environmental Compliance</FONT></TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.19</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Material Agreements</FONT></TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.20</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Transactions With Affiliates</FONT></TD>
    <TD STYLE="text-align: center">16</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">table of contents</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(continued)</P>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in; width: 14%"><FONT STYLE="font-size: 10pt">Section 5.21</FONT></TD>
    <TD STYLE="text-indent: 0in; width: 78%"><FONT STYLE="font-size: 10pt">Employees; Labor Laws</FONT></TD>
    <TD STYLE="text-align: center; width: 8%">17</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.22</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Investment Company Act Status</FONT></TD>
    <TD STYLE="text-align: center">17</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.23</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">ERISA</FONT></TD>
    <TD STYLE="text-align: center">17</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.24</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Taxes</FONT></TD>
    <TD STYLE="text-align: center">18</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.25</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Insurance</FONT></TD>
    <TD STYLE="text-align: center">18</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.26</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Exemption from Registration</FONT></TD>
    <TD STYLE="text-align: center">18</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.27</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No General Solicitation or Advertising</FONT></TD>
    <TD STYLE="text-align: center">18</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.28</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Integrated Offering</FONT></TD>
    <TD STYLE="text-align: center">18</TD></TR>

  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.29</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Dilutive Effect</FONT></TD>
    <TD STYLE="text-align: center">18</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.30</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Manipulation of Price</FONT></TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.31</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Securities Act</FONT></TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.32</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Listing and Maintenance Requirements; DTC Eligibility</FONT></TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.33</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Application of Takeover Protections</FONT></TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.34</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Unlawful Payments</FONT></TD>
    <TD STYLE="text-align: center">20</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.35</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Money Laundering Laws</FONT></TD>
    <TD STYLE="text-align: center">20</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.36</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">OFAC</FONT></TD>
    <TD STYLE="text-align: center">20</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.37</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">U.S. Real Property Holding Corporation</FONT></TD>
    <TD STYLE="text-align: center">21</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.38</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Bank Holding Company Act</FONT></TD>
    <TD STYLE="text-align: center">21</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.39</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Information Technology; Compliance With Data Privacy Laws</FONT></TD>
    <TD STYLE="text-align: center">21</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.40</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Disqualification Events</FONT></TD>
    <TD STYLE="text-align: center">21</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.41</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Accuracy of Certain Summaries and Statements</FONT></TD>
    <TD STYLE="text-align: center">22</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 5.42</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Acknowledgement Regarding Investor&rsquo;s Acquisition of Securities</FONT></TD>
    <TD STYLE="text-align: center">22</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: center; text-transform: uppercase"></TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article VI COVENANTS</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">22</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Securities Compliance</FONT></TD>
    <TD STYLE="text-align: center">22</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Reservation of Common Stock</FONT></TD>
    <TD STYLE="text-align: center">23</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.3</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Registration and Listing</FONT></TD>
    <TD STYLE="text-align: center">23</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.4</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Compliance with Laws</FONT></TD>
    <TD STYLE="text-align: center">24</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.5</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Keeping of Records and Books of Account; Due Diligence</FONT></TD>
    <TD STYLE="text-align: center">24</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.6</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">No Frustration; No Variable Rate Transactions</FONT></TD>
    <TD STYLE="text-align: center">25</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.7</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Corporate Existence</FONT></TD>
    <TD STYLE="text-align: center">25</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.8</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Fundamental Transaction</FONT></TD>
    <TD STYLE="text-align: center">25</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.9</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Selling Restrictions</FONT></TD>
    <TD STYLE="text-align: center">26</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.10</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Effective Registration Statement</FONT></TD>
    <TD STYLE="text-align: center">26</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.11</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Blue Sky</FONT></TD>
    <TD STYLE="text-align: center">26</TD></TR>

<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.12</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Non-Public Information</FONT></TD>
    <TD STYLE="text-align: center">26</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.13</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Broker/Dealer</FONT></TD>
    <TD STYLE="text-align: center">27</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.14</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Disclosure Schedule</FONT></TD>
    <TD STYLE="text-align: center">27</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 6.15</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Delivery of Bring-Down Opinions and Compliance Certificates Upon Occurrence of Certain Events</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">27</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: center; text-transform: uppercase">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article VII CONDITIONS TO CLOSING AND CONDITIONS to the SALE AND PURCHASE OF THE SHARES</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; text-transform: uppercase">30</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 7.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Conditions to Closing</FONT></TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 7.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Conditions Precedent to Commencement</FONT></TD>
    <TD STYLE="text-align: center">31</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 7.3</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Conditions Precedent to VWAP Purchases after Commencement Date</FONT></TD>
    <TD STYLE="text-align: center">34</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: center; text-transform: uppercase">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article VIII TERMINATION</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">37</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 8.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Automatic Termination</FONT></TD>
    <TD STYLE="text-align: center">37</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 8.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Other Termination</FONT></TD>
    <TD STYLE="text-align: center">37</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 8.3</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Effect of Termination</FONT></TD>
    <TD STYLE="text-align: center">38</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">table of contents</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(continued)</P>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding-left: 0in; text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article IX INDEMNIFICATION</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">39</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 9.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Indemnification of Investor</FONT></TD>
    <TD STYLE="text-align: center">39</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 9.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Indemnification Procedures</FONT></TD>
    <TD STYLE="text-align: center">40</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase">&nbsp;</TD>
    <TD STYLE="text-align: center; text-transform: uppercase">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; text-transform: uppercase"><FONT STYLE="font-size: 10pt">Article X MISCELLANEOUS</FONT></TD>
    <TD STYLE="text-align: center; text-transform: uppercase">40</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.1</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Certain Fees and Expenses; Commitment Fee; Commencement Irrevocable Transfer Agent Instructions</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center">40</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.2</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Specific Enforcement, Consent to Jurisdiction, Waiver of Jury Trial</FONT></TD>
    <TD STYLE="text-align: center">42</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.3</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Entire Agreement</FONT></TD>
    <TD STYLE="text-align: center">42</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.4</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: center">43</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.5</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Waivers</FONT></TD>
    <TD STYLE="text-align: center">43</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.6</FONT></TD>
    <TD STYLE="text-indent: 0in"><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Amendments</P></TD>
    <TD STYLE="text-align: center">43</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.7</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Headings</FONT></TD>
    <TD STYLE="text-align: center">44</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.8</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Construction</FONT></TD>
    <TD STYLE="text-align: center">44</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in"><FONT STYLE="font-size: 10pt">Section 10.9</FONT></TD>
    <TD STYLE="text-indent: 0in"><FONT STYLE="font-size: 10pt">Binding Effect</FONT></TD>
    <TD STYLE="text-align: center">44</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in">Section 10.10</TD>
    <TD STYLE="text-indent: 0in">No Third-Party Beneficiaries</TD>
    <TD STYLE="text-align: center">44</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in">Section 10.11</TD>
    <TD STYLE="text-indent: 0in">Governing Law</TD>
    <TD STYLE="text-align: center">44</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in">Section 10.12</TD>
    <TD STYLE="text-indent: 0in">Survival</TD>
    <TD STYLE="text-align: center">44</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in">Section 10.13</TD>
    <TD STYLE="text-indent: 0in">Counterparts</TD>
    <TD STYLE="text-align: center">44</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in">Section 10.14</TD>
    <TD STYLE="text-indent: 0in">Publicity</TD>
    <TD STYLE="text-align: center">45</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in">Section 10.15</TD>
    <TD STYLE="text-indent: 0in">Severability</TD>
    <TD STYLE="text-align: center">45</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in">Section 10.16</TD>
    <TD STYLE="text-indent: 0in">Further Assurances</TD>
    <TD STYLE="text-align: center">45</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>

<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 14%"><FONT STYLE="font-size: 10pt"><U>Annex I</U></FONT></TD>
    <TD STYLE="width: 78%"><FONT STYLE="font-size: 10pt">Definitions</FONT></TD>
    <TD STYLE="text-align: center; width: 8%">I-1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><U>Exhibit A</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Registration Rights Agreement</FONT></TD>
    <TD STYLE="text-align: center">A-1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt"><U>Exhibit B</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form of VWAP Purchase Notice</FONT></TD>
    <TD STYLE="text-align: center">B-1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><U>Exhibit C</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form of VWAP Purchase Confirmation</FONT></TD>
    <TD STYLE="text-align: center">C-1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt"><U>Exhibit D</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form of Closing Certificate</FONT></TD>
    <TD STYLE="text-align: center">D-1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD><FONT STYLE="font-size: 10pt"><U>Exhibit E</U></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Form of Compliance Certificate</FONT></TD>
    <TD STYLE="text-align: center">E-1</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Disclosure Schedule</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-transform: uppercase; text-align: justify; text-indent: -76.5pt">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>COMMON
STOCK PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This COMMON
STOCK PURCHASE AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;) is made and entered into as of May 14, 2025, by and between Tumim Stone
Capital, LLC, a Delaware limited liability company (the &ldquo;<B>Investor</B>&rdquo;), and Capstone Holding Corp., a Delaware corporation
with offices located at 5141 W. 122nd Street, Alsip, IL 60803 (the &ldquo;<B>Company</B>&rdquo; and, together with the Investor, the &ldquo;<B>Parties</B>&rdquo;).</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>RECITALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Parties desire
that, upon the terms and subject to the conditions and limitations set forth herein, the Company may issue and sell to the Investor, from
time to time as provided herein, and the Investor shall purchase from the Company, up to the lesser of: (a)&nbsp;$20,000,000 in aggregate
gross purchase price of newly issued shares of the Company&rsquo;s common stock, $0.0005 par value per share (&ldquo;<B>Common Stock</B>&rdquo;);
and (b)&nbsp;the Exchange Cap (to the extent applicable under <U>Section&nbsp;3.3</U> hereof);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, such sales of Common
Stock by the Company to the Investor shall be made in reliance upon the provisions of Section&nbsp;4(a)(2) of the Securities Act (&ldquo;<B>Section&nbsp;4(a)(2)</B>&rdquo;)
or Rule 506(b)&nbsp;of Regulation D promulgated by the SEC under the Securities Act (&ldquo;<B>Regulation D</B>&rdquo;), and upon such
other exemption from the registration requirements of the Securities Act as may be available with respect to any or all of the sales of
Common Stock to the Investor to be made hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Parties are concurrently
entering into a Registration Rights Agreement in the form attached as <U>Exhibit A</U> hereto (the &ldquo;<B>Registration Rights Agreement</B>&rdquo;),
pursuant to which the Company shall agree to register the resale of the Registrable Securities (as defined in the Registration Rights
Agreement), upon the terms and subject to the conditions set forth therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, in consideration
for the Investor&rsquo;s execution and delivery of this Agreement and its obligation to purchase shares of Common Stock from the Company
upon the terms and subject to the conditions set forth in this Agreement, the Company will cause its transfer agent to issue to the Investor
the Commitment Shares or the Commitment Fee pursuant to and in accordance with <U>Section&nbsp;2.4</U> or <U>Section 10.1(b)</U>, as applicable
and, in each case, upon the terms and subject to the conditions set forth herein and therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, the Parties,
intending to be legally bound, hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;I<BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">Capitalized terms
used but not defined in this Agreement shall have the meanings ascribed to such terms in <U>Annex I</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;II<BR>
</B></FONT><B>PURCHASE AND SALE OF COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;2.1&nbsp;</B><U>Purchase
and Sale of Stock</U>. Upon the terms and subject to the conditions of this Agreement, during the Investment Period, the Company, in
its sole discretion, shall have the right, but not the obligation, to issue and sell to the Investor, and the Investor shall purchase
from the Company, up to the lesser of: (a)&nbsp;$20,000,000 in aggregate gross purchase price of duly authorized, validly issued, fully
paid and non-assessable shares of Common Stock (the amount thereof, the &ldquo;<B>Total Commitment</B>&rdquo;); and (b)&nbsp;the Exchange
Cap, to the extent applicable under <U>Section&nbsp;3.3</U> (such lesser amount of shares of Common Stock, the &ldquo;<B>Aggregate Limit</B>&rdquo;),
by the delivery to the Investor of VWAP Purchase Notices in the form attached as <U>Exhibit B</U> hereto and as provided in <U>Article&nbsp;III</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;2.2&nbsp;</B><U>Closing
Date; Settlement Dates</U>. This Agreement shall become effective and binding (the &ldquo;<B>Closing</B>&rdquo;) upon: (a)&nbsp;the payment
of the Investor Expense Reimbursement to the Investor at or prior to the Closing pursuant to <U>Sections 7.1</U> and <U>10.1(a)</U>;
(b)&nbsp;the delivery of counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each of the
Parties; and (c)&nbsp;the delivery of all other documents, instruments and writings required to be delivered at the Closing, in each
case as provided in <U>Section&nbsp;7.1</U>, to the offices of Stradling Yocca Carlson &amp; Rauth LLP, 660 Newport Center Drive, Newport
Beach, California 92660, at 4:00 p.m., New York City time, or at such other time as the Parties may agree, on the Closing Date. In consideration
of and in express reliance upon the representations, warranties and covenants contained in, and upon the terms and subject to the conditions
of, this Agreement, during the Investment Period the Company shall issue and sell to the Investor, and the Investor shall purchase from
the Company, the Shares in respect of each VWAP Purchase. The payment for, against simultaneous delivery of, the Shares in respect of
each VWAP Purchase shall occur in accordance with <U>Section&nbsp;3.2</U>, provided that all of the conditions precedent in <U>Article&nbsp;VII</U>
shall have been fulfilled at the applicable times set forth in <U>Article&nbsp;VII</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;2.3&nbsp;</B><U>Initial
Public Announcement and Required Filings</U>. The Company shall, within the time period required under the Exchange Act, file with the
SEC a Current Report on Form 8-K describing the material terms of the transactions contemplated by the Transaction Documents, including,
without limitation, attaching as exhibits thereto copies of each of this Agreement, the Registration Rights Agreement and, if applicable,
any press release issued by the Company disclosing the execution of this Agreement by the Company (including all exhibits thereto, the
&ldquo;<B>Current Report</B>&rdquo;). The Company shall provide the Investor a reasonable opportunity to comment on a draft of the Current
Report prior to filing the Current Report with the SEC and shall give due consideration to all such comments. From and after the filing
of the Current Report with the SEC, the Company shall have publicly disclosed all material, nonpublic information delivered to the Investor
(or the Investor&rsquo;s representatives or agents) by the Company, or any of its officers, directors, employees, agents or representatives
(if any) in connection with the transactions contemplated by the Transaction Documents. The Investor covenants that until such time as
the transactions contemplated by this Agreement are publicly disclosed by the Company as described in this <U>Section&nbsp;2.3</U>, the
Investor shall maintain the confidentiality of all disclosures made to it in connection with the transactions contemplated by the Transaction
Documents (including the existence and terms of the transactions), except that the Investor may disclose the terms of such transactions
to its financial, accounting, legal and other advisors (provided that the Investor directs such Persons to maintain the confidentiality
of such information). Not later than fifteen (15) calendar days following the Closing Date, the Company shall file a Form D with respect
to the issuance and sale of the Securities in accordance with Regulation D and shall provide a copy thereof to the Investor promptly
after such filing. The Company shall use its commercially reasonable efforts to prepare and, as soon as practicable, but in no event
later than the applicable Filing Deadline, file with the SEC the Initial Registration Statement and any Subsequent Registration Statement
covering only the resale by the Investor of the Registrable Securities in accordance with the Securities Act and the Registration Rights
Agreement. At or before 5:30 p.m. New York City time on the second (2nd) Trading Day immediately following the Effective Date of the
Initial Registration Statement and any Subsequent Registration Statement (or any post-effective amendment thereto), the Company shall
file with the SEC in accordance with Rule 424(b)&nbsp;under the Securities Act the final Prospectus to be used in connection with sales
pursuant to such Registration Statement (or post-effective amendment thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;2.4&nbsp;</B><U>Commitment
Shares</U>. In consideration for the Investor&rsquo;s execution and delivery of this Agreement and its obligation to purchase shares
of Common Stock from the Company on the terms and subject to the conditions set forth in this Agreement, concurrently with the execution
and delivery of this Agreement on the Closing Date, the Company shall deliver irrevocable instructions to its Transfer Agent to electronically
issue to the Investor or its designee(s) the Commitment Shares as DWAC Shares, such that the Commitment Shares are credited to the Investor&rsquo;s
or its designee&rsquo;s specified DWAC account with DTC under its Fast Automated Securities Transfer (FAST) Program not later than 4:00
p.m. New York City time on the Trading Day immediately following the Effective Date, all of which Commitment Shares shall be registered
for resale under the Securities Act pursuant to the Initial Registration Statement and the Investor shall be permitted to utilize the
Prospectus therein to resell the Shares, including but not limited to the Commitment Shares, included in such Prospectus, all of which
shall be freely tradable and transferable and without restriction on resale, without restrictive legend, and without any stop transfer
instructions maintained against the transfer thereof; <U>provided</U>, <U>however</U>, that (a) if (i) the Initial Registration Statement
is not filed by the Company with the SEC on or before the Filing Deadline in accordance with the Company&rsquo;s obligations under Section
2(a) of the Registration Rights Agreement; or (ii)&nbsp;the Initial Registration Statement is not declared effective under the Securities
Act by the SEC on or before the Effectiveness Deadline, then effective immediately following the first to occur of the events described
in the forgoing clauses (i) and (ii) (each, a &ldquo;<B>Registration Failure</B>&rdquo;), or (b)&nbsp;this Agreement shall be earlier
terminated pursuant to <U>Section&nbsp;8.1</U> or <U>Section&nbsp;8.2</U> hereof, then, in either of the cases described in the forgoing
clauses (a) and (b), and effective immediately following the occurrence thereof, the obligations of the Company with respect to the issuance
of the Commitment Shares to the Investor pursuant to the forgoing provisions of this <U>Section&nbsp;2.4</U> shall terminate and the
Company shall become obligated to pay to the Investor the Commitment Fee pursuant to and in accordance with <U>Section&nbsp;10.1(b)</U>.
For the avoidance of doubt, the Company shall become obligated to issue all of the Commitment Shares (or pay the full Commitment Fee
in lieu thereof, as applicable) pursuant to the terms of this Agreement upon the consummation of the Closing and effective as of the
Closing Date, regardless of whether any VWAP Purchases are made or settled hereunder or any subsequent termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;III<BR>
PURCHASE TERMS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">Subject to the satisfaction
or (to the extent permitted by applicable law) waiver of the conditions set forth in Article&nbsp;VII, the Parties agree (unless otherwise
mutually agreed upon by the Parties in writing) as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;3.1&nbsp;</B><U>VWAP
Purchases</U>. Upon the initial satisfaction of all of the conditions set forth in <U>Section&nbsp;7.2</U> (such event, the &ldquo;<B>Commencement</B>&rdquo;
and the date of initial satisfaction of all of such conditions, the &ldquo;<B>Commencement Date</B>&rdquo;) and from time to time thereafter,
subject to the satisfaction of all of the conditions set forth in <U>Section&nbsp;7.3</U> and in this <U>Section&nbsp;3.1</U>, the Company
shall have the right, but not the obligation, to direct the Investor, by its delivery to the Investor of a VWAP Purchase Notice on a
VWAP Purchase Exercise Date to purchase the applicable VWAP Purchase Share Amount, not to exceed the applicable VWAP Purchase Maximum
Amount, at the applicable VWAP Purchase Price therefor (as confirmed in the applicable VWAP Purchase Confirmation) in accordance with
this Agreement (each such purchase, a &ldquo;<B>VWAP Purchase</B>&rdquo;). The Company may deliver to the Investor a VWAP Purchase Notice
on a VWAP Purchase Exercise Date, provided that: (a)&nbsp;the Company may not deliver more than one (1) VWAP Purchase Notice to the Investor
on any single Trading Day; (b) at least three (3) Trading Days have elapsed since the Trading Day on which most recent prior VWAP Purchase
Notice was delivered by the Company to the Investor, in each case pursuant to and in accordance with this Agreement; (c)&nbsp;all Shares
subject to all prior VWAP Purchase Notices (as applicable) delivered by the Company to the Investor pursuant to this Agreement (if any)
have theretofore been received by the Investor or its Broker-Dealer as DWAC Shares; and (d) the Company shall not deliver any VWAP Purchase
Notice or otherwise effectuate a VWAP Purchase during any Price Reset Period, and any VWAP Purchase Notice delivered during a Price Reset
Period shall be deemed null and void <I>ab initio</I> and of no force and effect, and the Investor shall have no obligation to purchase
any Shares in connection therewith. The Investor is obligated to accept each VWAP Purchase Notice prepared and delivered by the Company
in accordance with the terms of and subject to the satisfaction of the foregoing and other conditions contained in this Agreement. If
the Company delivers any VWAP Purchase Notice directing the Investor to purchase a VWAP Purchase Share Amount in excess of the applicable
VWAP Purchase Maximum Amount that the Company is then permitted to include in such VWAP Purchase Notice, such VWAP Purchase Notice shall
be void ab initio to the extent of the amount by which the VWAP Purchase Share Amount set forth in such VWAP Purchase Notice exceeds
such applicable VWAP Purchase Maximum Amount, and the Investor shall have no obligation to purchase such excess Shares in respect of
such VWAP Purchase Notice; <U>provided</U>, <U>however</U>, that the Investor shall remain obligated to purchase the applicable VWAP
Purchase Maximum Amount in such VWAP Purchase. At or prior to 9:30&nbsp;a.m., New York City time, on the Trading Day immediately following
the VWAP Purchase Valuation Period for each VWAP Purchase (the &ldquo;<B>VWAP Purchase Date</B>&rdquo;), the Investor shall provide to
the Company a written confirmation for such VWAP Purchase setting forth the applicable VWAP Purchase Share Amount and the applicable
VWAP Purchase Price (both on a per Share basis and the total aggregate VWAP Purchase Price to be paid by the Investor for such applicable
VWAP Purchase Share Amount) for such VWAP Purchase (each, in the form attached as <U>Exhibit C</U> hereto, a &ldquo;<B>VWAP Purchase
Confirmation</B>&rdquo;). Notwithstanding the foregoing, the Company shall not deliver any VWAP Purchase Notices to the Investor during
the PEA Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;3.2&nbsp;</B><U>Settlement</U>.
The payment for, against simultaneous delivery of, Shares in respect of each VWAP Purchase shall be settled on the applicable VWAP Purchase
Date for such VWAP Purchase. For each VWAP Purchase, the Investor shall pay to the Company an amount in cash equal to the product of:
(a)&nbsp;the total number of Shares purchased by the Investor in such VWAP Purchase (as confirmed in the applicable VWAP Purchase Confirmation);
and (b)&nbsp;the applicable VWAP Purchase Price for such Shares (as confirmed in the applicable VWAP Purchase Confirmation), in each
case as full payment for such Shares, via wire transfer of immediately available funds on the same Trading Day that the Investor receives
such Shares as DWAC Shares in accordance with this Agreement, if all of such Shares are so received by the Investor before 1:00 p.m.,
New York City time, or, if such Shares are received by the Investor after 1:00 p.m., New York City time, then payment therefor shall
be made on the Trading Day immediately following the Trading Day on which the Investor has received all of such Shares as DWAC Shares.
If the Company or the Transfer Agent shall fail for any reason, other than a failure of the Investor or its Broker-Dealer to set up a
DWAC and required instructions, to electronically transfer any Shares as DWAC Shares in respect of a VWAP Purchase within three (3) Trading
Days following the receipt by the Company of the applicable purchase price therefor in compliance with this <U>Section&nbsp;3.2</U>,
and if on or after such Trading Day the Investor purchases (in an open market transaction or otherwise) shares of Common Stock to deliver
in satisfaction of a sale by the Investor of such Shares that the Investor anticipated receiving from the Company in respect of such
VWAP Purchase, then the Company shall, within three (3) Trading Days after the Investor&rsquo;s request, either: (i)&nbsp;pay cash to
the Investor in an amount equal to the Investor&rsquo;s total purchase price (including brokerage commissions, if any) for the shares
of Common Stock so purchased (the &ldquo;<B>Cover Price</B>&rdquo;), at which point the Company&rsquo;s obligation to deliver such Shares
as DWAC Shares shall terminate; or (ii)&nbsp;promptly honor its obligation to deliver to the Investor such Shares as DWAC Shares and
pay cash to the Investor in an amount equal to the excess (if any) of the Cover Price over the total purchase price paid by the Investor
pursuant to this Agreement for all of the Shares to be purchased by the Investor in connection with such VWAP Purchase. The Company shall
not issue any fraction of a share of Common Stock upon any VWAP Purchase. If the issuance would result in the issuance of a fraction
of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up or down to the nearest whole share. All
payments made under this Agreement shall be made in lawful money of the United States of America or wire transfer of immediately available
funds to such account as the Company may from time to time designate by written notice in accordance with the provisions of this Agreement.
Whenever any amount expressed to be due by the terms of this Agreement is due on any day that is not a Trading Day, the same shall instead
be due on the next succeeding day that is a Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;3.3&nbsp;</B><U>Compliance
with Rules of Trading Market</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Exchange
Cap</U>. Subject to <U>Section&nbsp;3.3(c)</U>, and until Stockholder Approval (as defined below) is obtained, the Company shall not issue
or sell any shares of Common Stock pursuant to this Agreement, and the Investor shall not purchase or acquire any shares of Common Stock
pursuant to this Agreement, to the extent that after giving effect thereto, the aggregate number of shares of Common Stock that would
be issued pursuant to this Agreement and the transactions contemplated hereby would exceed 1,038,050 (representing 19.99% of the number
of shares of Common Stock issued and outstanding immediately prior to the execution of this Agreement), which number of shares shall be
reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series
of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules of the Trading Market
(such maximum number of shares, the &ldquo;<B>Exchange Cap</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Stockholder
Approval</U>. As soon as practicable after the Closing Date, but in any event no later than seventy-five (75) days thereafter, the Company
shall obtain the written consent of a majority of its stockholders to approve of a waiver of the Exchange Cap and, if needed, an increase
in the authorized number of shares of Common Stock to ensure that the number of authorized shares is sufficient to meet the Required Reserve
Amount (approval of all such proposals, the &ldquo;<B>Stockholder Approval</B>&rdquo;). For the avoidance of doubt, if the Company fails
to obtain Stockholder Approval, the Exchange Cap shall be applicable for all purposes of this Agreement and the transactions contemplated
hereby at all times during the term of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>At-Market
Transaction</U>. Notwithstanding <U>Section&nbsp;3.3(a)</U> above, the Exchange Cap shall not be applicable for any purposes of this Agreement
and the transactions contemplated hereby, solely to the extent that (and only for so long as) the Average Price shall equal or exceed
the Minimum Price (it being hereby acknowledged and agreed that the Exchange Cap shall be applicable for all purposes of this Agreement
and the transactions contemplated hereby at all other times during the term of this Agreement, unless Stockholder Approval is obtained).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;<U>General</U>.
The Company shall not issue or sell any shares of Common Stock pursuant to this Agreement if such issuance or sale would reasonably be
expected to result in: (i)&nbsp;a violation of the Securities Act; or (ii)&nbsp;a breach of the rules of the Trading Market. The provisions
of this <U>Section&nbsp;3.3</U> shall be implemented in a manner otherwise than in strict conformity with the terms of this <U>Section&nbsp;3.3</U>
only if necessary to ensure compliance with the Securities Act and the applicable rules of the Trading Market. The limitations contained
in this <U>Section&nbsp;3.3</U> may not be waived by the Company or the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;3.4&nbsp;</B><U>Beneficial
Ownership Limitation</U>. Notwithstanding anything to the contrary contained in this Agreement, the Company shall not issue or sell,
and the Investor shall not purchase or acquire, any shares of Common Stock under this Agreement which, when aggregated with all other
shares of Common Stock then beneficially owned by the Investor and its affiliates (as calculated pursuant to Section&nbsp;13(d)&nbsp;of
the Exchange Act and Rule 13d-3 promulgated thereunder), would result in the beneficial ownership by the Investor of more than 4.99%
of the outstanding shares of Common Stock (the &ldquo;<B>Beneficial Ownership Limitation</B>&rdquo;). If the Company issues a VWAP Purchase
Notice with respect to any VWAP Purchase that would cause the aggregate number of shares of Common Stock then beneficially owned (as
calculated pursuant to Section&nbsp;13(d)&nbsp;of the Exchange Act and Rule 13d-3 promulgated thereunder) by the Investor and its Affiliates
to exceed the Beneficial Ownership Limitation, such VWAP Purchase Notice shall be void <I>ab initio</I> to the extent of the amount by
which the number of shares of Common Stock otherwise issuable pursuant to such VWAP Purchase Notice, together with all shares of Common
Stock then beneficially owned (as calculated pursuant to Section&nbsp;13(d)&nbsp;of the Exchange Act and Rule 13d-3 promulgated thereunder)
by the Investor and its Affiliates, would exceed the Beneficial Ownership Limitation. Upon the written or oral request of the Investor,
the Company shall promptly (but not later than the next Trading Day) confirm orally or in writing to the Investor the number of shares
of Common Stock then outstanding. The Investor and the Company shall each cooperate in good faith in the determinations required under
this <U>Section&nbsp;3.4</U> and the application of this <U>Section&nbsp;3.4</U>. The Investor&rsquo;s written certification to the Company
of the applicability of the Beneficial Ownership Limitation, and the resulting effect thereof hereunder at any time, shall be conclusive
with respect to the applicability thereof and such result absent manifest error. Upon delivery of a written notice to the Company, the
Investor may from time to time increase or decrease the Beneficial Ownership Limitation to any other amount of Common Stock not in excess
of 9.99% of the then issued and outstanding shares of Common Stock as specified in such notice; <U>provided</U> that any such increase
in the Beneficial Ownership Limitation shall not be effective until the sixty-first (61st) day after such written notice is delivered
to the Company. The provisions of this <U>Section&nbsp;3.4</U> shall be construed and implemented in a manner otherwise than in strict
conformity with the terms of this <U>Section&nbsp;3.4</U> to the extent necessary to correct this <U>Section&nbsp;3.4</U> (or any portion
of this <U>Section&nbsp;3.4</U>) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained in
this <U>Section&nbsp;3.4</U> or to make changes or supplements necessary or desirable to properly give effect to such limitation. The
limitations contained in this <U>Section&nbsp;3.4</U> may not be waived by the Company or the Investor, except as expressly provided
for in this <U>Section&nbsp;3.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;IV<BR>
REPRESENTATIONS AND WARRANTIES OF THE INVESTOR</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Investor hereby makes
the following representations, warranties and covenants to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.1&nbsp;</B><U>Organization
and Standing of the Investor</U>. The Investor is a limited liability company duly organized and validly existing under the laws of the
State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.2&nbsp;</B><U>Authorization
and Power</U>. The Investor has the requisite limited liability company power and authority to enter into and perform its obligations
under this Agreement and the Registration Rights Agreement, and to purchase the Securities in accordance with the terms hereof. The execution,
delivery and performance by the Investor of this Agreement and the Registration Rights Agreement, and the consummation by it of the transactions
contemplated hereby and thereby, have been duly authorized by all necessary limited liability company action, and no further consent
or authorization of the Investor, its board of managers or its members is required. Each of this Agreement and the Registration Rights
Agreement has been duly executed and delivered by the Investor, and constitutes a valid and binding obligation of the Investor enforceable
against it in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation, conservatorship, receivership, or similar laws relating to, or affecting generally the enforcement of, creditor&rsquo;s
rights and remedies or by other equitable principles of general application (including any limitation of equitable remedies).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.3&nbsp;</B><U>No
Conflicts</U>. The execution, delivery and performance by the Investor of this Agreement and the Registration Rights Agreement, and the
consummation by the Investor of the transactions contemplated hereby and thereby, do not and shall not: (a)&nbsp;result in a violation
of such Investor&rsquo;s certificate of formation, limited liability company agreement or other applicable organizational instruments;
(b)&nbsp;conflict with, constitute a default (or an event which, with notice or lapse of time or both, would become a default) under,
or give rise to any rights of termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust,
indenture, note, bond, license, lease agreement, instrument or obligation to which the Investor is a party or is bound; (c)&nbsp;create
or impose any lien, charge or encumbrance on any property of the Investor under any agreement or any commitment to which the Investor
is party or under which the Investor is bound or under which any of its properties or assets are bound; or (d)&nbsp;result in a violation
of any federal, state, local or foreign statute, rule, or regulation, or any order, judgment or decree of any court or governmental agency
applicable to the Investor or by which any of its properties or assets are bound or affected, except, in the case of clauses (b), (c)&nbsp;and
(d)&nbsp;above, for such conflicts, defaults, terminations, amendments, acceleration, cancellations and violations as would not, individually
or in the aggregate, prohibit or otherwise interfere with, in any material respect, the ability of the Investor to enter into and perform
its obligations under this Agreement and the Registration Rights Agreement. The Investor is not required under federal, state, local
or foreign law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court
or governmental agency in order for it to execute, deliver or perform any of its obligations under this Agreement or the Registration
Rights Agreement, or to purchase the Securities in accordance with the terms hereof; <U>provided</U>, <U>however</U>, that for purposes
of the representation made in this sentence, the Investor is assuming and relying upon the accuracy of the relevant representations and
warranties and the compliance with the relevant covenants and agreements of the Company in the Transaction Documents to which it is a
party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.4&nbsp;</B><U>Investment
Purpose</U>. The Investor is acquiring the Securities for its own account, for investment purposes and not with a view towards, or for
resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under or exempt from the registration
requirements of the Securities Act; <U>provided</U>, <U>however</U>, that by making the representations herein, the Investor does not
agree, or make any representation or warranty, to hold any of the Securities for any minimum or other specific term and reserves the
right to dispose of the Securities at any time in accordance with, or pursuant to, a registration statement filed pursuant to the Registration
Rights Agreement or an applicable exemption under the Securities Act. The Investor does not presently have any agreement or understanding,
directly or indirectly, with any Person to sell or distribute any of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.5&nbsp;</B><U>Accredited
Investor Status</U>. The Investor is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a)&nbsp;of Regulation D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.6&nbsp;</B><U>Reliance
on Exemptions</U>. The Investor understands that the Securities are being offered and sold to it in reliance on specific exemptions from
the registration requirements of U.S. federal and state securities laws and that the Company is relying in part upon the truth and accuracy
of, and the Investor&rsquo;s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the
Investor set forth herein in order to determine the availability of such exemptions and the eligibility of the Investor to acquire the
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.7&nbsp;</B><U>Information</U>.
All materials relating to the business, financial condition, management and operations of the Company and materials relating to the offer
and sale of the Securities which have been requested by the Investor have been furnished or otherwise made available to the Investor
or its advisors, including, without limitation, the SEC Documents. The Investor and its advisors have been afforded the opportunity to
ask questions of and receive answers from representatives of the Company concerning the financial condition and business of the Company
and other matters relating to an investment in the Securities. Neither such inquiries nor any other due diligence investigations conducted
by the Investor or its advisors, if any, or its representatives shall modify, amend or affect the Investor&rsquo;s right to rely on the
Company&rsquo;s representations and warranties contained in this Agreement or in any other Transaction Document to which the Company
is a party or the Investor&rsquo;s right to rely on any other document or instrument executed and/or delivered in connection with this
Agreement or the consummation of the transaction contemplated hereby (including, without limitation, the opinions of the Company&rsquo;s
counsel delivered pursuant to <U>Section&nbsp;7.1(d)</U>&nbsp;and <U>Section&nbsp;7.2(p)</U>). The Investor has sought such accounting,
legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.
The Investor understands that it (and not the Company) shall be responsible for its own tax liabilities that may arise as a result of
this investment or the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.8&nbsp;</B><U>No
Governmental Review</U>. The Investor understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in
the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.9&nbsp;</B><U>No
General Solicitation</U>. The Investor is not purchasing or acquiring the Securities as a result of any form of general solicitation
or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.10&nbsp;</B><U>Not
an Affiliate</U>. The Investor is not an officer, director or an Affiliate of the Company. As of the date of this Agreement, the Investor
does not beneficially own any shares of Common Stock or securities exercisable for or convertible into shares of Common Stock, and during
the Restricted Period, Investor shall not acquire beneficial ownership of any shares of the Company&rsquo;s capital stock (including
shares of Common Stock or securities exercisable for or convertible into shares of Common Stock) other than pursuant to this Agreement;
provided, however, that nothing in this Agreement shall prohibit or be deemed to prohibit the Investor from purchasing, in an open market
transaction or otherwise, shares of Common Stock necessary to make delivery by the Investor in satisfaction of a sale by the Investor
of Securities that the Investor anticipated receiving from the Company in connection with the settlement of a VWAP Purchase, as applicable,
if the Company or its Transfer Agent shall have failed for any reason (other than a failure of Investor or its Broker-Dealer to set up
a DWAC and required instructions) to electronically transfer all of the Shares subject to such VWAP Purchase, as applicable, to the Investor
on the applicable VWAP Purchase Date by crediting the Investor&rsquo;s or its designated Broker-Dealer&rsquo;s account at DTC through
its DWAC delivery system in compliance with <U>Section&nbsp;3.2</U> of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.11&nbsp;</B><U>No
Prior Short Sales</U>. At no time prior to the date of this Agreement has any of the Investor, its agents, representatives or Affiliates
engaged in or effected, in any manner whatsoever, directly or indirectly, any: (a)&nbsp;&ldquo;short sale&rdquo; (as such term is defined
in Rule 200 of Regulation SHO of the Exchange Act) of the Common Stock; or (b)&nbsp;hedging transaction, which establishes a net short
position with respect to the Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.12&nbsp;</B><U>Selling
Stockholder</U>. The Investor acknowledges that it shall be disclosed as a &ldquo;selling stockholder&rdquo; in each Registration Statement
and in any Prospectus contained therein to the extent required by applicable law and to the extent the Prospectus is related to the resale
of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.13&nbsp;</B><U>Resales
of Securities</U>. The Investor represents, warrants and covenants that it shall resell such Securities only pursuant to the Registration
Statement in which the resale of such Securities is registered under the Securities Act, in a manner described under the caption &ldquo;Plan
of Distribution&rdquo; in such Registration Statement, and in a manner in compliance with all applicable U.S. federal and state securities
laws, rules and regulations, including, without limitation, any applicable prospectus delivery requirements of the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;V<BR>
REPRESENTATIONS AND WARRANTIES OF THE COMPANY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth in the
disclosure schedule delivered by the Company to the Investor (which is hereby incorporated by reference in, and constitutes an integral
part of, this Agreement) (the &ldquo;<B>Disclosure Schedule</B>&rdquo;), the Company hereby makes the following representations, warranties
and covenants to the Investor:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.1&nbsp;</B><U>Organization,
Good Standing and Power</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary
is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing
or seeking to revoke, limit or curtail such power and authority or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.2&nbsp;</B><U>Authorization,
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and perform its obligations under each of
the Transaction Documents to which it is a party and to issue the Securities in accordance with the terms hereof and thereof. Except
for approvals of the Company&rsquo;s board of directors or a committee thereof as may be required in connection with any issuance and
sale of Shares to the Investor hereunder (which approvals shall be obtained prior to the delivery of any VWAP Purchase Notice), the execution,
delivery and performance by the Company of each of the Transaction Documents to which it is a party and the consummation by it of the
transactions contemplated hereby and thereby have been duly and validly authorized by all necessary corporate action, and no further
consent or authorization of the Company, its board of directors or its stockholders is required. Each of the Transaction Documents to
which the Company is a party has been duly executed and delivered by the Company and constitutes a valid and binding obligation of the
Company enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation, conservatorship, receivership or similar laws relating to, or affecting generally
the enforcement of, creditor&rsquo;s rights and remedies or by other equitable principles of general application (including any limitation
of equitable remedies).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.3&nbsp;</B><U>Capitalization</U>.
The authorized capital stock of the Company and the shares thereof issued and outstanding were as set forth in the SEC Documents as of
the dates reflected therein. All of the outstanding shares of Common Stock have been duly authorized and validly issued, and are fully
paid and nonassessable. Except as set forth in the SEC Documents, this Agreement, and the Registration Rights Agreement, there are no
agreements or arrangements under which the Company is obligated to register the sale of any securities under the Securities Act. Except
as set forth in the SEC Documents, no shares of Common Stock are entitled to preemptive rights and there are no outstanding debt securities
and no contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue additional shares
of the capital stock of the Company or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever
relating to, or securities or rights convertible into or exchangeable for, any shares of capital stock of the Company other than those
issued or granted in the ordinary course of business pursuant to the Company&rsquo;s equity incentive and/or compensatory plans or arrangements.
Except for customary transfer restrictions contained in agreements entered into by the Company to sell restricted securities, the Company
is not a party to, and it has no Knowledge of, any agreement restricting the voting or transfer of any outstanding shares of the capital
stock of the Company. The offer and sale of all capital stock, convertible or exchangeable securities, rights, warrants or options of
the Company issued prior to the Commencement Date complied, in all material respects, with all applicable federal and state securities
laws, and no stockholder has any right of rescission or damages or any &ldquo;put&rdquo; or similar right with respect thereto that would
have a Material Adverse Effect. Except as set forth in the SEC Documents, there are no securities or instruments containing anti-dilution
or similar provisions that shall be triggered by this Agreement or any of the other Transaction Documents or the consummation of the
transactions described herein or therein. The Company has filed with the SEC true and correct copies of the Company&rsquo;s articles
of incorporation as in effect on the Closing Date (the &ldquo;<B>Charter</B>&rdquo;), and the Company&rsquo;s bylaws as in effect on
the Closing Date (the &ldquo;<B>Bylaws</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.4&nbsp;</B><U>Issuance
of Securities</U>. The Commitment Shares, if any, to be issued in consideration for the Investor&rsquo;s execution and delivery of this
Agreement, and the Shares to be issued pursuant to VWAP Purchases under this Agreement have been, or with respect to Shares to be purchased
by the Investor pursuant to a particular VWAP Purchase Notice, shall be, prior to the delivery to the Investor hereunder of such VWAP
Purchase Notice, duly authorized by all necessary corporate action on the part of the Company. The Commitment Shares, if any, when issued
and sold to the Investor in accordance with this Agreement, and the Shares, when issued and sold against payment therefor in accordance
with this Agreement, shall, in each case, be validly issued and outstanding, fully paid and non-assessable and free from all liens, charges,
taxes, security interests, encumbrances, rights of first refusal, preemptive or similar rights and other encumbrances with respect to
the issue thereof, and the Investor shall be entitled to all rights accorded to a holder of Common Stock with respect thereto. An aggregate
of 39,777,249 of shares of Common Stock have been duly authorized and reserved by the Company for issuance and sale to the Investor as
Shares pursuant to VWAP Purchases under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.5&nbsp;</B><U>No
Conflicts</U>. The execution, delivery and performance by the Company of each of the Transaction Documents to which it is a party and
the consummation by the Company of the transactions contemplated hereby and thereby do not and shall not: (a)&nbsp;result in a violation
of any provision of the Charter or Bylaws; (b)&nbsp;result in a breach or violation of any of the terms or provisions of, or constitute
a default (or an event which, with notice or lapse of time or both, would become a default) under, or give rise to any rights of termination,
amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement,
instrument or obligation to which the Company or any of its Subsidiaries is a party or is bound; (c)&nbsp;create or impose a lien, charge
or encumbrance on any property or assets of the Company or any of its Subsidiaries under any agreement or any commitment to which the
Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound or to which any of their respective
properties or assets is subject; or (d)&nbsp;result in a violation of any federal, state, local or foreign statute, rule, regulation,
order, judgment or decree applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any
of its Subsidiaries are bound or affected (including federal and state securities laws and regulations and the rules and regulations
of the Trading Market or applicable Eligible Market), except, in the case of clauses (b), (c)&nbsp;and (d)&nbsp;above, for such conflicts,
defaults, terminations, amendments, acceleration, cancellations, liens, charges, encumbrances and violations as would not, individually
or in the aggregate, have a Material Adverse Effect. Except as specifically contemplated by this Agreement, the Registration Rights Agreement,
the SEC Documents and as required under the Securities Act and any applicable state securities laws or rules of the Trading Market, the
Company is not required under any federal, state, local or foreign law, rule or regulation to obtain any consent, authorization or order
of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its
obligations under the Transaction Documents to which it is a party, or to issue the Securities to the Investor in accordance with the
terms hereof and thereof (other than such consents, authorizations, orders, filings or registrations as have been obtained or made prior
to the Closing Date); <U>provided</U>, <U>however</U>, that, for purposes of the representation made in this sentence, the Company is
assuming and relying upon the accuracy of the representations and warranties of the Investor in this Agreement and the compliance by
it with its covenants and agreements contained in this Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.6&nbsp;</B><U>SEC
Documents, Financial Statements; Disclosure Controls and Procedures; Internal Controls Over Financial Reporting; Accountants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;Except
as set forth in the SEC Documents, the Company has timely filed (giving effect to permissible extensions in accordance with Rule 12b-25
under the Exchange Act) all SEC Documents for the twelve (12) months preceding the date of this Agreement. The Company has delivered or
made available to the Investor via EDGAR or otherwise true and complete copies of the SEC Documents filed with or furnished to the SEC
by the Company under the Securities Act or the Exchange Act, including those required to be filed with or furnished to the SEC under Section
13(a) or Section 15(d) of the Exchange Act. As of the date of this Agreement, no Subsidiary of the Company is required to file or furnish
any report, schedule, registration, form, statement, information or other document with the SEC. As of its filing date, each SEC Document
filed with or furnished to the SEC prior to the Closing Date (including, without limitation, the IPO Registration Statement) complied
in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and other federal, state and
local laws, rules and regulations applicable to it, and, as of its filing date (or, if amended or superseded by a filing prior to the
Closing Date, on the date of such amended or superseded filing). Each Registration Statement, on the date it is filed with the SEC, on
the date it is declared effective by the SEC, on each VWAP Purchase Exercise Date shall comply in all material respects with the requirements
of the Securities Act (including, without limitation, Rule 415 under the Securities Act) and shall not contain any untrue statement of
a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not
misleading, except that this representation and warranty shall not apply to statements in or omissions from such Registration Statement
made in reliance upon and in conformity with information relating to the Investor furnished to the Company in writing by or on behalf
of the Investor expressly for use therein. The Prospectus and each Prospectus Supplement required to be filed pursuant to this Agreement
or the Registration Rights Agreement after the Closing Date, when taken together, on its date, on each VWAP Purchase Exercise Date, shall
comply in all material respects with the requirements of the Securities Act (including, without limitation, Rule 424(b)&nbsp;under the
Securities Act) and shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, except
that this representation and warranty shall not apply to statements in or omissions from the Prospectus or any Prospectus Supplement made
in reliance upon and in conformity with information relating to the Investor furnished to the Company in writing by or on behalf of the
Investor expressly for use therein. Each SEC Document (other than the Initial Registration Statement or any Subsequent Registration Statement,
or the Prospectus included therein or any Prospectus Supplement thereto) to be filed with or furnished to the SEC after the Closing Date
and incorporated by reference in the Initial Registration Statement or any Subsequent Registration Statement, or the Prospectus included
therein or any Prospectus Supplement thereto required to be filed pursuant to this Agreement or the Registration Rights Agreement (including,
without limitation, the Current Report), when such document is filed with or furnished to the SEC and, if applicable, when such document
becomes effective, as the case may be, shall comply in all material respects with the requirements of the Securities Act or the Exchange
Act, as applicable, and other federal, state and local laws, rules and regulations applicable to it. The Company has delivered or made
available to the Investor via EDGAR or otherwise true and complete copies of all comment letters and substantive correspondence received
by the Company from the SEC relating to the SEC Documents filed with or furnished to the SEC as of the Closing Date, together with all
written responses of the Company thereto in the form such responses were filed via EDGAR. There are no outstanding or unresolved comments
or undertakings in such comment letters received by the Company from the SEC. The SEC has not issued any stop order or other order suspending
the effectiveness of any registration statement filed by the Company under the Securities Act or the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;The
financial statements of the Company included or incorporated by reference in the SEC Documents, together with the related notes and schedules,
comply in all material respects with the requirements of the Securities Act and the Exchange Act and fairly present the financial condition
of the Company and its consolidated subsidiaries as of the dates indicated and the results of operations and changes in cash flows for
the periods therein specified in conformity with generally accepted accounting principles in the United States (&ldquo;<B>GAAP</B>&rdquo;)
consistently applied throughout the periods involved; all non-GAAP financial information included or incorporated by reference in the
SEC Documents complies with the requirements of Regulation G and Item 10 of Regulation S-K under the Securities Act, to the extent applicable;
and, except as disclosed in the SEC Documents, there are no material off-balance sheet arrangements (as defined in Regulation S-K under
the Securities Act, Item 303(a)(4)(ii)) or any other relationships with unconsolidated entities or other persons, that may have a material
current or, to the Company&rsquo;s Knowledge, material future effect on the Company&rsquo;s financial condition, results of operations,
liquidity, capital expenditures, capital resources or significant components of revenue or expenses. No other financial statements or
schedules are required to be included in the SEC Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;The
Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i)&nbsp;transactions
are executed in accordance with management&rsquo;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii)&nbsp;access to assets
is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv)&nbsp;the recorded accountability for
assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The
Company is not aware of any material weaknesses in the internal control over financial reporting (other than as set forth in the SEC Documents).
Except as set forth in the SEC Documents, since the date of the latest audited financial statements of the Company included in its Annual
Report on Form 10-K for the year ended December 31, 2024, there has been no change in the Company&rsquo;s internal control over financial
reporting that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over financial
reporting. Except as set forth in the SEC Documents, the Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e)&nbsp;and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&rsquo;s rules and forms. The Company&rsquo;s
certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as
of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<B>Evaluation
Date</B>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially adversely affected, or is reasonably likely to materially adversely affect,
the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;To
the Company&rsquo;s Knowledge, GBQ Partners LLC (the &ldquo;<B>Auditor</B>&rdquo;), which has expressed its opinion with respect to the
consolidated financial statements and schedule as of December 31, 2024 and 2023, and for each of the years ended December 31, 2024 and
December 31, 2023, is: (i)&nbsp;an independent public accounting firm within the meaning of the Securities Act; (ii)&nbsp;a registered
public accounting firm (as defined in Section&nbsp;2(a)(12) of the Sarbanes-Oxley Act of 2002 (the &ldquo;<B>Sarbanes-Oxley Act</B>&rdquo;));
and (iii)&nbsp;not in violation of the auditor independence requirements of the Sarbanes-Oxley Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;There
is no failure on the part of the Company or, to the Knowledge of the Company, any of the Company&rsquo;s directors or officers, in their
capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act and the rules and regulations promulgated
in connection therewith that are applicable to the Company or its directors or officers in their capacities as directors or officers of
the Company. Each of the principal executive officer and the principal financial officer of the Company (or each former principal executive
officer and principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of
the Sarbanes-Oxley Act with respect to all periodic reports required to be filed by it with the SEC during the past twelve (12) months.
For purposes of the preceding sentence, &ldquo;principal executive officer&rdquo; and &ldquo;principal financial officer&rdquo; shall
have the meanings given to such terms in the Exchange Act Rules 13a-15 and 15d-15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.7&nbsp;</B><U>Subsidiaries</U>.
The SEC Documents set forth each Subsidiary of the Company as of the Closing Date, other than those that may be omitted pursuant to Item
601 of Regulation S-K, showing its jurisdiction of incorporation or organization, and the Company does not have any other Subsidiaries
as of the Closing Date. No Subsidiary of the Company is currently prohibited, directly or indirectly, from paying any dividends to the
Company, from making any other distribution on such Subsidiary&rsquo;s capital stock, from repaying to the Company any loans or advances
to such Subsidiary from the Company or from transferring any of such Subsidiary&rsquo;s property or assets to the Company or any other
Subsidiary of the Company, except as described in or contemplated by the SEC Documents or as would not reasonably be expected to have
a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.8&nbsp;</B><U>No
Material Adverse Effect or Material Adverse Change</U>. Except as otherwise disclosed or incorporated by reference in the SEC Documents,
since December 31, 2024: (a) the Company has not experienced or suffered any Material Adverse Effect, and there exists no current state
of facts, condition or event which would have a Material Adverse Effect; (b)&nbsp;there has not occurred any material adverse change,
or any development that would reasonably be expected to result in a prospective material adverse change, in the condition, financial
or otherwise, or in the earnings, business or operations of the Company from that disclosed or incorporated by reference in the SEC Documents;
(c) neither the Company nor any of its Subsidiaries has incurred any material liability or obligation, direct or contingent, nor entered
into any material transaction; (d)&nbsp;the Company has not purchased any of its outstanding capital stock, nor declared, paid or otherwise
made any dividend or distribution of any kind on its capital stock other than ordinary and customary dividends; and (e)&nbsp;there has
not been any material change in the capital stock, short-term debt or long-term debt of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.9&nbsp;</B><U>No
Undisclosed Liabilities</U>. Neither the Company nor any of its Subsidiaries has any liabilities, obligations, claims or losses (whether
liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent or otherwise) that would be required to be disclosed
on a balance sheet of the Company or any Subsidiary (including the notes thereto) in conformity with GAAP and are not disclosed or incorporated
by reference in the SEC Documents, other than those incurred in the ordinary course of the Company&rsquo;s or its Subsidiaries respective
businesses since December 31, 2024, and which, individually or in the aggregate, would not reasonably be expected to have a Material
Adverse Effect. No event, liability, development or circumstance has occurred or exists, or is reasonably expected to occur or exist,
with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties, liabilities, prospects, operations
(including results thereof) or condition (financial or otherwise), that (a) would be required to be disclosed by the Company under applicable
securities laws in the SEC Documents, which has not been disclosed or incorporated by reference in the SEC Documents, or (b) would reasonably
be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.10&nbsp;</B><U>No
Undisclosed Events or Circumstances</U>. No event or circumstance has occurred or information exists with respect to the Company or any
of its Subsidiaries or its or their business, properties, liabilities, operations (including results thereof) or conditions (financial
or otherwise), which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company at or before
the Closing but which has not been so publicly announced or disclosed, except for events or circumstances which, individually or in the
aggregate, would not reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.11&nbsp;</B><U>Indebtedness;
Solvency</U>. <U>Schedule 5.11</U> attached hereto sets forth, as of the Closing Date, all outstanding secured and unsecured Indebtedness
of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments through such date. For the purposes of this
Agreement, &ldquo;<B>Indebtedness</B>&rdquo; shall mean (a) any liabilities for borrowed money or amounts owed in excess of $100,000
(other than trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements, indemnities and other
contingent obligations in respect of Indebtedness of others in excess of $100,000, whether or not the same are or should be reflected
in the Company&rsquo;s balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or
collection or similar transactions in the ordinary course of business; and (c) the present value of any lease payments in excess of $100,000
due under leases required to be capitalized in accordance with GAAP. Except as set forth on <U>Schedule 5.11</U>, to the Knowledge of
the Company, there is no existing or continuing default or event of default in respect of any Indebtedness of the Company or any of its
Subsidiaries. The Company has not taken any steps, and does not currently expect to take any steps, to seek protection pursuant to any
Bankruptcy Law or law for the relief of debtors, nor does the Company have any Knowledge that its creditors intend to initiate involuntary
bankruptcy, insolvency, reorganization or liquidation proceedings or other proceedings for relief under any Bankruptcy Law or any law
for the relief of debtors. The Company is financially solvent and is generally able to pay its debts as they become due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.12&nbsp;</B><U>Title
To Assets</U>. The Company and each of its Subsidiaries have good and marketable title in fee simple to all real property and good and
marketable title to all personal property owned by them which is material to the business of the Company, in each case free and clear
of all liens, encumbrances and defects except such as are described in the SEC Documents or such as do not materially affect the value
of such property and do not interfere with the use made and proposed to be made of such property by the Company and its Subsidiaries;
and any real property and buildings held under lease by the Company and its Subsidiaries are held by it under valid, subsisting and enforceable
leases with such exceptions as are not material and do not interfere in any material respect with the use made and proposed to be made
of such property and buildings by the Company and its Subsidiaries, in each case except as described in the SEC Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.13&nbsp;</B><U>Actions
Pending</U>. To the Knowledge of the Company, there are no legal or governmental proceedings pending or threatened to which the Company
or any of its Subsidiaries are a party or to which any of the properties of the Company or any of its Subsidiaries is subject: (a)&nbsp;other
than proceedings accurately described in all material respects in the SEC Documents and proceedings that, individually or in the aggregate,
would not reasonably be expected to have a Material Adverse Effect, or on the power or ability of the Company to perform its obligations
under this Agreement and the Registration Rights Agreement or to consummate the transactions contemplated by the Transaction Documents;
or (b)&nbsp;that are required to be described in the SEC Documents and are not so described. There are no statutes, regulations, contracts
or other documents that are required to be described in the SEC Documents or to be filed as exhibits to the SEC Documents that are not
described or filed as required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.14&nbsp;</B><U>Compliance
With Law; Compliance with Continued Listing Standards</U>. The business of the Company and the Subsidiaries has been and is presently
being conducted in compliance with all applicable federal, state, local and foreign governmental laws, rules, regulations and ordinances,
except as set forth in the SEC Documents and except for such non-compliance which, individually or in the aggregate, would not have a
Material Adverse Effect. Neither the Company nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute,
ordinance, rule or regulation applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries
shall conduct its business in violation of any of the foregoing, except in all cases for any such violations which could not, individually
or in the aggregate, have a Material Adverse Effect. Except as set forth in the SEC Documents, the Company has not received any notice
of any continuing failure to maintain requirements for continued listing or quotation of its Common Stock on an applicable Trading Market
or in violation of any of the rules, regulations or requirements of any applicable Trading Market, other than as disclosed to the Investor
(including any intended changes with respect to another applicable Trading Market in connection with any failure to maintain such requirements).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.15&nbsp;</B><U>Certain
Fees</U>. Except as provided in this Agreement and the other Transaction Documents, including the payment of fees or commissions payable
by the Company to the Placement Agent as set forth in <U>Section 10.1(a)</U>, no brokerage or finder&rsquo;s fees or commissions are
or shall be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or
other Person with respect to the transactions contemplated by the Transaction Documents. The Investor shall have no obligation with respect
to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this <U>Section&nbsp;5.15</U>
incurred by the Company or its Subsidiaries that may be due or payable in connection with the transactions contemplated by the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.16&nbsp;</B><U>Disclosure</U>.
The Company confirms that neither it nor any other Person acting on its behalf has provided the Investor or any of its agents, advisors
or counsel with any information that constitutes or could reasonably be expected to constitute material, nonpublic information concerning
the Company or any of its Subsidiaries, other than the existence of the transactions contemplated by the Transaction Documents. The Company
understands and confirms that the Investor shall rely on the foregoing representations in effecting resales of Securities under the Registration
Statement. All disclosure provided to Investor regarding the Company and its Subsidiaries, their businesses and the transactions contemplated
by the Transaction Documents (including, without limitation, the representations and warranties of the Company contained in the Transaction
Documents to which it is a party (as modified by the Disclosure Schedule)) furnished in writing by or on behalf of the Company or any
of its Subsidiaries for purposes of or in connection with the Transaction Documents (other than forward-looking information and projections
and information of a general economic nature and general information about the Company&rsquo;s industry), taken together, is true and
correct in all material respects on the date on which such information is dated or certified, and does not contain any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading at such time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.17&nbsp;</B><U>Operation
of Business</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;The
Company and its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state or foreign
regulatory authorities necessary to conduct its business, except where the failure to possess such certificates, authorizations or permits
would not, individually or in the aggregate, have a Material Adverse Effect; and neither the Company nor any of its Subsidiaries have
received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit which,
singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a Material
Adverse Effect, except as described in the SEC Documents. This <U>Section&nbsp;5.17(a)</U>&nbsp;does not relate to environmental matters,
such items being the subject of <U>Section&nbsp;5.18</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;The
Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service
marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary
or required for use in connection with their respective businesses as described in the SEC Documents and which the failure to so have
could have a Material Adverse Effect (collectively, the &ldquo;<B>Intellectual Property Rights</B>&rdquo;). None of, and neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement, except
where such action would not reasonably be expected to have a Material Adverse Effect. Other than as specifically described in the SEC
Documents, neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within
the SEC Documents, a written notice of a claim or otherwise has any Knowledge that the Company&rsquo;s products or planned products as
described in the SEC Documents violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to
not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is
no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable
security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do
so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.18&nbsp;</B><U>Environmental
Compliance</U>. To the Knowledge of the Company, the Company and its Subsidiaries: (a)&nbsp;are in compliance with all federal, state,
local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water,
groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of
chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<B>Hazardous Materials</B>&rdquo;)
into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport
or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments,
licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<B>Environmental
Laws</B>&rdquo;); (b)&nbsp;have received all permits licenses or other approvals required of them under applicable Environmental Laws
to conduct their respective businesses; and (c)&nbsp;are in compliance with all terms and conditions of any such permit, license or approval
where, in each of clause (a), (b)&nbsp;and (c)&nbsp;above, the failure to so comply could be reasonably expected to have, individually
or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.19&nbsp;</B><U>Material
Agreements</U>. Except as set forth in the SEC Documents, neither the Company nor any Subsidiary of the Company is a party to any written
or oral contract, instrument, agreement commitment, obligation, plan or arrangement, a copy of which would be required to be filed with
the SEC as an exhibit to an Annual Report on Form 10-K (collectively, &ldquo;<B>Material Agreements</B>&rdquo;). Each of the Material
Agreements described in the SEC Documents conform in all material respects to the descriptions thereof contained or incorporated by reference
therein. Except as set forth in the SEC Documents, the Company and each of its Subsidiaries have performed in all material respects all
the obligations then required to be performed by them under the Material Agreements, have received no notice of default or an event of
default by the Company or any of its Subsidiaries thereunder and are not aware of any basis for the assertion thereof, and neither the
Company or any of its Subsidiaries nor, to the Knowledge of the Company, any other contracting party thereto are in default under any
Material Agreement now in effect, the result of which would have a Material Adverse Effect. Except as set forth in the SEC Documents,
each of the Material Agreements is in full force and effect, and constitutes a legal, valid and binding obligation enforceable in accordance
with its terms against the Company and/or any of its Subsidiaries and, to the Knowledge of the Company, each other contracting party
thereto, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation,
conservatorship, receivership or similar laws relating to, or affecting generally the enforcement of, creditor&rsquo;s rights and remedies
or by other equitable principles of general application.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.20&nbsp;</B><U>Transactions
With Affiliates</U>. Except as set forth in the SEC Documents, none of the officers or directors of the Company and, to the Knowledge
of the Company, none of the Company&rsquo;s stockholders, the officers or directors of any stockholder of the Company, or any family
member or Affiliate of any of the foregoing, has either directly or indirectly any interest in, or is a party to, any transaction that
is required to be disclosed as a related-party transaction pursuant to Item 404 of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.21&nbsp;</B><U>Employees;
Labor Laws</U>. No material labor dispute with the employees of the Company exists, except as described in the SEC Documents, or, to
the Knowledge of the Company, is imminent; and the Company is not aware of any existing, threatened or imminent labor disturbance by
the employees of any of its principal suppliers, manufacturers or contractors that would reasonably be expected to have a Material Adverse
Effect. Neither the Company nor any Subsidiary is in violation of or has received notice of any violation with respect to any federal
or state law relating to discrimination in the hiring, promotion or pay of employees, nor any applicable federal or state wage and hour
laws, nor any state law precluding the denial of credit due to the neighborhood in which a property is situated, the violation of any
of which could reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.22&nbsp;</B><U>Investment
Company Act Status</U>. The Company is not and, as a result of the consummation of the transactions contemplated by the Transaction Documents
and the application of the proceeds from the sale of the Securities as shall be set forth in the Prospectus included in any Registration
Statement (and any post-effective amendment thereto) and any Prospectus Supplement thereto filed pursuant to the Registration Rights
Agreement, the Company shall not, be an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as
amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.23&nbsp;</B><U>ERISA</U>.
The Company is not a party to an &ldquo;employee benefit plan,&rdquo; as defined in Section&nbsp;3(3) of the Employee Retirement Income
Security Act of 1974, as amended (&ldquo;<B>ERISA</B>&rdquo;), which: (a)&nbsp;is subject to any provision of ERISA; and (b)&nbsp;is
or was at any time maintained, administered or contributed to by the Company or any of its ERISA Affiliates (as defined hereafter). These
plans are referred to collectively herein as the &ldquo;<B>Employee Plans</B>.&rdquo; An &ldquo;<B>ERISA Affiliate</B>&rdquo; of any
person or entity means any other person or entity which, together with that person or entity, could be treated as a single employer under
Section&nbsp;414(b), (c), (m) or (o) of the Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;). Each Employee
Plan has been maintained in material compliance with its terms and the requirements of applicable law. No Employee Plan is subject to
Title IV of ERISA. The SEC Documents identify each employment, severance or other similar agreement, arrangement or policy and each material
plan or arrangement required to be disclosed pursuant to the rules and regulations providing for insurance coverage (including any self-insured
arrangements), workers&rsquo; compensation, disability benefits, severance benefits, supplemental unemployment benefits, vacation benefits
or retirement benefits, or deferred compensation, profit-sharing, bonuses, stock options, stock appreciation rights or other forms of
incentive compensation, or post-retirement insurance, compensation or benefits, which: (i)&nbsp;is not an Employee Plan; (ii)&nbsp;is
entered into, maintained or contributed to, as the case may be, by the Company or any of its ERISA Affiliates; and (iii)&nbsp;covers
any officer or director or former officer or director of the Company or any of its ERISA Affiliates. These agreements, arrangements,
policies or plans are referred to collectively as &ldquo;<B>Benefit Arrangements</B>.&rdquo; Each Benefit Arrangement has been maintained
in material compliance with its terms and with the requirements of applicable law. Except as disclosed in the SEC Documents, there is
no liability in respect of post-retirement health and medical benefits for retired employees of the Company or any of its ERISA Affiliates,
other than medical benefits required to be continued under applicable law. No &ldquo;prohibited transaction&rdquo; (as defined in either
Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code) has occurred with respect to any Employee Plan; and each Employee Plan that
is intended to be qualified under Section&nbsp;401(a)&nbsp;of the Code is so qualified, and nothing has occurred, whether by action or
by failure to act, which could cause the loss of such qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.24&nbsp;</B><U>Taxes</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each: (a)&nbsp;has made or filed all United States federal, state and local income and all foreign income
and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject; (b)&nbsp;has paid all taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations; and (c)&nbsp;has set aside on its books provision reasonably adequate for the payment of all material taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any
such claim. The provisions for taxes payable, if any, shown on the financial statements filed with or as part of the SEC Documents are
sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated
financial statements. The term &ldquo;taxes&rdquo; mean all federal, state, local, foreign, and other net income, gross income, gross
receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment,
excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges
of any kind whatsoever, together with any interest and any penalties, additions to tax, or additional amounts with respect thereto. The
term &ldquo;returns&rdquo; means all returns, declarations, reports, statements, and other documents required to be filed in respect
to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.25&nbsp;</B><U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in
such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not
limited to, directors and officers insurance coverage. Neither the Company nor any Subsidiary has any reason to believe that it shall
not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.26&nbsp;</B><U>Exemption
from Registration</U>. Subject to, and in reliance on, the representations, warranties and covenants made herein by the Investor, the
offer and sale of the Securities in accordance with the terms and conditions of this Agreement is exempt from the registration requirements
of the Securities Act pursuant to Section&nbsp;4(a)(2) and/or Rule 506(b)&nbsp;of Regulation D; <U>provided</U>, <U>however</U>, that
at the request of and with the express agreements of the Investor (including, without limitation, the representations, warranties and
covenants of Investor set forth in <U>Section&nbsp;4.9</U> through <U>Section&nbsp;4.13</U>), the Securities to be issued from and after
Commencement to or for the benefit of the Investor pursuant to this Agreement shall be issued to the Investor or its designee only as
DWAC Shares and shall not bear legends noting restrictions as to resale of such securities under federal or state securities laws, nor
shall any such securities be subject to stop transfer instructions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.27&nbsp;</B><U>No
General Solicitation or Advertising</U>. Neither the Company, nor any of its Subsidiaries or Affiliates, nor any Person acting on its
or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection
with the offer or sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.28&nbsp;</B><U>No
Integrated Offering</U>. None of the Company, its Subsidiaries, or any of their respective Affiliates, nor any Person acting on their
behalf has, directly or indirectly, sold, offered for sale, or solicited any offers to buy or otherwise negotiated in respect of any
security (as defined in the Securities Act) which shall be integrated with the sale of the Securities in a manner which would require
registration of the Securities under the Securities Act, whether through integration with prior offerings or otherwise, or cause this
offering of the Securities to require approval of stockholders of the Company for purposes of the Securities Act or under any applicable
stockholder approval provisions, including, without limitation, under the listing rules of the Trading Market. Except in accordance with
the requirements of the Registration Rights Agreement, none of the Company, its Subsidiaries, their Affiliates, nor any Person acting
on their behalf shall take any action or steps that would require registration of the issuance of any of the Securities under the Securities
Act or cause the offering of any of the Securities to be integrated with other offerings of securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.29&nbsp;</B><U>Dilutive
Effect</U>. The Company is aware and acknowledges that issuance of the Securities could cause dilution to existing stockholders and could
significantly increase the outstanding number of shares of Common Stock. The Company further acknowledges that its obligation to issue
the Commitment Shares, if any, and to issue the Shares pursuant to the terms of a VWAP Purchase in accordance with this Agreement is,
in each case, absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of
other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.30&nbsp;</B><U>Manipulation
of Price</U>. Neither the Company nor any of its officers, directors or Affiliates has, and, to the Knowledge of the Company, no Person
acting on their behalf has: (a)&nbsp;taken, directly or indirectly, any action designed or intended to cause or to result in the stabilization
or manipulation of the price of any security of the Company, or which caused or resulted in, or which would in the future reasonably
be expected to cause or result in, the stabilization or manipulation of the price of any security of the Company, in each case to facilitate
the sale or resale of any of the Securities; (b)&nbsp;sold, bid for, purchased, or paid any compensation for soliciting purchases of,
any of the Securities; or (c)&nbsp;paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company. Neither the Company nor any of its officers, directors or Affiliates shall during the term of this Agreement,
and, to the Knowledge of the Company, no Person acting on their behalf shall during the term of this Agreement, take any of the actions
referred to in the immediately preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.31&nbsp;</B><U>Securities
Act</U>. The Company has complied and shall comply with all applicable federal and state securities laws in connection with the offer,
issuance and sale of the Securities hereunder, including, without limitation, the applicable requirements of the Securities Act. Each
Registration Statement, upon filing with the SEC and at the time it is declared effective by the SEC, shall satisfy all of the requirements
of the Securities Act to register the resale of the Registrable Securities included therein by the Investor in accordance with the Registration
Rights Agreement on a delayed or continuous basis under Rule 415 under the Securities Act at then-prevailing market prices, and not fixed
prices. The Company is not, and has not previously been at any time, an issuer identified in, or subject to, Rule 144(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.32&nbsp;</B><U>Listing
and Maintenance Requirements; DTC Eligibility</U>. As of the Closing Date, the Common Stock is registered pursuant to Section&nbsp;12(b)&nbsp;of
the Exchange Act, and the Company has taken no action designed to, or which to its Knowledge is likely to have the effect of, terminating
the registration of the Common Stock under the Exchange Act, nor has the Company received any notification that the SEC is contemplating
terminating such registration. Except as set forth in the SEC Documents, the Company has not received notice from the Trading Market
or any Eligible Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market or Eligible Market, as applicable. Except as set forth in the SEC
Documents, the Company is in compliance with all such listing and maintenance requirements. The Common Stock is eligible for participation
in the DTC book entry system and has shares on deposit at DTC for transferred electronically to third parties via DTC through its Deposit/Withdrawal
at Custodian (&ldquo;<B>DWAC</B>&rdquo;) delivery system. The Company has not received notice from DTC to the effect that a suspension
of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect
to the Common Stock is being imposed or is contemplated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.33&nbsp;</B><U>Application
of Takeover Protections</U>. The Company and its board of directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s Charter or the laws of its state of incorporation that is or could become applicable
to the Investor as a result of the Investor and the Company fulfilling their respective obligations or exercising their respective rights
under the Transaction Documents (as applicable), including, without limitation, as a result of the Company&rsquo;s issuance of the Securities
and the Investor&rsquo;s ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.34&nbsp;</B><U>No
Unlawful Payments</U>. Neither the Company nor any of its Subsidiaries nor any director or officer, nor, to the Knowledge of the Company,
any employee, agent, representative or Affiliate of the Company, has taken within the past five years any action in furtherance of an
offer, payment, promise to pay, or authorization or approval of the payment or giving of money, property, gifts or anything else of value,
directly or indirectly, to any &ldquo;government official&rdquo; (including any officer or employee of a government or government-owned
or controlled entity or of a public international organization, or any person acting in an official capacity for or on behalf of any
of the foregoing, or any political party or party official or candidate for political office) to influence official action or secure
an improper advantage (to the extent acting on behalf of or providing services to the Company); and the Company and its Subsidiaries
have conducted their businesses within the past five years in compliance with the U.S. Foreign Corrupt Practices Act of 1977, as amended
(the &ldquo;<B>FCPA</B>&rdquo;), any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public
Officials in International Business Transactions, signed December 17, 1997, the U.K. Bribery Act 2010 and other applicable anti-corruption,
anti-money laundering and anti-bribery laws, and have instituted and maintain policies and procedures designed to promote and achieve
compliance with such laws and with the representation and warranty contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.35&nbsp;</B><U>Money
Laundering Laws</U>. The operations of the Company are and have been conducted at all times within the past five years in material compliance
with all applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting
Act of 1970, as amended, and the applicable anti-money laundering statutes, including but not limited to, applicable federal, state,
international, foreign or other laws, regulations or government guidance regarding anti-money laundering, including, without limitation,
Title 18 U.S. Code section 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or
procedures by an intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which the United
States is a member and with which designation the United States representative to the group or organization continues to concur, all
as amended, and any Executive order, directive, or regulation pursuant to the authority of any of the foregoing, or any orders or licenses
issued thereunder, of jurisdictions where the Company conducts business, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &ldquo;<B>Money Laundering
Laws</B>&rdquo;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.36&nbsp;</B><U>OFAC</U>.
Neither the Company nor any of its Subsidiaries, nor any director, officer, or employee thereof, nor, to the Company&rsquo;s Knowledge,
any agent, Affiliate or representative of the Company, is a Person that is, or is owned or controlled by a Person that is: (a)&nbsp;the
subject of any sanctions administered or enforced by the U.S. Department of Treasury&rsquo;s Office of Foreign Assets Control, the United
Nations Security Council, the European Union, Her Majesty&rsquo;s Treasury, or other relevant sanctions authority (collectively, &ldquo;<B>Sanctions</B>&rdquo;);
nor (b)&nbsp;located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation,
Crimea, Cuba, Iran, North Korea, Sudan and Syria). Neither the Company nor any of its Subsidiaries shall, directly or indirectly, use
the proceeds from the sale of Securities under this Agreement, or lend, contribute or otherwise make available such proceeds to any Subsidiary,
joint venture partner or other Person: (i)&nbsp;to fund or facilitate any activities or business of or with any Person or in any country
or territory that, at the time of such funding or facilitation, is the subject of Sanctions; or (ii)&nbsp;in any other manner that shall
result in a violation of Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor,
investor or otherwise). For the past five (5) years, neither the Company nor any of its Subsidiaries have knowingly engaged in, or are
now knowingly engaged in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing
or transaction is or was the subject of Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.37&nbsp;</B><U>U.S.
Real Property Holding Corporation</U>. Neither the Company nor any of its Subsidiaries is, or has ever been, and so long as any of the
Securities are held by the Investor, shall become a U.S. real property holding corporation within the meaning of Section&nbsp;897 of
the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.38&nbsp;</B><U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of
1956, as amended (the &ldquo;<B>BHCA</B>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal
Reserve</B>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of
a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.39&nbsp;</B><U>Information
Technology; Compliance With Data Privacy Laws</U>. Except as would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect, the Company and its Subsidiaries&rsquo; information technology equipment, computers, systems, networks, hardware,
software, websites, and databases (collectively, &ldquo;<B>IT Systems</B>&rdquo;) are adequate for, and operate and perform as reasonably
required to operate the business of the Company and its Subsidiaries as currently conducted, free and clear of all material bugs, errors,
defects, Trojan horses, time bombs, malware and other malicious code. Except as would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect, the Company and its Subsidiaries have implemented and maintained commercially reasonable
physical, technical and administrative controls, policies, procedures, and safeguards designed to protect their material confidential
information and the integrity, continuous operation, and security of all IT Systems and Personal Data used in connection with their businesses.
&ldquo;<B>Personal Data</B>&rdquo; means any information about an individual person that would enable the Company, either alone or in
combination with other information, to identify a natural person. Within the past five years, neither the Company nor its Subsidiaries
have experienced a material information security incident except for those that have been remedied without causing a Material Adverse
Effect or a legal obligation to notify any other Person. The Company and its Subsidiaries are in material compliance with all applicable
state and federal data privacy and security laws of jurisdictions where the Company and its Subsidiaries conduct business (collectively,
the &ldquo;<B>Privacy Laws</B>&rdquo;). Neither the Company nor any Subsidiary: (a) has received notice of any actual or potential liability
under or relating to, or actual or potential violation of, any Privacy Law, and the Company has no Knowledge of any event or condition
that would reasonably be expected to result in any such notice; (b) is currently conducting or paying for, in whole or in part, any investigation,
remediation, or other corrective action pursuant to any Privacy Law; or (c) is a party to any order, decree, or agreement that imposes
any obligation or liability under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.40&nbsp;</B><U>No
Disqualification Events</U>. None of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other
officer of the Company participating in the offering contemplated hereby, any beneficial owner of twenty percent (20%) or more of the
Company&rsquo;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined
in Rule 405 under the Securities Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<B>Issuer Covered
Person</B>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i)&nbsp;to (viii) under
the Securities Act (a &ldquo;<B>Disqualification Event</B>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or
(d)(3) under the Securities Act. The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject
to a Disqualification Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.41&nbsp;</B><U>Stock
Option Plans</U>. Each stock option granted by the Company was granted (a) in accordance with the terms of the applicable stock option
plan of the Company and (b) with an exercise price equal to the fair market value of the Common Stock on the date such stock option would
be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option plan has been backdated.
The Company has not knowingly granted, and there is no and has been no policy or practice of the Company to knowingly grant, stock options
prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information
regarding the Company or its subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.42&nbsp;</B><U>Accuracy
of Certain Summaries and Statements</U>. The statements to be set forth or incorporated by reference, as applicable, in (a)&nbsp;each
Registration Statement (and each post-effective amendment thereto) and the Prospectus included therein under the captions &ldquo;Description
of Capital Stock&rdquo; and &ldquo;Certain Relationships and Related Transactions,&rdquo; and (b) in the IPO Registration Statement under
the caption &ldquo;Certain Relationships and Related Transactions,&rdquo; insofar as they purport to summarize the provisions of the
laws and documents referred to therein, are accurate summaries in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.43&nbsp;</B><U>Acknowledgement
Regarding Investor&rsquo;s Acquisition of Securities</U>. The Company acknowledges and agrees that the Investor is acting solely in the
capacity of an arm&rsquo;s-length purchaser with respect to this Agreement and the transactions contemplated by the Transaction Documents.
The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to this Agreement and the transactions contemplated by the Transaction Documents, and any advice given by the
Investor or any of its representatives or agents in connection therewith is merely incidental to the Investor&rsquo;s acquisition of
the Securities. The Company further represents to the Investor that the Company&rsquo;s decision to enter into the Transaction Documents
to which it is a party has been based solely on the independent evaluation of the transactions contemplated thereby by the Company and
its representatives. The Company acknowledges and agrees that the Investor has not made and does not make any representations or warranties
with respect to the transactions contemplated by the Transaction Documents other than those specifically set forth in Article&nbsp;IV.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;VI<BR>
COVENANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company covenants with
the Investor, and the Investor covenants with the Company, as follows, which covenants of one Party are for the benefit of the other Party,
that during the period commencing on the Closing Date and expiring on the date this Agreement is terminated pursuant to <U>Article&nbsp;VIII</U>
or such other period as may be expressly set forth below with respect to a particular covenant (and, with respect to the Company, for
the period following the termination of this Agreement specified in <U>Section&nbsp;8.3</U> pursuant to and in accordance with <U>Section&nbsp;8.3</U>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.1&nbsp;</B><U>Securities
Compliance</U>. The Company shall notify the SEC and the Trading Market, if and as applicable, in accordance with their respective rules
and regulations, of the transactions contemplated by the Transaction Documents, and shall take all necessary action, undertake all proceedings
and obtain all registrations, permits, consents and approvals for the legal and valid issuance of the Securities to the Investor in accordance
with the terms of the Transaction Documents, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.2&nbsp;</B><U>Reservation
of Common Stock</U>. The Company has available and the Company shall reserve and keep available at all times, free of preemptive and
other similar rights of stockholders, the requisite aggregate number of authorized but unissued shares of Common Stock to enable the
Company to timely effect (a) the issuance and delivery of all Commitment Shares to be issued and delivered to the Investor under <U>Section&nbsp;2.4</U>
hereof within the time period specified in <U>Section&nbsp;2.4</U>; and (b) the issuance, sale and delivery of all Shares to be issued,
sold and delivered in respect of each VWAP Purchase effected under this Agreement, in the case of this clause (b), at least prior to
the delivery by the Company to the Investor of each VWAP Purchase Notice in connection with such VWAP Purchase (collectively, the &ldquo;<B>Required
Reserve Amount</B>&rdquo;). Without limiting the generality of the foregoing: (a) as of the Trading Day on which the Initial Registration
Statement is initially filed by the Company with the SEC (and in no event later than the Filing Deadline with respect to the Initial
Registration Statement as set forth in the Registration Rights Agreement), the Company shall have reserved, out of its authorized and
unissued Common Stock, a sufficient number of shares of Common Stock solely for the purpose of issuing all of the Commitment Shares under
this Agreement to be issued and delivered to the Investor under <U>Section&nbsp;2.4</U> hereof within the time period specified in <U>Section&nbsp;2.4</U>
hereof, and (ii) as of the Closing Date the Company shall have reserved, and as of the Commencement Date shall have continued to reserve,
out of its authorized and unissued Common Stock, 39,777,249 shares of Common Stock solely for the purpose of effecting VWAP Purchases
under this Agreement. The number of shares of Common Stock so reserved for the purpose of effecting VWAP Purchases under this Agreement
may be increased from time to time by the Company from and after the Commencement Date, and such number of reserved shares may be reduced
from and after the Commencement Date only by the number of Shares actually issued, sold and delivered to the Investor pursuant to any
VWAP Purchase effected from and after the Commencement Date pursuant to this Agreement. If at any time the number of shares of Common
Stock authorized and reserved for issuance is not sufficient to meet the Required Reserve Amount, the Company shall promptly take all
corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation, calling a special meeting
of stockholders to authorize additional shares to meet the Company&rsquo;s obligations pursuant to the Transaction Documents, in the
case of an insufficient number of authorized shares, obtain stockholder approval of an increase in such authorized number of shares,
and voting the management shares of the Company in favor of an increase in the authorized shares of the Company to ensure that the number
of authorized shares of Common Stock is sufficient to meet the Required Reserve Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.3&nbsp;</B><U>Registration
and Listing</U>. During the Investment Period, the Company shall take all action necessary to cause the Common Stock to continue to be
registered as a class of securities under Sections 12(b)&nbsp;or 12(g) of the Exchange Act, and to comply with its reporting and filing
obligations under the Exchange Act, and shall not take any action or file any document (whether or not permitted by the Securities Act
or the Exchange Act) to terminate or suspend such registration or to terminate or suspend its reporting and filing obligations under
the Exchange Act or Securities Act, except as permitted herein. Without limiting the generality of the foregoing, the Company shall file
all reports, schedules, registrations, forms, statements, information, and other documents required to be filed by the Company with the
SEC pursuant to the Exchange Act, including all material required to be filed pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange
Act, in each case within the time periods required by the Exchange Act (giving effect to permissible extensions in accordance with Rule
12b-25 under the Exchange Act). The Company shall use its best efforts to continue the listing and trading of its Common Stock and the
listing of the Securities purchased by the Investor hereunder on the Trading Market and to comply with the Company&rsquo;s reporting,
filing and other obligations under the Bylaws, listed securities maintenance standards, and other rules and regulations of FINRA and
the Trading Market. The Company shall not take any action which could be reasonably expected to result in the delisting or suspension
of the Common Stock on the Trading Market. If the Company receives any final and non-appealable notice that the listing or quotation
of the Common Stock on the Trading Market shall be terminated on a date certain, the Company shall promptly (and in any case within twenty-four
(24) hours) notify the Investor of such fact in writing and shall use its commercially reasonable efforts to cause the Common Stock to
be listed or quoted on another Eligible Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.4&nbsp;</B><U>Compliance
with Laws</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;During
the Investment Period, the Company: (i)&nbsp;shall comply, and cause each Subsidiary (if any) to comply, with all laws, rules, regulations
and orders applicable to the business and operations of the Company and its Subsidiaries, except as would not have a Material Adverse
Effect; and (ii)&nbsp;with applicable provisions of the Securities Act and the Exchange Act, including Regulation M thereunder, applicable
state securities or &ldquo;Blue Sky&rdquo; laws, and applicable listing rules of the Trading Market or Eligible Market, except as would
not, individually or in the aggregate, prohibit or otherwise interfere with the ability of the Company to enter into and perform its obligations
under this Agreement in any material respect or for Investor to conduct resales of Securities under the Registration Statement in any
material respect. Without limiting the foregoing: (A) neither the Company nor any of its officers or directors (1) shall take, directly
or indirectly, any action designed or intended to cause or to result in, or which would in the future reasonably be expected to cause
or result in, the stabilization or manipulation of the price of any security of the Company, in each case to facilitate the sale or resale
of any of the Securities, or (2) sell, bid for, purchase, or pay any compensation for soliciting purchases of, any of the Securities;
and (B) neither the Company, nor any of its Subsidiaries, nor to the Knowledge of the Company, any of their respective directors, officers,
agents, employees or any other Persons acting on their behalf shall, in connection with the operation of the Company&rsquo;s and its Subsidiaries&rsquo;
respective businesses: (x)&nbsp;use any corporate funds for unlawful contributions, payments, gifts or entertainment or to make any unlawful
expenditures relating to political activity to government officials, candidates or members of political parties or organizations; (y)&nbsp;pay,
accept or receive any unlawful contributions, payments, expenditures or gifts; or (z)&nbsp;violate or operate in noncompliance with any
export restrictions, anti-boycott regulations, embargo regulations or other applicable domestic or foreign laws and regulations, including,
without limitation, the FCPA and the Money Laundering Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;The
Investor shall comply with all laws, rules, regulations and orders applicable to the performance by it of its obligations under this Agreement
and its investment in the Securities, except as would not, individually or in the aggregate, prohibit or otherwise interfere with the
ability of the Investor to enter into and perform its obligations under this Agreement in any material respect. Without limiting the foregoing,
the Investor shall comply with all applicable provisions of the Securities Act and the Exchange Act, including Regulation M thereunder,
and all applicable state securities or &ldquo;Blue Sky&rdquo; laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.5&nbsp;</B><U>Keeping
of Records and Books of Account; Due Diligence</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;During
the Investment Period: (i)&nbsp;the Company shall keep and cause each Subsidiary to keep adequate records and books of account, in which
complete entries shall be made in accordance with GAAP consistently applied, reflecting all financial transactions of the Company and
its Subsidiaries, and in which, for each fiscal year, all proper reserves for depreciation, depletion, obsolescence, amortization, taxes,
bad debts and other purposes in connection with its business shall be made; and (ii)&nbsp;the Company shall maintain a system of internal
accounting controls that: (a)&nbsp;pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions
and dispositions of the assets of the Company; (b)&nbsp;provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of
the Company are being made only in accordance with authorizations of management and directors of the Company; and (c)&nbsp;provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&rsquo;s assets that
could have a material effect on the Company&rsquo;s financial statements (it being acknowledged and agreed that the identification by
the Company and/or its independent registered public accounting firm of any &ldquo;significant deficiencies&rdquo; or &ldquo;material
weaknesses&rdquo; (each as defined by the Public Company Accounting Oversight Board) in the Company&rsquo;s internal controls over its
financial reporting shall not, in and of itself, constitute a breach of this Section&nbsp;6.5(a)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;Subject
to the requirements of <U>Section&nbsp;6.12</U>, from time to time from and after the Closing Date, the Company shall make available for
inspection and review by the Investor during normal business hours and after reasonable notice, customary documentation reasonably requested
by the Investor and/or its appointed counsel or advisors to conduct due diligence; provided, however, that after the Closing Date, the
Investor&rsquo;s continued due diligence shall not be a condition precedent to the Company&rsquo;s right to deliver to the Investor any
VWAP Purchase Notice or the settlement thereof</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.6&nbsp;</B><U>No
Frustration; No Variable Rate Transactions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>No
Frustration</U>. During the period commencing on the Closing Date and expiring on the twenty-four (24)-month anniversary of the Effective
Date (it being hereby acknowledged and agreed that such term may not be extended by the Parties and notwithstanding any earlier termination
of this Agreement pursuant to <U>Article&nbsp;VIII</U>), the Company shall not enter into, announce or recommend to its stockholders any
agreement, plan, arrangement or transaction in or of which the terms thereof would restrict, materially delay, conflict with or impair
the ability or right of the Company to perform its obligations under the Transaction Documents to which it is a party, including, without
limitation, the obligation of the Company to deliver (i)&nbsp;the Commitment Shares, if any, to the investor not later than 4:00&nbsp;p.m.
New York City time on the Trading Day immediately following the Effective Date, and (ii) the Shares to the Investor in respect of a VWAP
Purchase not later than the applicable VWAP Purchase Date. For the avoidance of doubt, nothing in this <U>Section&nbsp;6.6(a)</U>&nbsp;shall
in any way limit the Company&rsquo;s right to terminate this Agreement in accordance with <U>Section&nbsp;8.2</U> (subject in all cases
to <U>Section&nbsp;8.3</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>No
Variable Rate Transactions</U>. During the period commencing on the Closing Date and expiring on the twenty-four (24)-month anniversary
of the Effective Date (it being hereby acknowledged and agreed that such term may not be extended by the Parties and notwithstanding any
earlier termination of this Agreement pursuant to <U>Article&nbsp;VIII</U>), the Company shall not effect or enter into an agreement to
effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof)
involving a Variable Rate Transaction, other than in connection with an Exempt Issuance or as set forth in the SEC Documents as of the
date of this Agreement. The Investor shall be entitled to seek injunctive relief against the Company and its Subsidiaries to preclude
any such issuance, which remedy shall be in addition to any right to collect damages, without the necessity of showing economic loss and
without any bond or other security being required</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.7&nbsp;</B><U>Corporate
Existence</U>. The Company shall take all steps necessary to preserve and continue the corporate existence of the Company; provided,
however, that, except as provided in <U>Section&nbsp;6.8</U>, nothing in this Agreement shall be deemed to prohibit the Company from
engaging in any Fundamental Transaction with another Person. For the avoidance of doubt, nothing in this <U>Section&nbsp;6.7</U> shall
in any way limit the Company&rsquo;s right to terminate this Agreement in accordance with <U>Section&nbsp;8.2</U> (subject in all cases
to <U>Section&nbsp;8.3</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.8&nbsp;</B><U>Fundamental
Transaction</U>. If a VWAP Purchase Notice has been delivered to the Investor and the transactions contemplated therein have not yet
been fully settled in accordance with the terms and conditions of this Agreement, the Company shall not effect any Fundamental Transaction
until the expiration of five (5) Trading Days following the date of full settlement thereof and the issuance to the Investor of all of
the Shares issuable pursuant to the VWAP Purchase to which such VWAP Purchase Notice, respectively, relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.9&nbsp;</B><U>Selling
Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;Except
as expressly set forth below, the Investor covenants that from and after the Closing Date through and including the Trading Day next following
the expiration or termination of this Agreement (the &ldquo;<B>Restricted Period</B>&rdquo;), neither the Investor nor any of its Affiliates
nor any entity managed or controlled by the Investor (collectively, the &ldquo;Restricted Persons&rdquo; and each of the foregoing is
referred to herein as a &ldquo;<B>Restricted Person</B>&rdquo;) shall, directly or indirectly: (i)&nbsp;engage in any Short Sales involving
the Company&rsquo;s securities; or (ii)&nbsp;grant any option to purchase, or acquire any right to dispose of or otherwise dispose for
value of, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for any shares of Common Stock,
or enter into any swap, hedge or other similar agreement that transfers, in whole or in part, the economic risk of ownership of the Common
Stock. Notwithstanding the foregoing, it is expressly understood and agreed that nothing contained herein shall (without implication that
the contrary would otherwise be true) prohibit any Restricted Person during the Restricted Period from: (a)&nbsp;selling &ldquo;long&rdquo;
(as defined under Rule 200 promulgated under Regulation SHO) the Securities; or (b)&nbsp;selling a number of shares of Common Stock equal
to the number of Shares that such Restricted Person is or may be obligated to purchase under a pending VWAP Purchase Notice but has not
yet taken possession of so long as such Restricted Person (or the Broker-Dealer, as applicable) delivers the Shares purchased pursuant
to such VWAP Purchase Notice (as applicable) to the purchaser thereof or the applicable Broker-Dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;In
addition to the foregoing, in connection with any sale of Securities (including any sale permitted by <U>Section&nbsp;6.9(a)</U>), the
Investor shall comply in all respects with all applicable laws, rules, regulations and orders, including, without limitation, the requirements
of the Securities Act and the Exchange Act</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.10&nbsp;</B><U>Effective
Registration Statement</U>. During the Investment Period, the Company shall use its commercially reasonable efforts to maintain the continuous
effectiveness of the Initial Registration Statement and each Subsequent Registration Statement filed with the SEC under the Securities
Act for the applicable Registration Period pursuant to and in accordance with the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.11&nbsp;</B><U>Blue
Sky</U>. The Company shall take such action, if any, as is necessary by the Company in order to obtain an exemption for or to qualify
the Securities for sale by the Company to the Investor pursuant to the Transaction Documents, and at the request of the Investor, the
subsequent resale of Registrable Securities by the Investor, in each case, under applicable state securities or &ldquo;Blue Sky&rdquo;
laws and shall provide evidence of any such action so taken to the Investor from time to time following the Closing Date; provided, however,
that the Company shall not be required in connection therewith or as a condition thereto to: (a)&nbsp;qualify to do business in any jurisdiction
where it would not otherwise be required to qualify but for this <U>Section&nbsp;6.11</U>; (b)&nbsp;subject itself to general taxation
in any such jurisdiction; or (c)&nbsp;file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.12&nbsp;</B><U>Non-Public
Information</U>. Neither the Company or any of its Subsidiaries, nor any of their respective directors, officers, employees or agents
shall disclose any material non-public information about the Company to the Investor, unless a simultaneous public announcement thereof
is made by the Company in the manner contemplated by Regulation FD. In the event of a breach of the foregoing covenant by the Company
or any of its Subsidiaries, or any of their respective directors, officers, employees and agents (as determined in the reasonable good
faith judgment of the Investor): (a)&nbsp;the Investor shall promptly provide written notice of such breach to the Company; and (b)&nbsp;after
such notice has been provided to the Company and, <U>provided</U> that the Company shall have failed to publicly disclose such material,
non-public information within twenty-four (24) hours following demand therefor by the Investor, in addition to any other remedy provided
herein or in the other Transaction Documents, the Investor shall have the right to make a public disclosure, in the form of a press release,
public advertisement or otherwise, of such material, non-public information without the prior approval by the Company, any of its Subsidiaries,
or any of their respective directors, officers, employees or agents. The Investor shall not have any liability to the Company, any of
its Subsidiaries, or any of their respective directors, officers, employees, stockholders or agents, for any such disclosure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.13&nbsp;</B><U>Broker/Dealer</U>.
The Investor shall use one or more broker-dealers to effectuate all sales, if any, of the Securities that it may purchase or otherwise
acquire from the Company pursuant to the Transaction Documents, as applicable, which (or whom) shall be unaffiliated with the Investor
and not then currently engaged or used by the Company, and a DTC participant (collectively, the &ldquo;<B>Broker-Dealer</B>&rdquo;).
The Investor shall, from time to time, provide the Company and its Transfer Agent with all information regarding the Broker-Dealer reasonably
requested by the Company. The Investor shall be solely responsible for all fees and commissions of the Broker-Dealer, which shall not
exceed customary brokerage fees and commissions and shall be responsible for designating only a DTC participant eligible to receive DWAC
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.14&nbsp;</B><U>Disclosure
Schedule</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;The
Company may, from time to time, update the Disclosure Schedule as may be required to satisfy the conditions set forth in <U>Section&nbsp;7.2(a)</U>&nbsp;and
<U>Section&nbsp;7.3(a)</U>&nbsp;(to the extent such condition set forth in <U>Section&nbsp;7.3(a)</U>&nbsp;relates to the condition in
<U>Section&nbsp;7.2(a)</U>&nbsp;as of a specific VWAP Exercise Purchase Date). For purposes of this <U>Section&nbsp;6.14</U>, any disclosure
made in a schedule to the Compliance Certificate shall be deemed to be an update of the Disclosure Schedule. Notwithstanding anything
in this Agreement to the contrary, no update to the Disclosure Schedule pursuant to this <U>Section&nbsp;6.14</U> shall cure any breach
of a representation or warranty of the Company contained in this Agreement and made prior to the update and shall not affect any of the
Investor&rsquo;s rights or remedies with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;Notwithstanding
anything to the contrary contained in the Disclosure Schedule or in this Agreement, the information and disclosure contained in any Schedule
of the Disclosure Schedule shall be deemed to be disclosed and incorporated by reference in any other Schedule of the Disclosure Schedule
as though fully set forth in such Schedule for which applicability of such information and disclosure is readily apparent on its face.
The fact that any item of information is disclosed in the Disclosure Schedule shall not be construed to mean that such information is
required to be disclosed by this Agreement. Except as expressly set forth in this Agreement, such information and the thresholds (whether
based on quantity, qualitative characterization, dollar amounts or otherwise) set forth herein shall not be used as a basis for interpreting
the terms &ldquo;material&rdquo; or &ldquo;Material Adverse Effect&rdquo; or other similar terms in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.15&nbsp;</B><U>Delivery
of Bring-Down Opinions and Compliance Certificates Upon Occurrence of Certain Events</U>. Within three (3) Trading Days immediately following:
(a)&nbsp;the end of each PEA Period, if the Company is required under the Securities Act to file with the SEC (i)&nbsp;a post-effective
amendment to the Initial Registration Statement required to be filed by the Company with the SEC pursuant to Section&nbsp;2(a)&nbsp;of
the Registration Rights Agreement; (ii)&nbsp;a Subsequent Registration Statement required to be filed by the Company with the SEC pursuant
to Section&nbsp;2(c)&nbsp;of the Registration Rights Agreement; or (iii)&nbsp;a post-effective amendment to a Subsequent Registration
Statement required to be filed by the Company with the SEC pursuant to Section&nbsp;2(c) of the Registration Rights Agreement, in each
case with respect to a fiscal year ending after the Commencement Date, to register the resale of Securities by the Investor under the
Securities Act pursuant to this Agreement and the Registration Rights Agreement; and (b)&nbsp;the date the Company files with the SEC
(i)&nbsp;a Prospectus Supplement to the Prospectus contained in the Initial Registration Statement or any Subsequent Registration Statement
under the Securities Act; (ii)&nbsp;an Annual Report on Form 10-K under the Exchange Act with respect to a fiscal year ending after the
Commencement Date; (iii)&nbsp;an amendment on Form 10-K/A to an Annual Report on Form 10-K under the Exchange Act with respect to a fiscal
year ending after the Commencement Date, which contains amended material financial information (or a restatement of material financial
information) or an amendment to other material information contained in a previously filed Form 10-K; and (iv)&nbsp;a SEC Document under
the Exchange Act (other than those referred to in clauses (b)(i)&nbsp;and (b)(ii)&nbsp;of this <U>Section&nbsp;6.15</U>), which contains
amended material financial information (or a restatement of material financial information) or an amendment to other material information
contained or incorporated by reference in the Initial Registration Statement, any Subsequent Registration Statement, or the Prospectus
or any Prospectus Supplement contained in the Initial Registration Statement or any Subsequent Registration Statement (it being hereby
acknowledged and agreed that the filing by the Company with the SEC of a Quarterly Report on Form 10-Q that includes only updated financial
information as of the end of the Company&rsquo;s most recent fiscal quarter shall not, in and of itself, constitute an &ldquo;amendment&rdquo;
or &ldquo;restatement&rdquo; for purposes of the foregoing clause (b)), in each case of the foregoing clause (b), if the Company is not
also then required under the Securities Act to file a post-effective amendment to the Initial Registration Statement, any Subsequent
Registration Statement or a post-effective amendment to any Subsequent Registration Statement, in each case with respect to a fiscal
year ending after the Commencement Date, to register the resale of Securities by the Investor under the Securities Act pursuant to this
Agreement and the Registration Rights Agreement, and in any case of the foregoing clause (b), not more than once per calendar quarter,
the Company shall: (A)&nbsp;deliver to the Investor a Compliance Certificate, dated such date; and (B)&nbsp;cause to be furnished to
the Investor an opinion &ldquo;bring down&rdquo; from outside counsel to the Company substantially in the form mutually agreed to by
the Company and the Investor prior to the date of this Agreement, modified, as necessary, to relate to such Registration Statement or
post-effective amendment, or the Prospectus contained therein as then amended or supplemented by such Prospectus Supplement, as applicable
(each such opinion, a &ldquo;<B>Bring-Down Opinion</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section
6.16</B> <U>Participation Right</U> At any time during the term of this Agreement, neither the Company nor any of its Subsidiaries shall,
directly or indirectly, effect any Subsequent Placement unless the Company shall have first complied with this <U>Section 6.16</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;At
least three (3) Trading Days prior to any proposed or intended Subsequent Placement, the Company shall deliver to the Investor a written
notice (each such notice, a &ldquo;<B>Pre-Notice</B>&rdquo;), which Pre-Notice shall not contain any information (including, without limitation,
material, non-public information) other than: (i) if the proposed Offer Notice (as defined below) constitutes or contains material, non-public
information, a statement asking whether the Investor is willing to accept material non-public information or (ii) if the proposed Offer
Notice does not constitute or contain material, non-public information, (A) a statement that the Company proposes or intends to effect
a Subsequent Placement, (B) a statement that the statement in clause (A) above does not constitute material, non-public information, and
(C) a statement informing the Investor that it is entitled to receive an Offer Notice with respect to such Subsequent Placement upon its
written request. Upon the written request of the Investor within one (1) Trading Day after the Company&rsquo;s delivery to the Investor
of such Pre-Notice, and only upon a written request by the Investor, the Company shall promptly, but no later than one (1) Trading Day
after such request, deliver to the Investor an irrevocable written notice (the &ldquo;<B>Offer Notice</B>&rdquo;) of any proposed or intended
issuance or sale or exchange (the &ldquo;<B>Offer</B>&rdquo;) of the securities being offered (the &ldquo;<B>Offered Securities</B>&rdquo;)
in a Subsequent Placement, which Offer Notice shall (1) identify and describe the Offered Securities, (2) describe the price and other
terms upon which they are to be issued, sold or exchanged, and the number or amount of the Offered Securities to be issued, sold or exchanged,
(3) identify the Persons (if known) to which or with which the Offered Securities are to be offered, issued, sold or exchanged, and (4)
offer to issue and sell to or exchange with the Investor in accordance with the terms of the Offer fifteen percent (15%) of the Offered
Securities (the &ldquo;<B>Basic Amount</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;To
accept an Offer, in whole or in part, the Investor must deliver a written notice to the Company prior to the end of the first (1st) Business
Day after the Investor&rsquo;s receipt of the Offer Notice (the &ldquo;<B>Offer Period</B>&rdquo;), setting forth the portion of the Basic
Amount the Investor elects to purchase (the &ldquo;<B>Notice of Acceptance</B>&rdquo;). Notwithstanding the foregoing, if the Company
desires to modify or amend the terms and conditions of the Offer prior to the expiration of the Offer Period, the Company may deliver
to the Investor a new Offer Notice and the Offer Period shall expire on the first (1st) Business Day after the Investor&rsquo;s receipt
of such new Offer Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;The
Company shall have five (5) Business Days from the expiration of the Offer Period above (i) to offer, issue, sell or exchange all or any
part of such Offered Securities as to which a Notice of Acceptance has not been given by the Investor (the &ldquo;<B>Refused Securities</B>&rdquo;)
pursuant to a definitive agreement(s) (the &ldquo;<B>Subsequent Placement Agreement</B>&rdquo;), but only to the offerees described in
the Offer Notice (if so described therein) and only upon terms and conditions (including, without limitation, unit prices and interest
rates) that are not more favorable to the acquiring Person or Persons or less favorable to the Company than those set forth in the Offer
Notice and (ii) to publicly announce (A) the execution of such Subsequent Placement Agreement, and (B) either (1) the consummation of
the transactions contemplated by such Subsequent Placement Agreement or (2) the termination of such Subsequent Placement Agreement, which
shall be filed with the SEC on a Current Report on Form 8-K with such Subsequent Placement Agreement and any documents contemplated therein
filed as exhibits thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;In
the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and on the terms specified
in <U>Section&nbsp;6.16(c)</U>), then the Investor may, at its sole option and in its sole discretion, withdraw its Notice of Acceptance
or reduce the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall be not less than
the number or amount of the Offered Securities that the Investor elected to purchase pursuant to <U>Section&nbsp;6.16(b)</U> multiplied
by a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually proposes to issue,
sell or exchange (including Offered Securities to be issued or sold to the Investor pursuant to this <U>Section&nbsp;6.16</U> prior to
such reduction) and (ii) the denominator of which shall be the original amount of the Offered Securities. In the event the Investor so
elects to reduce the number or amount of Offered Securities specified in its Notice of Acceptance, the Company may not issue, sell or
exchange more than the reduced number or amount of the Offered Securities unless and until such securities have again been offered to
the Investor in accordance with <U>Section&nbsp;6.16(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;Upon
the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, the Investor shall acquire from the Company,
and the Company shall issue to the Investor, the number or amount of Offered Securities specified in its Notice of Acceptance, as reduced
pursuant to <U>Section&nbsp;6.16(d)</U> if the Investor has so elected, upon the terms and conditions specified in the Offer. The purchase
by the Investor of any Offered Securities is subject in all cases to the preparation, execution and delivery by the Company and the Investor
of a separate purchase agreement relating to such Offered Securities reasonably satisfactory in form and substance to the Investor and
its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;Any
Offered Securities not acquired by the Investor or other Persons in accordance with this <U>Section&nbsp;6.16</U> may not be issued, sold
or exchanged until they are again offered to the Investor under the procedures specified in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;The
Company and the Investor agree that if the Investor elects to participate in the Offer, (i) neither the Subsequent Placement Agreement
with respect to such Offer nor any other transaction documents related thereto (collectively, the &ldquo;<B>Subsequent Placement Documents</B>&rdquo;)
shall include any term or provision whereby the Investor shall be required to agree to any restrictions on trading as to any securities
of the Company or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection
with, any agreement previously entered into with the Company or any instrument received from the Company, and (ii) any registration rights
set forth in such Subsequent Placement Documents shall be similar in all material respects to the registration rights contained in the
Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;Notwithstanding
anything to the contrary in this <U>Section&nbsp;6.16</U> and unless otherwise agreed to by the Investor, the Company shall either confirm
in writing to the Investor that the transaction with respect to the Subsequent Placement has been abandoned or shall publicly disclose
its intention to issue the Offered Securities, in either case, in such a manner such that the Investor will not be in possession of any
material, non-public information, by the fifth (5<SUP>th</SUP>) Business Day following delivery of the Offer Notice. If by such fifth
(5<SUP>th</SUP>) Business Day, no public disclosure regarding a transaction with respect to the Offered Securities has been made, and
no notice regarding the abandonment of such transaction has been received by the Investor, such transaction shall be deemed to have been
abandoned and the Investor shall not be in possession of any material, non-public information with respect to the Company or any of its
Subsidiaries. Should the Company decide to pursue such transaction with respect to the Offered Securities, the Company shall provide the
Investor with another Offer Notice and the Investor shall again have the right of participation set forth in this <U>Section&nbsp;6.16</U>.
The Company shall not be permitted to deliver more than one such Offer Notice to the Investor in any sixty (60)-day period, except as
expressly contemplated by the last sentence of <U>Section&nbsp;6.16(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;The
restrictions contained in this <U>Section&nbsp;6.16(c)</U> shall not apply in connection with the issuance of any Exempt Issuances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.17&nbsp;</B><U>Notification
of Price Reset Period</U>. The Company shall notify the Investor in writing within two (2) Trading Days following the issuance of any
Common Stock or Common Stock Equivalents that would trigger a Price Reset Period, including the date of issuance, the terms of any price
reset or adjustment feature, and the terms associated with the registration of such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;6.18&nbsp;</B><U>Amendment
of Bylaws to Permit Stockholder Action by Written Consent</U>. The Company shall cause its board of directors to act by written consent
as soon as practicable, but in no event later than five (5) Trading Days following the Closing Date, to amend the Company&rsquo;s bylaws
to permit stockholder action by written consent in accordance with applicable law. The Company shall provide to the Investor prompt written
notice and a copy of such amendment upon its effectiveness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;VII<BR>
CONDITIONS TO CLOSING AND CONDITIONS to the SALE AND PURCHASE OF THE SHARES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;7.1&nbsp;</B><U>Conditions
to Closing</U>. The Closing is subject to the satisfaction of each of the conditions set forth in this <U>Section&nbsp;7.1</U> on the
Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Accuracy
of the Investor&rsquo;s Representations and Warranties</U>. The representations and warranties of the Investor contained in this Agreement:
(i)&nbsp;that are not qualified by &ldquo;materiality&rdquo; shall be true and correct in all material respects as of the Closing Date,
except to the extent such representations and warranties are as of another date, in which case, such representations and warranties shall
be true and correct in all material respects as of such other date; and (ii)&nbsp;that are qualified by &ldquo;materiality&rdquo; shall
be true and correct as of the Closing Date, except to the extent such representations and warranties are as of another date, in which
case, such representations and warranties shall be true and correct as of such other date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Accuracy
of the Company&rsquo;s Representations and Warranties</U>. The representations and warranties of the Company contained in this Agreement:
(i)&nbsp;that are not qualified by &ldquo;materiality&rdquo; or &ldquo;Material Adverse Effect&rdquo; shall be true and correct in all
material respects as of the Closing Date, except to the extent such representations and warranties are as of another date, in which case,
such representations and warranties shall be true and correct in all material respects as of such other date; and (ii)&nbsp;that are qualified
by &ldquo;materiality&rdquo; or &ldquo;Material Adverse Effect&rdquo; shall be true and correct as of the Closing Date, except to the
extent such representations and warranties are as of another date, in which case, such representations and warranties shall be true and
correct as of such other date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Payment
of Investor Expense Reimbursement; Acknowledgement of Obligation to Issue Commitment Shares or Pay Commitment Fee</U>. On or prior to
the Closing Date, the Company shall have paid by wire transfer of immediately available funds to an account designated by the Investor
on or prior to the date hereof, the Investor Expense Reimbursement in accordance with <U>Section&nbsp;10.1(a)</U>. The Investor Expense
Reimbursement and Commitment Fee shall be fully earned and non-refundable as of the Closing Date, regardless of whether any VWAP Purchases
are made or settled hereunder or any subsequent termination of this Agreement. Effective as of the Closing Date, the Company shall be
obligated to (i) deliver, not later than 4:00&nbsp;p.m. New York City time on the Trading Day immediately following the Effective Date,
a certificate or book-entry statement representing the Commitment Shares in the name of the Investor or its designee (in which case such
designee name shall have been provided to the Company not later than two (2) Trading Days prior to the Effective Date), in consideration
for the Investor&rsquo;s execution and delivery of this Agreement, which certificate or book-entry statement shall be delivered to the
Investor by overnight courier at its address set forth in <U>Section&nbsp;10.4</U> hereof, or (ii) in the event of a Registration Failure
or upon the earlier termination of this Agreement pursuant to <U>Section&nbsp;8.1</U> or <U>Section&nbsp;8.2</U> hereof, then, effective
immediately following the occurrence of either of the events described in this clause (ii), the obligations of the Company to deliver
the Commitment Shares to the Investor pursuant to the forgoing provisions of this <U>Section&nbsp;7.1(c)</U> shall terminate and the entire
Commitment Fee shall become immediately due and payable by the Company to the Investor in accordance with <U>Section&nbsp;10.1(b)</U>.
For the avoidance of doubt, all Commitment Shares (or the entire Commitment Fee, as applicable) shall be fully earned by the Investor
upon the consummation of the Closing and effective as of the Closing Date, regardless of whether any VWAP Purchases are made or settled
hereunder or any subsequent termination of this Agreement. The Company shall pay all U.S. federal, state and local stamp and other similar
transfer and other taxes and duties levied in connection with issuance of the Securities pursuant hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;<U>Closing
Deliverables</U>. At the Closing, counterpart signature pages of this Agreement and the Registration Rights Agreement executed by each
of the Parties shall be delivered as provided in <U>Section&nbsp;2.2</U>. Simultaneously with the execution and delivery of this Agreement
and the Registration Rights Agreement, the Investor&rsquo;s counsel shall have received: (i)&nbsp;the opinions of outside counsel to the
Company, dated the Closing Date, in the forms mutually agreed to by the Company and the Investor prior to the date of this Agreement;
and (ii)&nbsp;the closing certificate from the Company, dated the Closing Date, in the form of <U>Exhibit D</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;7.2&nbsp;</B><U>Conditions
Precedent to Commencement</U>. The right of the Company to commence delivering VWAP Purchase Notices under this Agreement, and the obligation
of the Investor to accept VWAP Purchase Notices delivered to the Investor by the Company under this Agreement, are subject to the initial
satisfaction, at Commencement, of each of the conditions set forth in this <U>Section&nbsp;7.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Accuracy
of the Company&rsquo;s Representations and Warranties</U>. The representations and warranties of the Company contained in this Agreement:
(i)&nbsp;that are not qualified by &ldquo;materiality&rdquo; or &ldquo;Material Adverse Effect&rdquo; shall have been true and correct
in all material respects when made and shall be true and correct in all material respects as of the Commencement Date with the same force
and effect as if made on such date, except to the extent such representations and warranties are as of another date, in which case, such
representations and warranties shall be true and correct in all material respects as of such other date; and (ii)&nbsp;that are qualified
by &ldquo;materiality&rdquo; or &ldquo;Material Adverse Effect&rdquo; shall have been true and correct when made and shall be true and
correct as of the Commencement Date with the same force and effect as if made on such date, except to the extent such representations
and warranties are as of another date, in which case, such representations and warranties shall be true and correct as of such other date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Performance
of the Company</U>. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements and
conditions required by this Agreement and the Registration Rights Agreement to be performed, satisfied or complied with by the Company
at or prior to the Commencement. The Company shall deliver to the Investor on the Commencement Date the compliance certificate substantially
in the form attached hereto as <U>Exhibit C</U> (the &ldquo;<B>Compliance Certificate</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Initial
Registration Statement Effective</U>. The Initial Registration Statement covering the resale by the Investor of the Registrable Securities
included therein required to be filed by the Company with the SEC pursuant to Section&nbsp;2(a)&nbsp;of the Registration Rights Agreement
shall have been declared effective under the Securities Act by the SEC, and the Investor shall be permitted to utilize the Prospectus
therein to resell (i) all of the Commitment Shares, if any, and (ii) all of the Shares included in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;<U>No
Material Notices</U>. None of the following events shall have occurred and be continuing: (i)&nbsp;receipt of any request by the SEC or
any other federal or state governmental authority for any additional information relating to the Initial Registration Statement, the Prospectus
contained therein or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement, the
Prospectus contained therein or any Prospectus Supplement thereto; (ii)&nbsp;the issuance by the SEC or any other federal or state governmental
authority of any stop order suspending the effectiveness of the Initial Registration Statement or prohibiting or suspending the use of
the Prospectus contained therein or any Prospectus Supplement thereto, or of the suspension of qualification or exemption from qualification
of the Securities for offering or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose;
or (iii)&nbsp;the occurrence of any event or the existence of any condition or state of facts, which makes any statement of a material
fact made in the Initial Registration Statement, the Prospectus contained therein or any Prospectus Supplement thereto untrue or which
requires the making of any additions to or changes to the statements then made in the Initial Registration Statement, the Prospectus contained
therein or any Prospectus Supplement thereto in order to state a material fact required by the Securities Act to be stated therein or
necessary in order to make the statements then made therein (in the case of the Prospectus or any Prospectus Supplement, in light of the
circumstances under which they were made) not misleading, or which requires an amendment to the Initial Registration Statement or a supplement
to the Prospectus contained therein or any Prospectus Supplement thereto to comply with the Securities Act or any other law. The Company
shall have no Knowledge of any event that could reasonably be expected to have the effect of causing the suspension of the effectiveness
of the Initial Registration Statement or the prohibition or suspension of the use of the Prospectus contained therein or any Prospectus
Supplement thereto in connection with the resale of the Registrable Securities by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;<U>Other
SEC Filings</U>. The Current Report and the Form D shall have been filed with the SEC as required pursuant to <U>Section&nbsp;2.3</U>.
The final Prospectus included in the Initial Registration Statement shall have been filed with the SEC prior to Commencement in accordance
with <U>Section&nbsp;2.3</U> and the Registration Rights Agreement. All reports, schedules, registrations, forms, statements, information
and other documents required to have been filed by the Company with the SEC pursuant to the reporting requirements of the Exchange Act,
including all material required to have been filed pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Exchange Act, prior to Commencement
shall have been filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;<U>No
Suspension of Trading in or Notice of Delisting of Common Stock</U>. Trading in the Common Stock shall not have been suspended by the
SEC, the Trading Market or the FINRA (except for any suspension of trading of limited duration agreed to by the Company, which suspension
shall be terminated prior to the Commencement Date), the Company shall not have received any final and non-appealable notice that the
listing or quotation of the Common Stock on the Trading Market shall be terminated on a date certain (unless, prior to such date certain,
the Common Stock is listed or quoted on any other Eligible Market), nor shall there have been imposed any suspension of, or restriction
on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock
that is continuing, the Company shall not have received any notice from DTC to the effect that a suspension of, or restriction on, accepting
additional deposits of the Common Stock, electronic trading or book-entry services by DTC with respect to the Common Stock is being imposed
or is contemplated (unless, prior to such suspension or restriction, DTC shall have notified the Company in writing that DTC has determined
not to impose any such suspension or restriction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;<U>Compliance
with Laws</U>. The Company shall have complied with all applicable federal, state and local governmental laws, rules, regulations and
ordinances in connection with the execution, delivery and performance of this Agreement and the other Transaction Documents to which it
is a party and the consummation of the transactions contemplated hereby and thereby, including, without limitation, the Company shall
have obtained all permits and qualifications required by any applicable state securities or &ldquo;Blue Sky&rdquo; laws for the offer
and sale of the Securities by the Company to the Investor and the subsequent resale of the Registrable Securities by the Investor (or
shall have the availability of exemptions therefrom).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;<U>No
Injunction</U>. No statute, regulation, order, decree, writ, ruling or injunction shall have been enacted, entered, promulgated, threatened
or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of or which would materially
modify or delay any of the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;<U>No
Proceedings or Litigation</U>. No action, suit or proceeding before any arbitrator or any court or governmental authority shall have been
commenced, and no inquiry or investigation by any governmental authority shall have been commenced, against the Company or any Subsidiary,
or any of the officers, directors or Affiliates of the Company or any Subsidiary, seeking to restrain, prevent or change the transactions
contemplated by the Transaction Documents, or seeking material damages in connection with such transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;<U>Listing
of Securities</U>. All of the Securities that have been and may be issued pursuant to this Agreement shall have been approved for listing
or quotation on the Trading Market as of the Commencement Date, subject only to notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;<U>No
Material Adverse Effect</U>. No condition, occurrence, state of facts or event constituting a Material Adverse Effect shall have occurred
and be continuing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;<U>No
Bankruptcy Proceedings</U>. No Person shall have commenced a proceeding against the Company pursuant to or within the meaning of any Bankruptcy
Law. The Company shall not have, pursuant to or within the meaning of any Bankruptcy Law: (i)&nbsp;commenced a voluntary case; (ii)&nbsp;consented
to the entry of an order for relief against it in an involuntary case; (iii)&nbsp;consented to the appointment of a Custodian of the Company
or for all or substantially all of its property; or (iv)&nbsp;made a general assignment for the benefit of its creditors. A court of competent
jurisdiction shall not have entered an order or decree under any Bankruptcy Law that: (a)&nbsp;is for relief against the Company in an
involuntary case; (b)&nbsp;appoints a Custodian of the Company or for all or substantially all of its property; or (c)&nbsp;orders the
liquidation of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;<U>Commitment
Shares Issued</U>. The Company shall have caused its Transfer Agent to issue and deliver to the Investor, not later than 4:00&nbsp;p.m.
New York City time on the Trading Day immediately following the Effective Date, a certificate or book-entry statement representing the
Commitment Shares in the name of the Investor or its designee (in which case such designee name shall have been provided to the Company
not later than two (2) Trading Days prior to the Effective Date), in consideration for the Investor&rsquo;s execution and delivery of
this Agreement, which certificate or book-entry statement shall be delivered to the Investor by overnight courier at its address set forth
in <U>Section&nbsp;10.4</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;<U>Delivery
of Commencement Irrevocable Transfer Agent Instructions and Notice of Effectiveness</U>. The Commencement Irrevocable Transfer Agent Instructions
shall have been executed by the Company and delivered to acknowledged in writing by the Transfer Agent, and the Notice of Effectiveness
relating to the Initial Registration Statement shall have been executed by the Company&rsquo;s outside counsel and delivered to the Transfer
Agent, in each case directing the Transfer Agent to issue to the Investor or its designated Broker-Dealer all of the Commitment Shares
and Shares included in the Initial Registration Statement as DWAC Shares in accordance with this Agreement and the Registration Rights
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)&nbsp;<U>Reservation
of Shares</U>. As of the Commencement Date, the Company shall have reserved out of its authorized and unissued Common Stock 39,777,249
shares of Common Stock solely for the purpose of effecting VWAP Purchases under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)&nbsp;<U>Opinions
and Bring-Down Opinions of Company Counsel</U>. On the Commencement Date, the Investor shall have received the opinions, bring-down opinions
and negative assurances from outside counsel to the Company, in each case dated the Commencement Date and in the respective forms thereof
mutually agreed to by the Company and the Investor prior to the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;7.3&nbsp;</B><U>Conditions
Precedent to VWAP Purchases after Commencement Date</U>. The right of the Company to deliver VWAP Purchase Notices under this Agreement
after the Commencement Date, and the obligation of the Investor to accept VWAP Purchase Notices under this Agreement after the Commencement
Date, are subject to the satisfaction of each of the conditions set forth in this <U>Section&nbsp;7.3</U> at each VWAP Purchase Exercise
Date after the Commencement Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Satisfaction
of Certain Prior Conditions</U>. Each of the conditions set forth in <U>Sections 7.2(a)</U>&nbsp;and <U>(b)</U>, and <U>Sections 7.2(g)</U>
through <U>(m)</U>, shall be satisfied on each VWAP Purchase Exercise Date after the Commencement Date (with the terms &ldquo;<B>Commencement</B>&rdquo;
and &ldquo;<B>Commencement Date</B>&rdquo; in the conditions set forth in <U>Sections&nbsp;7.2(a)</U>&nbsp;and <U>(b)</U>&nbsp;replaced
with &ldquo;applicable VWAP Purchase Exercise Date&rdquo;); <U>provided</U>, <U>however</U>, that the Company shall not be required to
deliver the Compliance Certificate after the Commencement Date, except as provided in <U>Section&nbsp;6.15</U> and <U>Section&nbsp;7.3(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Initial
Registration Statement Effective</U>. The Initial Registration Statement covering the resale by the Investor of the Registrable Securities
included therein filed by the Company with the SEC pursuant to Section&nbsp;2(a)&nbsp;of the Registration Rights Agreement, and any post-effective
amendment thereto required to be filed by the Company with the SEC after the Commencement Date and prior to the applicable VWAP Purchase
Exercise Date (as applicable) pursuant to the Registration Rights Agreement, in each case shall have been declared effective under the
Securities Act by the SEC and shall remain effective for the applicable Registration Period (as defined in the Registration Rights Agreement),
and the Investor shall be permitted to utilize the Prospectus therein, and any Prospectus Supplement thereto, to resell: (i)&nbsp;all
of the Commitment Shares, if any; (ii)&nbsp;all of the Shares included in the Initial Registration Statement, and any post-effective amendment
thereto, that have been issued and sold to the Investor hereunder pursuant to all VWAP Purchase Notices (as applicable) delivered by the
Company to the Investor prior to such applicable VWAP Purchase Exercise Date (as applicable), respectively; and (iii)&nbsp;all of the
Shares included in the Initial Registration Statement, and any post-effective amendment thereto, that are issuable pursuant to the applicable
VWAP Purchase Notice (as applicable) delivered by the Company to the Investor with respect to a VWAP Purchase to be effected hereunder
on such applicable VWAP Purchase Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Any
Required Subsequent Registration Statement Effective</U>. Any Subsequent Registration Statement covering the resale by the Investor of
the Registrable Securities included therein, and any post-effective amendment thereto, required to be filed by the Company with the SEC
pursuant to the Registration Rights Agreement after the Commencement Date and prior to the applicable VWAP Purchase Exercise Date, in
each case shall have been declared effective under the Securities Act by the SEC and shall remain effective for the applicable Registration
Period, and the Investor shall be permitted to utilize the Prospectus therein, and any Prospectus Supplement thereto, to resell: (i)&nbsp;all
of the Commitment Shares, if any, included in such Subsequent Registration Statement; (ii)&nbsp;all of the Shares included in such Subsequent
Registration Statement, and any post-effective amendment thereto, that have been issued and sold to the Investor hereunder pursuant to
all VWAP Purchase Notices delivered by the Company to the Investor prior to such applicable VWAP Purchase Exercise Date (as applicable),
respectively; and (iii)&nbsp;all of the Shares included in such Subsequent Registration Statement, and any post-effective amendment thereto,
that are issuable pursuant to the applicable VWAP Purchase Notice delivered by the Company to the Investor with respect to a VWAP Purchase,
respectively, to be effected hereunder on such applicable VWAP Purchase Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;<U>Delivery
of Subsequent Irrevocable Transfer Agent Instructions and Notice of Effectiveness</U>. With respect to any post-effective amendment to
the Initial Registration Statement, any Subsequent Registration Statement or any post-effective amendment to any Subsequent Registration
Statement, in each case declared effective by the SEC after the Commencement Date, the Company shall have delivered or caused to be delivered
to its Transfer Agent: (i)&nbsp;irrevocable instructions in the form substantially similar to the Commencement Irrevocable Transfer Agent
Instructions executed by the Company and acknowledged in writing by the Transfer Agent; and (ii)&nbsp;the Notice of Effectiveness, in
each case modified as necessary to refer to such Registration Statement or post-effective amendment and the Registrable Securities included
therein, to issue the Registrable Securities included therein as DWAC Shares in accordance with the terms of this Agreement and the Registration
Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;<U>No
Material Notices</U>. None of the following events shall have occurred and be continuing: (i)&nbsp;receipt of any request by the SEC or
any other federal or state governmental authority for any additional information relating to the Initial Registration Statement or any
post-effective amendment thereto, any Subsequent Registration Statement or any post-effective amendment thereto, or the Prospectus contained
in any of the foregoing or any Prospectus Supplement thereto, or for any amendment of or supplement to the Initial Registration Statement
or any post-effective amendment thereto, any Subsequent Registration Statement or any post-effective amendment thereto, or the Prospectus
contained in any of the foregoing or any Prospectus Supplement thereto; (ii)&nbsp;the issuance by the SEC or any other federal or state
governmental authority of any stop order suspending the effectiveness of the Initial Registration Statement or any post-effective amendment
thereto, any Subsequent Registration Statement or any post-effective amendment thereto, or prohibiting or suspending the use of the Prospectus
contained in any of the foregoing or any Prospectus Supplement thereto, or of the suspension of qualification or exemption from qualification
of the Securities for offering or sale in any jurisdiction, or the initiation or contemplated initiation of any proceeding for such purpose;
or (iii)&nbsp;the occurrence of any event or the existence of any condition or state of facts, which makes any statement of a material
fact made in the Initial Registration Statement or any post-effective amendment thereto, any Subsequent Registration Statement or any
post-effective amendment thereto, or the Prospectus contained in any of the foregoing or any Prospectus Supplement thereto untrue or which
requires the making of any additions to or changes to the statements then made in the Initial Registration Statement or any post-effective
amendment thereto, any Subsequent Registration Statement or any post-effective amendment thereto, or the Prospectus contained in any of
the foregoing or any Prospectus Supplement thereto in order to state a material fact required by the Securities Act to be stated therein
or necessary in order to make the statements then made therein (in the case of the Prospectus or any Prospectus Supplement, in light of
the circumstances under which they were made) not misleading, or which requires an amendment to the Initial Registration Statement or
any post-effective amendment thereto, any Subsequent Registration Statement or any post-effective amendment thereto, or the Prospectus
contained in any of the foregoing or any Prospectus Supplement thereto to comply with the Securities Act or any other law (other than
the transactions contemplated by the applicable VWAP Purchase Notice, delivered by the Company to the Investor with respect to a VWAP
Purchase, to be effected hereunder on such applicable VWAP Purchase Exercise Date, as applicable, and the settlement thereof). The Company
shall have no Knowledge of any event that could reasonably be expected to have the effect of causing the suspension of the effectiveness
of the Initial Registration Statement or any post-effective amendment thereto, any Subsequent Registration Statement or any post-effective
amendment thereto, or the prohibition or suspension of the use of the Prospectus contained in any of the foregoing or any Prospectus Supplement
thereto in connection with the resale of the Registrable Securities by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;<U>Other
SEC Filings</U>. The final Prospectus included in any post-effective amendment to the Initial Registration Statement, and any Prospectus
Supplement thereto, required to be filed by the Company with the SEC pursuant to <U>Section&nbsp;2.3</U> and the Registration Rights Agreement
after the Commencement Date and prior to the applicable VWAP Purchase Exercise Date (as applicable), shall have been filed with the SEC
in accordance with <U>Section&nbsp;2.3</U> and the Registration Rights Agreement. The final Prospectus included in any Subsequent Registration
Statement and in any post-effective amendment thereto, and any Prospectus Supplement thereto, required to be filed by the Company with
the SEC pursuant to <U>Section&nbsp;2.3</U> and the Registration Rights Agreement after the Commencement Date and prior to the applicable
VWAP Purchase Exercise Date, shall have been filed with the SEC in accordance with <U>Section&nbsp;2.3</U> and the Registration Rights
Agreement. All reports, schedules, registrations, forms, statements, information and other documents required to have been filed by the
Company with the SEC pursuant to the reporting requirements of the Exchange Act, including all material required to have been filed pursuant
to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Exchange Act, after the Commencement Date and prior to the applicable VWAP Purchase Exercise
Date, shall have been filed with the SEC and, if any Registrable Securities are covered by a Registration Statement on Form S-3, such
filings shall have been made within the applicable time period prescribed for such filing under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;<U>No
Suspension of Trading in or Notice of Delisting of Common Stock</U>. Trading in the Common Stock shall not have been suspended by the
SEC, the Trading Market or the FINRA (except for any suspension of trading of limited duration agreed to by the Company, which suspension
shall be terminated prior to the applicable VWAP Purchase Exercise Date, as applicable), the Company shall not have received any final
and non-appealable notice that the listing or quotation of the Common Stock on the Trading Market shall be terminated on a date certain
(unless, prior to such date certain, the Common Stock is listed or quoted on any other Eligible Market), nor shall there have been imposed
any suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by
DTC with respect to the Common Stock that is continuing, the Company shall not have received any notice from DTC to the effect that a
suspension of, or restriction on, accepting additional deposits of the Common Stock, electronic trading or book-entry services by DTC
with respect to the Common Stock is being imposed or is contemplated (unless, prior to such suspension or restriction, DTC shall have
notified the Company in writing that DTC has determined not to impose any such suspension or restriction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;<U>Certain
Limitations</U>. The issuance and sale of the Shares issuable pursuant to the applicable VWAP Purchase Notice shall not: (i)&nbsp;exceed
the VWAP Purchase Maximum Amount; (ii)&nbsp;cause the Aggregate Limit or the Beneficial Ownership Limitation to be exceeded; or (iii)&nbsp;cause
the Exchange Cap (to the extent applicable under <U>Section&nbsp;3.3</U>) to be exceeded, unless in the case of this clause (iii), the
Company&rsquo;s stockholders have theretofore approved the issuance of Common Stock under this Agreement in excess of the Exchange Cap
in accordance with the applicable rules of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;<U>Shares
Authorized and Delivered</U>. All of the Shares issuable pursuant to the applicable VWAP Purchase Notice shall have been duly authorized
by all necessary corporate action of the Company. The Company shall have delivered all Shares relating to all prior VWAP Purchase Notices
as DWAC Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;<U>Opinions
and Bring-Down Opinions of Company Counsel</U>. The Investor shall have received: (i)&nbsp;all Bring-Down Opinions from the Company&rsquo;s
outside counsel for which the Company was obligated to instruct its outside counsel to deliver to the Investor prior to the applicable
VWAP Purchase Exercise Date; and (ii)&nbsp;all Compliance Certificates from the Company that the Company was obligated to deliver to the
Investor prior to the applicable VWAP Purchase Exercise Date, in each case in accordance with <U>Section&nbsp;6.15</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;VIII<BR>
TERMINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;8.1&nbsp;</B><U>Automatic
Termination</U>. Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically on the earliest to occur
of: (a)&nbsp;the first day of the calendar month immediately following the twenty-four (24)-month anniversary of the Effective Date (it
being hereby acknowledged and agreed that such term may not be extended by the Parties); (b)&nbsp;the date on which the Investor shall
have purchased the Total Commitment worth of Shares pursuant to this Agreement; (c)&nbsp;the date on which the Common Stock shall have
failed to be listed or quoted on the Trading Market or any other Eligible Market; and (d)&nbsp;the date on which, pursuant to or within
the meaning of any Bankruptcy Law, the Company commences a voluntary case or any Person commences a proceeding against the Company, a
Custodian is appointed for the Company or for all or substantially all of its property, or the Company makes a general assignment for
the benefit of its creditors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;8.2&nbsp;</B><U>Other
Termination</U>. Subject to <U>Section&nbsp;8.3</U>, the Company may terminate this Agreement after the Commencement Date effective upon
ten (10) Trading Days&rsquo; prior written notice to the Investor in accordance with <U>Section&nbsp;10.4</U>; <U>provided</U>, <U>however</U>,
that: (a)&nbsp;the Company shall have paid all fees and amounts to the Investor&rsquo;s counsel required to be paid pursuant to <U>Section&nbsp;10.1(a)</U>
prior to such termination; (b)&nbsp;if this Agreement is terminated by a Party prior to the Effective Date, then, prior to such termination,
the Company shall have paid the Commitment Fee to the Investor pursuant to <U>Section&nbsp;10.1(b)</U>; (c) if this Agreement is terminated
by a Party after the Effective Date, then, prior to such termination, the Company shall have issued all Commitment Shares to the Investor
pursuant to <U>Section&nbsp;2.4</U> of this Agreement; and (d)&nbsp;prior to issuing any press release, or making any public statement
or announcement, with respect to such termination, the Company shall consult with the Investor and its counsel on the form and substance
of such press release or other disclosure. Subject to <U>Section&nbsp;8.3</U>, this Agreement may be terminated at any time by the mutual
written consent of the Parties, effective as of the date of such mutual written consent unless otherwise provided in such written consent.
Subject to <U>Section&nbsp;8.3</U>, the Investor shall have the right to terminate this Agreement effective upon ten (10) Trading Days&rsquo;
prior written notice to the Company in accordance with <U>Section&nbsp;10.4</U>, if: (i)&nbsp;any condition, occurrence, state of facts
or event constituting a Material Adverse Effect has occurred and is continuing; (ii)&nbsp;a Fundamental Transaction shall have occurred;
(iii)&nbsp;the Initial Registration Statement and any Subsequent Registration Statement is not filed by the applicable Filing Deadline
therefor or declared effective by the SEC by the applicable Effectiveness Deadline (as defined in the Registration Rights Agreement)
therefor, or the Company is otherwise in breach or default in any material respect under any of the other provisions of the Registration
Rights Agreement, and, if such failure, breach or default is capable of being cured, such failure, breach or default is not cured within
ten (10) Trading Days after notice of such failure, breach or default is delivered to the Company pursuant to <U>Section&nbsp;10.4</U>;
(iv)&nbsp;while a Registration Statement, or any post-effective amendment thereto, is required to be maintained effective pursuant to
the terms of the Registration Rights Agreement and the Investor holds any Registrable Securities, the effectiveness of such Registration
Statement, or any post-effective amendment thereto, lapses for any reason (including, without limitation, the issuance of a stop order
by the SEC) or such Registration Statement or any post-effective amendment thereto, the Prospectus contained therein or any Prospectus
Supplement thereto otherwise becomes unavailable to the Investor for the resale of all of the Registrable Securities included therein
in accordance with the terms of the Registration Rights Agreement, and such lapse or unavailability continues for a period of twenty
(20) consecutive Trading Days or for more than an aggregate of sixty (60) Trading Days in any 365-day period, other than due to acts
of the Investor; (v)&nbsp;trading in the Common Stock on the Trading Market (or if the Common Stock is then listed on an Eligible Market,
trading in the Common Stock on such Eligible Market) shall have been suspended and such suspension continues for a period of three (3)
consecutive Trading Days; or (vi) the Company is in material breach or default of this Agreement, and, if such breach or default is capable
of being cured, such breach or default is not cured within ten (10) Trading Days after notice of such breach or default is delivered
to the Company pursuant to <U>Section&nbsp;10.4</U>. Unless notification thereof is required elsewhere in this Agreement (in which case
such notification shall be provided in accordance with such other provision), the Company shall promptly (but in no event later than
twenty-four (24) hours) notify the Investor (and, if required under applicable law, including, without limitation, Regulation FD promulgated
by the SEC, or under the applicable rules and regulations of the Trading Market, the Company shall publicly disclose such information
in accordance with Regulation FD and the applicable rules and regulations of the Trading Market) upon becoming aware of any of the events
set forth in the immediately preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;8.3&nbsp;</B><U>Effect
of Termination</U>. In the event of termination by the Company or the Investor (other than by mutual termination) pursuant to <U>Section&nbsp;8.2</U>,
written notice thereof shall forthwith be given to the other Party as provided in <U>Section&nbsp;10.4</U> and the transactions contemplated
by this Agreement shall be terminated without further action by either Party. If this Agreement is terminated as provided in <U>Section&nbsp;8.1</U>
or <U>Section&nbsp;8.2</U>, this Agreement shall become void and of no further force and effect, except that: (a)&nbsp;the provisions
of <U>Article&nbsp;V</U> (Representations and Warranties of the Company), <U>Article&nbsp;IX</U> (Indemnification), <U>Article&nbsp;X</U>
(Miscellaneous) and this <U>Article&nbsp;VIII</U> (Termination) shall remain in full force and effect indefinitely notwithstanding such
termination; and (b)&nbsp;so long as the Investor owns any Shares, the covenants and agreements of the Company contained in <U>Article&nbsp;VI</U>
(Covenants) shall remain in full force and effect notwithstanding such termination for a period of six (6) months following such termination.
Notwithstanding anything in this Agreement to the contrary, no termination of this Agreement by any Party shall: (i)&nbsp;become effective
prior to the first Trading Day immediately following the settlement date related to any pending VWAP Purchase Notice that has not been
fully settled in accordance with the terms and conditions of this Agreement (it being hereby acknowledged and agreed that no termination
of this Agreement shall limit, alter, modify, change or otherwise affect any of the Company&rsquo;s or the Investor&rsquo;s rights or
obligations under the Transaction Documents with respect to any pending VWAP Purchase, and that the Parties shall fully perform their
respective obligations with respect to any such pending VWAP Purchase under the Transaction Documents, provided all of the conditions
to the settlement thereof set forth in Article&nbsp;VII are timely satisfied); (ii)&nbsp;limit, alter, modify, change or otherwise affect
the Company&rsquo;s or the Investor&rsquo;s rights or obligations under the Registration Rights Agreement, all of which shall survive
any such termination; (iii)&nbsp;affect the Investor Expenses Reimbursement payable to the Investor, all of which fees and expenses shall
be non-refundable when paid on the Closing Date pursuant to <U>Section&nbsp;10.1(a)</U>, regardless of whether any VWAP Purchases are
made or settled hereunder or any subsequent termination of this Agreement; (iv)&nbsp;affect the Commitment Fee payable to the Investor
pursuant to <U>Section&nbsp;10.1(b)</U> or the issuance of the Commitment Shares to the Investor pursuant to <U>Section&nbsp;2.4</U>,
which Commitment Fee or Commitment Shares, as the case may be, shall be fully earned and non-refundable as of the Closing Date, regardless
of whether any VWAP Purchases are made or settled hereunder or any subsequent termination of this Agreement. Nothing in this <U>Section&nbsp;8.3</U>
shall be deemed to release the Company or the Investor from any liability for any breach or default under this Agreement or any of the
other Transaction Documents to which it is a party, or to impair the rights of the Company and the Investor to compel specific performance
by the other Party of its obligations under the Transaction Documents to which it is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;IX<BR>
INDEMNIFICATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;9.1&nbsp;</B><U>Indemnification
of Investor</U>. In consideration of the Investor&rsquo;s execution and delivery of this Agreement and acquiring the Securities hereunder
and in addition to all of the Company&rsquo;s other obligations under the Transaction Documents to which it is a party, subject to the
provisions of this <U>Section&nbsp;9.1</U>, the Company shall indemnify and hold harmless the Investor, each of its directors, officers,
shareholders, members, partners, employees, representatives, agents and advisors (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding the lack of such title or any other title), each Person, if any, who controls the
Investor (within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20(a)&nbsp;of the Exchange Act), and the respective
directors, officers, shareholders, members, partners, employees, representatives, agents and advisors (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) of such controlling Persons
(each, an &ldquo;<B>Investor Party</B>&rdquo;), from and against all losses, liabilities, obligations, claims, contingencies, damages,
costs and expenses (including all judgments, amounts paid in settlement, court costs, reasonable attorneys&rsquo; fees and costs of defense
and investigation) (collectively, &ldquo;<B>Damages</B>&rdquo;) that any Investor Party may suffer or incur as a result of or relating
to: (a)&nbsp;any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in
the other Transaction Documents to which it is a party; or (b)&nbsp;any action, suit, claim or proceeding (including for these purposes
a derivative action brought on behalf of the Company) instituted against such Investor Party arising out of or resulting from the execution,
delivery, performance or enforcement of the Transaction Documents, other than claims for indemnification within the scope of Section&nbsp;6
of the Registration Rights Agreement; <U>provided</U>, <U>however</U>, that: (i)&nbsp;the foregoing indemnity shall not apply to any
Damages to the extent, but only to the extent, that such Damages resulted directly and primarily from a breach of any of the Investor&rsquo;s
representations, warranties, covenants or agreements contained in this Agreement or the Registration Rights Agreement; and (ii)&nbsp;the
Company shall not be liable under the foregoing clause (b) to the extent, but only to the extent, that a court of competent jurisdiction
shall have determined by a final judgment (from which no further appeals are available) that such Damages resulted directly and primarily
from any acts or failures to act, undertaken or omitted to be taken by such Investor Party through its fraud, bad faith, gross negligence,
or willful or reckless misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company shall reimburse
any Investor Party promptly upon demand (with accompanying presentation of documentary evidence) for all legal and other costs and expenses
reasonably incurred by such Investor Party in connection with: (a)&nbsp;any action, suit, claim or proceeding, whether at law or in equity,
to enforce compliance by the Company with any provision of the Transaction Documents; or (b)&nbsp;any other any action, suit, claim or
proceeding, whether at law or in equity, with respect to which it is entitled to indemnification under this <U>Section&nbsp;9.1</U>; <U>provided</U>
that the Investor shall promptly reimburse the Company for all such legal and other costs and expenses to the extent a court of competent
jurisdiction determines that any Investor Party was not entitled to such reimbursement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An Investor Party&rsquo;s
right to indemnification or other remedies based upon the representations, warranties, covenants and agreements of the Company set forth
in the Transaction Documents shall not in any way be affected by any investigation or knowledge of such Investor Party. Such representations,
warranties, covenants and agreements shall not be affected or deemed waived by reason of the fact that an Investor Party knew or should
have known that any representation or warranty might be inaccurate or that the Company failed to comply with any agreement or covenant.
Any investigation by such Investor Party shall be for its own protection only and shall not affect or impair any right or remedy hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent that the foregoing
undertakings by the Company set forth in this Section&nbsp;9.1 may be unenforceable for any reason, the Company shall make the maximum
contribution to the payment and satisfaction of each of the Damages which is permissible under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;9.2&nbsp;</B><U>Indemnification
Procedures</U>. Promptly after an Investor Party receives notice of a claim or the commencement of an action for which the Investor Party
intends to seek indemnification under Section&nbsp;9.1, the Investor Party shall notify the Company in writing of the claim or commencement
of the action, suit or proceeding; <U>provided</U>, <U>however</U>, that failure to notify the Company shall not relieve the Company
from liability under <U>Section&nbsp;9.1</U>, except to the extent it has been materially prejudiced by the failure to give notice. The
Company shall be entitled to participate in the defense of any claim, action, suit or proceeding as to which indemnification is being
sought, and if the Company acknowledges in writing the obligation to indemnify the Investor Party against whom the claim or action is
brought, the Company may (but shall not be required to) assume the defense against the claim, action, suit or proceeding with counsel
satisfactory to it. After the Company notifies the Investor Party that the Company wishes to assume the defense of a claim, action, suit
or proceeding, the Company shall not be liable for any further legal or other expenses incurred by the Investor Party in connection with
the defense against the claim, action, suit or proceeding except that if, in the opinion of counsel to the Investor Party, it would be
inappropriate under the applicable rules of professional responsibility for the same counsel to represent both the Company and such Investor
Party. In such event, the Company shall pay the reasonable fees and expenses of no more than one separate counsel for all such Investor
Parties promptly as such fees and expenses are incurred. Each Investor Party, as a condition to receiving indemnification as provided
in <U>Section&nbsp;9.1</U>, shall cooperate in all reasonable respects with the Company in the defense of any action or claim as to which
indemnification is sought. The Company shall not be liable for any settlement of any action effected without its prior written consent,
which consent shall not be unreasonably withheld, delayed or conditioned. Notwithstanding the foregoing sentence, if at any time the
Investor Party shall have requested (by written notice) the Company to reimburse the Investor Party for fees and expenses of counsel,
the Company agrees that it shall be liable for any settlement of the nature contemplated hereby effected without its written consent
if (a) such settlement is entered into more than forty-five (45) days after receipt by the Company of the aforesaid request, (b) the
Company shall have received written notice of the terms of such settlement at least thirty (30) days prior to such settlement being entered
into, and (c) the Company shall not have reimbursed the Investor Party in accordance with such request prior to the date of such settlement.
The Company shall not, without the prior written consent of the Investor Party, effect any settlement of a pending or threatened action
with respect to which an Investor Party is, or is informed that it may be, made a party and for which it would be entitled to indemnification,
unless the settlement includes an unconditional release of the Investor Party from all liability and claims which are the subject matter
of the pending or threatened action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The remedies provided for
in this <U>Article&nbsp;IX</U> are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Investor
Party at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;X<BR>
MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.1&nbsp;</B><U>Certain
Fees and Expenses; Commitment Fee; Commencement Irrevocable Transfer Agent Instructions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Certain
Fees and Expenses</U>. Each Party shall bear its own fees and expenses related to the transactions contemplated by this Agreement; <U>provided</U>,
<U>however</U>, that the Company shall pay, on or prior to the Closing Date, by wire transfer of immediately available funds to an account
designated by the Investor on or prior to the date of this Agreement, an aggregate amount of up to $80,000 (net of $25,000 previously
paid to the Investor as an initial deposit) as reimbursement for the costs and expenses incurred by the Investor or its Affiliates in
connection with the preparation, structuring, documentation, negotiation and closing of the transactions contemplated by the Transaction
Documents (including, without limitation, as applicable, all reasonable legal fees of Stradling Yocca Carlson &amp; Rauth LLP, counsel
to the Investor, any other reasonable and documented fees and expenses in connection with the structuring, documentation, negotiation
and closing of the transactions contemplated by the Transaction Documents and due diligence and regulatory filings in connection therewith)
(collectively, the &ldquo;<B>Transaction Expenses</B>&rdquo;). The Company shall be responsible for the payment of fees or commissions
payable to the Placement Agent, which is the Company&rsquo;s sole placement agent in connection with the transactions contemplated by
this Agreement, financial advisory fees, transfer agent fees, DTC (as defined below) fees or broker&rsquo;s commissions (other than for
Persons engaged by the Investor) relating to or arising out of the transactions contemplated hereby. The Company shall pay, and hold the
Investor harmless against, any liability, loss or expense (including, without limitation, reasonable attorneys&rsquo; fees and out-of-pocket
expenses) arising in connection with any claim relating to any such payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Commitment
Fee; Commitment Shares</U>. In consideration of the Investor&rsquo;s execution and delivery of this Agreement on the Closing Date, effective
as of the Closing Date, the Company shall become obligated to issue to the Investor the Commitment Shares (or pay to the Investor the
Commitment Fee, as applicable), in either case in accordance with the applicable provisions of this Agreement relating thereto. For the
avoidance of doubt, the Company shall become obligated to issue all of the Commitment Shares (or pay to the Investor the Commitment Fee,
as applicable), upon the consummation of the Closing and effective as of the Closing Date, regardless of whether any VWAP Purchases are
made or settled hereunder or any subsequent termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Irrevocable
Transfer Agent Instructions; Notice of Effectiveness</U>. On the Effective Date of the Initial Registration Statement and prior to Commencement,
the Company shall deliver or cause to be delivered to its transfer agent (and thereafter, shall deliver or cause to be delivered to any
subsequent transfer agent of the Company) (as applicable the &ldquo;<B>Transfer Agent</B>&rdquo;): (i)&nbsp;irrevocable instructions executed
by the Company and acknowledged in writing by the Transfer Agent (the &ldquo;<B>Commencement Irrevocable Transfer Agent Instructions</B>&rdquo;);
and (ii)&nbsp;the notice of effectiveness in the form attached as an exhibit to the Registration Rights Agreement (the &ldquo;<B>Notice
of Effectiveness</B>&rdquo;) relating to the Initial Registration Statement executed by the Company&rsquo;s outside counsel, in each case
directing the Transfer Agent to issue to the Investor or its designee all of the Securities included in the Initial Registration Statement
as DWAC Shares in accordance with this Agreement and the Registration Rights Agreement. With respect to any post-effective amendment to
the Initial Registration Statement, any Subsequent Registration Statement or any post-effective amendment to any Subsequent Registration
Statement, in each case declared effective by the SEC after the Commencement Date, the Company shall deliver or cause to be delivered
to its Transfer Agent: (a)&nbsp;irrevocable instructions in the form substantially similar to the Commencement Irrevocable Transfer Agent
Instructions executed by the Company and acknowledged in writing by the Transfer Agent; and (b)&nbsp;the Notice of Effectiveness, in each
case modified as necessary to refer to such Registration Statement or post-effective amendment and the Registrable Securities included
therein, to issue the Registrable Securities included therein as DWAC Shares in accordance with the terms of this Agreement and the Registration
Rights Agreement. For the avoidance of doubt, all Securities to be issued from and after Commencement to or for the benefit of the Investor
pursuant to this Agreement shall be issued to the Investor or its designee only as DWAC Shares. The Company represents and warrants to
the Investor that, while this Agreement is effective, no instruction other than those referred to in this <U>Section&nbsp;10.1(c)</U>&nbsp;shall
be given by the Company to its Transfer Agent with respect to the Securities from and after Commencement, and the Securities covered by
the Initial Registration Statement or any post-effective amendment thereof, or any Subsequent Registration Statement or post-effective
amendment thereof, as applicable, shall otherwise be freely transferable on the books and records of the Company and no stop transfer
instructions shall be maintained against the transfer thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.5pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.2&nbsp;</B><U>Specific
Enforcement, Consent to Jurisdiction, Waiver of Jury Trial</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;The
Company and the Investor acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement
were not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that either Party shall
be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement by the other party and to
enforce specifically the terms and provisions hereof (without the necessity of showing economic loss and without any bond or other security
being required), this being in addition to any other remedy to which either Party may be entitled by law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;Each
of the Company and the Investor: (i)&nbsp;hereby irrevocably submits to the jurisdiction of the U.S. District Court and other courts of
the United States sitting in the State of New York for the purposes of any suit, action or proceeding arising out of or relating to this
Agreement; and (ii)&nbsp;hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally
subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of
the suit, action or proceeding is improper. Each of the Company and the Investor consents to process being served in any such suit, action
or proceeding by mailing a copy thereof to such party at the address in effect for notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice thereof. Nothing in this <U>Section&nbsp;10.2</U> shall
affect or limit any right to serve process in any other manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;EACH
OF THE COMPANY AND THE INVESTOR HEREBY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY
IN RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY OR DISPUTES RELATING HERETO. EACH OF THE COMPANY AND THE INVESTOR: (i)&nbsp;CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY
OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE
THE FOREGOING WAIVER; AND (ii)&nbsp;ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN TO ENTER INTO THIS AGREEMENT BY, AMONG
OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN <FONT STYLE="text-transform: uppercase">THIS <U>Section&nbsp;10.2</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.3&nbsp;</B><U>Entire
Agreement</U>. The Transaction Documents set forth the entire agreement and understanding of the Parties with respect to the subject
matter hereof and supersedes all prior and contemporaneous agreements, negotiations and understandings between the Parties, both oral
and written, with respect to such matters. There are no promises, undertakings, representations or warranties by either Party relative
to subject matter hereof not expressly set forth in the Transaction Documents. The Disclosure Schedule and all exhibits to this Agreement
are hereby incorporated by reference in, and made a part of, this Agreement as if set forth in full herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.4&nbsp;</B><U>Notices</U>.
Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall be in writing and shall
be effective: (a)&nbsp;upon hand delivery or electronic mail delivery at the address or number designated below (if delivered on a business
day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered
other than on a business day during normal business hours where such notice is to be received); or (b)&nbsp;on the second business day
following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing,
whichever shall first occur. The address for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Capstone Holding Corp. 5141</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">W.
122nd Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Alsip, Illinoi 60803</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Telephone Number: (708) 371-0660</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: [_________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Matthew Lipman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">with a copy (which shall not
constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Lucosky Brookman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">101 Wood Avenue South</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Woodbridge,
New Jersey 08830]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Telephone Number: (732) 395-4400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: [_________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Seth Brookman, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Investor:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Tumim Stone Capital, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">2 Wooster
Street, 2nd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">New York, New York 10013</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Telephone Number: [_________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: [_________]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attention: Maier Joshua Tarlow</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">with a copy (which shall not
constitute notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Stradling Yocca Carlson &amp; Rauth LLP<BR>
660 Newport Center Drive, Suite 1600</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Newport Beach, California 92660-6422<BR>
Telephone Number: (949) 725-4000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Email: [_________]<BR>
Attention: Ryan C. Wilkins, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Either Party may from time to time change
its address for notices by giving at least five (5) calendar days&rsquo; advance written notice of such changed address to the other Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.5&nbsp;</B><U>Waivers</U>.
No provision of this Agreement may be waived by the Parties from and after the date that is one (1) Trading Day immediately preceding
the filing of the Initial Registration Statement with the SEC. Subject to the immediately preceding sentence, no provision of this Agreement
may be waived other than in a written instrument signed by the party against whom enforcement of such waiver is sought. No failure or
delay in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise
of any such power, right or privilege preclude other or further exercises thereof or of any other right, power or privilege.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.6&nbsp;</B><U>Amendments</U>.
No provision of this Agreement may be amended by the Parties from and after the date that is one (1) Trading Day immediately preceding
the filing of the Initial Registration Statement with the SEC. Subject to the immediately preceding sentence, no provision of this Agreement
may be amended other than by a written instrument signed by both Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.7&nbsp;</B><U>Headings</U>.
The article, section and subsection headings in this Agreement are for convenience only and shall not constitute a part of this Agreement
for any other purpose and shall not be deemed to limit or affect any of the provisions hereof. Unless the context clearly indicates otherwise,
each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms &ldquo;including,&rdquo;
&ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed broadly as if followed by the words &ldquo;without
limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo; and words of like import refer to this
entire Agreement instead of just the provision in which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.8&nbsp;</B><U>Construction</U>.
The Parties agree that each of them and their respective counsel has reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents. In addition, each and every reference to share prices and number
of shares of Common Stock in any Transaction Document shall, in all cases, be subject to adjustment for any stock splits, stock combinations,
stock dividends, recapitalizations, reorganizations and other similar transactions that occur on or after the date of this Agreement.
Any reference in this Agreement to &ldquo;Dollars&rdquo; or &ldquo;$&rdquo; means the lawful currency of the United States of America.
Any references to &ldquo;Section&rdquo; or &ldquo;Article&rdquo; in this Agreement shall, unless otherwise expressly stated herein, refer
to the applicable Section&nbsp;or Article&nbsp;of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.9&nbsp;</B><U>Binding
Effect</U>. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors. Neither the
Company nor the Investor may assign this Agreement or any of their respective rights or obligations hereunder to any Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.10&nbsp;</B><U>No
Third-Party Beneficiaries</U>. Except as expressly provided in <U>Article&nbsp;IX</U>, this Agreement is intended only for the benefit
of the Parties and their respective successors, and is not for the benefit of, nor may any provision hereof be enforced by, any other
Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.11&nbsp;</B><U>Governing
Law</U>. This Agreement shall be governed by and construed in accordance with the internal procedural and substantive laws of the State
of New York, without giving effect to the choice of law provisions of such state that would cause the application of the laws of any
other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.12&nbsp;</B><U>Survival</U>.
The representations, warranties, covenants and agreements of the Company and the Investor contained in this Agreement shall survive the
execution and delivery hereof until the termination of this Agreement; provided, however, that: (a)&nbsp;the provisions of <U>Article&nbsp;V</U>
(Representations and Warranties of the Company), <U>Article&nbsp;VIII</U> (Termination), <U>Article&nbsp;IX</U> (Indemnification), and
this <U>Article&nbsp;X</U> (Miscellaneous) shall remain in full force and effect indefinitely notwithstanding such termination; and (b)&nbsp;so
long as the Investor owns any Shares, the covenants and agreements of the Company and the Investor contained in <U>Article&nbsp;VI</U>
(Covenants), shall remain in full force and effect notwithstanding such termination for a period of six months following such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.13&nbsp;</B><U>Counterparts</U>.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each Party and delivered to the other Party; <U>provided</U> that a facsimile
signature or signature delivered by e-mail in a &ldquo;.pdf&rdquo; format data file, including any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall
be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.14&nbsp;</B><U>Publicity</U>.
The Company shall afford the Investor and its counsel with a reasonable opportunity to review and comment upon, shall consult with the
Investor and its counsel on the form and substance of, and shall give due consideration to all such comments from the Investor or its
counsel on, any press release, SEC filing or any other public disclosure made by or on behalf of the Company relating to the Investor,
its purchases hereunder or any aspect of the Transaction Documents or the transactions contemplated thereby, prior to the issuance, filing
or public disclosure thereof. For the avoidance of doubt, the Company shall not be required to submit for review any such disclosure:
(a)&nbsp;contained in periodic reports filed with the SEC under the Exchange Act if it shall have previously provided the same disclosure
to the Investor or its counsel for review in connection with a previous filing; or (b)&nbsp;any Prospectus Supplement if it contains
disclosure that does not reference the Investor, its purchases hereunder or any aspect of the Transaction Documents or the transactions
contemplated thereby. The Company agrees and acknowledges that its failure to comply with this provision in all material respects constitutes
a Material Adverse Effect for purposes of <U>Section&nbsp;7.2(k)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.15&nbsp;</B><U>Severability</U>.
The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction shall determine that any one
or more of the provisions or part of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal
or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision
of this Agreement, and this Agreement shall be reformed and construed as if such invalid or illegal or unenforceable provision, or part
of such provision, had never been contained herein, so that such provisions would be valid, legal and enforceable to the maximum extent
possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.75pt; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;10.16&nbsp;</B><U>Further
Assurances</U>. From and after the Closing Date, upon the request of the Investor or the Company, each of the Company and the Investor
shall execute and deliver such instrument, documents and other writings as may be reasonably necessary or desirable to confirm and carry
out and to effectuate fully the intent and purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Remainder of page intentionally left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Parties
have caused this Agreement to be duly executed by their respective authorized officer as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Company:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-size: 10pt; text-transform: uppercase">CAPSTONE HOLDING CORP.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><I>/s/ Matthew E. Lipman</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 4%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="text-align: justify; width: 31%"><FONT STYLE="font-size: 10pt">Matthew E. Lipman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page to Common Stock Purchase Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the Parties have caused this Agreement to be duly executed by their respective authorized officer as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in"><FONT STYLE="font-size: 10pt"><B>INVESTOR:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in">TUMIM STONE CAPITAL, LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; width: 3%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify; text-indent: 0in; width: 37%">3i Management, LLC, its Manager</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: justify"><I>/s/ Maier Joshua Tarlow</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 4%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">Name:</TD>
    <TD STYLE="text-align: justify; width: 31%">Maier Joshua Tarlow</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Manager</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page to Common Stock Purchase Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Annex I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls, is controlled by, or is under common control
with a Person, as such terms are used in and construed under Rule 144. With respect to the Investor, without limitation, any Person owning,
owned by, or under common ownership with the Investor, and any investment fund or managed account that is managed on a discretionary basis
by the same investment manager as the Investor shall be deemed to be an Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Aggregate Limit</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Agreement</B>&rdquo;
shall have the meaning assigned to such term in the introductory paragraph of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Average Price</B>&rdquo;
means a price per Share (rounded to the nearest tenth of a cent) equal to the quotient obtained by dividing: (a)&nbsp;the aggregate gross
purchase price paid by the Investor for all Shares purchased pursuant to this Agreement, by (b)&nbsp;the aggregate number of Shares issued
pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bankruptcy Law</B>&rdquo;
means Title 11, U.S. Code, or any similar U.S. federal or state law for the relief of debtors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Basic Amount</B>&rdquo; shall
have the meaning assigned to such term in <U>Section 6.15</U>.<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Beneficial Ownership
Limitation</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;3.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>BHCA</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.38</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg, L.P. or its affiliates, successors, and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bring-Down Opinion</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.15</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Broker-Dealer</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.13</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Bylaws</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Charter</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Stock</B>&rdquo;
shall have the meaning assigned to such term in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Common Stock Equivalents</B>&rdquo;
means any securities of the Company or its Subsidiaries which entitle the holder thereof to acquire at any time Common Stock, including,
without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable
or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;2.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing Date</B>&rdquo;
means the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Closing Sale Price</B>&rdquo;
means, for the Common Stock as of any date, the last closing trade price for the Common Stock on the Trading Market, as reported by Bloomberg,
or, if the Trading Market begins to operate on an extended hours basis and does not designate the closing trade price for the Common Stock,
then the last trade price for the Common Stock prior to 4:00 p.m., New York City time, as reported by Bloomberg, or, if the foregoing
do not apply, the last trade price for the Common Stock in the over-the-counter market on the electronic bulletin board for the Common
Stock as reported by Bloomberg, or, if no last trade price is reported for the Common Stock by Bloomberg, the average of the bid prices,
or the ask prices, respectively, of any market makers for such security as reported by OTC Markets Group Inc. All such determinations
shall be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions
during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Code</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.23</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commencement</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commencement Date</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commencement Irrevocable
Transfer Agent Instructions</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;10.1(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commitment Fee</B>&rdquo;
means an amount in cash equal to $400,000 (or such lesser amount as determined in accordance with the definition of Commitment Shares),
which shall become immediately due and payable by the Company to the Investor upon the occurrence of certain events described in the Agreement
any payment thereof shall be made by wire transfer of immediately available funds to an account designated by the Investor to the Company,
and, in the event the Commitment Fee becomes due and payable under this Agreement, no such termination of this Agreement shall become
effective unless and until such entire cash amount has been paid by the Company to the Investor pursuant to and in accordance with this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Commitment Shares</B>&rdquo;
means such number of shares of duly authorized, validly issued, fully paid and non-assessable shares of Common Stock (rounded up or down
to the nearest whole share) in book-entry form equal to the quotient obtained by dividing: (x) $400,000 by (y) the lower of (i) Nasdaq
official closing price of the Common Stock on the Trading Market (as reflected on Nasdaq.com) on the Trading Day immediately prior to
the date on which the Initial Registration Statement is initially filed by the Company with the SEC (subject to adjustment for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction that occurs on or after the Closing
Date), and (ii) the average Nasdaq official closing price of the Common Stock on the Trading Market (as reflected on Nasdaq.com) for the
five (5) consecutive Trading Days ending on the Trading Day immediately prior to the date on which the Initial Registration Statement
is initially filed by the Company with the SEC (subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock
split, reverse stock split or other similar transaction that occurs on or after the Closing Date) (such lower amount, the &ldquo;<B>Commitment
Share Price Per Share</B>&rdquo;). If the Commitment Shares, if any, are issued to the Investor pursuant to this Agreement, the Company
shall cause its Transfer Agent to issue and deliver to the Investor not later than 4:00 p.m. (New York City time) on the Trading Day immediately
following the Effective Date in accordance with this Agreement; <U>provided</U>, <U>however</U>, that if the number of Commitment Shares
determined in accordance with the foregoing would cause the aggregate number of shares of Common Stock then beneficially owned (as calculated
pursuant to Section&nbsp;13(d)&nbsp;of the Exchange Act and Rule 13d-3 promulgated thereunder) by the Investor and its Affiliates to exceed
the Beneficial Ownership Limitation, then the number of Commitment Shares shall be equal to that number of shares that would cause the
aggregate number of shares of Common Stock then beneficially owned (as calculated pursuant to Section&nbsp;13(d)&nbsp;of the Exchange
Act and Rule 13d-3 promulgated thereunder) by the Investor and its Affiliates to equal one (1) share less than the Beneficial Ownership
Limitation, and the Company shall be obligated to pay the Investor a cash amount equal to (x) $400,000, <I><U>minus</U></I> (y) the number
of Commitment Shares actually delivered, multiplied by the Commitment Share Price Per Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company</B>&rdquo;
shall have the meaning assigned to such term in the introductory paragraph of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Cover Price</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;3.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Current Report</B>&rdquo;
shall have the meaning assigned to such term in <U>Section 2.3</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Custodian</B>&rdquo;
means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Damages</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;9.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Disclosure Schedule</B>&rdquo;
shall have the meaning assigned to such term in the introductory paragraph to <U>Article&nbsp;V</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Disqualification
Event</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;5.40</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>DTC</B>&rdquo; means
The Depository Trust Company, a subsidiary of The Depository Trust &amp; Clearing Corporation, or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>DWAC</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.32</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>DWAC Shares</B>&rdquo;
means shares of Common Stock issued pursuant to this Agreement that are: (a)&nbsp;issued in electronic form; (b)&nbsp;freely tradable
and transferable and without restriction on resale and without stop transfer instructions maintained against the transfer thereof; and
(c)&nbsp;timely credited by the Company to the Investor&rsquo;s or its designated Broker-Dealer at which the account or accounts to be
credited with the Shares being purchased by Investor are maintained specified DWAC account with DTC under its Fast Automated Securities
Transfer (FAST) Program, or any similar program hereafter adopted by DTC performing substantially the same function.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>EDGAR</B>&rdquo;
means the SEC&rsquo;s Electronic Data Gathering, Analysis and Retrieval System.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Effective Date</B>&rdquo;
means, with respect to the Initial Registration Statement filed pursuant to Section&nbsp;2(a)&nbsp;of the Registration Rights Agreement
(or any post-effective amendment thereto) or any Subsequent Registration Statement filed pursuant to Section&nbsp;2(c)&nbsp;of the Registration
Rights Agreement (or any post-effective amendment thereto), as applicable, the date on which the Initial Registration Statement (or any
post-effective amendment thereto) or any Subsequent Registration Statement (or any post-effective amendment thereto) is declared effective
by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Effectiveness Deadline</B>&rdquo;
shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Eligible Market</B>&rdquo;
means the Trading Market, The New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market or the Nasdaq
Global Select Market (or any nationally recognized successor to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Employee Plans</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.23</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Environmental Laws</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.18</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.23</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA Affiliate</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.23</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Evaluation Date</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.6(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exchange Cap</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;3.3</U>&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Exempt Issuance</B>&rdquo;
means the issuance of: (a)&nbsp;Common Stock, options or other equity incentive awards to employees, officers, directors or vendors of
the Company pursuant to any equity incentive plan duly adopted for such purpose, by the Company&rsquo;s board of directors or a majority
of the members of a committee of the board of directors established for such purpose; (b)&nbsp;(i)&nbsp;any Securities issued to the Investor
pursuant to this Agreement, (ii)&nbsp;any securities issued upon the exercise, exchange, or conversion of any shares of Common Stock or
Common Stock Equivalents held by the Investor or any of its Affiliates at any time, or (iii)&nbsp;any securities issued upon the exercise
or exchange of or conversion of any Common Stock Equivalents issued and outstanding on the date of this Agreement, provided that such
securities referred to in this clause&nbsp;(iii)&nbsp;have not been amended since the date of this Agreement to increase the number of
such securities or to decrease the exercise price, exchange price or conversion price of such securities; or (c)&nbsp;securities issued
pursuant to acquisitions, divestitures, licenses, partnerships, collaborations or strategic transactions approved by the Company&rsquo;s
board of directors or a majority of the members of a committee of directors established for such purpose, which acquisitions, divestitures,
licenses, partnerships, collaborations or strategic transactions can have a Variable Rate Transaction component, provided that any such
issuance shall only be to a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating company
or an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition
to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of
raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>FCPA</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.34</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Federal Reserve</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.38</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Filing Deadline</B>&rdquo;
shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>FINRA</B>&rdquo;
means the Financial Industry Regulatory Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Fundamental Transaction</B>&rdquo;
means (a)&nbsp;that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more
related transactions, (i)&nbsp;consolidate or merge with or into (whether or not the Company is the surviving corporation) another Subject
Entity, or (ii)&nbsp;sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the
Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of Regulation S-X) to one or more Subject Entities,
or (iii)&nbsp;make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its Common Stock be subject
to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders of at least either
(x)&nbsp;fifty percent (50%) of the outstanding shares of Common Stock, (y)&nbsp;fifty percent (50%) of the outstanding shares of Common
Stock calculated as if any shares of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities
making or party to, such purchase, tender or exchange offer were not outstanding; or (z)&nbsp;such number of shares of Common Stock such
that all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange
offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the Exchange Act) of at least fifty percent (50%) of
the outstanding shares of Common Stock, or (iv)&nbsp;consummate a stock or share purchase agreement or other business combination (including,
without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby all
such Subject Entities, individually or in the aggregate, acquire, either (x)&nbsp;at least fifty percent (50%) of the outstanding shares
of Common Stock, (y)&nbsp;at least 50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all
the Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such stock purchase agreement or other
business combination were not outstanding; or (z)&nbsp;such number of shares of Common Stock such that the Subject Entities become collectively
the beneficial owners (as defined in Rule 13d-3 under the Exchange Act) of at least fifty percent (50%) of the outstanding shares of Common
Stock, or (v)&nbsp;reorganize, recapitalize or reclassify its Common Stock, (b)&nbsp;that the Company shall, directly or indirectly, including
through subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject Entity individually or the Subject
Entities in the aggregate to be or become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the Exchange Act), directly
or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding
shares of Common Stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off, scheme of arrangement,
reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x)&nbsp;at least fifty percent
(50%) of the aggregate ordinary voting power represented by issued and outstanding Common Stock, (y)&nbsp;at least fifty percent (50%)
of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by all such Subject Entities as of
the date of this Note calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding, or (z)&nbsp;a
percentage of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity securities
of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring other
stockholders of the Company to surrender their shares of Common Stock without approval of the stockholders of the Company or (c)&nbsp;directly
or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering
into any other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which
case this definition shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition
to the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the intended
treatment of such instrument or transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>GAAP</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.6(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Hazardous Materials</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.18</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Indebtedness</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.11</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Initial Registration
Statement</B>&rdquo; shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Intellectual Property
Rights</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;5.17(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investment Period</B>&rdquo;
means the period commencing on the Effective Date of the Initial Registration Statement and expiring on the date this Agreement is terminated
pursuant to <U>Article&nbsp;VIII</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor</B>&rdquo;
shall have the meaning assigned to such term in the introductory paragraph of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Expense
Reimbursement</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;10.1(a)</U>&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Investor Party</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;9.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Issuer Covered Person</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.40</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>IT Systems</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.39</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Knowledge</B>&rdquo;
means the actual knowledge of any of (a) the Company&rsquo;s Chief Executive Officer, (b) the Company&rsquo;s Chief Financial Officer,
(c) the Company&rsquo;s Lead Independent Director, and (d) the Company&rsquo;s General Counsel, in each case after reasonable inquiry
of all officers, directors and employees of the Company and its Subsidiaries under such Person&rsquo;s direct supervision who would reasonably
be expected to have knowledge or information with respect to the matter in question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material Adverse
Effect</B>&rdquo; means (a) any condition, occurrence, state of facts or event having, or insofar as reasonably can be foreseen would
likely have, any material adverse effect on the legality, validity or enforceability of the Transaction Documents or the transactions
contemplated thereby, (b) any condition, occurrence, state of facts or event having, or insofar as reasonably can be foreseen would likely
have, any effect on the business, operations, properties, financial condition, or prospects of the Company that is material and adverse
to the Company and its Subsidiaries, taken as a whole, and/or (c) any condition, occurrence, state of facts or event that would, or insofar
as reasonably can be foreseen would likely, prohibit or otherwise materially interfere with or delay the ability of the Company to perform
any of its obligations under the Transaction Documents; <U>provided</U>, <U>however</U>, that no facts, circumstances, changes or effects
exclusively and directly resulting from, relating to or arising out of the following, individually or in the aggregate, shall be taken
into account in determining whether a Material Adverse Effect has occurred or insofar as reasonably can be foreseen would likely occur:
(i)&nbsp;changes in conditions in the U.S. or global capital, credit or financial markets generally, including changes in the availability
of capital or currency exchange rates, provided such changes shall not have affected the Company in a materially disproportionate manner
as compared to other similarly situated companies; (ii)&nbsp;changes generally affecting the industries in which the Company and its Subsidiaries
operate, provided such changes shall not have affected the Company and its Subsidiaries, taken as a whole, in a materially disproportionate
manner as compared to other similarly situated companies; (iii)&nbsp;any effect of the announcement of, or the consummation of the transactions
contemplated by, the Transaction Documents on the Company&rsquo;s relationships, contractual or otherwise, with customers, suppliers,
vendors, bank lenders, strategic venture partners or employees; (iv) changes arising in connection with earthquakes, pandemics, epidemics,
human health crises, hostilities, acts of war, sabotage or terrorism or military actions or any escalation or material worsening of any
such pandemic, hostilities, acts of war, sabotage or terrorism or military actions existing as of the Closing Date; (v) any action taken
by the Investor with respect to the transactions contemplated by this Agreement; and (f) the effect of any changes in applicable laws
or accounting rules, provided such changes shall not have affected the Company in a materially disproportionate manner as compared to
other similarly situated companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Material Agreements</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.19</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Minimum Price</B>&rdquo;
means $1.77, representing the lower of (i) Nasdaq official closing price of the Common Stock on the Trading Market (as reflected on Nasdaq.com)
on the Closing Date (subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split
or other similar transaction that occurs on or after the Closing Date), or (ii) the average Nasdaq official closing price of the Common
Stock on the Trading Market (as reflected on Nasdaq.com) for the five (5) consecutive Trading Days ending on the Closing Date (subject
to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction
that occurs on or after the Closing Date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Money Laundering
Laws</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;5.35</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Notice of Acceptance</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Notice of Effectiveness</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;10.1(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Offer</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Offer Notice</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Offer Period</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Offered Securities</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Option</B>&rdquo;
means any contract, commitment, understanding, or arrangement by which the Company is or may become bound to issue additional shares of
the capital stock of the Company or rights, warrants, or options to subscribe for or purchase shares of Common Stock or Common Stock Equivalent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>PEA Period</B>&rdquo;
means the period commencing at 9:30 a.m., New York City time, on the fifth (5th) Trading Day immediately prior to the filing of any post-effective
amendment to the Initial Registration Statement or any Subsequent Registration Statement, and ending at 9:30 a.m., New York City time,
on the Trading Day immediately following, the Effective Date of such post-effective amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership, limited liability company,
trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Personal Data</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.39</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Placement Agent</B>&rdquo;
means Joseph Gunnar &amp; Co.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Plan</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.23</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Pre-Notice</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Price Reset Period</B>&rdquo;
means, with respect to any issuance or sale by the Company, other than pursuant to this Agreement, of shares of Common Stock or Common
Stock Equivalents at a price per share that is subject to adjustment or reset upon the effectiveness of any registration statement covering
such securities (or the resale thereof), the period commencing on the date of initial issuance of such securities and ending on the later
of (a) thirty (30) Trading Days following the effective date of such registration statement, and (b) the final date on which any adjustment
or reset mechanism applicable to such securities may be triggered or applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prospectus</B>&rdquo;
means the prospectus in the form included in a Registration Statement, as supplemented from time to time by any Prospectus Supplement,
including the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Prospectus Supplement</B>&rdquo;
means any prospectus supplement to the Prospectus filed with the SEC from time to time pursuant to Rule 424(b)&nbsp;under the Securities
Act, including the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Refused Securities</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registrable Securities</B>&rdquo;
shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registration Failure</B>&rdquo;
shall have the meaning assigned to such term in <U>Section 2.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registration Rights
Agreement</B>&rdquo; shall have the meaning assigned to such term in the recitals hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Registration Statement</B>&rdquo;
shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Regulation D</B>&rdquo;
shall have the meaning assigned to such term in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Required Reserve
Amount</B>&rdquo; shall have the meaning assigned to such term in <U>Section 6.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Restricted Period</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.9(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Restricted Person</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6.9(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Rule 144</B>&rdquo;
means Rule 144 promulgated by the SEC pursuant to the Securities Act, as such rule may be amended from time to time, or any similar rule
or regulation hereafter adopted by the SEC having substantially the same effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Sale Price</B>&rdquo;
means any trade price for a share of Common Stock on the Trading Market, or if the Common Stock is then traded on an Eligible Market,
on such Eligible Market, as reported by Bloomberg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Sarbanes-Oxley Act</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;5.6(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC</B>&rdquo; means
the U.S. Securities and Exchange SEC or any successor entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>SEC Documents</B>&rdquo;
means (a)&nbsp;all reports, schedules, registrations, forms, statements, information and other documents filed with or furnished to the
SEC by the Company pursuant to the reporting requirements of the Exchange Act, including all material filed with or furnished to the Commission
pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act, since December 31, 2024, including, without limitation, the Annual
Report on Form 10-K filed by the Company for its fiscal year ended December 31, 2024, and which hereafter shall be filed with or furnished
to the SEC by the Company during the Investment Period, including, without limitation, the Current Report; (b)&nbsp;each Registration
Statement, as the same may be amended from time to time, the Prospectus contained therein and each Prospectus Supplement thereto; and
(c)&nbsp;all information contained in such filings and all documents and disclosures that have been and heretofore shall be incorporated
by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Section&nbsp;4(a)(2)</B>&rdquo;
shall have the meaning assigned to such term in the recitals of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities</B>&rdquo;
means, collectively, the Shares and the Commitment Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Securities Act</B>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations of the SEC thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Shares</B>&rdquo;
means the shares of Common Stock that are and/or may be purchased by the Investor under this Agreement pursuant to one or more VWAP Purchase
Notices, but not including the Commitment Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Short Sales</B>&rdquo;
means &ldquo;short sales&rdquo; as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subject Entity</B>&rdquo;
means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsequent Placement</B>&rdquo;
means, directly or indirectly, the issuance, offer, sale, grant of any Option or right to purchase, or other disposition of, or the announcement
of any issuance, offer, sale, grant of any Option, warrant, or right to purchase, or other disposition of, any equity security or any
equity-linked or related security, including, without limitation, any &ldquo;equity security&rdquo; (as that term is defined under Rule
405 promulgated under the Securities Act), any Common Stock Equivalent, any debt, any preferred stock or any purchase rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsequent Placement
Agreement</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsequent Placement
Documents</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6.15.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsequent Registration
Statement</B>&rdquo; shall have the meaning assigned to such term in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
means any Person in which the Company, directly or indirectly, (a) owns any of the outstanding capital stock or holds any equity or similar
interest of such Person or (b) controls or operates all or any part of the business, operations, or administration of such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Total Commitment</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Day</B>&rdquo;
means a full trading day (beginning at 9:30:01 a.m., New York City time, and ending at 4:00 p.m., New York City time) on the Trading Market
or, if the Common Stock is then listed on an Eligible Market, on such Eligible Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Trading Market</B>&rdquo;
means The Nasdaq Capital Market (or any nationally recognized successor thereto).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transaction Documents</B>&rdquo;
means, collectively, this Agreement (as qualified by the Disclosure Schedule) and the exhibits hereto, the Registration Rights Agreement,
and each of the other agreements, documents, certificates and instruments entered into or furnished by the Parties in connection with
the transactions contemplated hereby and thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Variable Rate Transaction</B>&rdquo;
means a transaction in which the Company: (a)&nbsp;issues or sells any equity or debt securities that are convertible into, exchangeable
or exercisable for, or include the right to receive additional shares of Common Stock or Common Stock Equivalents either (i)&nbsp;at a
conversion price, exercise price, exchange rate or other price that is based upon and/or varies with the trading prices of or quotations
for the Common Stock at any time after the initial issuance of such equity or debt securities, or (ii)&nbsp;with a conversion, exercise
or exchange price that is subject to being reset at some future date after the initial issuance of such equity or debt security or upon
the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common
Stock (including, without limitation, any &ldquo;full ratchet&rdquo; or &ldquo;weighted average&rdquo; anti-dilution provisions, but not
including any standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend, stock split or other similar
transaction); (b)&nbsp;issues or sells any equity or debt securities, including without limitation, Common Stock or Common Stock Equivalents,
either (i)&nbsp;at a price that is subject to being reset at some future date after the initial issuance of such debt or equity security
or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for
the Common Stock (other than standard anti-dilution protection for any reorganization, recapitalization, non-cash dividend, stock split
or other similar transaction) (but which shall not include Common Stock or Common Stock Equivalents issued in a &ldquo;PIPE&rdquo; or
similar transaction whose price resets on the registration of such Common Stock or the Common Stock underlying such Common Stock Equivalents),
(ii)&nbsp;that are subject to or contain any put, call, redemption, buy-back, price-reset or other similar provision or mechanism (including,
without limitation, a &ldquo;Black-Scholes&rdquo; put or call right, other than in connection with a &ldquo;fundamental transaction&rdquo;)
that provides for the issuance of additional equity securities of the Company or the payment of cash by the Company; or (c)&nbsp;enters
into any agreement, including, but not limited to, an &ldquo;equity line of credit&rdquo; or &ldquo;at the market offering&rdquo; or other
continuous offering or similar offering of Common Stock or Common Stock Equivalents, whereby the Company may sell Common Stock or Common
Stock Equivalents at a future determined price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP</B>&rdquo;
means, for the Common Stock as of any Trading Day, the dollar volume-weighted average price for the Common Stock on the Trading Market
(or, if the Common Stock is then listed on an Eligible Market, on such\Eligible Market) during the period beginning at 9:30:01 a.m., New
York City time, or such other time publicly announced by the Trading Market (or by such Eligible Market, as applicable) as the official
open (or commencement) of trading on the Trading Market (or on such Eligible Market, as applicable) on such Trading Day, and ending at
4:00 p.m., New York City time, or such other time publicly announced by the Trading Market (or by such Eligible Market, as applicable)
as the official close of trading on the Trading Market (or on such Eligible Market, as applicable) on such Trading Day, as reported by
Bloomberg through its &ldquo;AQR&rdquo; function or, if no dollar volume-weighted average price is reported for the Common Stock by Bloomberg
through its &ldquo;AQR&rdquo; function for such hours, the average of the highest closing bid price and the lowest closing ask price of
any of the market makers for such security on such Trading Day as reported by OTC Markets Group Inc. All such determinations shall be
appropriately adjusted for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Confirmation</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Commencement
Time</B>&rdquo; means, with respect to a VWAP Purchase made pursuant to <U>Section&nbsp;3.1</U>, 9:30:01 a.m., New York City time, on
the Trading Day immediately following the applicable VWAP Purchase Exercise Date, or such other time publicly announced by the Trading
Market as the official open (or commencement) of trading on the Trading Market on such Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Date</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Exercise
Date</B>&rdquo; means, with respect to a VWAP Purchase made pursuant to <U>Section&nbsp;3.1</U>, the Trading Day on which the Investor
receives, after 4:00 p.m. New York City time but prior to 6:30 p.m. New York City time on such Trading Day, a valid VWAP Purchase Notice
for such VWAP Purchase in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Maximum
Amount</B>&rdquo; means, with respect to a VWAP Purchase made pursuant to <U>Section&nbsp;3.1</U>, such number of shares of Common Stock
equal to the lowest of: (a)&nbsp;100% of the average daily trading volume in the Common Stock on the Trading Market (or, in the event
the Common Stock is then listed on an Eligible Market, 100% of the average daily trading volume in the Common Stock on such Eligible Market)
for the five (5) consecutive Trading-Day period ending on (and including) the Trading Day immediately preceding the applicable VWAP Purchase
Exercise Date for such VWAP Purchase; (b)&nbsp;the product (rounded up or down to the nearest whole number) obtained by multiplying (x)&nbsp;the
daily trading volume in the Common Stock on the Trading Market (or an Eligible Market, as applicable) on the applicable VWAP Purchase
Exercise Date for such VWAP Purchase by (y)&nbsp;0.40; and (c)&nbsp;the quotient (rounded up or down to the nearest whole number) obtained
by dividing (x)&nbsp;$2,000,000 by (y)&nbsp;the VWAP on the Trading Market (or an Eligible Market, as applicable) on the Trading Day immediately
preceding the applicable VWAP Purchase Exercise Date for such VWAP Purchase (in each case to be appropriately adjusted for any reorganization,
recapitalization, non-cash dividend, stock split, reverse stock split or other similar transaction during the applicable period).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Notice</B>&rdquo;
means, with respect to a VWAP Purchase made pursuant to <U>Section&nbsp;3.1</U>, an irrevocable written notice delivered by the Company
to the Investor on a VWAP Purchase Exercise Date directing the Investor to purchase a VWAP Purchase Share Amount (such specified VWAP
Purchase Share Amount subject to adjustment as set forth in <U>Section&nbsp;3.1</U> as necessary to give effect to the VWAP Purchase Maximum
Amount), at the applicable VWAP Purchase Price therefor in accordance with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Price</B>&rdquo;
means, with respect to a VWAP Purchase made pursuant to <U>Section&nbsp;3.1</U>, the purchase price per Share to be purchased by the Investor
in such VWAP Purchase equal to ninety-seven percent (97%) of the lowest daily VWAP during the applicable VWAP Purchase Valuation Period
for such VWAP Purchase (to be appropriately adjusted for any reorganization, recapitalization, non-cash dividend, stock split, reverse
stock split or other similar transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Share
Amount</B>&rdquo; means, with respect to a VWAP Purchase made pursuant to <U>Section&nbsp;3.1</U>, the number of Shares to be purchased
by the Investor in such VWAP Purchase as specified by the Company in the applicable VWAP Purchase Notice, which number of Shares shall
not exceed the applicable VWAP Purchase Maximum Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Termination
Time</B>&rdquo; means, with respect to a VWAP Purchase made pursuant to <U>Section&nbsp;3.1</U>, 4:00 p.m., New York City time, on the
third (3rd) consecutive Trading Day immediately following the applicable VWAP Purchase Exercise Date, or such other time publicly announced
by the Trading Market as the official close of trading on the Trading Market on such third (3rd) consecutive Trading Day immediately following
the applicable VWAP Purchase Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VWAP Purchase Valuation
Period</B>&rdquo; means, with respect to a VWAP Purchase made pursuant to <U>Section&nbsp;3.1</U>, the three (3) consecutive Trading-Day
Period immediately following the applicable VWAP Purchase Exercise Date, beginning at the VWAP Purchase Commencement Time for such VWAP
Purchase and ending at the applicable VWAP Purchase Termination Time for such VWAP Purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&nbsp;*&nbsp;*&nbsp;*&nbsp;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">I-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Registration
Rights Agreement&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 63; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: left"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>FORM
OF VWAP PURCHASE NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>FORM
OF VWAP Purchase CONFIRMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 65; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit D</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>FORM
OF Closing Certificate</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 66; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit E</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>FORM
OF Compliance Certificate</B></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B></B></FONT></P>

<!-- Field: Page; Sequence: 67; Options: NewSection; Value: 1 -->
    <DIV STYLE="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>DISCLOSURE
SCHEDULE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.35
<SEQUENCE>3
<FILENAME>ea024508401ex10-35_capstone.htm
<DESCRIPTION>REGISTRATION RIGHTS AGREEMENT, DATED MAY 14, 2025, BY AND BETWEEN CAPSTONE HOLDING CORP. AND TUMIM STONE CAPITAL, LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 10.35</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">REGISTRATION RIGHTS
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS REGISTRATION
RIGHTS AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;), dated as of May 14, 2025, is by and between Tumim Stone Capital, LLC, a Delaware
limited liability company (the &ldquo;<B>Investor</B>&rdquo;), and Capstone Holding Corp., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">RECITALS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and the
Investor have entered into that certain Common Stock Purchase Agreement, dated as of the date hereof (the &ldquo;<B>Purchase Agreement</B>&rdquo;),
pursuant to which the Company may issue and sell to the Investor, from time to time as provided therein, and the Investor shall purchase
from the Company, up to the lesser of: (a)&nbsp;$20,000,000 in aggregate gross purchase price of newly issued shares of the Company&rsquo;s
common stock, par value $0.0005 per share (&ldquo;<B>Common Stock</B>&rdquo;); and (b)&nbsp;the Exchange Cap (to the extent applicable
under Section&nbsp;3.3 of the Purchase Agreement), on the terms and subject to the conditions set forth in the Purchase Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to the terms
of, and in consideration for the Investor entering into, the Purchase Agreement, the Company may issue to the Investor the Commitment
Shares, in accordance with the Purchase Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to the terms
of, and in consideration for the Investor entering into, the Purchase Agreement, and to induce the Investor to execute and deliver the
Purchase Agreement, the Company has agreed to provide the Investor with certain resale registration rights with respect to the Registrable
Securities (as defined herein) upon the terms and subject to the conditions as set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the representations, warranties, covenants and agreements contained herein and in the Purchase Agreement, and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, intending to be legally bound hereby, the Company and the
Investor hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify"><U>Definitions</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used herein
and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement. As used in this Agreement, the
following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>&ldquo;<B>Agreement</B>&rdquo; shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>&ldquo;<B>Allowable Grace Period</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;3(p)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>&ldquo;<B>Blue Sky Filing</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or any other day on which commercial banks in the City
of New York, New York State are authorized or required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;
</FONT>&ldquo;<B>Claims</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) &ldquo;<B>Closing
Date</B>&rdquo; means the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) &ldquo;<B>Common Stock</B>&rdquo;
shall have the meaning assigned to such term in the recitals to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) &ldquo;<B>Company</B>&rdquo;
shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) &ldquo;<B>Company
Party</B>&rdquo; and &ldquo;<B>Company Parties</B>&rdquo; shall have the meanings assigned to such terms in <U>Section&nbsp;6(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) &ldquo;<B>Effective Date</B>&rdquo;
means the date that the applicable Registration Statement has been declared effective by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) &ldquo;<B>Effectiveness
Deadline</B>&rdquo; means: (i) with respect to the Initial Registration Statement required to be filed to pursuant to <U>Section&nbsp;2(a)</U>,
the earlier of (A) the seventy-fifth (75th) calendar day after the earlier of (1) the date on which the Initial Registration Statement
is filed and (2) the Filing Deadline, if such Registration Statement is subject to review by the SEC, and (B) the thirtieth (30th) calendar
day after the earlier of (1) the date on which the Initial Registration Statement is filed and (2) the Filing Deadline, if the Company
is notified (orally or in writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed; and (ii) with
respect to any Subsequent Registration Statements that may be required to be filed by the Company pursuant to this Agreement, the earlier
of (A) the sixtieth (60th) calendar day following the date on which the Company was required to file such additional Registration Statement,
if such Registration Statement is subject to review by the SEC, and (B) the thirtieth (30th) calendar day following the date on which
the Company was required to file such Subsequent Registration Statement, if the Company is notified (orally or in writing, whichever
is earlier) by the SEC that such Registration Statement will not be reviewed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) &ldquo;<B>Filing Deadline</B>&rdquo;
means: (i) with respect to the Initial Registration Statement required to be filed to pursuant to <U>Section&nbsp;2(a)</U>, the thirtieth
(30th) calendar day after the Closing Date; and (ii) with respect to any Subsequent Registration Statements that may be required to be
filed by the Company pursuant to this Agreement, the thirtieth (30th) calendar day following the sale of substantially all of the Registrable
Securities included in the Initial Registration Statement or the most recent prior Subsequent Registration Statement, as applicable,
or such other date as permitted by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) &ldquo;<B>FINRA</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;3(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) &ldquo;<B>Indemnified
Damages</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) &ldquo;<B>Initial Registration
Statement</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) &ldquo;<B>Investor</B>&rdquo;
shall have the meaning assigned to such term in the preamble of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) &ldquo;<B>Investor Party</B>&rdquo;
and &ldquo;<B>Investor Parties</B>&rdquo; shall have the meaning assigned to such terms in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) &ldquo;<B>Legal
Counsel</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) &ldquo;<B>Person</B>&rdquo;
means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership, limited liability company,
trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) &ldquo;<B>Prospectus</B>&rdquo;
means the prospectus in the form included in a Registration Statement at the time such Registration Statement is declared effective by
the SEC under the Securities Act, as supplemented from time to time by any Prospectus Supplement, including the documents incorporated
by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) &ldquo;<B>Prospectus
Supplement</B>&rdquo; means any prospectus supplement to a Prospectus filed with the SEC from time to time pursuant to Rule 424(b) under
the Securities Act, including the documents incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) &ldquo;<B>Purchase Agreement</B>&rdquo;
shall have the meaning assigned to such term in the recitals to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w) &ldquo;<B>register</B>,&rdquo;
&ldquo;<B>registered</B>,&rdquo; and &ldquo;<B>registration</B>&rdquo; refer to a registration effected by preparing and filing one or
more Registration Statements in compliance with the Securities Act and pursuant to Rule 415 and the declaration of effectiveness of such
Registration Statement(s) by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x) &ldquo;<B>Registrable
Securities</B>&rdquo; means: (i) all of the Commitment Shares, if any; (ii) all of the Shares; and (iii) any capital stock of the Company
issued or issuable with respect to the Commitment Shares or the Shares, including, without limitation, (A) as a result of any stock split,
stock dividend, recapitalization, exchange or similar event or otherwise, and (B) shares of capital stock of the Company into which the
shares of Common Stock are converted or exchanged and shares of capital stock of a successor entity into which the shares of Common Stock
are converted or exchanged, in each case until such time as such securities cease to be Registrable Securities pursuant to <U>Section&nbsp;2(f)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y) &ldquo;<B>Registration
Statement</B>&rdquo; means a registration statement or registration statements of the Company filed under the Securities Act covering
the resale by the Investor of Registrable Securities, as such registration statement or registration statements may be amended and supplemented
from time to time, including all documents filed as part thereof or incorporated by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z) &ldquo;<B>Registration
Period</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;3(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) &ldquo;<B>Rule 144</B>&rdquo;
means Rule 144 promulgated by the SEC under the Securities Act, as such rule may be amended from time to time, or any other similar or
successor rule or regulation of the SEC that may at any time permit the Investor to sell securities of the Company to the public without
registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) &ldquo;<B>Rule 415</B>&rdquo;
means Rule 415 promulgated by the SEC under the Securities Act, as such rule may be amended from time to time, or any other similar or
successor rule or regulation of the SEC providing for offering securities on a delayed or continuous basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) &ldquo;<B>SEC</B>&rdquo;
means the U.S. Securities and Exchange Commission or any successor entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) &ldquo;<B>Staff</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;2(e)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) &ldquo;<B>Subsequent
Registration Statement</B>&rdquo; shall have the meaning assigned to such term in <U>Section&nbsp;2(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) &ldquo;<B>Violations</B>&rdquo;
shall have the meaning assigned to such term in <U>Section&nbsp;6(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify"><U>Registration</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Mandatory
Registration</U>. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline, file with the
SEC an initial Registration Statement on Form S-1 (or any successor form) covering the resale by the Investor of: (i) all of the Commitment
Shares, if any; and (ii) the maximum number of additional Registrable Securities as shall be permitted to be included thereon in accordance
with applicable SEC rules, regulations and interpretations so as to permit the resale of such Commitment Shares and other Registrable
Securities by the Investor under Rule 415 under the Securities Act at then prevailing market prices (and not fixed prices) (the &ldquo;<B>Initial
Registration Statement</B>&rdquo;). The Initial Registration Statement shall contain the &ldquo;Selling Stockholder&rdquo; and &ldquo;Plan
of Distribution&rdquo; sections in substantially the form attached hereto as <U>Exhibit B</U>, with such changes or modifications thereto
the Company and its counsel shall deem reasonably necessary or required. The Company shall use commercially reasonable efforts to have
the Initial Registration Statement declared effective by the SEC as soon as reasonably practicable following the filing thereof with the
SEC, but in no event later than the applicable Effectiveness Deadline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Legal Counsel</U>.
Subject to <U>Section 5</U> hereof, the Investor shall have the right to select one legal counsel to review, solely on the Investor&rsquo;s
behalf, each Registration Statement filed with the SEC pursuant to this <U>Section&nbsp;2</U> (&ldquo;<B>Legal Counsel</B>&rdquo;), which shall
be Stradling Yocca Carlson &amp; Rauth LLP, or such other counsel as hereafter designated by the Investor. Except as provided under <U>Section
5</U> of this Agreement and Section 10.1(a) of the Purchase Agreement, the Company shall have no obligation to reimburse the Investor
for any legal fees and expenses of the Legal Counsel incurred in connection with the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Sufficient Number
of Shares Registered</U>. If at any time all Registrable Securities are not covered by the Initial Registration Statement filed pursuant
to <U>Section&nbsp;2(a)</U> as a result of <U>Section&nbsp;2(e)</U> or otherwise, the Company shall use its commercially reasonable efforts
to file with the SEC one or more additional Registration Statements so as to cover all of the Registrable Securities not covered by such
initial Registration Statement, in each case, as soon as practicable (taking into account any position of the staff of the SEC (&ldquo;<B>Staff</B>&rdquo;)
with respect to the date on which the Staff will permit such additional Registration Statement(s) to be filed with the SEC and the rules
and regulations of the SEC) (each such additional Registration Statement, a &ldquo;<B>Subsequent Registration Statement</B>&rdquo;),
but in no event later than the applicable Filing Deadline for such Subsequent Registration Statement(s). The Company shall use commercially
reasonable efforts to cause each such Subsequent Registration Statement to become effective as soon as practicable following the filing
thereof with the SEC, but in no event later than the applicable Effectiveness Deadline for such Subsequent Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>No
Inclusion of Other Securities</U>. In no event shall the Company include any securities other than Registrable Securities on any Registration
Statement pursuant to <U>Section&nbsp;2(a)</U> or <U>Section&nbsp;2(c)</U> without consulting the Investor and Legal Counsel prior to
filing such Registration Statement with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Offering</U>.
If the Staff or the SEC seeks to characterize any offering pursuant to a Registration Statement filed pursuant to this Agreement as constituting
an offering of securities that does not permit such Registration Statement to become effective and be used for resales by the Investor
on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed prices), or if after the filing of any
Registration Statement pursuant to <U>Section&nbsp;2(a)</U> or <U>Section&nbsp;2(c)</U>, the Company is otherwise required by the Staff
or the SEC to reduce the number of Registrable Securities included in such Registration Statement, then the Company shall reduce the number
of Registrable Securities to be included in such Registration Statement (after consultation with the Investor and Legal Counsel as to
the specific Registrable Securities to be removed therefrom) until such time as the Staff and the SEC shall so permit such Registration
Statement to become effective and be used as aforesaid. Notwithstanding anything in this Agreement to the contrary, if after giving effect
to the actions referred to in the immediately preceding sentence, the Staff or the SEC does not permit such Registration Statement to
become effective and be used for resales by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices
(and not fixed prices), the Company shall not request acceleration of the Effective Date of such Registration Statement, the Company shall
promptly (but in no event later than 48 hours) request the withdrawal of such Registration Statement pursuant to Rule 477 under the Securities
Act, and the Effectiveness Deadline shall automatically be deemed to have elapsed with respect to such Registration Statement at such
time as the Staff or the SEC has made a final and non-appealable determination that the SEC will not permit such Registration Statement
to be so utilized (unless prior to such time the Company has received assurances from the Staff or the SEC that a Subsequent Registration
Statement filed by the Company with the SEC promptly thereafter may be so utilized). In the event of any reduction in Registrable Securities
pursuant to this paragraph, the Company shall use its commercially reasonable efforts to file one or more Subsequent Registration Statements
with the SEC in accordance with <U>Section&nbsp;2(c)</U> until such time as all Registrable Securities have been included in Registration
Statements that have been declared effective and the Prospectuses contained therein are available for use by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Registrable
Securities</U>. Any Registrable Security shall cease to be a &ldquo;Registrable Security&rdquo; at the earliest of the following: (i)
when a Registration Statement covering such Registrable Security becomes or has been declared effective by the SEC and such Registrable
Security has been sold or disposed of pursuant to such effective Registration Statement; (ii) when such Registrable Security is held by
the Company or one of its Subsidiaries; and (iii) the date that is the later of (A) the first (1st) anniversary of the date of termination
of the Purchase Agreement in accordance with Article&nbsp;VIII of the Purchase Agreement and (B) the first (1st) anniversary of the date
of the last sale of any Registrable Securities by the Company to the Investor pursuant to the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify"><U>Related Obligations</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company shall use commercially
reasonable efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof,
and, pursuant thereto, the Company shall have the following obligations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) Subject
to Allowable Grace Periods, the Company shall keep each Registration Statement effective (and the Prospectus contained therein available
for use) pursuant to Rule 415 for resales by the Investor on a continuous basis at then-prevailing market prices (and not fixed prices)
at all times until the earlier of (i) the date on which the Investor shall have sold all of the Registrable Securities covered by such
Registration Statement and (ii) the date of termination of the Purchase Agreement if as of such termination date the Investor holds no
Registrable Securities (or, if applicable, the date on which such securities cease to be Registrable Securities after the date of termination
of the Purchase Agreement) (the &ldquo;<B>Registration Period</B>&rdquo;). Notwithstanding anything to the contrary contained in this
Agreement, the Company shall ensure that, when filed and at all times while effective, each Registration Statement (including, without
limitation, all amendments and supplements thereto) and the Prospectus (including, without limitation, all amendments and supplements
thereto) used in connection with such Registration Statement shall not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein, or necessary to make the statements therein (in the case of Prospectuses, in the light
of the circumstances in which they were made) not misleading. The Company shall submit to the SEC, as soon as reasonably practicable after
the date that the Company learns that no review of a particular Registration Statement will be made by the Staff or that the Staff has
no further comments on a particular Registration Statement (as the case may be), a request for acceleration of effectiveness of such Registration
Statement to a time and date as soon as reasonably practicable in accordance with Rule 461 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Subject
to <U>Section&nbsp;3(p)</U> of this Agreement, the Company shall use its commercially reasonable efforts to prepare and file with the
SEC such amendments (including, without limitation, post-effective amendments) and supplements to each Registration Statement and the
Prospectus used in connection with each such Registration Statement, which Prospectus is to be filed pursuant to Rule 424 promulgated
under the Securities Act, as may be necessary to keep each such Registration Statement effective (and the Prospectus contained therein
current and available for use) at all times during the Registration Period for such Registration Statement, and, during such period, comply
with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required to be
covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the Investor as set forth in such Registration Statement. Without limiting the generality
of the foregoing, the Company covenants and agrees that (i) at or before 9:00 a.m. (New York City time) on the Trading Day immediately
following the Effective Date of the Initial Registration Statement and any Subsequent Registration Statement (or any post-effective amendment
thereto), the Company shall file with the SEC in accordance with Rule 424(b) under the Securities Act the final Prospectus to be used
in connection with sales pursuant to such Registration Statement (or post-effective amendment thereto), and (ii) if the transactions contemplated
by any VWAP Purchase are material to the Company (individually or collectively with all other prior VWAP Purchases, the consummation of
which have not previously been reported in any Prospectus Supplement filed with the SEC under Rule 424(b) under the Securities Act or
in any report, statement or other document filed by the Company with the SEC under the Exchange Act), or if otherwise required under the
Securities Act (or the interpretations of the SEC thereof), in each case as reasonably determined by the Company and the Investor, then,
at or before 9:00 a.m., New York City time, on the first (1st) Trading Day immediately following the VWAP Purchase Date, if a VWAP Purchase
Notice was properly delivered to the Investor hereunder, the Company shall file with the SEC a Prospectus Supplement pursuant to Rule
424(b) under the Securities Act with respect to the applicable VWAP Purchase(s), disclosing the total number of Shares that are to be
(and, if applicable, have been) issued and sold to the Investor pursuant to such VWAP Purchase(s), the total purchase price for the Shares
subject to such VWAP Purchase(s) (as applicable), the applicable purchases price(s) for such Shares and the net proceeds that are to be
(and, if applicable, have been) received by the Company from the sale of such Shares. To the extent not previously disclosed in the Prospectus
or a Prospectus Supplement, the Company shall disclose in its Quarterly Reports on Form 10-Q and in its Annual Reports on Form 10-K the
information described in the immediately preceding sentence relating to all VWAP Purchase(s) consummated during the relevant fiscal quarter
and shall file such Quarterly Reports and Annual Reports with the SEC within the applicable time period prescribed for such report under
the Exchange Act. In the case of amendments and supplements to any Registration Statement on Form S-1 or Prospectus related thereto which
are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this Section&nbsp;3(b)) by reason of the
Company filing a report on Form 8-K, Form 10-Q or Form 10-K or any analogous report under the Exchange Act, the Company shall have incorporated
such report by reference into such Registration Statement and Prospectus, if applicable, or shall file such amendments or supplements
to the Registration Statement or Prospectus with the SEC on the same day on which the Exchange Act report is filed which created the requirement
for the Company to amend or supplement such Registration Statement or Prospectus, for the purpose of including or incorporating such report
into such Registration Statement and Prospectus. The Company consents to the use of the Prospectus (including, without limitation, any
supplement thereto) included in each Registration Statement in accordance with the provisions of the Securities Act and with the securities
or &ldquo;Blue Sky&rdquo; laws of the jurisdictions in which the Registrable Securities may be sold by the Investor, in connection with
the resale of the Registrable Securities and for such period of time thereafter as such Prospectus (including, without limitation, any
supplement thereto) (or in lieu thereof, the notice referred to in Rule 173(a) under the Securities Act) is required by the Securities
Act to be delivered in connection with resales of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The
Company shall (i) permit Legal Counsel an opportunity to review and comment upon (A) each Registration Statement at least two (2) Business
Days prior to its filing with the SEC and (B) all amendments and supplements to each Registration Statement (including, without limitation,
the Prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K,
and any similar or successor reports or Prospectus Supplements the contents of which is limited to that set forth in such reports) within
a reasonable number of days prior to their filing with the SEC, and (ii) shall reasonably consider any comments of the Investor and Legal
Counsel on any such Registration Statement or amendment or supplement thereto or to any Prospectus contained therein. The Company shall
promptly furnish to Legal Counsel, without charge, (x) electronic copies of any correspondence from the SEC or the Staff to the Company
or its representatives relating to each Registration Statement (which correspondence shall be redacted to exclude any material, non-public
information regarding the Company or any of its Subsidiaries), (y)&nbsp;after the same is prepared and filed with the SEC, one (1) electronic
copy of each Registration Statement and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements
and schedules, all documents incorporated therein by reference, if requested by the Investor, and all exhibits, and (z)&nbsp;upon the
effectiveness of each Registration Statement, one (1) electronic copy of the Prospectus included in such Registration Statement and all
amendments and supplements thereto; provided, however, the Company shall not be required to furnish any document (other than the Prospectus,
which may be provided in .PDF format) to Legal Counsel to the extent such document is available on EDGAR).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) Without
limiting any obligation of the Company under the Purchase Agreement, the Company shall promptly furnish to the Investor, without charge,
(i) after the same is prepared and filed with the SEC, at least one (1) electronic copy of each Registration Statement and any amendment(s)
and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference,
if requested by the Investor, all exhibits thereto (or such other number of copies as the Investor may reasonably request from time to
time), (ii) upon the effectiveness of each Registration Statement, one (1) electronic copy of the Prospectus included in such Registration
Statement and all amendments and supplements thereto (or such other number of copies as the Investor may reasonably request from time
to time), and (iii) such other documents, including, without limitation, copies of any final Prospectus and any Prospectus Supplement
thereto, as the Investor may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities
owned by the Investor; provided, however, the Company shall not be required to furnish any document (other than the Prospectus, which
may be provided in .PDF format) to the Investor to the extent such document is available on EDGAR).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The
Company shall take such action as is reasonably necessary to (i) register and qualify, unless an exemption from registration and qualification
applies, the resale by the Investor of the Registrable Securities covered by a Registration Statement under such other securities or &ldquo;Blue
Sky&rdquo; laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions, such amendments (including,
without limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain
the effectiveness thereof during the Registration Period, (iii) take such other actions as may be reasonably necessary to maintain such
registrations and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary
or advisable to qualify the Registrable Securities for sale in such jurisdictions; <U>provided</U>, <U>however</U>, the Company shall
not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not
otherwise be required to qualify but for this <U>Section&nbsp;3(e)</U>, (y) subject itself to general taxation in any such jurisdiction,
or (z) file a general consent to service of process in any such jurisdiction. The Company shall promptly notify Legal Counsel and the
Investor of the receipt by the Company of any notification with respect to the suspension of the registration or qualification of any
of the Registrable Securities for sale under the securities or &ldquo;Blue Sky&rdquo; laws of any jurisdiction in the United States or
its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) The
Company shall notify Legal Counsel and the Investor in writing of the happening of any event, as promptly as reasonably practicable after
becoming aware of such event, as a result of which the Prospectus included in a Registration Statement, as then in effect, includes an
untrue statement of a material fact or omission to state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain
any material, non-public information regarding the Company or any of its Subsidiaries), and, subject to <U>Section&nbsp;3(p)</U>, promptly
prepare a supplement or amendment to such Registration Statement and such Prospectus contained therein to correct such untrue statement
or omission and deliver one (1) electronic copy of such supplement or amendment to Legal Counsel and the Investor (or such other number
of copies as Legal Counsel or the Investor may reasonably request). The Company shall also promptly notify Legal Counsel and the Investor
in writing (i) when a Prospectus or any Prospectus Supplement or post-effective amendment has been filed, when a Registration Statement
or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to Legal Counsel and the Investor
by facsimile or e-mail on the same day of such effectiveness, and by overnight delivery), and when the Company receives written notice
from the SEC that a Registration Statement or any post-effective amendment will be reviewed by the SEC, (ii) of any request by the SEC
for amendments or supplements to a Registration Statement or related Prospectus or related information, (iii) of the Company&rsquo;s reasonable
determination that a post-effective amendment to a Registration Statement would be appropriate, and (iv) of the receipt of any request
by the SEC or any other federal or state governmental authority for any additional information relating to the Registration Statement
or any amendment or supplement thereto or any related Prospectus. The Company shall respond as promptly as reasonably practicable to any
comments received from the SEC with respect to a Registration Statement or any amendment thereto. Nothing in this <U>Section&nbsp;3(f)</U>
shall limit any obligation of the Company under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) The
Company shall (i) use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness
of a Registration Statement or the use of any Prospectus contained therein, or the suspension of the qualification, or the loss of an
exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is
issued, to obtain the withdrawal of such order or suspension at the earliest possible time, and (ii) notify Legal Counsel and the Investor
of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) The
Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is
necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in such
Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant to a subpoena or other
final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally
available to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company agrees
that it shall, upon learning that disclosure of such information concerning the Investor is sought in or by a court or governmental body
of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor, at the Investor&rsquo;s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) Without
limiting any obligation of the Company under the Purchase Agreement, the Company shall use its commercially reasonable efforts either
to (i) cause all of the Registrable Securities covered by each Registration Statement to be listed on the Trading Market, (ii) secure
designation and quotation of all of the Registrable Securities covered by each Registration Statement on another Eligible Market, or (iii)&nbsp;if,
despite the Company&rsquo;s commercially reasonable efforts to satisfy the preceding clauses (i) or (ii) the Company is unsuccessful in
satisfying the preceding clauses (i) or (ii), without limiting the generality of the foregoing, to use its commercially reasonable efforts
to arrange for at least two (2) market makers to register with the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;)
as such with respect to such Registrable Securities. In addition, the Company shall reasonably cooperate with the Investor and any Broker-Dealer
through which the Investor proposes to sell its Registrable Securities in effecting a filing with the FINRA pursuant to FINRA Rule 5110
as requested by the Investor. The Company shall pay all fees and expenses in connection with satisfying its obligation under this <U>Section&nbsp;3(i)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) The
Company shall cooperate with the Investor and, to the extent applicable, facilitate the timely preparation and delivery of Registrable
Securities, as DWAC Shares, to be offered pursuant to a Registration Statement and enable such DWAC Shares to be in such denominations
or amounts (as the case may be) as the Investor may reasonably request from time to time and registered in such names as the Investor
may request. Investor hereby agrees that it shall cooperate with the Company, its counsel and Transfer Agent in connection with any issuances
of the DWAC Shares, and hereby represents, warrants and covenants to the Company that that it will resell such Shares only pursuant to
the Registration Statement in which such DWAC Shares are included, in a manner described under the caption &ldquo;Plan of Distribution&rdquo;
in such Registration Statement, and in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations,
including, without limitation, any applicable prospectus delivery requirements of the Securities Act. DWAC Shares shall be free from all
restrictive legends may be transmitted by the transfer agent to the Investor by crediting an account at DTC as directed in writing by
the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) Upon
the written request of the Investor, the Company shall as soon as reasonably practicable after receipt of notice from the Investor and
subject to <U>Section&nbsp;3(p)</U> hereof, (i) incorporate in a Prospectus Supplement or post-effective amendment such information as
the Investor reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without
limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor
and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such
Prospectus Supplement or post-effective amendment after being notified of the matters to be incorporated in such Prospectus Supplement
or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement or Prospectus contained therein if
reasonably requested by the Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) The
Company shall use its commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to be registered
with or approved by such other governmental agencies or authorities in the United States as may be necessary to consummate the disposition
of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) The
Company shall make generally available to its security holders (which may be satisfied by making such information available on EDGAR)
as soon as practical, but not later than ninety (90) days after the close of the period covered thereby, an earnings statement (in form
complying with, and in the manner provided by, the provisions of Rule 158 under the Securities Act) covering a twelve (12)-month period
beginning not later than the first day of the Company&rsquo;s fiscal quarter next following the applicable Effective Date of each Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) The
Company shall otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the SEC in connection
with any registration hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) Within
one (1) Business Day after each Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company
shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies
to the Investor) confirmation that such Registration Statement has been declared effective by the SEC in the form attached hereto as <U>Exhibit
A</U>, or in such other form as requested by the Company&rsquo;s transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) Notwithstanding
anything to the contrary contained herein (but subject to the last sentence of this <U>Section&nbsp;3(p)</U>), at any time after the Effective
Date of a particular Registration Statement, the Company may, upon written notice to Investor, suspend Investor&rsquo;s use of any prospectus
that is a part of any Registration Statement (in which event the Investor shall discontinue sales of the Registrable Securities pursuant
to such Registration Statement contemplated by this Agreement, but shall settle any previously made sales of Registrable Securities) if
the Company (x) is pursuing an acquisition, merger, tender offer, reorganization, disposition or other similar transaction and the Company
determines in good faith that (A) the Company&rsquo;s ability to pursue or consummate such a transaction would be materially adversely
affected by any required disclosure of such transaction in such Registration Statement or other registration statement or (B) such transaction
renders the Company unable to comply with SEC requirements, in each case under circumstances that would make it impractical or inadvisable
to cause any Registration Statement (or such filings) to be used by Investor or to promptly amend or supplement any Registration Statement
contemplated by this Agreement on a post effective basis, as applicable, or (y) has experienced some other material non-public event the
disclosure of which at such time, in the good faith judgment of the Company, would materially adversely affect the Company (each, an &ldquo;<B>Allowable
Grace Period</B>&rdquo;); <U>provided</U>, <U>however</U>, that in no event shall the Investor be suspended from selling Registrable Securities
pursuant to any Registration Statement for a period that exceeds twenty (20) consecutive Trading Days or an aggregate of sixty (60) Trading
Days in any three hundred sixty-five (365)-day period; and <U>provided</U>, <U>further</U>, the Company shall not effect any such suspension
during (A) the first ten (10) consecutive Trading Days after the Effective Date of the particular Registration Statement or (B) the five
(5) consecutive Trading-Day period following each VWAP Purchase Date. Upon disclosure of such information or the termination of the condition
described above, the Company shall provide prompt notice, but in any event within one Business Day of such disclosure or termination,
to the Investor and shall promptly terminate any suspension of sales it has put into effect and shall take such other reasonable actions
to permit registered sales of Registrable Securities as contemplated in this Agreement (including as set forth in the first sentence of
<U>Section&nbsp;3(f)</U> with respect to the information giving rise thereto unless such material, non-public information is no longer
applicable). Notwithstanding anything to the contrary contained in this <U>Section&nbsp;3(p)</U>, the Company shall cause its transfer
agent to deliver DWAC Shares to a transferee of the Investor in accordance with the terms of the Purchase Agreement in connection with
any sale of Registrable Securities with respect to which (i) the Company has made a sale to Investor and (ii) the Investor has entered
into a contract for sale, and delivered a copy of the Prospectus included as part of the particular Registration Statement to the extent
applicable, in each case prior to the Investor&rsquo;s receipt of the notice of an Allowable Grace Period and for which the Investor has
not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify"><U>Obligations of the Investor</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) At
least five (5) Business Days prior to the first anticipated filing date of each Registration Statement (or such shorter period to which
the parties agree), the Company shall notify the Investor in writing of the information the Company requires from the Investor with respect
to such Registration Statement. It shall be a condition precedent to the obligations of the Company to complete the registration pursuant
to this Agreement with respect to the Registrable Securities of the Investor that the Investor shall furnish to the Company such information
regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it,
as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities and shall
execute such documents in connection with such registration as the Company may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) The
Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of each Registration Statement hereunder, unless the Investor has notified the Company in
writing of the Investor&rsquo;s election to exclude all of the Registrable Securities from such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) The
Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in <U>Section&nbsp;3(p)</U>
or the first sentence of <U>Section 3(f)</U>, the Investor shall immediately discontinue disposition of Registrable Securities pursuant
to any Registration Statement(s) covering such Registrable Securities until the Investor&rsquo;s receipt of the copies of the supplemented
or amended Prospectus contemplated by <U>Section&nbsp;3(p)</U> or the first sentence of <U>Section&nbsp;3(f)</U> or receipt of notice
that no supplement or amendment is required. Notwithstanding anything to the contrary in this <U>Section&nbsp;4(c)</U>, the Company shall
cause its transfer agent to deliver DWAC Shares to a transferee of the Investor in accordance with the terms of the Purchase Agreement
in connection with any sale of Registrable Securities with respect to which the Investor has entered into a contract for sale prior to
the Investor&rsquo;s receipt of a notice from the Company of the happening of any event of the kind described in <U>Section&nbsp;3(p)</U>
or the first sentence of <U>Section&nbsp;3(f)</U> and for which the Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) The
Investor covenants and agrees that it shall comply with the prospectus delivery and other requirements of the Securities Act as applicable
to it in connection with sales of Registrable Securities pursuant to a Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify"><U>Expenses of Registration</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with any registration,
filing or qualification pursuant to Section 2 or 3 of this Agreement, the Company agrees to reimburse the Investor for the fees and disbursements
of Legal Counsel incurred by the Investor in connection therewith, in an amount not to exceed $10,000 (such amount to count towards
the Investor Expense Reimbursement as defined in and pursuant to the Purchase Agreement). Except as provided under the forgoing sentence
of this Section 5 and Section&nbsp;10.1(a) of the Purchase Agreement, the Company shall have no obligation to reimburse the Investor for
any expenses of the Investor incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3 of this
Agreement, including Legal Counsel fees incurred in connection with the transactions contemplated hereby. All registration, listing and
qualification fees, printers and accounting fees incurred by the Company, and fees and disbursements of counsel for the Company, shall
be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify"><U>Indemnification</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) In
the event any Registrable Securities are included in any Registration Statement under this Agreement, to the fullest extent permitted
by law, the Company shall, and hereby does, indemnify, hold harmless and defend the Investor, each of its directors, officers, shareholders,
members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding the lack of such title or any other title) and each Person, if any, who controls the Investor within
the meaning of the Securities Act or the Exchange Act and each of the directors, officers, shareholders, members, partners, employees,
agents, advisors, representatives (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
the lack of such title or any other title) of such controlling Persons (each, an &ldquo;<B>Investor Party</B>&rdquo; and collectively,
the &ldquo;<B>Investor Parties</B>&rdquo;), against any losses, obligations, claims, damages, liabilities, contingencies, judgments, fines,
penalties, charges, costs (including, without limitation, court costs, attorneys&rsquo; fees, costs of defense and investigation), amounts
paid in settlement or expenses, joint or several, (collectively, &ldquo;<B>Claims</B>&rdquo;) reasonably incurred in investigating, preparing
or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or
governmental, administrative or other regulatory agency, body or the SEC, whether pending or threatened, whether or not an Investor Party
is or may be a party thereto (&ldquo;<B>Indemnified Damages</B>&rdquo;), to which any of them may become subject insofar as such Claims
(or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon: (i) any untrue statement
or alleged untrue statement of a material fact in a Registration Statement or any post-effective amendment thereto or in any filing made
in connection with the qualification of the offering under the securities or other &ldquo;Blue Sky&rdquo; laws of any jurisdiction in
which Registrable Securities are offered (&ldquo;<B>Blue Sky Filing</B>&rdquo;), or the omission or alleged omission to state a material
fact required to be stated therein or necessary to make the statements therein not misleading, or (ii) any untrue statement or alleged
untrue statement of a material fact contained in any Prospectus (as amended or supplemented) or in any Prospectus Supplement or the omission
or alleged omission to state therein any material fact necessary to make the statements made therein, in light of the circumstances under
which the statements therein were made, not misleading (the matters in the foregoing clauses (i) and (ii) being, collectively, &ldquo;<B>Violations</B>&rdquo;).
Subject to <U>Section&nbsp;6(c)</U>, the Company shall reimburse the Investor Parties, promptly as such expenses are incurred and are
due and payable, for any reasonable legal fees or other reasonable expenses incurred by them in connection with investigating or defending
any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement contained in this <U>Section&nbsp;6(a)</U>:
(i) shall not apply to a Claim by an Investor Party arising out of or based upon a Violation which occurs in reliance upon and in conformity
with information furnished in writing to the Company by such Investor Party for such Investor Party expressly for use in connection with
the preparation of such Registration Statement, Prospectus or Prospectus Supplement or any such amendment thereof or supplement thereto
(it being hereby acknowledged and agreed that the written information set forth on <U>Exhibit B</U> attached hereto is the only written
information furnished to the Company by or on behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus
Supplement); (ii) shall not be available to the Investor to the extent such Claim is based on a failure of the Investor to deliver or
to cause to be delivered the Prospectus (as amended or supplemented) made available by the Company (to the extent applicable), including,
without limitation, a corrected Prospectus, if such Prospectus (as amended or supplemented) or corrected Prospectus was timely made available
by the Company pursuant to <U>Section&nbsp;3(d)</U> and then only if, and to the extent that, following the receipt of the corrected Prospectus
no grounds for such Claim would have existed; (iii) shall not apply in connection with, as a result of, or arising out of the Investor&rsquo;s
negligence or willful misconduct; and (iv) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of the Investor Party and shall survive the transfer of any
of the Registrable Securities by the Investor pursuant to <U>Section&nbsp;9</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) In
connection with any Registration Statement in which the Investor is participating, the Investor agrees to severally and not jointly indemnify,
hold harmless and defend, to the same extent and in the same manner as is set forth in <U>Section&nbsp;6(a)</U>, the Company, each of
its directors, each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the
meaning of the Securities Act or the Exchange Act (each, an &ldquo;<B>Company Party</B>&rdquo; and collectively, the &ldquo;<B>Company
Parties</B>&rdquo;), against any Claim or Indemnified Damages to which any of them may become subject, under the Securities Act, the Exchange
Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or are based upon any Violation, in each case, to the extent,
and only to the extent, that such Violation occurs in reliance upon and in conformity with written information relating to the Investor
furnished to the Company by the Investor expressly for use in connection with such Registration Statement, the Prospectus included therein
or any Prospectus Supplement thereto (it being hereby acknowledged and agreed that the written information set forth on <U>Exhibit B</U>
attached hereto is the only written information furnished to the Company by or on behalf of the Investor expressly for use in any Registration
Statement, Prospectus or Prospectus Supplement); and, subject to <U>Section&nbsp;6(c)</U> and the below provisos in this <U>Section&nbsp;6(b)</U>,
the Investor shall reimburse a Company Party any legal or other expenses reasonably incurred by such Company Party in connection with
investigating or defending any such Claim; <U>provided</U>, <U>however</U>, the indemnity agreement contained in this <U>Section&nbsp;6(b)</U>
and the agreement with respect to contribution contained in <U>Section&nbsp;7</U> shall not apply to amounts paid in settlement of any
Claim if such settlement is effected without the prior written consent of the Investor, which consent shall not be unreasonably withheld
or delayed; and <U>provided, further</U> that the Investor shall be liable under this <U>Section&nbsp;6(b)</U> for only that amount of
a Claim or Indemnified Damages as does not exceed the net proceeds to the Investor as a result of the applicable sale of Registrable Securities
pursuant to such Registration Statement, Prospectus or Prospectus Supplement. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of such Company Party and shall survive the transfer of any of the Registrable Securities by
the Investor pursuant to <U>Section&nbsp;9</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Promptly
after receipt by an Investor Party or Company Party (as the case may be) under this <U>Section&nbsp;6</U> of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Investor Party
or Company Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section&nbsp;6,
deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate
in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control
of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Investor Party or the Company Party (as the
case may be); <U>provided</U>, <U>however</U>, an Investor Party or Company Party (as the case may be) shall have the right to retain
its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the indemnifying party has agreed
in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume the defense of such Claim and
to employ counsel reasonably satisfactory to such Investor Party or Company Party (as the case may be) in any such Claim; or (iii) the
named parties to any such Claim (including, without limitation, any impleaded parties) include both such Investor Party or Company Party
(as the case may be) and the indemnifying party, and such Investor Party or such Company Party (as the case may be) shall have been advised
by counsel that a conflict of interest is likely to exist if the same counsel were to represent such Investor Party or such Company Party
and the indemnifying party (in which case, if such Investor Party or such Company Party (as the case may be) notifies the indemnifying
party in writing that it elects to employ separate counsel at the expense of the indemnifying party, then the indemnifying party shall
not have the right to assume the defense thereof on behalf of the indemnified party and such counsel shall be at the expense of the indemnifying
party, <U>provided further</U> that in the case of clause (iii) above the indemnifying party shall not be responsible for the reasonable
fees and expenses of more than one (1) separate legal counsel for all Investor Parties or Company Parties (as the case may be). The Company
Party or Investor Party (as the case may be) shall reasonably cooperate with the indemnifying party in connection with any negotiation
or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably
available to the Company Party or Investor Party (as the case may be) which relates to such action or Claim. The indemnifying party shall
keep the Company Party or Investor Party (as the case may be) reasonably apprised at all times as to the status of the defense or any
settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of any action, claim or proceeding
effected without its prior written consent; <U>provided</U>, <U>however</U>, the indemnifying party shall not unreasonably withhold, delay
or condition its consent. No indemnifying party shall, without the prior written consent of the Company Party or Investor Party (as the
case may be), consent to entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional
term thereof the giving by the claimant or plaintiff to such Company Party or Investor Party (as the case may be) of a release from all
liability in respect to such Claim or litigation, and such settlement shall not include any admission as to fault on the part of the Company
Party. For the avoidance of doubt, the immediately preceding sentence shall apply to <U>Sections 6(a)</U> and <U>6(b)</U> hereof. Following
indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Company Party or Investor Party
(as the case may be) with respect to all third parties, firms or corporations relating to the matter for which indemnification has been
made. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action
shall not relieve such indemnifying party of any liability to the Investor Party or Company Party (as the case may be) under this <U>Section&nbsp;6</U>,
except to the extent that the indemnifying party is materially and adversely prejudiced in its ability to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) No
Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)
of the Securities Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale of Registrable
Securities who is not guilty of fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The
indemnification required by this Section&nbsp;6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred; <U>provided</U> that any Person receiving any payment
pursuant to this Section&nbsp;6 shall promptly reimburse the Person making such payment for the amount of such payment to the extent a
court of competent jurisdiction determines that such Person receiving such payment was not entitled to such payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) The
indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Company
Party or Investor Party against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant
to the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify"><U>Contribution</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under <U>Section&nbsp;6</U> to the fullest extent permitted by law; <U>provided</U>,
<U>however</U>: (a) no contribution shall be made under circumstances where the maker would not have been liable for indemnification under
the fault standards set forth in <U>Section&nbsp;6</U> of this Agreement, (b) no Person involved in the sale of Registrable Securities
which Person is guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) in connection
with such sale shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of
fraudulent misrepresentation; and (c) contribution by any seller of Registrable Securities shall be limited in amount to the amount of
net proceeds received by such seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement.
Notwithstanding the provisions of this <U>Section&nbsp;7</U>, the Investor shall not be required to contribute, in the aggregate, any
amount in excess of the amount by which the net proceeds actually received by the Investor from the applicable sale of the Registrable
Securities subject to the Claim exceeds the amount of any damages that the Investor has otherwise been required to pay, or would otherwise
be required to pay under <U>Section&nbsp;6(b)</U>, by reason of such untrue or alleged untrue statement or omission or alleged omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify"><U>Reports Under the Exchange Act</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With a view to making available
to the Investor the benefits of Rule 144, the Company agrees to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) use
commercially reasonable efforts to make and keep public information available, as those terms are understood and defined in Rule 144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) use
commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under
the Securities Act and the Exchange Act so long as the Company remains subject to such requirements (it being understood that nothing
herein shall limit any of the Company&rsquo;s obligations under the Purchase Agreement) and the filing of such reports and other documents
is required for the applicable provisions of Rule 144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) furnish
to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company, if
true, that it has complied with the reporting, submission and posting requirements of Rule 144 and the Exchange Act, (ii) a copy of the
most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the SEC if such
reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably requested to permit the Investor to
sell such securities pursuant to Rule 144 without registration; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) take
such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to
Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the
Company&rsquo;s Transfer Agent as may be reasonably requested from time to time by the Investor and otherwise fully cooperate with Investor
and Investor&rsquo;s broker to effect such sale of securities pursuant to Rule 144.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify"><U>Assignment of Registration Rights</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither the Company nor the
Investor shall assign this Agreement or any of their respective rights or obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify"><U>Amendment or Waiver</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No provision of this Agreement
may be amended or waived by the parties from and after the date that is one (1) Trading Day immediately preceding the date on which the
Initial Registration Statement is first filed with the SEC. Subject to the immediately preceding sentence, no provision of this Agreement
may be (a) amended other than by a written instrument signed by both parties hereto or (b) waived other than in a written instrument signed
by the party against whom enforcement of such waiver is sought. Failure of any party to exercise any right or remedy under this Agreement
or otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify"><U>Miscellaneous</U>.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) Solely
for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to
own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons
with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from
such record owner of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement shall be given
in accordance with Section&nbsp;10.4 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) Failure
of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy,
shall not operate as a waiver thereof. The Company and the Investor acknowledge and agree that irreparable damage would occur in the event
that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It
is accordingly agreed that either party shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions
of this Agreement by the other party and to enforce specifically the terms and provisions hereof (without the necessity of showing economic
loss and without any bond or other security being required), this being in addition to any other remedy to which either party may be entitled
by law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws
of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New
York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each
party hereby irrevocably submits to the jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan,
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such
suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall
be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of
the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other
jurisdiction. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) The
Transaction Documents set forth the entire agreement and understanding of the parties solely with respect to the subject matter thereof
and supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, solely
with respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to the subject
matter hereof not expressly set forth in the Transaction Documents. Notwithstanding anything in this Agreement to the contrary and without
implication that the contrary would otherwise be true, nothing contained in this Agreement shall limit, modify or affect in any manner
whatsoever (i) the conditions precedent to a VWAP Purchase contained in Article&nbsp;VII of the Purchase Agreement or (ii) any of the
Company&rsquo;s obligations under the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) This
Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors. This Agreement is not
for the benefit of, nor may any provision hereof be enforced by, any Person, other than the parties hereto, their respective successors
and the Persons referred to in <U>Sections 6</U> and <U>7</U> hereof (and in such case, solely for the purposes set forth therein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless the
context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural
forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed
broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo;
and words of like import refer to this entire Agreement instead of just the provision in which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) This
Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a &ldquo;.pdf&rdquo; or comparably commercially recognized electronic or digital format, including
any electronic signature complying with the U.S. Electronic Signatures in Global and National Commerce Act of 2000 shall be considered
due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Remainder of page intentionally left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed by their respective authorized officer as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt; text-transform: uppercase"><B>Company:</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt; text-transform: uppercase">CAPSTONE HOLDING CORP.</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><I>/s/ Matthew E. Lipman</I></TD>
    </TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="vertical-align: top; width: 31%"><FONT STYLE="font-size: 10pt">Matthew E. Lipman</FONT></TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">[<I>Signature Page to Registration Rights Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the Parties have caused this Agreement to be duly executed by their respective authorized officer as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt"><B>INVESTOR:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">TUMIM STONE CAPITAL, LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD COLSPAN="2">3i Management, LLC, its Manager</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><I>/s/ Maier Joshua Tarlow</I></TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="vertical-align: top; width: 31%"><FONT STYLE="font-size: 10pt">Maier Joshua Tarlow</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Manager</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page to Registration Rights Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit A</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">FORM OF NOTICE
OF EFFECTIVENESS<BR>
OF REGISTRATION STATEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">SELLING STOCKHOLDER</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ea024508401ex23-1_capstone.htm
<DESCRIPTION>CONSENT OF GBQ PARTNERS LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 23.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%; font-size: 10pt"><IMG SRC="image_005.jpg" ALT=""></TD>
    <TD STYLE="text-align: center; width: 50%; font-size: 10pt"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 68.4pt; width: 324.6pt"></TD></TR>
  </TABLE>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B><U>Independent
Registered Public Accounting Firm&rsquo;s Consent</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-size: 10pt">We consent to the incorporation by reference
in the Prospectus constituting a part of this Registration Statement of our report dated March 31, 2025 related to the consolidated financial
statements of Capstone Holding Corp. appearing in the Annual Report on Form 10-K for the year ended December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">We also consent
to the reference to us under the caption &ldquo;Experts&rdquo; in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">/s/ GBQ Partners LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Columbus, Ohio</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">June 9, 2025</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %" CL# 2(  A$! Q$!_\0
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MPS';^&]6GM[CPEHNIW7B;1-,L+ZT?QWXD2R\-:M>Z!I4#W]Y[YX,_P""47[
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MA'\8?!_Q[^ 7PW\4?#2TOI[*;P1J?Q(T#P]XT\$>(([O4-1\$>)9YM'D2?\
MI+\(_LR? ?P-X&^+?PT\,_#70[+P%\>/&WQ<^(OQ>\*W<NIZUI/CSQC\=]3U
M'5_BYJ^M0:WJ&HDKXXU#5M1GU33+1[72(ENY;?3["RMML*_,_@O_ ()2?L#>
M [)K+1/@+'>L/%WP2\:P:KXN^)/Q=\>>)+'5OV;M>E\3_ ?3]-\5>-O'VO\
MB73O"'PLUZ>?4O"O@.SU6#P5;7,\[W.@77GS>8 ?">J_\%@OC5IOPN\=6E[\
M _@3H'[2WPO_ &T/B[^QUXM^'VM?'SQ_K'@[Q1JOPG^%&A_&:;QA\%;'X?\
MP"\9_'+XM+K?A3Q5X<L;CPWHWP?L[OP;<S:GX@\9W^C^&].-U+R?AW_@N9X[
M\;Z5\-?'_A3]E#38_A+_ ,.U;+_@II^T+XBU[XO_ &;Q)\,?AEIOBCXE^$_%
M_P .? GARR\#W4/Q)\>OJ7P[G?PA-?ZIX+T2_M+B>?7KG0G@B@G_ $V\<_\
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M\1/!7C+P_P#$0^%]>\-:?8Z+XFT&_P#%5YIGB>SL[3^W[;49K2VFBY_XL?\
M!)W_ ()X_&RT\#:=\0OV8O!UUI/PZ^#L7[/?AC1/#.M^./AYH:?!"TE-SI?P
MMUW1?AYXI\+:9XN\&:%J+/K'AO1O%EKK=OX;UZ6?7="&GZO<W%Y* ?%4G_!7
M+Q1\.OAA^T%)K/PHM?&_B+]EKQQ_P3&^#MYK5]XW31[GXJZO^W3X9^!$^M>,
M[NWA\-RQ>';GP=>_%F\O8](MH]0CUX:0P$VDI<G[-UV@_P#!2C]J;XQ']I+Q
M?\$?V8?A2/@'\+O'W[8/[/G@/XG>._VA[/0/B-??&W]E;0/%D<WB7Q+\'9_
MQ2?X9>+_ !UX3U30-*T[PGXN\0_$2QT>V'BW7?"UAHCSM:_5?CO_ ()2_L _
M$OXA'XI>-OV>=*U?QG)IWP=T^]OX_''Q0TC3=5;]GV72G^"^L:YX;T3QOIWA
MO7O%'PY@T73M,\.>+M9TF^\46^AQ2Z!/J]QHMU=6$W3Z=_P35_8?TK]H3Q!^
MU+8_L_\ AN/XU>)M4\:>(=6U^36_&5UX;/BWXD>')/"'Q$\=:=\-+KQ)-\,=
M%^('CSPM+/H/C#Q[HW@ZP\8>(=,NK^WU/6KD:EJ)NP#\0_AW_P %O/VI_A)^
MS-_P3^\:?M,_ WX=2_\ #0'[+GPN^.WQ&_:?\;^-_B#X$^!OB"Y\?>*3I%OX
M7M_&O@+]G_QC\/?A!\2U\&+:_$?Q)8?%Z\^'OPPTW^W=.\,^&O&.L"WN=0A_
M9S]M3]LWQA^S_P"(?V5/@_\  SX:^%OC!\>OVSOB7XE^'WP=L/&_CZZ^'GPG
MTJR\"?#'Q)\7O&WC#QKXYT3PKX[U9-,LO!_AF>/0M+\/>&-4U'Q!JNHVB6SQ
M6\,[MPA_X(R_\$VSX1\(> 3^SF3X)\$^')_!&E^%6^+GQRDT+5_A[)XNF\=V
MWPT\<:=)\2WM_B/\,M)\57$VI^'_ (=_$!/$O@[P['-=:7HFBV.CWU]877U?
M^T?^R'^SM^UIX%\._#KX\_#BU\7^&O!GB32_&'@>32]>\5> O$O@/Q5HUE=Z
M9INO^!?&WP\USPKXS\&ZG;Z7?WVDO/X;U[3/M>D7MYI-ZMSIUU/:R 'Y:?%/
M_@K!^TMX5U.;P#X&_8W^'7B'XP_!O]C#5/VXOVM_">O?M3^'K+PEX#^'>C>-
M/&W@H> ?@W\1/"W@7Q9I/Q5\?>(I_AMXWU?3M0U2R\&>#_#EI8:;I?C#5]+U
MW4Y+"Q\;\=_\%X/B#'JOC#Q=\&/V2=!^(GP&\&:W_P $\=-F\3^+OC=+\.?B
M1XE/_!1OP'X;\0?"W3=%\$?\*W\4:+IVH^#O$/BO1K#QI>ZYXMM=,CT66:^T
MDZA=P36D7Z1>-_\ @D9_P3G^(?@_X4> /$?[+_A&/PE\%?!%_P##'P'I'AGQ
M%X_\$;/AEK&L+XBUWX;^,+_P7XNT#4_B7X!\1^(Q)XB\2^#_ (DWGBSP_P"(
M]>N]1UG6]/O]3U34KJ[]6\2_\$^?V-_%U[X_O]=^!/AF>?XG^+OV>O'7CB.Q
MU/Q5HMCK'BC]E*WTFT_9[U"'3-$U_3M-T:#X8VFAZ3:Z+I.@VFF:->6UE%;Z
MWI^J0F1' /S!\-?\%@/VD/&?C'P#^SWX7_9-^%-Y^U)XE_;,_:\_8G\2:+J'
M[0VMZ7\%M!\<?LM?!;PM\=Y?'NG>/9?A#-XNUKP7XC\%^++)'TQ? %KXHMM4
MM9[2WL)@^^#R7XF?\' /BKPS^S#\//VBO"'[./PWU+5+?X<_'+QY\=_@SK_Q
MT\2W_P 3_#5W^SE\9=5^"7Q*T;X;Z)\+O@Q\1QK'A"?Q%X;\1ZEX=^.'Q,D^
M&'PFFM;6RTB_UNVU^ZFL+7[N_:!_X([?LS?''XS_  :^(D6D)X-\%^%OV@_V
MB_VG?C?X(T+5OB#IFL_&CXR_'_X,Z'\);GQY8?$'P_X\T/Q7\,?$GAY?"OA;
M6;>[\%7EA:R_V+'9VEEIYN[VXN/1O%?_  1[_P"";WC+PUX(\&:Q^S#X=MO"
M?P_^#VI?L_Z%X>\-^,OB?X,TN_\ @YJ^NW7BR_\  7C.#PAXVT/_ (6+I$OB
M^]O?&:R^/F\2ZC#XSO;WQ9#?1^(;RYU&4 ^.[G_@L9\6$^-.K:39?LL^%;G]
MG7PK_P %!O@-^P)XG^)<WQIN;7XEMXH_:0\#?#3Q5X)\;Z'\,Q\.Y]&NM'\)
M7OQ+T>R\<6=YX\M;J>VN()O#1U&2#4Q9?+6@_P#!;;XE_#'P9H/@3P7\&?&O
M[2/Q;N]3_;^^,GB2V^)OCC7)]<D^$O[,O[5_C'X)Z1\._AU>_!7]GKQ$-8\>
M^,M1LDTGX9Z9XK\*>%_!_A;1--TRP\>?$S4M5O1JEQ^Z47[ 7[(45IJ-@OP7
MTEK;5OV@_AG^U5J23>(_&]P]Y^T!\'=(\'Z%\-OB5-//XFDG.J^&-*\!>$;6
M#3A*- U#^QHY]7TG4+FZOYKKS;QE_P $I_V!?'GA[PYX8U_X 6D6E>%M:^,6
MM:4_AWX@_%?P=J\B_M!>,;CX@?&WP[K'B+PEXZT3Q#XB\!_$WQC=3:]XK^'7
MB#5-3\"7UZ8]OAV&*WMXX@#XRO\ _@L?XETW]L_X3_L^>*OV>K/X)_"/XM77
MP$T_P3\2/VC/$GQ%^%?B'XBS?';P!IWBR-_AS<K\'O$'P4F\4>!_%&LV?PSU
M;X0>-/C'X0^*7B#Q;::E'H.ANGV2.;]VJ^&O$7_!-G]B?Q9\9M(^/FO_  ,T
MN^^(FB^)?AWXUM0/%?C^T\!W7CCX1Z1:Z!\+?'6M?"2R\5VWPIU_QK\/M&L;
M+3_"?BK7/!>H:[H\5AIDEM?+<:5I<ME]RT %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\I?[?O[77[0FD>,
M?^"GGBGPM\8/''P9\(_";]I?_@FU^P-+X]\.ZT^CK^S?^S]\93X$^(G[1G[1
M^AB\\_P_H?C77?\ A=,/AJW^)NHZ:]YX6TKPUH4]C?6[:)'+%[CX[^-GP>_X
M)1^$?VJ[K]EO]K#XC?M6^,[6W_9)TR+]FC]I'X_^)OC#\,_V=O&/[27Q7C^$
M'@WXY>-/C9KZ^)?'7@OX<^,+O6H_$_CSPJOBR\BDMO#T.J:+IN@1^*+'44_8
M^T_8[^%\/QV_:/\ C%J%M:>(_#_[6'PT^&G@'XY_!_Q3X?T/Q%\/?&NI_"ZV
M\4Z!HOC'4K#5K6Z%Q?ZMX#\2Q>!?$FCW4-QHVL:-X<\.RS6RW5C(]Q8^&W["
MW[&/P=^%7COX&_"W]ECX!^ _@[\4/M/_  LKX9^&?A7X.TSP7X_%W;?8YE\9
MZ!!I(L/$R?9 +:%-9AO%MH (K81( H /QGUS_@JY^VOX:^(=S^RB_@[]DOQ9
M^TIX=_X*#?L[_L::Y\7_  VOQ2;]FW6/"_[2/[-OC_X^:/XKTSPTGBN]\<:-
M\2/AJW@Y-%\;_#J[\::K!>QW-A-:Z[I*:]!<Z7X]\.?^"VO[:,GA+X<>/?B?
M\+/V8KGP_P#%CX3_ /!5&W\*Z;\/XOBK!KFG?&G_ ()D>'O%&JWWB/6I-?\
M$EU:3_#7XP7OA>]@M/!5A"OB?PC:&SEE\;ZY/>RP6/\ 01X _8J_9%^%7A+P
M'X#^&W[-7P3\$>#OAA\2&^,7P]\.^&OASX7TK3/"'Q9:QU'2S\3-#@M=.C%G
MX[_LO5]2TL>*T)UP:;>36 OA:$0CB_B;^P%^RWX^^$'B7X2Z)\(/AU\-5O\
MP'^TGX,\#>+_  3X#\+:?XC^$M_^UAX9U_PY\;?&/P]E&G"+1/$OCH^(;S5?
M%=U;B(>)]0 ?6S=B23< ?AKJO_!=+]IOX0?#?7O&'Q=^&?[+?Q(U7Q__ ,$]
M_P!GS]N7X(R?!#Q?XXTWP5\.;GX[_&_X:?L^1>!?VB_$7B74/$<D?A/PYXH^
M*6D^-KOXF>'K?P];S^&/"OCW2$T%+S1X=7?V]_\ @K9^TU\+?BSK/[-GQH\,
M_LQ^+_B;\._V[/\ @GK^SCX\^+WP@O/'.F_!G5?A5^W9I?BG4UN=+T;Q-XFU
MC6_!WQB^'3^%I+>YTG7/%>O:%JVEZYX8\1"TM(]973(?U-_9R_X)U_L@?LS_
M  AN_A%X&^ ?P@DL?%_PP\%?"[XSZ]-\+_!%IJ7QYTGP;X2M_"8NOBM;6>C)
M8>)CK<"7VHZIIE[!-I4FHZOJEPMKYE[</+T.D?\ !/[]A_0?@AKO[-6B_LF_
M #2_@'XGUV#Q3XB^$EC\+O"5MX'USQ/:W5I>V?B75=$CTQ;:^\0V-SI]A)I^
MMW"OJ=@+&SBL[J"*U@2, _)NV_X*K_M7_%SXU^#O@'\ /"G[,D'B#XD?\%#O
M^"A'[&GAWQ]X]7XA^(?!^A>"?V./A7IWQ#T'QY?Z9X2\6:7?^(_%&KW9U;1M
M?T;3=5TO2KNZ6SBLKK0XX[R]3YAU3_@LI^UW^T9^SQH6D?#WPU^S7\"_B%JW
M_!,S]KK]L?XW>,?'/BCXA6VAW%S\$OB[\0OV:Y?!_P"SEJ^EZWHFI^&=>3Q#
MX0N_B%)XU\62>+(O!5IJ?A33+K1-2N;B34W_ *-O W[(?[+'PRO/!VH?#G]G
M;X,^!+WX>>*O&7CKP)<^$?ASX5\/2^#_ !G\1/#=OX/\>^*O#;:5IEK_ &/X
M@\9^%K6W\/\ B?5;$07NMZ3"EEJ,UQ -E<;XF_X)_P#[#OC/PS\.O!GBW]DC
M]GCQ)X1^$5SXMNOACX9UOX2>"M2T+P)+X]U*]UGQNGAG2[K1Y+/2[;Q=K&HW
MNK>)+.WA6SUK4[AM0U""XNU290#X.M/VPOB-\#/^"1W[!WQ@LO'/@[4OCI\:
MOA9^Q=\._#.M_''1_BK\4=3^(OQ/^,/@GPH;JTTWP;\+8G\=_%3XK>(XQKFJ
M:)X<;Q#X/T_7=6AN;OQ%XW\/:;#=WU?#WPR_X+$_MY_'>S^%?@3X:_#3]ESP
MG\6=:^'/_!2'Q/\ $77?B;HGQ6'A.TU7]@;XR>'?AI9MH/@CP]\09=<TIOB/
M#KL$6K^'=2\;Z\_@O4I;J_A\1>(+;2%TG6/Z%_'?[+W[.?Q/^#NC?L]_$/X(
M_#'QE\#_  W:>%;+PY\*O$'@[1-1\#^';;P,EK'X,3P_X?GM&L=$;PK%96L7
MA^;2XK2;2HH5BLI(8]RG!\%?L:_LF_#:YLKSX??LW?!3P3<Z9H_Q#\/Z;+X6
M^&_A70FT[0OBW>:3J'Q1T:P&FZ9;K9Z7\0K_ $+1K[QC86RQ6WB&\TRRN=4B
MN9X$=0#^?;QY_P %M?VT-4^$'BKXZ_!WX0_LRZ9X/^%/_!*K]DC_ (*7?$CP
M]\2KCXG:MX@UJX^.MSX[_P"$Q^#?@O5/#>O:+86$4%EX)OI/#'C?6]-OCI=Q
M!!!JWAS6EUD3:']2?$#_ (*]_$CPIK/[4&D67@SX3I?_  ?_ &_?^">G[)_P
M[T/5K_7!K_B?P-^V5HGP"\0^)]=U:QCUZTDO/&'AS2_BGXLN?#$ND0VFB36_
MA<75]87L-IJ/F?K+'^QK^R;#X8UWP5%^S?\ !6/PAXG^#OA3]GKQ%X93X<^%
MET/6_@5X%_M7_A#/A!JFFC31:7OPY\+?V[K/]@^$+B)]$TO^U+_[)9Q?:I=V
M3XG_ &%_V,_&OQ+@^,OB_P#9:^ WB;XKVUOX"M[?XBZY\+_"&I^,(%^%FIZ9
MK'PVEAUV[TJ6_CO/ FHZ-I-QX3U!)EOM"&FV4&G7%O;6\4*@'\\_[4O_  5^
M_:+UJX_:L^$'A.^^%UY\'OB+^S5_P5IL/@9\<?@MX=^-/@?Q9\//&O[%/P<\
M9:EINM^'_B]XYU;3=&^+7B?3];TZ;3O'%U\//AQX4\.?#CQM96D'AGQYXYM8
MUOY_TR^/G[:WQ6_9@_X)]_L%>-O!,7@OQ-\8OVG?%'[$_P"S?I7Q"^.>IZ[+
M\-/!'BOX^>%M+74OBY\7+K1M1TOQ!K6D:<;#4&DLK37M%O/$'BK6=%L)-:LQ
M?23'[,'_  3T_85'BCQCXU_X9$_9X/B[X@S?$&?QKXC;X4>#FUCQ,_Q9\/ZO
MX5^**:M?-I1GN;?XB^'?$&N:3XWM2XM?%%KJ^HC6H;U[R=W7]KC]CSPQ^U'^
MS%?_ ++VF^)D^$7@]T\%VNE1:/\ #KX8?$/PC#H7@:^T^YTKP1X@^%OQ1\*>
M*O 7B;P!=VFFVVEW_AN?2[">.T@M9-&U;2+RSM[F, _&GPG_ ,%8?VZ_B=XG
M\$? WX=>$_V,;_XT^,O^"EO[4G[!:?$!)?BQK_P0C\+?LX?LR>'_ ([W/Q4T
MZTTCQ;'XGO=8O[R;Q#8WOA0:S):6<UO;>&&UA+JSO/$TVIX$_P""O'[67CKQ
ME\)?$=EX!_9A3X1_M+_MC_M#_L$_"'X8PZMX^G_:8^'7Q:^#.E?%C3_#_P 6
M_C%IO]M)X?O/ .M^-/A/=WGC[P!HVA^'M>^'/P_\6^$-;;QOK]S=3H_Z7_L6
M_P#!-/X&?L?^#[2PDMM'^+GQ&@^.WQ)_:0M?B9X@^'7P^\'-X-^*?Q3\$Z5\
M,/$MS\'O!/@?0M)\+?!WPRGPPT/2_ %AX<\&V\$:>'4O;:\O+TZG>-)]$:!^
MQ[^RIX4^.VO?M/\ AG]G3X,:!^T3XGM[ZW\0?&O2/AUX6L/B5JRZK!;VNK37
M?BVWTQ-7DO=8M+2VM-9U 7*W^K6D$5MJ-Q<P(L8 /YOOA_\ \'$/QS^+?B'P
M9X$\#_L]> +3QG\9-$_9]^ WP>;Q!#XW70KW_@H1?^-_A#HG[8OP<U]X=8@O
MHO ?[.W@_P"*UQXQ6ZV:=K-Q9>#M2:XU+4$NRMEYAX+_ &JO^"CGC2]_9KAO
MOVAO!7B3XH:Y_P %]/VS?V;= /F>//#WPTF^&7PP\"?M"Z*G@?XF>&/#_B&R
MU3Q1\,_"VH^%+/Q-\._ T%WI5]=V>DZ#%XA\03:]/=>)HOZF-(_9(_9<\/ZQ
MX?\ $&A?L\_!K1]<\*?%?QQ\=?#.KZ;\.?"MGJ&@?&CXF6EQ8?$+XJ:1=V^F
M1S:?X^\:V5U<6GB;Q5;/'K&LV\K0WUW,FT"EHO[&_P"RCX<\:7WQ%T']G3X-
MZ/X[U+XM7'QZO?%NG?#[PW::[/\ &R\\/ZKX4O?BN=0AT])T^(%]X;UW6M%O
M?%43)K%YI^KZG;W-W*E]<B0 _/+X>?\ !23XQZY_P21_:@_;H\6^ OAI%\=O
MV7_#G[;&G:WX7\/3>)_^%2^+O'O[(/C'XH>"DU/3(M2O_P#A+M+\(>-;KX?6
MVJOI5UK%UK&D6^ISV*ZM=26\=W)\,?M4_P#!7_\ ;E_95^$OAOQEXFTK]C?Q
MA\4O#_[-OAC]KSXS?!CX?^!_VC?$-YX;^%?Q&\<:5X=\$:#JWCN^\1:!X)^%
M=A]BDUS1XOBCXDU7QEJ7C/QUIC:?H/P8TW1D&H7?]$EK^SO\"++X7>-?@E9_
M!_X<6WP?^)$GC^7Q_P##&#PAHD7@;QG)\5=0U75OB6_B;PREF-)UEO'NJ:[K
M6H>+6O[6<Z]>:K?W&H_:)+J9G\W^*_["W[&7QUU3P[K7QG_9:^ _Q2U7PGX)
ME^&WAR^\>?##PEXGGTGX?RH8QX,M6U;2[H#PU;;FEL-'D#V6FW+O=Z?#;7+O
M*0#^?37_ /@IS^W'\!_C?^WOIU[K'PX^+:^*_P#@IW^S'^Q3^S'X2O\ PEX]
M\36OP&L/B_\ LX:1\8)=>U'P3X3\0:%KOC[1(/"%D+"V\(Z%J7AW7_''QLU7
M5KB/Q3IOAN:PTNT_6OX._M$_$G]J3_@G'\6/B;\?/$K_ +"WC:PT;]H#P-XZ
M^-/A"\TF#3OASI/PUUOQ/X9NOC]X&'C&\\0+X1MIO#FD_P#"76N@>-[C4->^
M'FN"_P##^MS7^I>'VO;KZ?\ %W["O[&GC[4?BAJ_C7]E_P"!WBG5?C7HO@GP
M]\6]2USX<>&=1O\ XBZ1\-OLG_"OK7Q;=W&GO/K+^"386#>%KN[DDO=#:QLF
MTZXMVM+<Q]I!^RY^S?:_ >3]ERU^!?PJM?V<9M D\+3_  .MO WAZW^%MSX>
MGO#J-UI%UX+AL$T*ZLK[42^H:A%<6<@U"_EFO+TSW,\TL@!_)5X6^(WQLO?@
MOX%/P^_:2_:E\._L _MS_P#!5#]B7X"?!K6OBG^T+XEUS]J2S_9;\0?#[X@3
M_%_XG7GQ4N]:N?B9\$_"7[8/Q5\(:#+X$\,:KK&@^*-+\+WVI7FF6/AA?B!:
MZ9#UWC;XU?MJ>*/^"0GP=^+6@?M>>/\ 1O!WP2_X*#ZE\!M9\4[1K_Q>_:H^
M%OA?_@I-X?\ @-\&Y_$/QT@UJRU"P\,:7\/X-3T_QQ?:5I-]K_Q;U+2-*?6/
M$,&C77B"T\0?TB^%O^":W_!/KP/\./B7\(/!W[%W[,_A;X6_&4^&V^*WP_T#
MX.>!M*\)_$&3P=<WMYX0G\5Z+9Z-#9:Q=>%KW4K^\\.W5U$]SHMW=SW.FRVT
M[EZ]NF_9K_9\N/A%X:^ ,WP4^%\GP/\ !K>$G\)_"0^"/#P^'GAV3P%K>G^)
M?!<NC^$A8#1-/F\,>(]*TW7M%FM[..6PUFRM]2@=;R,34 ?@Q^W!JGBJ;_@I
M]\,/"/[.W[6W[2FO?M(Z7X\^ _QD^*GPPT3XGQZ'^S!^R9^QCX)%NOQ-\#>+
M/A%875EHOQ@^+/[8,D-[I/PZ\#ZWI_B'XE:MK^JZ7XBTW4_!?@OPIIM]>_>7
MC[]NGPK\;_A?\6/A[=>$OV]OV%-/U7X2_$74]9_:U^*G[+WB7X2>$_@-H6@^
M$]2UK7?'4WQ ^(5I/X0\.ZYI.D6=Z_AVZU.&?&N?8_L2/>BV!^E?&7_!.G]@
MOXB?&.3]H;QY^QY^SEXQ^.TOB/P]XOE^+_B7X1^"]9^(TGBGPE'ID/A?Q _B
MZ_TB?6WU;P[#HFD1:+?->&?38M,L8[1XDMH@OTC\3OA?\.?C3X"\3?"WXN>!
M_"_Q*^&_C/3QI/BWP+XUT6P\1>%?$NF"Y@N_[/UO1-3AN-/U*R-S;6\[6UU!
M+"TD,;,A*B@#^/+PO\0_C9JGP=^%MMX(_:*_:E\)?L _MW_\%6/V1_@G\&+[
MXG?M#^)M<_:FTG]E'5_A%\0]3^(WC?6/BS<ZY<_$[X,^&OVPOB[X*T75?!'A
M'5]:T/Q9HOA+4;\6-GX=_P"$^@TN#)USXX?$KXK?\$_?V;K'6?VQOVLO$O[6
M_BOQK^W1^S'^P%\./AE\?8_A5J7QV\9_"?\ :)\<>"?A3^VE^T'\6-.NM'F\
M1_#W]G#X=^$-+?QUK_CK5+GP+XGMX=0O+C2M?\8>++(3_P!0?AK_ ()J_P#!
M/KP9\-OB1\'/"7[%W[,_AGX4_&";PY<_%'X>Z%\'/ ^E^$O'MWX/N+N[\)WG
MBC1+/1X;'5;WPQ=W]Y=>'[VYB>ZT>YN9I]/EMY7+TGQ$_P"":?\ P3W^+>F?
M#[1?B?\ L5?LQ^/='^$_@VT^'GPQTKQ7\&/ FM:=X \"V-U/>VOA+PA97VBR
MVV@:!%>7-Q=C3=-CM[9[J>6XDC>5V8@'XP:S_P +2UK_ (*;_LZ?"WX5?MO?
M&GXQ?M-> _%7P'^(W[>%\OQ8M?"W[&WP7_9ID^#-KX>U3]GO2/@C:W5EX3\:
M?%;]JWQY:R?$GP1:VNC:W\2?#$&J?\)WJNK:%X<TK1(=1_3O_@D[\2O&WC'X
M%_&_X:^.O$NL^-[[]E7]M7]K#]E3P]XZ\1ZE=:SXB\6^ /A+\4=0'P]N]=U>
M]DFN]5U70_!NNZ+X-N]4NIIKS4G\,_;;^::_GN97]?T__@F=_P $]M'^)N@?
M&K1_V*_V8],^,'A/6?#?B/PK\3K7X,^!HO&WA[Q!X-ATZW\(:SI7B./2(]6L
M]0\,0Z1I4.AW-O>13:9!IME#920);0A/4OV4?V:O"_[)_P &M-^$GAK6M5\5
MW,GBOXA?$7QMXYU^"RM_$/C_ .)7Q7\<Z_\ $;X@^,];AT^.*S@NM;\4^)=1
MDM+&U7[-I.DQ:;HUJQM-.@H ^D**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **_"7X1?&[]I#4OBI^VM\7_%MU^TUXK^&G[.'Q[_:U
ML/#3:7X__9V\/_LY2^%_@EX2EU/PQ\.-8\%MHTGQTFN9;J-M)N->@BN(WUV6
M/5)[]]'A9:[6S_X*:_'.R\5:-X:U[]FB+6KGP_X;_9V\8?%JV^&3?$GQC;V.
MB_M0ZS=#P?:>$_&,O@33/ ]AJ7PZ\*"TUCQ=+\0=:\,VOCG6XM6\,^!%2>SM
M[R\ /VEHK\=] _X*5?$UV\&ZSXI^$WPOM_"7Q;^%7PT^-?PUE\.?%/4-3\1:
M5X1^)G[4/PB_9\T_P_\ $#3+WPO8PVGB/2]*^*MKXIN]4TB>;1+CQ!INH^"H
M4CFTV35[O"^)7_!5/QSH/Q$^)_P\^&O[/]S\1M4^#FL?'[4O% T0^-_$<?B+
MP=\"O%7AOPA+HNC7_@WPAKNE>$?&?B75=4UN.^UWX@7>C^ ? L^C:?9>(-5F
M?6Y9]' /VEHK\2?CO_P49_:&T+P?\>=8\ _#/X:^%]'TB[_:S^$'PH\4^)/%
M>M:AXST;XO? 7]FOQ3\?M&\8^-_!/_"*R>'#X1N8O"VK^&[_ ,.VFOZAJMIK
M=KIU]-)>Z-?7EM9?L!\--2\0:S\.? .L>+&TQ_%&J^"_"^I>(WT4W#:0^NWV
MB6-UJSZ6;J*"Y.GM?2SM9FXABF-N8_-C1\J #MJ*** "BBB@".2:*+'FRQQ[
ML[?,=4W8ZXW$9QWQTJ/[7:?\_-O_ -_H_P#XJN-U/3-.U3QK8PZG86>H11>%
MM2EBBO;:&ZCCD.K:8ID1)D=5<K\I90&*\9Q6Q_PB'A3_ *%K0?\ P4V'_P 8
MH VOM=I_S\V__?Z/_P"*H^UVG_/S;_\ ?Z/_ .*K%_X1#PI_T+6@_P#@IL/_
M (Q1_P (AX4_Z%K0?_!38?\ QB@6O=?<_P#,VOM=I_S\V_\ W^C_ /BJ/M=I
M_P _-O\ ]_H__BJQ?^$0\*?]"UH/_@IL/_C%'_"(>%/^A:T'_P %-A_\8H#7
MNON?^9M?:[3_ )^;?_O]'_\ %4?:[3_GYM_^_P!'_P#%5B_\(AX4_P"A:T'_
M ,%-A_\ &*/^$0\*?]"UH/\ X*;#_P",4!KW7W/_ #-K[7:?\_-O_P!_H_\
MXJC[7:?\_-O_ -_H_P#XJL7_ (1#PI_T+6@_^"FP_P#C%'_"(>%/^A:T'_P4
MV'_QB@->Z^Y_YFU]KM/^?FW_ ._T?_Q5'VNT_P"?FW_[_1__ !58O_"(>%/^
MA:T'_P %-A_\8H_X1#PI_P!"UH/_ (*;#_XQ0&O=?<_\S:^UVG_/S;_]_H__
M (JC[7:?\_-O_P!_H_\ XJL7_A$/"G_0M:#_ ."FP_\ C%'_  B'A3_H6M!_
M\%-A_P#&* U[K[G_ )FU]KM/^?FW_P"_T?\ \51]KM/^?FW_ ._T?_Q58O\
MPB'A3_H6M!_\%-A_\8H_X1#PI_T+6@_^"FP_^,4!KW7W/_,VOM=I_P _-O\
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M_P!"UH/_ (*;#_XQ0&O=?<_\S:^UVG_/S;_]_H__ (JC[7:?\_-O_P!_H_\
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M[:&XTRRFBM]2LE"66H01R0LD5]:(JI:W<:K<6ZJ%BD4  <?XJ^$?P^\;>./
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M: 6YXP  .!MP*^A?VTX8D_95^/+1QQQM)\//$)D9$"EV-FWS.5 +-C')R<#
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M1J7A=M5OKW4=$\007D/(?$7]IG]D;Q)\<?@[\3].^ OQ4^)GQ(U7XKZCX/\
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MN+::3Z&\<_MR?L#?"**4>./CC\&O"":5\2O'7P8NX+CR%DT;Q_X)T_0C\3=
MU&UL-,GFT>P\':5JWAL^/O$-]%:^%?#>GW^C_P#"1ZS96T]IN_(FP_X(U_M*
M>(?&'QC^%WQ._:%T?7/AZ?V,/^"=OP?^ ?[1NC_";P?X;O/#7C7]A+]J/QQ\
M;? WA7Q/\$['QW?W'BNSM+33? M[XU\17GB'P_8>+&\6:[I7AE/#4.D6EGI_
M9^.?^""M_P".]2UKQUKG[6JZU\5_'/Q"_:R\0?$G7M=^!1;P#XF\"?MA+\-I
M?B#X&M/AIX=^,'AR.WF\-ZA\-K*3POJ6O^)O%/A[5-'U.\T+QYX+\70I%>4
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M(SZL0XG\2:]9V:3>*O%U^TI,LNJ^,/%%QK'BC5[B9FFN=3U>[N)F,DKD_0%
M!1110!R<G_(]6G_8IZC_ .GC2ZZF0R>6YA"M*%8QJ[%49P#M5W"NR(6P&949
ME&2%8C:>6D_Y'JT_[%/4?_3QI==90!ROVCQK_P! GPS_ .#W4_\ Y04?:/&O
M_0)\,_\ @]U/_P"4%=510*R\_O?^9ROVCQK_ - GPS_X/=3_ /E!1]H\:_\
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M@++S^]_YG*_:/&O_ $"?#/\ X/=3_P#E!1]H\:_] GPS_P"#W4__ )05U5%
M67G][_S.5^T>-?\ H$^&?_![J?\ \H*/M'C7_H$^&?\ P>ZG_P#*"NJHH"R\
M_O?^9ROVCQK_ - GPS_X/=3_ /E!1]H\:_\ 0)\,_P#@]U/_ .4%=510%EY_
M>_\ ,Y7[1XU_Z!/AG_P>ZG_\H*/M'C7_ *!/AG_P>ZG_ /*"NJHH"R\_O?\
MF10&<P1&Y2*.X,:&=(9&EA24J/,6*5XXGDC5LA'>*-F4 E$)P):*HW.HVUK>
M:=8S%Q<:I)<QV@5"R%K2V>[F\QQQ&!#&Q4M]YL*.30,O5S4\_B\32BVTSPZ]
MN)'$#S:UJ,<SQ!CY;2QIH<J1R,N"R++(JMD!V&">EHH Y7[1XU_Z!/AG_P '
MNI__ "@H^T>-?^@3X9_\'NI__*"NJHH%9>?WO_,Y7[1XU_Z!/AG_ ,'NI_\
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MM#OO% NMD?JGPM_X)F?L]?#SQ7X[UG4]/UGQAX6UOQ/H^J^!/AEK'BOQU/\
M#7P'H^@_L_>#?V==)@D\#WOBV_\ "WBCQ?8>!_#VN:=:?$'6-(?Q-!IOB>XM
M5NOMMC;ZFWI?@#]@3]F+X<:_X4\5Z'X2\5ZGXF\#IX MO"6N^+_BI\4/&E]H
M&E_"FS\>:=\--!TT>)_%^IVMMX?\$Z;\3?&]AH>C1VPL$M]=G-Y#=SPVLT(!
M\GZU_P %8_AOX?3PCKFI^&O$VF77Q+\'?#N'PG\-O%4W@[PM;Z+\1=;\?_M"
M^#O&FF^*?BA)XAU#0[+3?";? +Q=)J6IPV-YI=S9:?HUWX;FUN[\2?8+'O\
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M[">QU'0)[.];2_&7C#PW=WT%S>>%_%7B#P_/INIW(!]+T444 %%%% !1110
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M=>$O#7[*GPD_9KTZ_D\0?'_]H'X;RV-C\3[W1KRTT?4-8T;Q%X\\!^,=-N=
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M-,T/3=(TG3;+4=::]ETS3K+3;6*QTS[):E7DB>63V&@ HHHH **** "BBB@
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MZ:WU:!8P#] U\ > TU7Q)KB^"?"*ZWXRL%TKQ=K"^&]&&J>*M+2 VJ:;XDU
M60N]<T];8FW6SU2:ZMU@)A$?EG;2:+\/? /AK5Y_$'ASP/X0T#7KG2-.\/W.
MMZ+X:T72M7N-!TB"WMM)T2?4K&R@O)=(TNVL[2WT[39)FL[*"UMXK:&*.")5
MZ^B@ HHHH **** "BBB@#DO%W^K\._\ 8VZ!_P"E+5UC=#]#_*N3\7?ZOP[_
M -C;H'_I2U=8W0_0_P J:W7JOS0UNO5?FCR;X(8_X5OI.>?^)IXMXQG_ )G'
M7_\ /M5WXQ?"+P#\>?AGXP^$GQ.T2/Q%X&\;Z3+I&NZ7+)+ [Q,\<]O=6ES"
MR3V6H:==PV^H:;?6[K/9WUO!<PLKQ+7FGPE^*OPST/P19:3K/Q#\$:3JECK/
MB^"^TW4O%>A6-_9SCQAKI:&ZM+F^CN+>905W131I(F<,H/3TD?&GX0<G_A:G
MPY)[9\:^&@1Z\_VC[],>OH:V:K0K>TIQJQG"HIPG&,TU*+4HRC)1W32:?<[I
M_7,/CI8G#K$4JU'$^VH5J4:L9TZE.HITZE.<8>[*,HQE&2;V6ZO?\QOAQ_P1
MK^"'A+Q=X!U/QO\ &'X\?&GP!\)M6&M?"WX._$KQ99ZE\._"=]%<)=VI;2;/
M3;5=0@M+B**6.R1;&QN/)CAU"VN[8/ _U^_[%_@.3]LR#]M0^,O'R^/;;X?_
M /"NX_!:ZCI2_#PZ7]C>T_M!M+_LG^UCJHCD+><NLB#> ?L^T;:]Y'QG^$ .
M?^%K?#CGK_Q6WAS_ .6)_E1_PNCX09#?\+5^')/0?\5KX;!].?\ B8D#KWKK
MJYAF=>4I5:M:;E2J4&G!*/LJC3JQ48TE%.HTG*2BIR:UFWJ>QC.)^*LPJ3JX
MS'XZO*I@L1ETE+#PC3^J8MPGBJ<:5/"0I0EB9TX5*]:-.->K.*G.JY7OXGI7
M['?P_P!*_;"\3_MGGQ%XOO?B+XE^'=E\-#X<NY]';P;I.B6?]FE;O2K:+1X]
M:CU.?^SR9I+C6KBU8WEWMM5W1^7];LA*E5;:V&"L5S@]B0". 2#C(SGMFO-!
M\:?A ,$_%;X<\]O^$U\.?TU$@>_^-'_"Z?A #Q\5?AUCT_X37PU_342/?IZ^
MF:Y:L\56=-U55FZ5.%*G>#?+3IZ0@DHK2.OWN[;/(Q>)S/'2P\L8\17>$PM#
M!89U*4[4<)A4U0H04:,4J=-.5DTV[MR;;/GOX'?L8>&/A=X)^/\ X?\ &_BJ
M_P#BSXI_:<\7>-/%'QB\<:II5OX>O]?M?%=G<:-8^&;.QL[N^72]!\)^&YET
M30+:.\E-M$)[E2DEPR+XA^S7_P $T=&^ OQ2^&_Q%\2?'+QW\7['X#^"?$/P
MZ_9[\)^)M"\-Z)9_#/PIXGG=M4CO=1T.!+SQCK'V%AI5KJVI"T^SV $0M7\J
MU-M]Z?\ "Z?A!_T57X='U/\ PFWAH#]=0S_]?-)_PNGX0C_FJOPY_#QKX:/7
M_N)>I_F>U=/U[,DJ\54K<N(2C57LE9I4U22A^[O37LDJ;]GR7I^X[Q=CTEQ!
MQ(HYA3CBL4HYI",,;'ZO'WX0PT<%&-+_ &:^%2P<5A+89T$\->@U[-N+]/';
MG/'7CG/MCC%?C9^U3S\>O'G.>?#//_<G>'J_43_A=/P@'_-5?ASD]QXU\-X_
M$'41C_/T'Y.?M+>+/"NM?&SQMJ>D>)-"U73KD^'?L]_IVL:?>6=QY/A/0K>;
MR;BWGEAD\J>*6&39(VR6-XVPZLH,OA.-6;E":_=M?!+^:/DA9!2K1Q=5RIU(
MIX=I<U.<?^7E/2\J:UTVO?0^U?B/X%_9"\/_ +0-IX]\?W<>F_&OQ!XK_9]\
M5P2OJGBET;Q'H6I^//@/\!Y[JRTT3Z/IPUC6_C5XT\):1;7RVT'B"_OKN[N$
MN(_#<MWIW4Z-^QA^S?X?&FS:;X7N+=?"]_X+U&UD?Q3K<B6%Y\./C?XB_:1\
M,O<M+J++C3?BKXMUKQ'/'<DK<V=W'I5V)-)A@MD^0/C/\#?BMXX_:9^.^B:"
MX@U#QYXT_P"">_QI^'OB/46:#3-*\ _L^?$^\7XG66G7KP/;W&O>!-6\SQK!
MX:EF@EU27QUIPLW4WEY-!\@_#G_@G/\ M,Z#\'_&?A;QCI/CS4]?3P5\!/#?
MBFVT/XK_  $TFT^-_P 0_AM\56\9>*?C%8Z$?A7<>&/B'J%Y;I=ZA./VH[X:
MM\3])\2:AX \>6NFPZ9IOB=/./GC]9]1_83_ &:]9UKQW=:OHGBG4M#^)H^(
M.H:U\-+CXD^.$^&,.N?$^XCN_B/XS\.> ;;7[?1=$\5^)=4E76KKQ!IEO%=:
M/XBN[CQ'X>;1=>U*\U&Z^4C^R;^RIX!^(7Q)\,_%'X]^.]6\8>,_V@?AC\1/
M!US+\7OB1;_&WPGXA^+_ ,"M._9TT_PUXE^(&F:_/XDU/0_C%I'PA\;V%O;7
MYTKP[%I-@UG:0V>H:#:ZR?!/A1^Q7^UGX4^,/[+_ (_UCX<> K35/!8^&6F^
M,KY/$_AC5?AIX.^'7A'Q1\3FU'3O#?A9[E?B5\)?BY;^!/%.FV\FF?!?QIXQ
M_9_\=>*;Z:R\2^'-/\+Z%I\A]G_:7_80\2?&;]K_ %CXA/\ "/P'XH^&?CW6
M?V%];\;>*]4U_3K*_O\ 2?V;OB%\<]2\>>#/$.@/&NK:S#>Z-X^\#ZKH\,37
M&B:U!HE]HVK?9WMX(+X ^N/!/[!?[-7PSU?P9?\ @32_&'A+2/"UAX.LM,\#
M:-\3_'%C\/M?U;X?^ [7X<^#/%/B;P?%KRZ3XL\6Z'X!TK3]"CU;5HKQM2M=
M(TO4-:@U/4]'T[4+2]=_L*_LX7=CX#TRV\/^(-*G^%G@[X)>"? FH:'XW\3:
M9K?ACP]\ ?&5UXY^%JVE_;:FMP]QI>NW&I)?7EY]IDU_3+V_TG5C>V4KQ+^1
MWQ@_X)^_M?:E\._#_P ,? GP_P#"!@\%Z!\4;/X.>*=.\>^&_P"U_AG?7/[8
M'C_XH_#_ $B7Q)X^&MZO\._#.A?!F7X<67@O4?@?X<7Q]%J6G7'@7Q/XLT3P
MEH>BLOW!^SK^QK\0OA+\<?A1\8KG0=$TG7[[5OV\6_:!\2V'BZ[U#6O&NB_%
MSX]6?CW]G6PUH2LX\36OAOPG;E=.L)MMO\/7:?2-'6*"]O/M !^JGF1F0Q"1
M/-5%D:/<OF+&[,BN4SN".R.JL1M9D8 DJ0&-<0)&TSSPK"C,CRM(BQHZ2&%T
M:0L%5EE!B9205D!0X88K\&/CC^PQ^U!XVUKXZ6O@?P=HVD_$+Q;XR_:U\91?
MM2I\79=+UGXG?"GXR_"'QWX0^%/[-=UHL&[Q3H=MX2USQ+X TV<ZI#;>"/!E
MI\(=-\9>#M0N_$6MM:6ECXO?\$]/C)IGB;Q!;_"#PCIT?[/=K\=/ WQ.3X >
M%M8^&]Y8>-XG_9@F^%WB?68_"?QMTS6_A7_:>D?%3[%XJU'3?%L,2>(I5F\>
M66H#QOIM@;\ _>6BO _V6OAWXN^$G[.GP9^&GCS6M:U_Q?X*\ >'] U_4_$/
MBB'QMK+7UE:(ILK[Q=;^'O"D/B2328C'I*:S'X=T@7T-C'/]D4N7?WR@#DY/
M^1ZM/^Q3U'_T\:7765R<G_(]6G_8IZC_ .GC2ZZR@ HHHH **** "BBB@ K^
M6;_@L!_P0G_:S_X*9?\ !1+]G']I_P"'W[6?@O\ 9R^$GP3^'WAOP=9:SH-K
MXTN/CSX(UG2?%'B[QCJOC'P!!IEOI?AVXUJ_U'6-'LM)N[GQIX>N=&^PG4R]
MX]K;V,O]3-?RO_\ !8+_ ()Z_P#!5BT_;A^$7_!3?_@E;\5M4\<>,? FDZ5I
MGC[]D?QW\3M0T?X>Z]=Z'HFI^&7U;0/"?B3Q1X?^'>L:+XR\(:@V@>+_  ]<
M:IX8UBSU:VMO%GA_5)=:O9KO2 #\D]7\8?MO_P#!NM_P5Q_9#^ GB']M;XO_
M +9W[&_[:6J>$=,\1>'OC7J^N:YK6EP>+O'EE\-O$6K6VGZ[XA\3KH7C7P+K
M>H:-XMTS7_"^H:;:^+-&N9O#VM:;N>Y>/_0,K^++X%?\$O/^"K'_  5#_P""
MEGP(_P""A7_!8KX??"_]G#X8?LIMX;O_ (3?LW^ M:T37[K7M9\%^(Y_&/AN
MP:UT+QA\0H[#0[KQN]OXI\::]XH\87FLZY:Z=IWA33-%M=*87.C_ +0ZO:_\
M%BS_ ,%E=$N=)NO#0_X)%CPA"-:MGD^$7_"0GQ3_ ,*<OUE*)+$?BUN_X6_]
MA8>3*+#[!N(_XEF]: /MK_@H!\+_ -KSXR_LP^-OAQ^PW\=O#/[-G[0OB'4O
M"T>@?&'Q5I)UNR\+>'[77[*]\7)96'_"/>*%;5M9T"WO-%T^Y.DL]B]^][;7
M=C=P6]U%_)9_P;?^)_#G[#W_  4N_;8_X)I?M6_"^:X_X*,^,]7\3>,O$W[6
M:^/]7\=V?QQT?18H?B8_AR&SUW3M.OO#T&M^'/$S?%>TUU#/J/C1WOU\90Z9
MJF@Z'9#V7]H3]@G_ (+B?\$W_P#@HQ^T!^VQ_P $LX?#G[9GP4_:<DU>Z\0_
M ?XU_$)]1N_ 4_B776\57GAUM&\=?$GP!(-%\)^*YM1O/A[KW@?QM;S:?X9U
M*7PKK.AK;PF74O<?^"+_ /P1\_;:\*_MW?&C_@KW_P %3M9\)6/[5WQ5T[7]
M-\#_  B\$ZEI6LVW@H>+M)TKP_J^O^(=0T"YU/PYI2Z)X)TZ#X?>"?"&@Z]X
MC%CH,^H7FO:Q)J:6D5 &I\3_ /@V%C\5:_\ &OX2?#S]OGXJ_"?_ ()W?M)?
M'VT_:0^-/[&^E?#3P?JMU>>.;/5+75SIOA'XLWNHQZIX?\/">RLX=.AFT&]7
M3[72_#_]IVOB.\T"SO6^,_!_[4/[/OB7]L7]J;_@LM\7+#4I/^";'_!&#P/I
MW[#'_!/?P;X<M8M4B^(GQA$.F^!?$7BGX>VVI26NF:EJ=TVJ6>B:%K=U>PVL
M7A_Q)X!UF\U"$^";F:#^BS_@L]XS_:^T3]A#XF?#[]A7X0^._BM^TC\?9+3X
M%^$[WP3!$L?PJT/X@0W6G>-/BOX@U:XGMX=#L?#7A==2L](U42F:P\4:OH>H
MB-K2PO7B_/']M3_@B+K\_P#P;_6?_!,/]E%-$U+XK?##0?AQX\T\WMQ9Z%:?
M&'XN^%_%=IXX^)LUUJUZ]G::=J'C_5;SQ0_ANXUF>.QTZ9O#NCWUY9:5:&[M
M #W?]AC_ (+JZ3^U#^U'X"_8_P#VA?V.?C/^Q#\9/CC\&;/X_P#[.%I\3_$O
MASQCH/QH^&5]IFHZY;W^G:IH=AHUQX?UNZT+2-8U6TT6_P!/N<IH>M:??7NG
MZS:6^FWO[Y5_&_\ L>?LO?M__MI?\%8_V"OVT_VC/V,/&_[$?PH_X)W?L<Z5
M\#-:'Q-\5^&]6UOXO_%*T\*?$+PW,W@32]%F-\WA:?4/'TVI)?W=LVGVNCZ(
MT<NJSZIJ=M91_P!D% !1110 4444 %%%% !7):W_ ,C+X+_Z^]<_],=S76UR
M6M_\C+X+_P"OO7/_ $QW--;_ "?Y,3V^:_-'6T444AA1110 4444 %%%% '^
M?3_P>7?$^?2OVN?^"97@_P 2Z)J/C/X:^#M%\7_$_5_A[97)@'C*XU3XF>"]
M+UW1(=UM=1)J&KZ#X/BT2TN9+6[, U.3%LZN\<WO_P"U)_P53_;Q_9K^('[*
M?C;_ (+B?\$F?V0)_P!A_P"*GC2(_#;^R=#TCXJ_$3]G'4=1TJ(F"]_X23Q+
MXU\.#QWX>\(3_;M?\*S^%/"<OB>PTG5;?0M0TN[T:ZTJT^H/^#L+_@G5\?/V
MD?AG^S-^VG^R_P"!=8^)WQ(_8W\1^(KCQMX"\-:9<Z]XGU7X;ZY?^&_$]GXG
MT3P[91S:AXA7P/XF\)J^M:/I<%UJ4NB>)+W5(;<VNC7I/XW?\%(?^"E7QD_X
M.1? 7[)O[ /[(O[#_P ;O"/Q7T[XO:%X]^/OB3QE86\WP_\ AOXDL/#.M>#[
MU8?$5@\YTKX>Z*OB;7M?UKQ1XZB\(ZR+;2]/T6P\/7VJ7A20 _T<?#^HZ+K&
M@Z)JWANXLKOP[JFD:;J.@W6FA!IUSHM[9PW.ESV B58A9S6,D$EJ(U5! T85
M57 K^-#_ (.:?V4?^"B'[77[;'_!-K3?V0/V7?%_QQ\&_ ZXO/'3^(+S3XA\
M&+#XG>)?B+X:OAI7Q-UZ35]'M]"\.VNA?#+1I_$6H:CJ&EVXTC5VL['41J-U
M'"WZG_MM_P#!2_Q]_P $L?B9_P $X?V,/!?[+OB3]H[0?C3HOP_^%&N?%+3-
M=UW1;;X=VOAWQ#\/_A4-;U&PTSP3XIMKYI;+5I_$3P7VKZ,!'8/"TWER/<Q>
M _\ !:_]O[_@JE_P37_:8_9Z_: ^#7PNB^.W_!-6YM]$@_:$\'^"OAO::W\1
M/#NMZ;JFIIXMLM:\:1V^J:IX0TWQ%X8N]*U3P1XFDL;;P_#XBT?4-%UN\@2>
MVCU  ^(_"/\ P6N_X*S_ /!./]O'X%?LO_\ !:OX5_ FZ^$7[4FHZ79>!OC#
M\#[:WL[?P.^M:_;^%EU>RU+2=4NM/\0^'?"6OZCI=IXZ\.^(=%T[Q=I.CZA;
M>)+#6-2M6LK+6_HK]LC_ ()__P#!2_\ 9W_X*8?M@?MS?\$]/@I\*?VF_"/_
M  4 _9<;X!>/O"'CCXJZ/\+_ !!\%O'LOA_PIX8M_B#&_B:2WL/%'AVR;P?I
M_B$:997;2W_]J:OHMU'HZV6FZG=_CU^U1\9/B)_P=&_\%"OV&/"7[*'[-WQL
M^&?[)?[+>L7OB'XN?''XM>';'0H]+L/$WB?P9KOQ#EFOM$U'7_#-MJ,>B^!-
M*\.> ?#5MXDU/7]?\27]U?W5AINBV]U=V?\ H!_&+XM^ ?@'\)_B/\;/BGK]
MKX7^''PG\$^)/B!XW\07CHD.E^&O"FDW6L:K<JKO'Y]S]EM)([*SC;S[Z\D@
ML[97N)XD8 _AL\6_L@_%WX#_ +*W_!.O_@V<\(^/[&_^.W[6OCC7OVFO^"AW
MC/X?WMQ=:'\)OV;K+QE/XR\1^'['4YQ9S&UU(^'HM(LM0O+6QM_$FJ> (;-[
M:+3?'EK!)_3#^SY_P5O_ ."047Q1\#?\$_?@%^UG\'8_'7@2#1O@M\.OAOHD
M7B>R\)23^#K&W\,Z)X#\&_$.]\/6WPV\2:I!#I]OI.E:?H7B[4;G6+U%LM+_
M +0OV:&OR?\ ^"4?P$^-W[87P-_X*;?\%?\ X@:-J.F?M-_\%*_A]\;/ '[(
MVAW5Q+%JOPL_9R\.^$M?\(?!K0-"NY9E;2W\2^(=*\/&2[A,,&J6/@KPUXIM
MW0Z[<M)_+3X9\6?#+XI?\$S/^"7'_!.;X+>#]7;_ (*A?#7_ (*8^-=6^(7P
MST_X:^(M"^+'@FVF\<^,9X_$/B7Q!-H%G)9:?:Z9J?P]@U&2XU7S-$A\%7-Q
MJ\.GV?@\W%L ?ZN-%-0,$0,06"J&(& 2!@D#)P">0,G XSWIU !1110 4444
M %%%% ')>+O]7X=_[&W0/_2EJZVN2\7?ZOP[_P!C;H'_ *4M76T 94FAZ--(
M\LNE:;++(Q>222QM7D=VY+.[1%F8GDLQ).3D],-_X1_0O^@-I7_@OM/_ (S_
M )R?;&O13YI?S/[W_F5SS_GG_P"!R_\ DC(_X1_0O^@+I7_@OM/_ (U1_P (
M_H7_ $!=*_\ !?:?_&JUZ*?-+^:7WO\ S#GJ?\_*G_@R?_R1D?\ "/Z%_P!
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M\>BW?AKQA:+\.-,\/:1:-#\0W\4_\(S(UE'R.B_\%!_C-\?/V>?C3\=OAO\
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M!-._^0ZXW4/^/^__ .OV[_\ 2B2JE;V79?<C"[[O[V=[_P +/\=_]##/_P"
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MM%>&/BCXL\,6$5Y\0-&\1'QYKFHWH]G_ &DOV)_&'QI\=_%/4_"WQ+\+^%O
MW[1WPY^$_P *_CMI?B/P-=>*?%UCX:^$'B_Q;XGT?4?A#K\/B/2=-\-ZYKMC
MXXU_1+\^(]&\066B:E'HWC+18EU73[BQU  ]X_97_:A\)_M:>#/&GQ&\ Z-?
MV'@CPY\6OB3\*M UG4=2TBZG\72?##Q+>>#]<\21:7IEU=7?A[3[[7M,U'^R
M-,UX6NMSZ0MAJUW8V2ZC%;Q_3=>*_L__  EG^"/PU3P!<:]'XDE7Q[\8O&AU
M6+3Y-,0I\5/C#X[^*<.G?99+W4'+:'#XS30Y+QKDG4I-.;4/)M!="T@]JH *
M*** "BBB@ HHHH **** "BBB@#F/&WC3PK\-_!GBWXA^.M=L/#'@GP)X:UWQ
MCXO\2:I(8=,\/^&/#.F76LZ]K6H2JKM'9:7I=E=7MTZH[K# Y5&;"G\_/V?O
M^"H/P@^.=Y=77B+X0_M'?LV?#R]^$;_'WP%\;/VFOAM9_"_X+?$7X,)=Z/:-
MXVT_XBMXDU?0O!4IB\0:+K,7A+XJS^ O&5QX;U6RUZVT*:S74/L'VA\?/@WX
M6_:)^!WQA^ 7C>74+?P=\:?ACXY^%?B>YTB9+?5;30O'OAK4O#&IW>ESR1RQ
M0ZC:6FIRW%C)-#-"EU%$9898PT;?C_XB_P""</[>_P ;/V3OC1^QQ^T3^V-\
M&;[X1ZI^QGK7[)OPDM/A=\"]4T2\\3>)C!H=CX4_:(^.UUXE\6:U?Q>+-%T7
MPQI^BS?#OX9:AI'@Z=]<\3ZV][/.^C:?I8!^M?C?]IG]G#X9G6E^(WQ_^"G@
M)_#E_%I/B"+QE\4_ _AF;1-5N/#<7C&WTO58=9UVRET_4[CPC/!XHM]/NDBO
M)_#TT.M0POILL=RU;0?VIOV9/%/]J_\ ",_M%? OQ"-"UKP7X;UHZ)\6O .J
MKI/B'XD2I!\.]#U%K'7YUL]7\>W$B6W@S3IREWXHN2;;0XKZ=6C'Y!^&O^"3
M/QR\7_M4:'^U7^T3\1OV>/$FNW'[2$/Q[\8?#OP3\-_%$_@@6UC^P=JG['FD
M>%]#'CO5-;N]0NM,UFXT_P <C7]<B5Y[>":V@T[3KI;3R/$=)_X(1?$KP5\+
MO@[H'@+XN?!>P\=_!/\ 9?\ ^"=OPTTF6]^'WB"R\&^.?C7^PG^U3XY_:-O/
M%_C:/0[ZTUIO"GQ/M/%L?AB:[M'G\8:)>P3:RT]^K+9N ?M=XU_;<_9V\"?%
M[X6?!O5O'6F7FL?%6W_:.EMO%>C:KX=U'X>^ [C]E+2O#>K_ !LTOXI>+EUR
M.S\"ZMX3M_%%C!>V&JQF>PO;74[;6ETEK)B_+ZO_ ,%&_P!BK3O%7P$\&Z9^
MT1\+_&>M?M,^*O'G@GX-/X#\9^&O%VC>*?%/PW\*R>+?%.BOXBTC5I]!TK4+
M>T;3=+LK/4M1MKK4O$&O:#H]E#-=:E$%_+6\_P"".O[2UWIEYXALOVD?@_X:
M^+^H^,/^"LOQ%E\2Z7\)=1USP;I_C#_@I ?"%WX<6Q\%>,-3UVSU'0_AQ>>'
MKZTUZS\2R:T=<L;VVN85DNX)(Y<[X,?\$8?C?\+?BOX%^-5U\3/@5J_BC2/V
MQ/B9^T;XB\.ZEHWQ-\6:=;>#_C1^QUX(_9:\9>'/#OC3Q?J^H^,+_P :>%=1
M\%0>/O"/B'6?LVD:C>7PM+G1_#]MIMA:H ?M-\+OVL_@-\5/AKX:^)VG_$;P
M5X:TWQ!9_#9[W0O%'CWX>Q^(?".N?%RRTR^^'7@[Q8F@>+M?T2P\7>,$UC2X
MO#&D6>MZC_PD\U]9_P#"-7&L17=K+-Z)X%^-?P<^*&N>,_#/PT^+'PV^(7B/
MX<ZK_87Q!T#P1XX\,^*M9\#ZT)KJV.E>+=,T/4[Z]\.Z@MU8:A:-9ZM#:3K>
M:?J%H8Q<V-U%#^)OP%_X(FWGPH^(/_!/[Q/K_P 8-$U?P=^R]\ /@/X)_: ^
M'6B>&;FPT/\ :$^/'[)7@_QGX5_9;^,XDN9GFTZ?X6M\3?%^J16^IF[NKNZ\
M/?#<,Q7PTF/1/^"7W_!)_P 4_L#?$G6O%OB[X@>"?B':^&/@_JWP#^&/B?1#
M\48O'GB?P)K'Q=U3XM7>N_%#3_$GC/4/A]I'B#[=-IMK)IG@[PU>"?6O^$D\
M3Q>)[*/Q1?>'8P#]*-1_;,_9!T?3_$NK:K^U1^SGIVE>#-?TWPIXPU.\^-GP
MVM]/\*^*-8EU:'2_#?B.]E\2K;:)KU_)H&NBVTC4Y;;4)%T;59%M_+TZ[:'C
MKW]O']F/0OB;\<?AGXW^)&A?#8_L_>'?@CXF\<?$#XD:WX9\&?"R[L?V@[+Q
M3?\ PUMO#'CC6==M].UK4]3B\'ZJLMB$MI6E>Q33SJ'VG,?Y(>/?^"'_ (NN
M?@C^S_X<^'OQ!^$L'Q9^"WQ\_;/^+7B-]:T+QOX5^'WQ>TO]L'7/B>+AO&FJ
M?#[5-.\?/XP^&WA?QUI>F:-J37=[::S86/B+PG*-*T/Q$MYIO2:__P $=OC7
MX<D>#X+_ !R^&NC>&E\&_L!_#:[\'>(_#/CF./Q!X"_8]^%_Q3^'6OZ+%X^3
MQ%XD^)G@";7[[Q[HGB;PMKWA3Q1<>-K>S\+S>$-:\9O8:Y?:J #]%?%/_!3#
M]D/0O'GCGX7:!\3=&^)'Q!\ _";X0_&_5/#G@#7O!VH)JWPU^-WCD>!/ _B#
MPMXDUOQ1H'@_Q&DEY)::[JL.F^(99-/\,ZKX>U,^;+XH\-VFJ_4+_'SX%QV=
MCJ,GQH^%$>GZI?>.],TV^D^(GA!+2_U/X6PZE<?$W3K.Y;6!#<WWPY@T;6)O
M'EI"[W'A"/2M2?Q!'IRV-R8OYVO"7_!!KXS^#_A/<_"*R^-/P,O-.\2?L9_L
MO?LT^*?%,WP]\66_B.Q\6?LL?MB>+_VCO#_BKPP1JET#X9\=^$/&+^$O$FCZ
MO>3ZOI>L>&_#LUKJFJZ9;[8?=?CQ_P $,[;XV_$']O76!\=&\*_#G]IKX8?$
MS2_@!X#M/"YO[/\ 9X^,G[2%Q\/M:_:J^)13[?8IKMI\:O$7PB\$S:OIEA<:
M7=KI7B+XE6/VV.7Q*]RP!^Y?PU^*OPQ^,WA2T\=_"'XB>!_BEX)O[F[L[+Q=
M\/?%6A^,O#5U>:?*;>_LX-;\/7VH:;)=V,X,%[;+<F>UF!BGCCD!6N^K\]?^
M"=O['7B;]D/P)\6X_'M_X'O/B'\;OB]>?%?QE%\-]4^)^K^$+2]7P=X1\#:<
ML.H_%7Q+KNNZMK4VD>#[*;5]9MM.\*V=TK6.GC0GDTEM8U3]"J "BBB@ HHH
MH *\@^./QM\&? #P!<_$#QK#KVI6SZWX;\)>'?"_A'26\0>-/'/C?QIK=EX;
M\'^"/!F@I-;'5_$OB77-1M+"PMY;JSL;9'GU+5]0TW1['4-1M?7Z^:?VI_@'
M?_'_ , ^&-.\,^*++P5\2?A=\4? /QN^$GBK6-&F\2>'=*^(WPWU5[_2K?Q7
MX<M]2T:ZUOPIXBTN[UKPIXBM+#5]+U2'2=>NM1T;4+35[*PG0 P_"W[7?@P6
M?C"3XZ^$/%_[)MWX*E\-_P!HM^T->>!O#/A76;;QBFM2^'+CP?\ $KP_XQ\3
M?#?Q5=7/_"/ZO;:GX?TSQ2WBK0;^R:'5]"MK6]TB^U/U2U_:"^ ][=>.K*T^
M-/PIN+OX7VDVH?$F"+X@^%'?P%I]L[QW5_XPQJV/#EE:31R07=WJYM+>UN(I
M;>XDCFC=%_.?PI_P3[^+6N?'2Q^/OQ<\7?"W3;S_ (77\+_BOJGPD\!W7Q:\
M9_#B?5OA]I'QD@U'QU9R_%?Q'J*:3\1/$^I_%+3K>&+PKX5\)>'- \/^$;"U
M\K6=1DCOK;ROPM_P2K^+7@7P_P"+M \)_%SP=#J.A^ _BEX%^$'CS7[KXI^+
M?$%UIOQ8^-7A/XM^([?Q7X3\3>)=5^&O@1[NQ\+?\(W?ZQX)\*>(-2D\1W]O
M\3-$7PYJVC0Z%>@'Z2VW[:W[+.H>-/A[X%T?XX?#G7M5^)_A;XK>,O"=_H7B
M[P_JOAVXT'X)KH<GQ*N;[7[34I--TZ;PS#KUO<:A:W,RSVUK8ZS=726]OI-]
M)%VT'[3/[.=SX:T'QE!\>?@[+X3\4^(E\'^&O$:_$GP?_8WB#Q:UQ;6H\,:+
MJ!U<6NI^(//O+2,Z-92S:B#=6Y-L%FC9OR/O/^"2_P 6?$'A_P")FAZ[\8_!
MMH/C+J'[3C>+;V!_B=XJUSP]IOQY\!_LT6.C#3?%OBKQ(_B;Q?J>B>-?V<+2
MT\6W6M7^A0^)_!'C+5DTB'PMJ%A9V#?2GP1_8#\1^"OBEX"^,'CO4_ 5SXBT
M'XR>//BQXBTG3M6^*/Q&-U=:]^SYI'P%\.2V7C/XN:_K.N7&OV%AI)O;S4H=
M,\.6D&C36GARWL+V736US4 #Z"^*G[>W[,GP:^).L_"GQ[\0;#2/&'AC5O@O
MIGB^WN+K2K*P\'6_QYN_&-GX"UWQ+J.JZGIUMIGA]IO!6H#6M2=G72AJGAP2
M1RR:[9(_J]W^TW^SA8VG@"_O?CY\&K6Q^*L=M<?#.]N/B9X-BM/']O>7L&FV
MEQX.N'UE8?$5M<ZG<VNE07&E/=0RZI=6FFH[7UU!;R?+/QA_8O\ &7Q,_:?M
M/C';^*O T7@";Q5^R7XYU70-8T/4[SQ0FO\ [,'BGXQ:O'9V4JR/HEQIWB.Q
M^*EO<V5[<I!?Z#KGAN">..[CN(9;+Y+^+?\ P2U^.7CCP;J_PU\-_&CP!I/@
M7Q!9_$T2::VF>,O#,7A[5/&?[4_Q!_:&L[R6Q\$WNDS_ !)TZ;1O%^C^$1X5
M\9:Y;>$/!VM:%=>+=(\/Z]+K=YIR@'Z^^&/C;\&O&OC/7OASX-^+'PW\6>/_
M  M;7%YXE\$>&_&_AO6_%F@6MGJ/]CWMQK'A_3=2N=5TZ*QU;;I=^]W:Q+9:
MB\5E=&&YECC?YOU3]O?X1Z3XR^/?AN[\+_$0^&/V:K?Q3+\6_BG!#\/I_!&B
M7/@[P/HGCG7=/L=%3XAGXKZU<00>(M*\-07.F_#.?2KOQC.^@P:B\D4DR\W\
M'OV+M3^&'Q&^"WCQO$7A65OAGK7[<VKZ[%I6@S6%]XB/[77QLT?XLZ5&MZ&1
MC)X7BTL6&ORWPF_MK41;7]N(A BKX'\>/^":_BO]H'QWXS;6M9^ /PY\):GX
MF^+_ (XT7XH?"GX1MX5_:$\2ZE\4/ACKOP^T[P3\6]5L[RVT3QIX.\/7^O6W
MB?Q-J-SJ$VI_$N7P3X!L=2TWP[<Z+-K-V >W:Q_P4C^%/AB&:R\8_#3XR^"_
M&FB^)Y=&\;_#GQ+HGA"W\8>!_#T7A?PIXS/CO54TWQKJFA:MX>F\-^-O#MW9
MV'A77->\57E^^L:';^'Y-:\.ZW8V7V?\./B/H_Q0TG6]?\.V>I1Z%I?C'Q3X
M/T[5KZ.WCM?$S^#]5F\/ZOKV@F"YN&N/#\FOV.K:;IM_,(#J2:9)J-K$^GW5
ME<7'Q#IW['GQ*\3Z=^T!X^^*^H_!:]_:#^.>M_#)])UG0/"NJZWX$^#>G?#+
MPU'X'T3Q5X 3QE%=Z^_Q(L-+UGQQXOT;6IDT^+3_ !+K&BZ&\UQI.BS:MJ7?
M?LO_ +,GQ(^ ?Q#^)]YJGQ(.N?"C5;1-%^&W@F'7/%NJ_P!EZ-9^*?$6I^%Y
M+[2?$-Q+X?\ !UYX&\":CX<^%5A:>!U%CXLTKPI;>+_$SCQ#?2P0 '2_&G]N
MG]F+X)?#+XS_ !-U?XL>"/%MO\!X+)/B#X3\#>-O!6M>,=*US5M?A\):#X8O
M-,F\1V%KHVLZWXLN(O#=J/$=_HUA;:JEW#J5[9+IU^]M]0>&-:/B3PUX>\1&
MQDTPZ]H>DZR=-EO=+U*73SJEA;WQLI=0T2]U/1;^2T,_D/>Z1J.H:7=-&9["
M]NK22*=_QYL_^"97Q4N?!N@_#G7/B-\);3PY\'OA!XE^"?PAUSPUX,UZS\5^
M-O#WC#XV_";XKZGXG^-LEUJ#V<FO:?9?"6SL[;2O#K7^GZKXR\4>)_'%W?V4
MES;Z-#^T*J%55  "J%  P %P  !P !T'X"@!U%%% !1110 4444 %%%% !11
M10!^?6H?\?\ ?_\ 7[=_^E$E8FK:1I'B#3+W1/$&CZ3X@T35(#:ZGHFO:78Z
MUHVIVS,K-;:CI6IV]UI]_;EU1S!=6\T6]$?9N52-O4/^/^__ .OV[_\ 2B2O
M+_BOIGC_ %GP#KND_#'4K#1?&.HQP6EAJNHW,MG'86LDH_M":WNH;>Z>"^:U
M#P6DPA;R7E,RLDD:,.@YSI%\#>#[;4= UN/P-X0M]8\*Z:=%\*:U'X1T&#5O
M"VBF)H/[&\+ZHFFI?>'M(\AW@&F:-<65B())(A;B.1U-V'0?#T"Q11>&_#8M
MXK6'3X[3_A']'-F-,M[T:C!I)M/L7V<Z3%J(&H1Z7Y?V!+__ $U+=;H^;7YR
M^-/!NM_L]^+/@G<>$/B1XR\0?$/QCKUAI_B[PWJVMS:QI^MV]Q+90ZC/#ISX
M>/2Y;JXN[*%[H3R2",7L,T4UM*$_2C4+9;NUO[(2R0+=VUW9B>%OWUN+F&2#
MSH'!&)81)YD3Y'SJK\535K:W3_3^M&!Y3\-_V??A-\*O!FH> _"/P]\.IX?U
MLZU_PE UCP_HVLZEXTCU[7=:\17UOXXU.\TQKGQC:)J&OZHEE:^(CJ,-E8S)
M8P(L$84]UIW@KP;HMK]AT?P3X.T:RCL9],-EI/A+P_I5FNEW<-K:W>F-:V.F
MV]N--O;:RL;:\L&C%G>6]C8V]Q#+%9VJ1?G5\:O@H?AAIOAK3O#WQ?\ BWXG
M\?\ CC7;7P_X.\.7.M"&"[F:6);W4+^2WF\^.PLDEC1FCP6FF3++''*1WGQ.
M\-P>!)?V=? 'Q0\7:U=_"VRTOQ@OCGQ)<ZKJUC::GXR6PN;S2TU;5+&87?V:
M&ZG$6C)<W#%XT7=EO,VBBM+/=/IV[+\MOO ^U-4\"^!M;AM[/7? G@C6[:RU
M6WUVTM-:\'>&]5MK/7K2WAM+77+:VU'3+B&UUJUL[>WM+;5XD34+>SM[>UBN
M4MX(HTM6OA;PI8Z]J?BRP\+>%K+Q7KD$-KK?BRP\/:+:^)]<M;81K;VNL^)+
M6RCUC5K>W$,(A@O[ZYBA$, 15\F,)\(>%O%OCK5?V>OAM\+[;4-6_P"$Z^,'
MB+Q!X7\.ZIJ$EP=9TWX666IROJ/B>XFF_P!+$5MH2O9:?=RG>ZRJ4<F-"/OK
M1="L?#&BZ1X>TR&2#3=%TVSTRP28R/*;:RA2".2620EY9I0AEFD9F9Y7=F.3
MPFK=>K7R77^O,#2KZ^^#G_(BV/\ U_:I_P"ELM?(-?7WP<_Y$6Q_Z_M4_P#2
MV6LY[+U_1E0^)?/\C\G/VH?BA\6/A5^VS\4=2^%_Q"\<:9XWUKX2_L7Z=\*O
M@C:_#8^*/ _[06O7'QP^,^E>/_#FI>++_P +:NF@#2/!.JM+KMQX5\2>#M5\
M&:?<V?Q \2WNHZ#I<5FN)J7[:7[4&M#3O"?@;6M0E^*7PFT']MKQ[\=?#FH?
M!Z:TTR:+]GS]HSP,_P *_AMJNO:CX;MM%T'5OBA\ #XMTSPE=Z!J#7_B"/4M
M/\=Q/+!;VM]+^Z%</\2/AQX+^+O@?Q'\-OB)HH\1^"?%UBNF>)-">_U33(=7
MTT7,%U)I]U=Z-?:=J'V*YDMXX[ZUCNXX-0LVGL+U+BQN;FWER-C\$OB-^VO^
MW%J=E\*?B!X+U=/ ?@3XY?";Q3^T!\!CXC\#M%%XLO?&OQ5EM_@?\"_%FE:1
M\&_BGXG\1ZE9? W_ (0;Q3XF\%>&[CP!\3=6UOXE^(+G3?%;6_@J*WTOW_Q.
M?VB+_P""7Q;_ &N_%'Q>UWP[\;_AQ\3_ (]?#;X0Z3K'@6;3?AG\(OA9=_M%
M:9X$UF*32/!_PT\9>)M=FUSX?^ -&DA^-'Q \)?$C1O [SR_$*3P@/"L.M6-
MU^SME96>FV=II^GVEM86%A:P65C8V4$5K9V5G:Q)!;6EI;0)'#;VUO#''#!!
M"B10Q1I'&BHH LT ?E!I7[0O[0?B7_@G:_Q2\*:CXZT_XU2_$_PQ\.]-\8^*
MO G@WQ7JUWHFJ_M.^&/ACJ?CKP[IGA;P_H/@OXA^%%^'^K:EJOA/Q[;^"O"6
MF^)]&M+7QCJ'A/0O,NK*+YRUG]H;]M'X.-XWU[Q+\3?B[\4/#.C:]^W;\-K:
MPM?@!\.;[Q!I^B_ C3--U/X)_%+3K;P[X0\)P:_XWU"XN+^WUFZO[[3_ (;^
M+=&_TVS\'V5SH=Q<:E^]E% '\]'PO_:$_;)^-?B;Q-\+;OXI^,(/AIIGB3XV
MW[^/M'\">#?&.M>/? 6A?LV?!OQSX=\%6WQ('P3^&W@W4M+O_B-XV\::4OC'
MP-\/]-O[ZUTV]\)Z#XHO]3T<>)+?@?AC^U%^W!X*_9=^ 7A7QJFH_"'Q!I&M
M_!SPC\5=26P@@\._"7]GN[_9DO=?^"GB[P_\4O&/P=^)IU;4/C!XQT"U\._%
M/Q;X[\":K+X)^*5GXE^&-OI'A5'\.>*=9_I5HH _(7_@GOXU^./BWXY?'#7_
M (\^-/$VI^-?&_[-?['WCVP\"R>'=7\+_#6*670_B7HWB'Q5\/+'Q1X&\*>(
M=)?7M3L-/N_%ND:C]FNM-UW5Y8KO0['3TT!(?FZ+]LSX[0?#KPG-KGQX^,$W
MQ4\=:KX+TCXV^%K?]GWP9\//!G[*'Q U"Z\<7FO_  \O?C%XJ^&?B+2?!>D2
MKHUOX*TF'Q9X*^-WC+7KK1M$U_0]3M3\0M.U%_Z"Z* /YM_#/[>G[6^M^%_A
MO'K'Q2U_2_C^?V;?@?X\\'_ *Q^ =MYW[0/Q;\1_M2_'KX3^+-'\;SZE\/['
M7?!^GZU\._AQX9GNM.T>+X63^&GU/5?B2MOIF@Z+>:/:_P!)%<K:>"/"=CXT
MUOXBVFA6,'C?Q)X<\.^$==\21JXU'4_#7A+4?$>K>&M'NG+^6]GHVH^+_$UW
M9*(U=)=:O2SL)%"]50 4444 %%%% !1110 4444 %%%% !7YA_\ !3W]ICXJ
M_LV>$?V:[CP#XYT;X)^"?BO^TQX:^%WQO_:2\0_#N;XH:/\  ;X=7_@3X@>)
M=.UZX\,&:+28)_'?Q!\->"_A19^)/$GFZ!H%SXX2YGA-_+IKQ_IY2$ C! (/
M4$9!_ T ?Q+_  +_ ."C?[?7P3_9Y_8J\$>!-:TF5/'GAG]I;XHZ1XU^-GA'
M7X-/_:@^,FH_\%(?BQ\/K7X%3WWC>74O'_@/0[3X;W>BZUI'A?P-I^M?%/0-
M,\9>&+V""X\'^#-5M;GV/]H__@I)^U'\6M?_ ."B'P.T;QGK]_\ "*__ &./
M^"FK>'-$C^%UK\+_ (K_  5^*7[,4FB^'/!FEZ#=>$-?USQY;3Z_8ZGKNH:?
MJ'Q"U"Q\3?$&SM=/\=^!?"WA3PZ\$%S_ &"%02I*@E3N4D E6(92RD\@[69<
MC!VLPZ$B@* 6( !8Y)  +' 7)]3M55R><*!P * /Q+_;F_:X_:F_8O\ V=OV
M2?C;\(O",WQ;\(>*?A])\%_&_P .H_"UYXA\;77QZ^*7PCLH_P!E/Q>-2CGA
MU&S\+GXVZ59> ?B3#=LR2V/Q#T_5Y9[231YGE^0=1_X*#_M@Z/\ MZ?#;]DW
MQ!\3=-\;:#_PD>H_LV_M'^''^"VA?#L6?C&U_87U[XU77QD^&>I6?B#5OB-=
M>'/$OQ@L+71_#/C?5[7PQ\.-3M=0E\!>%_#FL>)-%O\ Q.G].E-VC); W$ %
ML#)"EBH)X)"EB0.@+''4T ?Q\?LT?\%-?VF?@7^R]\!?@MK'B55\?7?[+W_!
M#;4?@+IOCOP'XG\2^.?B3IO[17Q$\.?#S]L_Q'J'B+4([G_A(F\,:&UU;7^N
M:U>VO_"":[<V4U]+<7NH6<-S^@7_  2]_;^_;(_:B_:L^+/PZ^.5IX*LO"^C
M:'\;=5\7_"M?#\'AGQ_^S1XK\ _M 7WPV^&G@V7[!'=ZEK&C>./A_;SZWJ\W
MQ/N=,\6:MK=E;>+O -K<_#W5'BT_^@; R&P-P! .!D D$@'J 2JDCH2!GH*0
M*H+$* 7(9B  68!5!8CEB%55!.?E4#H * '4444 %%%% !1110 4444 %%%%
M '\[>O?M5_'OX/?$K]KG3/A+\4X_B3XU3]I;]J:&']F:_P# %SX@\1> /A]X
M7_9=;XC^'OC78:F9)/%%WX=TGXD>'O#6B6=A"A\ >)AXV/@/0[0>.8UNG]>\
M5?\ !3'QCHK?&'XY>#]3T3XK?LT_ GQ9^S_HWBH^"_"]Q?R^)=-^.'P)U7R)
M?"?BBW#C6[G1?VB]:^%^BZLVC1ZA!I.DZSXHT74A#JNA3Q6G[B[5W;]HW$!2
MV!N*@DA2<9V@DD#. 23W->;_ !$^$G@+XKQ>$+;QYH]SK6G^"/&FA?$#1-'7
M6]<TO19O%/ABX:^\.WGB#1](U*QTWQ79:-JPMM=L-%\2VVK:+#KVG:5K/]GM
MJ.F6-Q  ?BQX=_;)_;GT3X[WOPM^)%[\,[?Q)X.\07/@OQ-X!9_"^F7OBCPG
MI?[-1^).K_&[P3X-LM,U7XH:G$_Q-%W;:+XADO=/^#4_AG2KKP;?7<'CMH[Z
M7T_QMXL^._PZ_9)^"O[7&J_%_P *M^T9\6/#'P1T'QWXT\4:;H_PL\(Z+\.O
M'[W/Q'U3P#X/M-=TWQ%\)O ?B72=9UF30_"OQ ^-]I+HUS$D6@>)O$%AK6LZ
M;=#]GMB;]^Q=^TIOVC=L)!*[L9VD@$KG&0#CO2LJNK(ZJZ.I5E8!E96!#*RD
M$%2#@@Y!!((Q0!^7>K_M(_&OQE^R-^QOX]^'?B'5?"?CS]H?XK_!?X;^*_&?
MBWX1:9;Z[H^A>+Y]>L_%GBF'X=)X@\1^%]-O;I-%^V^'M337M>\&R17MAKUD
M=5T"\MK.X^*HOVX_VM/ /@_PEK/Q2^*D6IQ?%GP5XHM['6]+^!_@WPG:_#3Q
M3\/?VN?#GP!MM8O==\5>)=-\#^%-,^(O@?6;G7/$WC#XJ:C>^"/ WB:"UUS1
MM"OM NH?",W]#=-95=61U5T=2K*P#*RL"&5E((*D'!!R""01B@#^;;6?VK/V
MN?CY^S9\5+"^\?/H-GX0_93_ ."@/BKQ9>>$/ ^GCQ1\5M8^#WQD\7_!KX56
M.F>--.M=.T[PG-J_A--.\3WGB;X>Z1:IXAU1=.\2>#$L/#-TD-WK^-_^"@/[
M:/AWP[X8T;54\$?!KQ]I6A_'J\^)6D^+9O"6G>%? WQC^'9^'7_"I/V<K'QA
MXSLKX_%3PUXR\ >)[?XK1>(O ]J_Q7^,FA:Z+OX96/AN71=3\+:;_1I361'Q
MO16VLKKN4-AE.589!PRGD$<@\@@T ?DO\%_C!\>= \+?\%/_ !?=ZSJGQ0^,
MOPX\6V_CWX<? ;4M/NKRW\"R:E^Q]\(/'/A?P1X6@M++2/%6O^!M>\=2>)-.
MT7%II^H:Y>:/KCVL%GXEO]8BB^<_B3^W7\1?"7PXT&P\ _M?Z3\9=>\4ZIK5
MSI_Q3T+X'^ /A_X9TS6-)^#.F^,)_A;>?$3QQJLWPGU+73XFU2QU73O GA7P
MCXJ^,5]8W,_PVDLX?%>CZEXD7]]<#).!D@ G') R0">N 6. >F2>YIGE1X"^
M7'M$AE"[%P)"YD,@&,!S(3(7^]O);.XYH _ _P" /_!07X]_%?XB?"J*Z^)'
M@G4?&'B?X@_LG>%/$7[*.B?#22QUU/AS\:OV4?A=\8/BU\6Y=?OKB;QAI=M\
M-_%/B[Q/KMO>3FV\,Z+HWAU? /BB"[\6:WI=S!^^E<7X:^'O@WP=KOCOQ+X:
MT*VTK7/B;XBM/%GCK489;J6;Q!XBL/#'A_P;::G<K<3S102P^&?"V@Z4(K*.
MVMFBTV&5X6N7FFE[2@ HHHH **** "BBB@ HHHH **** /SZU#_C_O\ _K]N
M_P#THDKR+XS?$RW^$?P]UGQG)9'4[Z P:?H>F .5O];U!FBL8I_+!D6SA*R7
M5XR#?]G@=$(DD0UZ[J'_ !_W_P#U^W?_ *4251>.*4;98HIE!R%FBCE4'D?=
MD5ER,G!QD9;GFNCU.<_*KX(?%[X9Z?XPF^)7Q:N/'/B_XQ^(]1%E8W,?A;S]
M \*6UY,+&UATAY+^%4E:*41B>.VBBTNR8V]K&TK7%Q+^AFG?%7P]J7Q2UWX2
M066M)XC\/Z/%K=[?2VD:Z)+:2I9R+':W@F,DER!>Q;HV@4 K(-QVC/HGV2S!
M!%E9 CD$6=J"&'0@B'(([$=.:E$40<RB*(2L,-,(HQ,P_NM*%\QEX'RLQ' X
MX%4VGT?W_P!:+RL!\<::'\<?MIZ]<7T<DFF_!_P%#::-%*C&"+6-7BM/M%U$
MS*(S,6UFY964EP((P2#$F/L*[BL9K:5=2BLI;%$:>Y&H0P3V<<<"M*]Q.ERD
MD(6! \K2,O[M59@1R:E$<:NTBQQ+(_WY%BC61\=-\BJ'?'&-S'&T>E)+%%<1
M2V\\4<\$\;PSP3(LD,T,JE)8I8W!22*1&99$<%74E6!!(I-WMY)+[@/@36=2
M\4>+?!7QY_:1\-B\@NO^$=NO GP::SB9;O2? 6B:A%;>(/$VEQQJ6M[G6I?M
MEQ%/ H:.UMG,9"*#6Y^SEJ=E'\6?$'A_P'XHU;Q3\.Y/A/X+\0:S+>Z[?^([
M+3_']]'9'4!#?WTLYM-0NFEO?M>GQ2*(]CH8E%L-GVU:V=G8VL-A8V=K9V-O
M%Y%O8VMM#;V<$&"/(BM8D6&.$AF!B2,(0S J=QS!IVDZ3H\4D&D:5IFDPS2F
M>:'2["TT^*:=L[IIH[2&%9)3D_O'4M@D \D4^;1JV^VNW;_/U T*^OO@Y_R(
MMC_U_:I_Z6RU\@U]??!S_D1;'_K^U3_TMEK*>R]?T94/B7S_ "/4J***R-@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PZ?X&:-//-.VO:NK3S2S,
MJQ6&U3*[.5&;<G +8&3G YS47_"A]%_Z#^L?]^K#_P"1Z]VHJN>7?\$3R1[?
MBSPG_A0^B_\ 0?UC_OU8?_(]'_"A]%_Z#^L?]^K#_P"1Z]VHHYY=_P $')'M
M^+/"?^%#Z+_T']8_[]6'_P CT?\ "A]%_P"@_K'_ 'ZL/_D>O=J*.>7?\$')
M'M^+/"?^%#Z+_P!!_6/^_5A_\CT?\*'T7_H/ZQ_WZL/_ )'KW:BCGEW_  0<
MD>WXL\)_X4/HO_0?UC_OU8?_ "/7J7A3PW;^$]&AT:VN9[N&&:YF$]RL2RL;
MF9IF4B%43"EB%PH.,9R<UTE%#DWN_P $OR2&HI;(****D84444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFE^$SXGT)?$MWI+:I9B;D+[_ ()V_"6YM]&33_B'\9O#=[HFC-I=OJGAG7/
MNCW,MW>6?Q?TC7?$#V,/PZ;0K36O$?ASXY?$+PWJ8TG1]-T>UTZ^TR[T'2-%
MU_1-,UFWV;?_ ()]? 2V\'ZUX&AN/B"NA:]X)^)/@"^4^+=]V- ^*ES\*[KQ
M3Y-R^FLRWQE^#WA'^S[N196M@VK^:ERU^&@ /5/%7[5?P7\"?%*?X0^,O%UE
MHWC1X_#$FD:);0:MX@UK4T\2B[VW<^B^'=*U.]T71M.:&U6^\0ZN+70[;[?
MUU?VJ\MPGBO]N+X+> ?C%\2OA-X\O-5\)K\,-%\&WVK^*;[1/$E_9:KJGBW1
M-7\6W%CH.FZ'H.JWNHZ-X.\&Z9%XC\<>,$9?#WA2VU"WCURYL4CEN%Q/C_\
ML8_ #XJ>,=4^*7Q,\6^+/"U_J7_"'WNKS6/BGPYH>FB+X80ZI>Z/?:7?ZUX?
MU#5_!FIZ;;7^HW%YXP\#ZSX8\7V5@;J.V\1Z?ITM]%/UOQ1_8U^&?Q5\7^(_
MB!=>)_B5X0\9>*["?1-6\0^!_$FF:==2>%-5\'1^!O$WA*UAU?0->L+;1?%N
MA6VF/K$\-H-=M=4T;2=8\.ZUH6HV@N' .TL?VJO@#J?A?XA^-=.^(ME?^$OA
M;XO/@#QCXBL]&\37.DP^-?[8@\.IX7\/7D.BO%XXUJ;Q#=6N@6]CX'/B*:YU
MRZMM(MUEU"XAMG\RUK_@H+^R;I&G^)KNW^*'_"07?A7PGK'BW4M%\.^$_&>I
MZKLT;P;K?CZ?PLJ+X?BL[?X@S^%_#>O:A:_#W4;VQ\92?V-J\3Z-%)I.I+:=
M!<_L8?!.;X$ZC^SM!8:U9?#NZ\>W7Q*TF);ZPU'4O"OBQ_B3_P +6TNZT%]=
MTK5]*>R\/>+5A?2=)U[2=<TV32X%TK6;;5[26Z2XX.R_X)Y? :R\+ZQX6%_\
M0)(->\21>,-5U*/7=&TR_G\3Q_!_QC\%'U>"VT/PUI6@Z=+/X5\<:WJ,EGI>
MBV6F)XC6PU"WL8+2T&G2 &[HG[?G[,&JS:WI]Q\0TM=>T#4'L-2\.V/AOQMX
MCUBUN+OQ9K?A+P[I,UIH/A:^E'C+Q'>>']7N++X?0I/XSBM](U^631FMO#FM
MW-C[)=_M&_ ZQT71_$=S\2_#2Z%K_@+_ (6AHVJQ7$]Q9ZCX _MCPWX?/B>W
MEMK>4-IZZWXN\-Z8X;;<QW>K01/ I2?ROF>'_@FU\ HM"\5:7)K'Q(U#5_%O
MQ(\._%Z]\7ZSJ_A/7-=LOB/X<O?'5Y%XGT_3-8\%7W@@S:F/B3XQM-6TS4O"
M&HZ'/9ZJ(K73+-[.REM]+Q1^R9^SS\3[7P+\,M.^)WBK2K[X0> ;CX7ZAH/@
M'QWX3M=>U_P':>)OA[XGU/P[X_TT:#J<T%N?%7@OP??ZC=Z#8^%=2BDNKC2O
MMD&D:Y<:9< '4R_M[_LLM)I[6/Q6T&>QN/&.G>#;[4;^V\0:#;6MWJ\OC;3=
M,U+2SK&A6A\4:-=>)? /B3PP^M>'3?Z%9ZII6JI?ZK:KI-\(^HUK]M']E[P[
MK&O:%K7QA\.V%]X6_P"$M3Q+-)::\^D:!=>!XO%UQXDTS6?$$.D2:#INMVMM
MX"\9W5CH5WJ46LZY:^&M7N=!L=3@M'DKRQ/V#?V9]?O=-MEO_$^MS?#GPUJ'
MPRN=+3QG;78TZRUK3OBQJ,EAX@M[:R%S;:V-._:#\2:K822/97EO#-X2U*W0
M"PMY[KD-2_X)P_LIV=SH/A^YUKQ5I$_B3X8P_!^;2KGQ-X3DU_XG)X;^%_BW
MP-_PE>HZ[KGA>^\<:G\0K'P;XCUW6=8U+PSKVE:?J6HVL'B/Q%H>H26+2$ ]
MLT7]NC]ECQ#I>J:QH_Q0>\L='FTNSN\>!?B1!>S:QK=WH]GI?AK2M+N?!\&I
MZ[XPO)O$.AM'X-T2SU'Q4MKJMC?2Z.EE<1W!]3MOV@?@Y>?#[5OBM;^.]+?X
M<:)X;TSQ;J'C$V^J1Z(NA:Q:M=:=<VEU+8)_:=U/M-DVDZ8MYJ]OJ^W0[FQA
MUEEL#\S>/O\ @G%\!/B/XVU3XA>)-6^($OB>[?PW=:-=0WW@QX/#6J^$Y/#C
MZ'K$5I?^!KZ'QI=Z;%X;CL](M/BNOQ#T;PYI^L^);#PMI6AVFN7D3>Q6?[+O
MA.+X1ZU\"K[Q/XLO_AI=^'/"6@^';".71M*USP?>^$YH]6A\6:-K6D:/91GQ
M/>^*[>Q\6O+/IS:-9ZQI]M'9:+#IC3Z?( $G[8_[-%OX>U?Q3?\ Q7T?1]'\
M/7DFG>(7U_2_$OA_4- U&'PIXM\<3Z;KNB:WHEAKFCZE;^$_ ?B_7+BPU+3K
M:\@M-!O!-"DQABFS/"_[;W[+?C'6K3P[H7Q6M'UJ^URQ\,VEAJOA?QQX<DN/
M$NI>(O"'A6S\.1R>(_#.E0MK\NL_$#P.C:-YO]I0:=XN\.Z[/;1:%J]EJ4WC
M7B7]@#X(?$S7O%EMXJ^,?QL\9:W?HEU\3M)NOB/X8GNM=\0ZS\./BA\-]$\5
M>*+"P\(07/A_4+?X?_%/Q+IGAG1?#J^%_ \%MI?AR^L_"<EQH,-P_H7B_P#9
M&^!_Q"UN_L!XO\8:7XX\->,K'XM17/AGQ?HQ\4>"O%FLZI\-=5\-^*$TO4]'
MUFS@@;4O@)H$F@V_B+1M1T34A8^)[6XL]3M[FZ@M@">Q_;P_9QGNO'!U#QC-
MI>@>"_'5OX"'BTZ)KVK>'M7OO^$7\">(-4U@WF@Z5J7_  CGAO0;_P ?Z3X7
MU?7_ !:NA:1:Z[%-$U[]GDMYI4^''[=_[.WQ'L=9U6#Q>OA:PTCPK=^-7@\9
M6.I^']>7PYI*69UR^OM O;".[L'L&U+3&L[8275SKMGJ%O?Z+%>VOFO'XG>_
M\$LOV9;S27\'7WBSXN7<>K7/B#7]6M-3\;Z!JM_X@N]6LO 6D:SXA>VU?PG?
M1:9K,!\&^'A#XL\+6>A>(=*.JZMI-IK-KHNOSZ3)Z-IW_!.WX"V9THWNJ?$O
M7CHGQ2\#?%+3CK'BNS/EW/P[L]:TWPYX(NETS0M,35/AV=*UN32];\-ZJM])
MXAM-.TG^V]1OKFR%Q( >V:#^U9^SYXE\-_$GQ?HWQ-T:X\,_"+PUJ/C3X@:S
M/9ZWIUEHO@O2K?7;F\\9VKZEI5HWB#P>(_#'B);7Q3X:36-!U"?1-3M=/U"Z
MNK.>%/--1_;X_9K33#>^'?&5SXIO$U7PIIC:1%X?\2>'+TKXC\8>"_"&HS0R
M^,='\/V=W>>"F\>:!K7C;0+2XG\2>&M'NX;G5=)M3=6JS1>!/V#/@A\//AY\
M8OA;H,_B[_A#?C-\/]3^%FL64MUX8L[WPSX!U*S\4V/]@>%M6T/PGH^IR-90
M^,-6-GK?B^Z\7>(]R6 N]8NX[**.O,/'O[&/[(-O\1]:A\6_$+4/!GBOXZ^(
M;G7]&\%Q>._!OA#6;_QK>^(/!NOZYXB\!ZA%H=E\2Y]9UK7/!VC-<1+XJU73
M-/O-0U"/PWINBWNJ1,H!WWBK_@H?^S+X<BMWM_%FIZIYL^MV]_-+X1\9Z#8^
M&GT'3O"&NSOXNGUWPY97?AVVUGP_XUT75_!U]>Z?_9_C..>.W\.W5]+-%N]*
MU3]LK]F/1KK2[*_^+WAY;C5],\.:Y;BUM-=U&&U\/^+-,T36=#\2:W<Z=I-U
M;>'/#,^F>)O#=W=^)/$,VF:'I">(="76-0L)-7T]+CX^\&_L.?L5)H.L7/A/
MXW:[?Z/'\1O"NE^,]7T?XF?#.*RU7QGH&G^$O!^A>!O$K:#X4LM(AU?4K_P[
MX.N;JUM;;3?&7B7Q3!;7MWJE_=:YJ4>J]1I7[#/[%_C#Q!JGASP3XRFO/%OP
M^\:_$;5_&.E>'_&7@?Q?XCT>Q^*?C#0O%.M?#7Q!9^(O#_BN^\+^"=%O/!>@
M>%_!6G:1%X=U[P7X:\.KX3T+Q!96\6H02@'TG\7OVOO@K\%_'7A+X<>*O$);
MQ7XF\1>'M%U"VMK:Z&E>"]/\1Z/XMU^S\0^-?$TUO'X8\-V(T?P3X@U..PU7
M6;36K[3;"?4-.TVZLX9)A#:_MK?LQWD6ASQ_%"&*+7_$&F^%[9KWPIXZTTZ7
MK.MW?AFQT&#Q:FH>&+5_ UIXBN?&GA)?#>J^-%T#2?$4?B+2)]%OK^WOH)6P
M_C#^Q%\'?CAXPUCQ/XVU'QZ-)\6/HEQX^^'NC>(K/3_ ?Q"O_#OA'Q5X#T;4
M?%5D^C7.OFXM/"?B_4M'D@T+Q'H>G:A'9Z+<ZG8WM[H]E<Q^!:K_ ,$X?V5%
MNK:T\4?$7QM-?>";3PWX\U2TU/Q-\,-$%CHOA+Q9X8\3>'/%6HZ/I/P_T33?
M"UK9ZG\+[33+[QMX>T[PUJ_B72+'6]'\5^(==MA,ML ?4WA3]K;X,Z[\.O /
MQ$\0>(D\ P?$'X9:-\6--T+Q4DD>KVGA36=;\-^%XY9S81WEE<W5MXG\7^&=
M N;73[FZG34=;TQ!$8[R"1^47]NK]GJ[\>>!? FE>*+J_N_&OB6Z\'OJ%UHN
MM^'8_#OB2;3?#VI>$K'6-+\3:9H^N26WQ!C\2Z?'X+UK3M-O-!UHBXFMM3:W
M@EE3A(?A/^QCXD\*_LBZ-:_%?1M2T?X/Z[=:-^SY?:;\7M)AN_&^KZ;X>D\,
MW7AJXO-,O;?_ (3B?3+\^'_$ATJR1+K3?'OACP5K,:V^H:;903_.6B?L=?\
M!/CPE#<^)-,_:2N=.U?1?&GA32+?QXOQF^%MGJGA[XG^#;#3[7PK</+;>'+;
M0-1\=:>FA1:I?R^*-(UR]\37L&J:OXRBU]IM3F< _0G2OVJ_V>]<\9:'X!TC
MXG:)J'BGQ%>WFEZ59VUIK3V+ZQ9ZOXMT(Z%?:]_98\/Z1X@OM5\">,+71= U
M?5+'6?$'_".ZG/H5CJ-M!YQI^#OVK/@QXR^).L_"#3O%MC+\2-%\5^*/"EWX
M9TR+5==:RN?#%WK-M(^OZOI>E3:%X5N]1'AW6GTW2O$.IZ??WS:;>0V$=[)
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M/I&I6VG-;:B-E?VOOVSO!>@^,=4L/AMK7B;Q2OB#Q#XP^&/PE\8>"/&-Q?\
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M..W\8?\ "9:#XS\'Z&_Q(G6'6O!\VEO?:9#)+X)\'-??:OQ.^(WC+QG^R?\
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MB':R^%+E)=/BC\2SW%C;V$'BS78]+_9NB@#\6]+_ &)?C!\-X?AUXH\66O\
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M77?#.A?#_P '^(;'QEX_\37-O\1/BQXPDU[6[X:],-&\*0VL6FW&LZ_^@U%
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+ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "( -\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/&/[B^N?7M7-"G35-TZ;3FU;2]M]]BU&/*XQ>K.@T92NBV2L,$0)D'Z5>I
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
#/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !; ;$# 2(  A$! Q$!_\0
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M+[MDJ-L.&PP.T^]%F%T245$MS;N4"3Q,7SMPX.['7%2TK FGL%%%% PHHHH
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MT;6T,K5M,-[<VEP(DG$ =6A=RH8-CG(!Z;1Q21Z;<K#IBO*I>V=V=MQ. 4<
M#/7&X#GTJSJ&HI8F)-H>67.U6<(,#J23T'(_,4C:@R7%E$]LZ_:LC=O4A"%+
M8X// /M6J<^5(P<:?.WUTO\ A_P"EI^C75AJ0F^UB:$0%"&0!G8MG)/ZYI^I
M1:I="&)+:!K9D!GC^T%2S?W,[3\OY$^U6H=3BGU26QC1R8DW&3^$G."!ZD=Z
M-0OY+%&D6T>6*-#)(X8*%4>F>I]OUI\TW)-K47)35-I-V_KU*LT.I3ZI$TMM
M UE$RE%%P0=W=B-O..PSCOZ8GAM;BWO]0N56-Q</$44N1P%"G/'U-+<ZFUM,
MF^TD^SLZ1^=D?><@#"]2,D TL-_,^H"SEM#&QC,FX2!@!G S]>WT-)\UMM!I
M04MW>_\ 70D:V<ZO'=97RU@:,C/.2RG^AJ!X+ZW349;187GFD#1"1B%'R*IS
MQ[&E.J@ZB;2*'?M<([&15.2 > >6P",_UJ.+7(W:-W@=+:5G6*8D'<4!)RO4
M<*Q'T[4)3[#<J??J_P#(@33;S[+#(8HUNX+G[1\TQ;SB5*G<VT8X8XP,# J_
M86\\<MS<W(19;AP=B,2%4  #/<]\X[^U55UY%C#S6LD>^#SX1N#&1<@?@?F7
M\^M6[2^-Q<2VTT/DW$2J[)O#?*V<$$?0_E3ESV=T33]G=6?]?\,7****P.H*
M1RP1BJ[F X&<9-+2-NVG;C=CC/3- $=N\LEM&\\0AE907C#;MI[C/>J>KZ?+
M?1Q?9W5)58J6;_GFPVN/K@Y'N!5V#SO(C^T;/.VC?Y>=N>^,]JDJE)Q=T0XJ
M4>5G/IH=Q%9W*QM#Y\;+]B)SA$0Y13^9!QVI;?P\R">"616MS"4BQU5WP9&/
M_ @"/J:WZ*OVTS+ZO3[?U_7Z=C M='O8;E+F5HI';,\R!B \^"%P<<#:<?\
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M$\ Y&,#'/04[^W+=6E9@Y@14D\U$) 1AD,?0?X59;4K9<9<\SBW^Z?OGM_\
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MFECT8_VH+N3[,%C=G011%6)8$?,<GL3TZGFM>BG[21/L(7O8Q+?03&\LC_9
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M8( -SG)/U/>GT44+0 HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
